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INTRODUCTION 
 
We welcome you to this report and in this introduction describe the background and 
context of the conference that led to the enclosed reviews and recommendations.  
 
In 1994 ISPO convened a consensus conference on the lower limb orthotic 
management of cerebral palsy held at Duke University, USA. The conference 
considered the evidence for the use of lower limb orthoses in the physical 
management of children with cerebral palsy from the multidisciplinary perspective, 
which underlies the ethos of ISPO. The report of that conference, published the 
following year, became the society’s most successful publication. The report has been 
used by ISPO as the basis for a series of nine instructional courses held around the 
world to disseminate the key treatment principles and clinical practices that were 
recommended. 
 
There have been many developments in the understanding and management of 
cerebral palsy in recent years. The methods of assessment, classification and overall 
approach to treatment planning and coordination have become more sophisticated. 
New treatments have emerged; in addition research and experience with some 
established interventions has accumulated. This has resulted in changes in the ways in 
which orthoses are, and can be, used. New designs of orthoses have also become 
available. The need to measure the outcomes of all forms of treatment is now widely 
accepted. 
 
In 2007 the Executive Board of ISPO, mindful of its responsibility to ensure that 
orthotic practice keeps apace with advances in healthcare, resolved to convene a 
follow-up to the previous consensus conference. This conference would consider 
relevant recent research and contemporary thinking in the healthcare of people with 
cerebral palsy identifying the implications for orthotic research and clinical practice. 
The scope of the conference was additionally expanded to include consideration of the 
evidence regarding the management of the spine, hips and upper limbs. 
 
An international, multidisciplinary group of 24 health care professionals and research 
scientists, all of whom are recognised experts in this subject area, were invited to take 
part in the conference which was held in Wolfson College, Oxford in September 
2008. Twelve of the participants were asked to prepare and present review papers. 
Their topics included a global health perspective, the definition and classification of 
cerebral palsy, the classification of gait, and physiotherapy, occupational therapy, 
medical, surgical and orthotic management of cerebral palsy. The reviewers of 
specific treatment areas were asked to synthesise the best available published 
evidence and where possible to grade their recommendations according to the level of 
evidence on which they were based using the Oxford Centre for Evidence-based 
Medicine Levels of Evidence (in Appendix).  
 
At the conference, ten participants were nominated to each lead a plenary discussion 
session that followed the presentation of review papers. Participants were then 
separated into three smaller groups with the composition varying over the course of 
the conference. The small groups were used to explore gaps in the evidence and 
consider areas of controversy. In order to structure the discussion sessions, the 
organisers in consultation with the chairperson of each session devised a number of 
questions for the groups to address. Further plenary sessions were then held to hear 
the reports from each group and agree upon recommendations. The whole conference, 
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which lasted for three and a half days, was extremely rich in content and involved a 
great deal of hard work for everyone due to the huge amount of material which was 
covered.  
 
Following the conference a first draft of conclusions and recommendations resulting 
from the small group reports was formulated by the organisers. This was first 
submitted to a previously agreed representative nominal group of the participants for 
comments. After modification to take account of their suggestions, this document was 
supplemented by the addition of the principal conclusions and recommendations 
contained in the reviews. The resulting composite Conclusions and Recommendations 
from the conference were then submitted to all participants for final comment and 
approval.  
 
This Final Report contains further details of the organisation of the conference, the 
text of all the papers presented and the Conclusions and Recommendations. The 
presentations and plenary discussions were all video and/or audio recorded by our 
equally industrious media team. The material has been collated and made available by 
ISPO free of charge on the Internet. ISPO intend to use the report as an educational 
resource for further instructional courses and the information will be disseminated as 
widely as possible with the aim of improving the health care of people with cerebral 
palsy worldwide. 
 
The organisers would like to thank all the participants for their sustained efforts and 
commitment to their tasks, and their contributions to this report. 
 
 
David Condie    John Fisk   Chris Morris 
Glasgow, Scotland   S Carolina, USA  Oxford, England  
 
 
 
 
 
 
 
 
 
 
 
Copies of this Report can be obtained from 
International Society for Prosthetics & Orthotics 
Hans Knudsens Plads 1A, 2100 Copenhagen Ø, Denmark  
Telephone: +45 39 20 72 60  Fax: +45 39 20 75 01  
Email: ispo@ispoint.org  
Web: www.ispoint.org 
 
The Report can be downloaded free of charge from  
www.ispoint.org  
 
The presentations can be viewed at 
http://homepage.mac.com/eaglesmoon/CP_Consensus_Conference/Home.html  
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CONCLUSIONS AND RECOMMENDATIONS 
 
The following Conclusions and Recommendations are are drawn from the Review 
papers presented at the meeting and the subsequent Discussion sessions. Further 
details relating to each topic can be found in the relevant Reviews.  
 
Despite improvements in the way people with cerebral palsy can be defined, classified 
and described, and the better quality of research methodologies generally employed in 
recent studies, it is apparent that the evidence for most interventions remains at a 
weak level or is inconclusive. Therefore, when producing this list, we found it 
difficult it distinguish evidence-based conclusions from opinion and consensus views. 
A caveat to many of the statements is that, in the absence of solid evidence, the 
statements reflect the best current practice based on the participants’ knowledge and 
experience. 
 
 
1. OVERARCHING THEMES 
 
1.1 An important overarching goal of improving the health of disabled people is to 
enable culturally-appropriate ‘activities and participation’ as defined in the World 
Health Organisation’s International Classification of Functioning, Disability and 
Health (ICF). ‘Participation’ in this context can be considered synonymous with the 
term ‘social inclusion’ often used in policymaking. The ICF is referred to through the 
report and it is recommended that readers familiarise themselves with the basic 
concepts; for further information see www.who.int/classifications/icf/en  
 
1.2 It is believed that there are significant unmet needs for disabled people worldwide, 
and particularly in low/middle income countries where health service infrastructure, 
education and public awareness are lacking. 
 
1.3 From a global health perspective, the appropriate means of promoting the 
participation/social inclusion of disabled people is dependent on local needs (both 
country and region-specific) and the availability of resources.  
 
1.4 From an individual perspective social inclusion will be influenced by child and 
family needs, priorities and preferences. A ‘family-centred’ approach in delivering 
health services is likely to improve the wellbeing of children and their parents, and 
parental wellbeing is believed to be associated with improved outcomes for the child. 
 
1.5 Transition from childhood to adulthood for disabled people needs to be supported 
by appropriate planning and coordination by the health, education and social services 
(including attention to housing, vocational and recreational opportunities). 
 
1.6 The aim of health care for people with cerebral palsy is to enable activities and 
participation by promoting efficient movement, limiting deformity, reducing pain, and 
employing cognitive and/or behavioural strategies. These objectives may sometimes 
conflict, for instance when strategies to limit deformity temporarily hinder activities. 
Thus, the rationale for any intervention should be shared with the individual with 
cerebral palsy and the family to enable them to make an informed decision with the 
professionals, to prioritise goals and to plan management regimens. 
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1.7 In addition to neurological and musculoskeletal problems, children with cerebral 
palsy may require care for multiple impairments of sensation, perception, cognition, 
communication, and behavioural problems, epilepsy, difficulties with sleeping, 
drooling and feeding.  
 
1.8 Health care for people with cerebral palsy requires the skills and input from a 
variety of professions who must work efficiently and collaboratively with the family 
as a team. Each professional, and the teams involved in managing different issues 
(e.g. orthopaedic, epilepsy, feeding etc) must understand the range of problems 
associated with the condition as well as the family goals and priorities. 
 
1.9 When a child needs to receive many health services there is the potential for stress 
and other undesirable impacts on the wellbeing of both the child and the family. 
 
1.10 Efficient co-ordination of health services is therefore crucial to minimise such 
adverse effects on the family. This issue is particularly pertinent at the times of 
transition, for example between primary and senior school, and from teenager to 
young adult. 
 
1.11 Differences exist across countries, settings and health care systems in efforts 
made to co-ordinate services. There are examples of good practice such as Key 
Workers and much can be learned and shared between models of good practice. (A 
key worker is a named person who liaises with the family and professionals about the 
disabled child, and who ensures access to services and coordination of care). 
 
1.12 For children attending multiple services including hospital and community-based 
health professionals, and/or education and social services, it is desirable to have a 
designated health or other professional to ensure information is exchanged efficiently 
and disseminated appropriately. 
 
1.13 Within each service or multidisciplinary team (e.g. musculoskeletal, feeding, 
epilepsy, etc.) one health professional (e.g., a therapist or nurse) should be the 
designated point of contact for families to provide information, and liaise with other 
team members as appropriate. 
 
1.14 Where appropriate, copies of letters and reports should be sent to the family to 
facilitate communication, understanding of treatment goals and the need for 
interventions.  
 
1.15 The KIT® and YouthKIT® (Keeping it Together and KIT for Youth, which are 
methods for organising such information have been shown to empower families 
(available from CanChild Centre for Childhood Disability Research 
www.canchild.ca). 
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2. DEFINITION AND CLASSIFICATION OF CEREBRAL PALSY 
 
2.1 Although there are various definitions of ‘cerebral palsy’ used in epidemiology 
and clinical practice, for the purposes of generalising the conclusions and 
recommendations of this report, the consensus amongst participants was to adopt the 
definition reported by Rosenbaum et al. (2007): 
 
“Cerebral palsy (CP) describes a group of permanent disorders of the 
development of movement and posture, causing activity limitation, that are 
attributed to non-progressive disturbances that occurred in the developing 
fetal or infant brain. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, perception, cognition, 
communication, and behaviour, by epilepsy, and by secondary musculoskeletal 
problems.” 
 
2.2 Further classification of such a heterogeneous condition (i.e., classification of 
subtypes) is fundamental in research and clinical practice for communicating clearly 
the type and severity of the condition. 
 
2.3 Classification of the type and distribution of motor impairment is recommended 
using the system advocated by the Surveillance of Cerebral Palsy in Europe (SCPE). 
The predominant types of motor impairment are spastic, dyskinetic (dystonia and 
choreoathetosis) and ataxic. The spastic type can be further classified according to the 
distribution as either unilateral or bilateral.  
 
2.4 The terms hemiplegia, diplegia and quadriplegia are also commonly used to 
describe distribution in spastic cerebral palsy for unilateral involvement, lower limbs 
more affected than upper limbs, and total body (4-limb) involvement, respectively. 
However, while these terms are conceptually useful they are clinically imprecise as 
they lack reliability among observers. 
 
2.5 When describing individuals or groups it is important to record associated 
impairments such as difficulties with (or impairments in) sensation, perception 
(hearing or vision), cognition, communication, behavioural problems, epilepsy, and 
musculoskeletal problems. Limitations in feeding and sleeping should also be 
recorded. 
 
2.6 It is recommended that function be classified using valid and reliable systems such 
as the Gross Motor Function Classification System (GMFCS), Manual Ability 
Classification System (MACS), cognitive function in terms of Intelligence Quotient 
(e.g. IQ </>70), and other such systems as they become available. 
 
2.7 The classification of gait is useful in the education of health professionals, for 
research and as part of a comprehensive clinical evaluation for children who can walk. 
Gait classifications have focused on children with spastic cerebral palsy 
predominantly in the sagittal plane and, although acceptable reliability has been 
shown, not all children can be classified in this way. 
 
2.8 The qualitative classifications of gait in the sagittal plane proposed by 
Winters/Gage/Hicks for hemiplegia, and the Sutherland/Davids and Melbourne 
classification of sagittal gait patterns in spastic diplegia, provide the best available 
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starting points for clinically relevant classification of sagittal gait patterns (for further 
details see Davis paper page ). 
 
2.9 Improving the utility of gait classification systems is likely to require inclusion of 
the coronal, transverse and sagittal plane kinematics and the incorporation of other 
assessed parameters such as kinetics, EMG, clinical examination etc. 
 
2.10 Longitudinal analyses of gait are desirable because of the tendency for gait 
patterns to change over time, and especially during growth. 
 
2.11 Instrumented gait analysis is an important tool for teaching health professionals 
about gait, and can be helpful both in determining treatment options and in explaining 
them to patients and families. 
 
2.12 Subject to the availability of resources and skilled personnel, instrumented gait 
analysis is desirable for assessing complex clinical problems to aid decision-making, 
in particular when considering orthopaedic and/or neurosurgical intervention and to 
evaluate the outcomes of intervention. 
 
2.13 Instrumented gait analysis requires trained experts to minimize the potential 
sources of error in the process of gathering, analysing and interpreting the data.  
 
2.14 In clinical settings where instrumented gait analysis is unavailable, observational 
analysis, with or without the use of video recording, is an acceptable alternative for 
the assessment and understanding of gait problems. 
 
2.15 Observational gait analysis should be structured to consider the stages of the gait 
cycle, each of the hip, knee and ankle joints, and all three planes. An appreciation and 
understanding of basic biomechanical principles is essential. 
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3. RESEARCH DESIGN 
 
3.1 There are key generic issues that are relevant to designing research studies to 
evaluate the effectiveness of interventions for people with cerebral palsy. 
 
3.2 Randomised controlled trials (RCTs) are the gold standard research methodology 
for evaluating discrete interventions for both their efficacy and effectiveness. 
 
3.3 RCTs are feasible for cerebral palsy research to evaluate discrete specific 
interventions provided the study uses a valid primary outcome measure in a well 
defined group of children and the appropriate sample size calculations have been 
performed and are realistically achievable. The intervention must be described in 
sufficient detail to allow replication. 
 
3.4 RCTs are ethical if there is consensual equipoise (uncertainty) about the effect of 
the intervention and the study design will substantially address that uncertainty. 
 
3.5 Blinding of researchers measuring outcomes to the mode of intervention is 
necessary whenever feasible; blinding of participants to the intervention is also 
desirable but may not be possible depending on the intervention being evaluated. 
 
3.6 Well designed single-case studies, within-subject crossover studies, and ‘Clinical 
Practice Improvement’ studies (i.e. comprehensive data collection and analyses of 
patients, processes and outcomes in routine clinical practice) are credible alternatives 
when RCTs are not feasible, or as pilot studies to inform the design of a subsequent 
RCT. 
 
3.7 The primary outcome measure should be directly related to the hypothesised 
benefits of the intervention. Any measure chosen must be known to be reliable and 
valid, and be able to detect relevant change in the phenomenon being evaluated. 
 
3.8 There is increasing interest in finding out which interventions improve activities 
and participation (as defined in the ICF), in addition to addressing impairments at the 
body functions and structures level, such as range of joint motion and muscle strength. 
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4. PHYSIOTHERAPY 
 
Physiotherapy interventions 
 
4.1 While there is some evidence that particular physiotherapy techniques for children 
with cerebral palsy are effective, evidence for other techniques is not consistent.  
 
4.2 There is consensus that the following interventions are not recommended: 
? An exercise program comprised primarily of passive stretching delivered 
by a therapist. Parents or patients can be instructed to carry out these 
exercises themselves.  
? Passive-reflexive (massage) techniques. 
? Therapeutic Electrical Stimulation (TES) to increase function. 
? Classical Bobath/neuro-developmental therapy (NDT) where the emphasis 
is on “normalization” of muscle tone through passive handling techniques 
such as the use of reflex inhibiting patterns. 
 
4.3 Emerging scientific evidence suggests that the following interventions can be 
recommended for clinical practice: 
? Exercise activities that include active participation of the child to attain 
functional goals. 
? Progressive Resistance Strength Training (PRST). 
? Use of assistive technology to promote mobility such as orthoses, 
wheelchairs, walkers or crutches. 
 
4.4 There is uncertainty about the efficacy and effectiveness of the following 
interventions which require systematic evaluation, preferably in a research context: 
? Partial Body Weight Supported Treadmill training 
? Robotic assisted walking (e.g. Lokomat®) 
? Night splinting 
 
Dosage 
 
4.5 The ‘dose’ of physiotherapy intervention (e.g., frequency, duration, etc.) is often 
decided following tradition and modified by economic considerations; the dose is 
seldom evidence-based and therefore the optimal dosage not known.  
 
4.6 Where possible, the dose should be based on known physiological principles and 
modified by the initial evidence of efficacy established in practice. 
 
4.7 Research is required to establish the optimum frequency, duration, intensity and 
timing of physiotherapy interventions. 
 
4.8 Despite the lack of evidence to support many interventions, there was broad 
consensus that parents generally value regular contact with therapists and the 
educational, emotional and technical or “hands on” support they provide. 
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5. OCCUPATIONAL THERAPY 
 
Seating/positional devices 
 
5.1 The Functional Sitting Position (FSP) is the optimum posture that a seating system 
should provide; the seat should be combined with foot rests, hip belt, and a cut-out 
tray as appropriate. The FSP is recommended to be determined for each individual. 
 
5.2 There is insufficient evidence that posterior tilting of the seat helps prevent 
deformity. In practice many children benefit of an upright/anteriorly tilted sitting 
positions for seeing, eating and using their upper limbs. 
 
5.3 Factors which must be considered when assessing the effectiveness of seating 
devices include the characteristics of the users (i.e. type of CP, GMFCS level, spinal 
alignment, hip status, Body Mass Index (BMI) and age). 
 
5.4 Outcomes assessed should address comfort/tolerance, ease of use and care-giving, 
achievement of posture appropriate for education, social function and use of upper 
limbs, and adverse outcomes such as hip subluxation/dislocation and scoliosis. 
 
5.5 Although the biomechanical effect of the device may be immediately apparent, 
follow-up at several intervals after provision is necessary to assess posture and 
function.  
 
Constraint-Induced Movement Therapy (CIMT) 
 
5.6 There is a growing body of evidence that CIMT can improve manual activity in 
children with unilateral involvement (hemiplegia) in MACS (Manual Ability 
Classification System) levels I & II; however the long-term effects have not yet been 
studied. 
 
5.7 For such children, CIMT is indicated when the child is motivated and the family is 
supportive of the intervention. 
 
5.8 The type of constraint (device or discouragement) seems not to influence the 
results. 
 
5.9 The intervention is probably dose-dependent in that its effectiveness might 
increases with the frequency and duration of therapy. 
 
5.10 Further research is required to understand how CIMT works (e.g. using brain 
function imaging) and for whom it works best (e.g., for what age, dosage of training 
other factors that might influence the result). 
 
Upper limb (including orthoses, splinting & casting) 
 
5.11 Due to the relatively poor quality of studies carried out to date, there is no good 
evidence to support claims that wrist hand orthoses (WHOs) prevent or correct 
deformities and improve manual ability over time; the effectiveness of WHOs should 
be evaluated in research studies both in isolation and in combination with CIMT and 
Botulinum neurotoxin A (BoNT-A) . 
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5.12 Given the lack of an adequate range of sizes of off-the-shelf devices for children, 
WHOs should generally be custom-made to achieve acceptable comfort and fit, and to 
optimise biomechanical efficacy. 
 
5.13 The results of studies that have evaluated periods of casting of the upper limb 
show some effect of increasing range of motion and decreasing spasticity in the short 
term. However it is not known whether these potential gains lead to improvements in 
activities and participation; or whether they can be sustained long term. 
 
5.14 Training that takes a functional, task-specific approach, with or without WHOs, 
may help to overcome activity limitations; this should be evaluated in future studies. 
 
Feeding Interventions 
 
5.15 There is moderate to weak evidence of the effectiveness of occupational therapy 
interventions that aim to improve feeding. Specifically, sensorimotor interventions 
may improve oral-motor skills, and positioning techniques may enhance oral-motor 
control. Future studies should address multi-modal approaches to promote growth and 
development. 
 
Virtual Reality (VR)  
 
5.16 Training using Virtual Reality (VR) is a new and emerging intervention that has 
shown promising, if preliminary, results on motor and visual-spatial skills, using a 
range of simulated situations. Therefore, VR may be a useful therapeutic intervention 
for children with cerebral palsy, and one that is similar to the games in which many 
children like to participate.  
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6. MEDICAL MANAGEMENT 
 
Life Expectancy 
 
6.1 Severity of impairment (particularly motor, but also cognitive and visual) is 
associated with decreased life-expectancy in people with cerebral palsy. Nevertheless, 
nearly all children with cerebral palsy become adults; consequently health care for 
people with cerebral palsy should be considered from a life-span perspective. 
 
Nutrition 
 
6.2 Gastrostomy, or other forms of parenteral feeding, can improve nutrition, increase 
body weight and improve growth in children in GMFCS levels IV and V that are 
unable to gain or maintain weight through feeding orally.   
 
Spasticity management 
 
6.3 Orally administered anti-spasticity medications can be used to decrease spasticity 
and improve comfort and well-being. Given the paucity of evidence, and the 
amenability of such pharmacological intervention to rigorous research, large 
randomised controlled trials are warranted using appropriate outcome measures. 
 
6.4 Focal management of spasticity with Botulinum neurotoxin A (BoNT-A) avoids 
the side effects associated with more global interventions for spasticity, although 
orally-administered medication may still be indicated. 
 
6.5 Botulinum neurotoxin A (BoNT-A) is useful for overcoming activity limitations 
caused by spasticity; BoNT-A is typically used in conjunction with orthoses and 
physical and/or occupational therapy. 
 
6.6 In GMFCS levels I, II & III treatment with BoNT-A can improve gait, limit 
progression of fixed deformity during growth, reduce intolerance to orthoses resulting 
from spasticity, and may delay the need for orthopaedic surgery.  
 
6.7 BoNT-A may be used in the upper limb to improve function and/or appearance. 
However, there is no evidence that BoNT-A is effective in improving bilateral hand 
function. Nevertheless,  in principle, the three months after injection would appear to 
be an ideal period for a therapist to provide training. It is recommended that the 
effectiveness of BoNT-A to improve manual ability be evaluated in research studies. 
 
6.8 In GMFCS levels IV and V, BoNT-A may be useful to improve posture and 
positioning, reduce pain, reduce drooling, improve hygiene, and ease caregiver 
burden. 
 
6.9 Intrathecal Baclofen (ITB) should be considered if hypertonia is severe and 
warrants aggressive management. Children using ITB should be followed closely for 
complications by an expert team. Functional gains and changes in quality of life and 
caregiver burden should be measured in controlled studies with consistent definitions 
and assessment tools.    
 
6.10 Selective Dorsal Rhizotomy is a well-researched treatment option that has been 
shown to improve gait and mobility for a defined group of children with bilateral 
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spastic cerebral palsy. Consideration must be given to the published criteria for 
identifying children likely to benefit.  
 
Weight-bearing programmes 
 
6.11 Weight-bearing programmes for children in GMFCS levels IV and V utilise a 
range of equipment to facilitate more upright posture in a variety of positions; some of 
these provide limited weight-bearing but encourage activity and experience in 
postures other than lying and sitting. 
 
6.12 There are many potential benefits from using weight-bearing programmes such 
as increasing bone density (and reducing the potential for osteopenia and fractures), 
and delaying progression of lower limb deformities and scoliosis, also possibly 
improving respiratory function (preventing aspiration) and bowel/bladder function 
(urinary drainage and reducing constipation). There are also potential social and 
behavioural benefits if the experience is enjoyed, and if the posture facilitates 
improved social interaction. 
 
6.13 Unfortunately, despite the wide range of potentially important benefits, no 
evidence is yet available from research studies to substantiate these outcomes and this 
is an important topic requiring further research to inform guidelines for clinical 
practice. 
 
6.14 There are potential harms from weight-bearing programmes including pain and 
fractures; there is also the physical burden of using and storing the equipment at 
home. 
 
Other forms of Medical Management 
 
6.15 There are many new and emerging medications and surgical procedures for the 
management of spasticity, movement disorders and posture; these require further 
research to better define their effectiveness and roles in physical management 
programmes.  
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7. ORTHOPAEDIC SURGERY 
 
Single event multilevel surgery 
 
7.1 A key development in strategic thinking of how to manage fixed musculoskeletal 
deformity in cerebral palsy has been the move from single level surgery, repeated at 
frequent intervals throughout childhood (sometimes referred to as the ‘birthday 
syndrome’), to single event multilevel surgery (SEMLS). 
 
Equinus  
 
7.2 Equinus is the most common musculoskeletal deformity in cerebral palsy and may 
adversely affect standing, posture and gait; specifically stability in stance and 
clearance in swing.  
 
7.3 Although the foot and ankle cannot be considered in isolation from the rest of the 
lower limb, the following strategies can be used to manage equinus in children in 
GMFCS levels I, II & III, subject to availability of resources. 
 
7.3.1 Intervention for equinus should start as soon as the problem becomes 
evident, for instance, stretching, taping and strapping can be used in infants. 
 
7.3.2 Dynamic equinus (where there is a good range of passive dorsiflexion) can 
be managed by focal injections of BoNT-A to the gastroc-soleus, stretching and 
ankle- foot orthoses.  
 
7.3.3 BoNT-A may also be indicated to treat gastrocnemius spasticity when it 
causes the knee to flex excessively during stance, or when ankle foot orthoses are 
not tolerated despite an adequate range of dorsiflexion being available. 
 
7.3.4 Serial casting can be used in an attempt to increase range of motion where 
there is a reduced range of dorsiflexion (fixed equinus); ankle foot orthoses should 
be used to maintain any gain in dorsiflexion range. 
 
7.3.5 Orthopaedic surgery is indicated to correct equinus if the deformity 
progresses to a stage that interferes with physical function, and should be followed 
by casting and ankle foot orthoses. The timing and amount of lengthening 
(dosage) are crucial to minimise the risk of over-lengthening, joint instability and 
likelihood of recurrence. 
 
7.3.6 If surgical correction is not possible then the deformity must be 
accommodated in ankle foot orthoses to promote stability and efficient gait. 
 
Upper limb surgery 
 
7.4 The development of the MACS (Manual Ability Classification System) is a major 
step forward in description of upper limb function. Assessments such as the 
Melbourne Assessment of Unilateral Limb Function are also useful outcome measures 
to evaluate upper limb surgery. 
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7.5 As with lower limb surgery, increasing numbers of surgeons are moving from a 
single level approach to a “single event multilevel surgery” approach in reconstructive 
surgery of the hemiplegic upper limb 
 
Hip subluxation/dislocation 
 
7.6 The risk of hip subluxation/dislocation in cerebral palsy increases linearly by 
GMFCS level from negligible in level I to almost universal in V. However, there is an 
increased risk for children with Winters’ type IV hemiplegia to develop late onset hip 
subluxation which may be extremely disabling.  
 
7.7 All health professionals involved in the care of children with cerebral palsy should 
be aware of the risk factors for hip subluxation/dislocation. A designated member of 
the multidisciplinary team must take responsibility for each child’s hip surveillance.  
 
7.8 The Australian Hip Surveillance Guidelines provide a carefully constructed 
framework for monitoring hip status in children with cerebral palsy. It is 
recommended that each centre should have such a guideline for follow-up and 
management of the hips in children with cerebral palsy.  
 
7.9 Surgical management of the hip should be considered when the migration index 
exceeds 30 degrees. Outcomes of hip surgery are better when performed as soon as 
indicated rather than being delayed while using alternative interventions. 
 
7.10 BoNT-A or phenol injections (obturator nerve only) can be used to reduce the 
deforming forces caused by spastic muscles when surgery is not possible, to delay the 
need for surgical intervention, or to treat pain and discomfort. 
 
Scoliosis 
 
7.11 The risk of scoliosis appears to be higher for non-ambulant children; therefore 
those in GMFCS levels IV and V are like to be at most risk for developing scoliosis. 
 
7.12 Surgical correction of scoliosis aims to improve posture, facilitate better seating 
positioning, reduce pain and discomfort, and reduce caregiver burden. 
 
7.13 Secondary benefits of surgery to correct scoliosis may include improved 
respiratory function, feeding and gastrointestinal motility, and decreased reflux. Other 
secondary benefits may include improved use of the upper limbs, improved head 
control enabling use of head switches and improved view. 
 
7.14 The results of scoliosis surgery are primarily measured on radiographs by a Cobb 
angle, however outcome measures such as the Spinal Alignment and Range of Motion 
Measure (SAROMM) or family-completed questionnaires such as the Caregiver 
Priorities and Child Health Index of Life with Disabilities (CPCHILD), Paediatric 
Pain Profile, Pediatric Outcomes Data Collection Instruments (PODCI), or the 
‘caregiver assistance’ scale of the Pediatric Evaluation of Disability Inventory (PEDI) 
are also available to evaluate various possible outcomes of scoliosis surgery. 
 
7.15 Corrective scoliosis surgery may be beneficial for patients with total-body-
involvement (GMFCS Level IV and V) cerebral palsy and scoliosis. However the 
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benefits and risks of surgery should be further evaluated in appropriate research 
studies.  
 
7.16 Segmental, third-generation instrumented spinal fusion appears to provide lasting 
correction of spinal deformity and improve quality of life in patients with cerebral 
palsy and scoliosis with a lower rate of pseudarthrosis than second-generation 
instrumented spinal fusion. 
 
7.17 Modern instrumentation has allowed more surgery to be completed from a 
posterior approach alone. In children with severe deformity, especially when there is 
significant growth potential, combined anterior and posterior surgery is indicated. 
There is discussion as to do this in a single or staged sitting. Some investigators 
believe that a two-stage procedure appears to be safer and associated with fewer 
complications than when conducted in a single operation, especially in individuals 
with very large curves and concomitant medical illness. 
 
7.18 Severe preoperative thoracic hyper-kyphosis appears to affect survival adversely 
and the parents of these high-risk children should be counselled about that likely 
prognosis. 
 
Orthopaedic Surgery Research  
 
7.19 The rigor of research in orthopaedic surgery in cerebral palsy will improve with 
well constructed research questions, prospective longitudinal design, well defined 
groups of patients (described by type and distribution of CP and GMFCS level), 
appropriate primary and secondary outcome measures, and long-term follow-up 
where possible. 
 
7.20 The clarity and transparency of papers describing orthopaedic surgery research 
will improve if the reporting guidelines advocated by The EQUATOR Network 
(Enhancing the Quality and Transparency of Health Research) are utilised. 
 
7.21 Orthopaedic surgeons and trainees need to be better educated consumers of the 
research literature to identify and reduce the number of poorly designed studies that 
are conducted and published. 
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8. ORTHOTICS 
 
Prescription of orthoses 
 
8.1 Dialogue between the orthotist and other members of the team (therapist, 
physician, surgeon, bioengineer etc.) is essential when deciding upon treatment goals 
and the biomechanical requirements to achieve these goals.  
 
8.2 The role of the orthotist is to formulate the design, fit, align, deliver and review 
the orthosis which will, in theory, achieve the biomechanical requirements agreed by 
the team. 
 
8.3 When an orthosis is prescribed consideration must be given as to when, and for 
how long in each twenty-four hour period it should be worn. The optimum duration of 
use (dose) and occurrence of side-effects (pressure sores, disturbed sleep, etc.) should 
be evaluated in future research studies. 
 
8.4 Adherence is likely to be higher when there is clear agreement between the 
physiotherapist and the orthotist regarding usage, and the family understands the 
rationale for the prescription. 
 
Lower limb orthotics 
 
8.5 For ambulant children, the available evidence from gait laboratory studies 
suggests that ankle foot orthoses (AFOs) that prevent plantarflexion can improve gait 
efficiency improving temporal and spatial parameters of gait, (i.e., velocity, cadence, 
step length, stride length, single and double support) and ankle kinematics.  
 
8.6 The indirect effects of AFOs on the kinetics and kinematics of the knee and hip 
joints have been demonstrated in gait laboratory studies; and these effects can be 
optimised by tuning the orthoses. 
 
8.7 The energy cost of walking may be decreased by the use of AFOs. 
 
8.8 It is unclear whether and how AFOs influence phasic activity of lower limb 
muscles.  
 
8.9 It is unclear how the assessment of the efficacy of AFOs in the gait laboratory can 
be used to predict children’s mobility and gait efficiency in their usual environments. 
 
8.10 There is inconclusive evidence of the effect of AFOs on children’s motor 
function. The Gross Motor Function Measure has been shown to be sensitive to the 
changes associated with use of orthoses and mobility aids and could be used to 
evaluate this outcome. 
 
8.11 It unclear whether AFOs can maintain/increases muscle length and hence 
prevent/reduce deformity developing over time. 
 
8.12 Long term effects of orthoses on muscle strength are unknown. Given recent 
recognition of the importance of muscle strength and endurance for maintaining 
mobility into adulthood, further research on this topic is desirable. 
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Upper limb orthoses 
 
8.13 Thumb abduction orthoses for children with hemiplegia are proposed to improve 
hand function by facilitating grasping and preventing fixed deformity; however there 
is no scientific evidence demonstrating these effects. 
 
8.14 A rigorously constructed study is required to address the research question ‘Does 
a thumb abduction orthosis improve use and manual function of the affected hand in 
children with hemiplegia?’ 
 
8.14.1 The subjects would be children with spastic hemiplegia, MACS level I or 
II, in a defined age group, perhaps focusing initially on preschool children. The 
Zancolli and House classifications of grasping and hand function may also be 
useful. 
 
8.14.2 The orthosis would be a custom-made thumb abduction orthosis with 
appropriate strapping; the comparison condition would be no orthosis. 
 
8.14.3 The research design should include a cross-sectional element to assess 
whether the orthosis achieves the biomechanical objective (maintaining 
abduction etc.) and a longitudinal study of whether it actually improves hand use 
and functioning with training. 
 
8.14.4 The outcomes assessed could comprise both unilateral and bilateral 
manual ability; measures could include the Assisting Hand Assessment (AHA), 
Quality of Upper Extremity Skills Test (QUEST), Melbourne Assessment of 
Unilateral Upper Limb Function, and the Canadian Occupational Performance 
Measure (COPM). 
 
8.15 There is the potential for a ‘factorial’ randomised controlled trial evaluating the 
individual and combined effectiveness of thumb abduction orthoses, constraint-
induced movement therapy and/or BoNT-A in the same study. 
 
Spinal orthoses 
 
8.16 It is generally accepted that spinal orthoses do not appear to prevent progression 
of scoliosis in children with cerebral palsy; however, by stabilising trunk posture, they 
may provide other substantive benefits. 
 
8.17 Although progression may not be arrested, in theory, spinal orthoses may reduce 
the rate of progression of scoliosis by reducing the deforming forces on the spine; 
hence delaying the timing of surgery until cessation of growth, or in some cases, 
avoiding the need for surgery. 
 
8.18 The benefits of spinal orthoses may include improved head control (perhaps 
enabling the use of head switches and improving view perspective) and/or upper limb 
function, and social interaction. Spinal orthoses can be used in conjunction with a 
seating system. 
 
8.19 A spinal orthosis may be beneficial for children for whom surgery is not feasible. 
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8.20 Spinal orthoses are particularly recommended for small curves, and to assure the 
family that all alternative interventions have been tried before surgery is considered. 
 
8.21 The primary measure of the effectiveness of spinal orthoses is the Cobb angle 
measured from X-ray; secondary outcomes could be the incidence of pressure sores or 
respiratory infections, improved head control and/or upper limb function, and social 
interaction. 
 
8.22 There may be an increased risk of rapidly progressing scoliosis following 
intervention using intrathecal Baclofen (ITB); a potential research study could 
compare rates of curve progression in children with and without a spinal orthosis 
following this intervention. 
 
Hip orthoses 
 
8.23 There is no evidence that hip orthoses (for example the SWASH orthosis) 
prevent progressive hip subluxation/dislocation over time. 
 
8.24 However, it is suggested that hip positioning devices (orthoses, seating, postural 
management devices) may produce other benefits. 
 
8.25 For non-ambulant children hip orthoses may improve symmetry of sitting 
posture and comfort; outcome measures that could be assessed include range of hip 
motion, seated pressure mapping, and/or timed sitting tolerance. 
 
8.26 For ambulant children hip orthoses may control scissoring of the lower limb 
during gait and thereby improve stability, acquisition of skills and gait efficiency. 
 
8.27 Further research is required to substantiate these potential benefits of hip 
orthoses. 
 
8.28 Hip orthoses are useful for positioning in postoperative management regimens.  
 
Orthotic research 
 
8.29 Research studies evaluating the effect of orthoses often lack sufficient detail of 
the research methodology, the subjects and/or the intervention, thereby failing to 
inform future research, and preventing generalisation or replication in the clinical 
setting. 
 
8.30 Papers describing orthotic research studies should include a minimum dataset of 
details of the subjects and the design of the orthosis being used by the subjects in the 
investigation. Details of this proposed minimum dataset should be disseminated to 
relevant journal editors to aid them in consideration of papers submitted for 
publication. 
 
8.31 The minimum dataset of details of the subjects should include age, sex, type and 
distribution of cerebral palsy, GMFCS level and/or MACS level (for studies of the 
upper limb) and whether subjects have had recent surgery or pharmacological 
intervention.  
 
 16          © International Society for Prosthetics & Orthotics 
8.32 Other requirements include a well constructed research question stating the 
hypothesis being investigated, the research methodology, and the outcome measures 
being used. 
 
8.33 There is often confusion about what is evaluated in orthotic research studies, 
between whether an orthosis achieves its biomechanical effect (e.g., improving gait 
pattern in the gait laboratory) and whether it improves function in daily life. 
 
8.34 It is acknowledged that comprehensive reporting of such details will increase the 
length of research papers, but is considered necessary for appreciation of what was 
done in the study, and supplementary material is now commonly published by 
journals online. 
 
8.35 Most studies of orthoses are cross-sectional in design; longitudinal studies are 
recommended to assess the long-term impact of orthoses. 
 
8.36 It is recommended that for any project investigating the use of orthoses an 
orthotist be an integral member of the research team. 
 
Research involving ankle foot orthoses 
 
8.37 Description of the subjects should include range of motion (ROM) of all lower 
limb joints, highlighting whether range is attained with ease or difficulty. Particular 
reference should be paid to dorsiflexion range with knee extended, which is an 
indication of gastrocnemius length. Any fixed deformities (including rotational 
deformity) should be reported, together with an assessment of muscle spasticity and 
strength. 
 
8.38 A description of gait, both with and without orthoses if appropriate, should be 
provided, stating whether or not mobility aids are used.  
 
8.39 A minimum description of AFOs used to improve gait should included the 
design and construction of the orthosis, alignment of the leg in the orthosis, alignment 
of the orthosis to the ground in footwear, and the footwear design. 
 
8.39.1 The design and construction description should include whether it is 
custom-made or prefabricated, materials (type and thickness), trimlines including 
foot plate length, type of any ankle articulations and range of motion permitted by 
these (or by flexible AFO designs), and the type and location of straps and 
fastenings. 
 
8.39.2 The foot and ankle alignment imposed by the AFO should be described in 
the sagittal, coronal and transverse planes. 
 
8.39.3 The alignment of the AFO and leg in the sagittal plane when the subject is 
standing wearing the orthosis with footwear should be stated.  
 
8.39.4 Details of the footwear should include the pitch (heel-sole differential), the 
design of the heel, the stiffness of the sole, the sole profile, and any additional 
footwear modifications. 
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Lycra garments 
 
8.40 There is considerable variation in the extent of body areas covered by garments 
ranging from gloves to body suits which may confound interpretations of 
effectiveness. 
 
8.41 Some subjects appear to experience functional gains using Lycra garments; 
however others experience difficulties with donning and doffing the garments, feeling 
hot and restricted, difficulties with toileting and incontinence, and respiratory 
compromise.  
 
8.42 The characteristics of people who benefit from using Lycra garments are not well 
defined; from the literature.  
 
8.43 The effectiveness of Lycra and similar garments should be evaluated carefully, 
preferably in a research context. 
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CEREBRAL PALSY - A GLOBAL PERSPECTIVE 
 
John R. Fisk, MD 
Emeritus Professor  
Southern Illinois University School of Medicine, USA 
 
The sponsoring body for this Consensus Conference Update is the International 
Society of Prosthetics and Orthotics. ISPO is a professional society familiar to nearly 
all of the participants but for those new to its activities let me say a few words. The 
International Society for Prosthetics and Orthotics (ISPO) is a multi-disciplinary 
organization comprised of persons who have a professional interest in the clinical, 
educational and research aspects of prosthetics, orthotics, rehabilitation engineering 
and related areas.  
ISPO was founded in Copenhagen, Denmark in 1970 as an international society by a 
group of surgeons, prosthetists, orthotists, physiotherapists, occupational therapists 
and engineers to promote improvements in the care of all persons with neuromuscular 
and skeletal impairments. ISPO is a Non-Governmental Organization (NGO) in 
Special Consultative Status with the Economic and Social Council of the United 
Nations, and is in Official Relations with the World Health Organization.  
ISPO presently has 3000 members worldwide in 84 countries. The image of ISPO is 
that of a professional society which has taken responsibility for setting the standards 
for and supervising the education of Orthotists and Prosthetists primarily in the 
developing world, however increasingly it is being called upon to do the same in the 
developed world.  It also promotes research and is a forum for the investigation and 
exchange of information on services for the physically disabled. 
One of its recurring activities is the sponsoring and organization of Consensus 
Conferences. Since1960 it has had held eight such conferences. 
• 1990 Amputation Surgery, Glasgow, Scotland 
• 1994 Lower Limb Orthotics Management of Cerebral Palsy, Durham, NC, USA 
• 1995 Appropriate Prosthetic Technology, Phnom Penh, Cambodia 
• 1997  Poliomyelitis, Hammamet, Tunisia 
• 2000 Appropriate Orthopaedic Technology Up-date, Moshi, Tanzania 
• 2003 Orthotic Management of Stroke Patients, Ellecom, the Netherlands 
• 2006 Appropriate Lower Limb Orthotics for Developing Countries, Hanoi, 
Vietnam 
• 2006 Wheelchair Technology for Developing Countries, Bangalore, India 
The purpose of each conference has been to review the pertinent body of literature 
and derive best practices reports.  Some topics clearly emphasized the needs of 
developing countries but none sought to set a different standard for high income and 
low income nations. Many led to the development of Short Courses based on the 
recommendations derived from the consensus. The Orthotic Management of Cerebral 
Palsy has been one such course. Under the able leadership of David Condie it has 
been given in seven different countries. It has become increasingly obvious that the 
material from 1994 on which the course has been based is out dated and needs to be 
revisited. That is what we are gathered here to consider this week. David has had a 
nice run. For this and other contributions to his professional field and ISPO he was 
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awarded the Knud Janssen Lectureship at the 2007 ISPO World Congress. It is never 
too late to congratulate him publicly. Jules Becher currently and for the next two 
triennia has the responsibility for being the Task Officer for Cerebral Palsy Courses. 
Since ISPO maintains a strong international perspective I felt this workshop should 
begin with just such an international view point. Most of what we will be discussing is 
information that comes from work and publications conducted in the developed 
world.  What is known about cerebral palsy in the developing world?  In a few words 
- not very much.  I would like to review the literature from low income countries, 
report on some interesting statistics we have available from those countries and report 
on some personal observations made after working in developing nations. 
LITERATURE REVIEW 
The literature review was not an arduous task. It is almost non existent.  I found four 
clinically based papers, fewer epidemiological papers and none having to do with 
orthotic management. I enlisted the reference librarians at my medical school library 
and they assured me that they went to non-standard sources. 
According to Msall and Hogan (1), 4 million of the 130 million infants born each year 
around the world die during the first 4 weeks of life.  Major associations with these 
early deaths include preterm birth, sever infections, and asphyxia, which in aggregate 
contribute to 80% of these deaths.  They note that the historic assumption has been 
that if one sequentially applies advances in preventive health, then the presence of 
child disability will be substantially reduced.  In the preschool years, this has 
happened with reduction of motor disability from polio and cerebral palsy from iodine 
deficiency; and other infectious diseases from vaccination.  In low income countries 
in south Asia and sub-Saharan Africa, 200 million children under 5 years of age fail to 
reach their cognitive potential because of poverty, poor health and nutrition and the 
suboptimal home environment. (2) 
The current knowledge on child disability in low-income (less than $875 gross 
national income) and middle-income countries ($875-$3465 gross national income) is 
woefully inadequate (3).  Two diseases causing an increase in childhood encephalitis 
and resultant upper motor neuron dysfunction about which there is some data are 
HIV-AIDS and Malaria (14). In 2006, the estimated number of children younger than 
15 years infected with AIDS was 2.3 million (8). In Zimbabwe 150% of children, in 
as much as many have two infections, contract Malaria.  
Cerebral palsy is 5 to 10 times more common in poorer countries (4). Disorders of the 
nervous system account for at least 15% of the global burden of disease and at least 
27% of average years lived with disability (5). These numbers refer only to disorders 
that arise within the brain. If we add the impact of the many conditions that damage 
the brain as part of their overall effect such as noted previously, the numbers become 
much larger approaching 30% of the global burden of disease (6).  Brain health and 
disease may be the best overall indicator of a nation’s success in promoting health. 
It is often noted that the majority of related causes for cerebral palsy in developed 
countries is idiopathic. The incidence of CP in very low birth weight children is 
consistent at 7.7% for children born at less than 1000 grams. Most of the identified 
pathologies in these children are periventricular leukomalacia and proencephaly. 
Increased survival rates as a result of improved neonatal intensive care units have not 
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increased the numbers of children thus affected. In a study from Soweto similar 
findings have been reported (7). Survivability was increased from 24% to 66% for 
children under 1500 grams. They did not have sufficient respirator facilities for 
children under 1000 grams. Similar survival figures in the United States between 1960 
and 1983 rose from 43% to 85%. Rates for cerebral palsy in both populations 
remained similar.  
Hagberg reported that “the prevalence of cerebral palsy in preterms is no longer 
increasing, in spite of additional improvements in survival.”(12) In a similar manner, 
Fanaroff et al. (13), reporting on prospective observations from 12 US centers, in 
1995 concluded that the increase in survival of very-low-birth-weight infants seen 
after the introduction of surfactant therapy in the 1080’s “was not accompanied by an 
increase in medical morbidity.” 
Over all global rates of Cerebral Palsy are between 2 and 3 per 1000 life births.(9) 
Although these figures are not available in low income countries there is data on the 
types of involvement in children with spasticity. Ozmen reported from Turkey that the 
types  encountered according to Hagberg’s categorization (10) were similar to 
developed countries.(11) My own unscientific observations in southern Asia and sub-
Saharan-Africa is that there are more dyskenitic types perhaps from untreated ABO 
incompatibility and resultant kernicterus. 
In a clinical study, M.A. Khan reported in 2007 on 85 children treated with single 
event multiple site surgery (15). He referenced the suggestions of Eugene Bleck and 
later of R.S. Paine that a child having spastic diplegia if unable to walk by age seven 
or eight probably would not walk. Reporting on his work done in Karachi, Pakistan he 
noted that there is a difference between western nations and his own. The children that 
the earlier authors were working with received treatment from the age of diagnosis. 
Khan’s patients on the other had presented on average at age 8.5 years. He was able to 
affect ambulation in all 85 who had not been walking at the time of presentation. 
18(21.2%) attained exercise ambulation, 39(45.9%) attained household ambulation 
and 28(33%) attained community ambulation.    
This literature review illustrates the need for improved data but more importantly the 
desire to identify problems unique to low income countries. As we send our foreign 
students back to their home countries we must encourage them to repeat many of the 
studies performed in our high income countries in their low and middle income 
countries. 
SURVEY RESULTS 
Early in 2008 a brief questionnaire was sent to a number of treatment facilities in low 
income countries. The address list of ISPO which consists of all the certified P&O 
schools, non certified schools and their related workshops was used. The same 
questioner was also sent to all of the International Committee of the Red Cross P&O 
workshops.  Seven questions were submitted for response. They dealt with requests 
for data on population incidence, numbers of patients served, types of services and 
needs for improved services. 
Responses were received from eighteen low income countries and twenty-five work 
treatment facilities.  Very few ISPO associated centers responded where as most 
ICRC workshops sent in their information.  
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Question 1: Do you have any data on the incidence of cerebral palsy in your region?   
Fourteen facilities reported that no data is kept. One country kept records but would 
not release it to the public.  
Question 2: Do you provide services to persons having cerebral palsy? 
Twenty reported that they do, but that most are very limited.  
Question 3: Which services do you or your facility provide? 
Physical therapy 16, Orthotics 11, Surgery 5. One said that since “CP is not 
correctable so they did not provide services”. Another facility said they have 
examples of equipment available for families to see so that they can construct them at 
home. 
Question 4: What volume of services for CP are you or your facility providing? 
Few had any data. One clinic said they saw as many 135 children with CP per month. 
One clinic fit 168 orthoses in 2007.   
Question 5: What age range are you patients/clients? 
Most said all of their CP patients were children, some worked with adults. 
Question 6: What is your ability to address the level of need in your region? 
“The ability will be defined according to the parents’ attitude to CP and with 
reference to social stigma which is a problem in my region. It is imperative that the 
disabled view themselves as functional beings and it is critical that parents do not shy 
away from seeking professional help for their child.” 
There are insufficient personnel to do home visits. Unrealistic expectations of families 
lead to discouragement. In Kashmir there are only two facilities for 12 million people. 
There is need for better awareness. 
Question 7: What are your needs, what are you lacking to provide services? 
There are needs in all areas, infrastructure, manpower, therapy equipment, social 
workers, CBR, education, transportation, and food.  “Lacking is specific training in 
the care of persons with CP for physicians and therapists.” Lacking is trust to dispel 
stigma and money for home services. 
One country acknowledged little interest or willingness in the care of people with 
cerebral palsy. 
CONCLUSION 
With a paucity of scientific literature concerning the adequacy of services for the care 
of persons with cerebral palsy in low and middle income countries few 
recommendations on best practices can be made. The World Health Organization 
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Task Force on Medical Rehabilitation Guidelines met in Geneva in October of 2005. 
One of the clear recommendations coming from that session was the need for accurate 
country by country data on the incidence and types of disabilities as a starting point in 
stimulating local governmental organizations to address service needs. Few Ministries 
of Health will act without identified needs and top down guidelines.  
All of you who have had the privilege to work in low income countries as I have 
know of the inadequacy of the orthotic services seen there. The fabricator is rarely a 
consultant and only a technician. Materials are clumsy. Design is with poor 
biomechanical understanding and there is very poor understanding of cerebral palsy as 
a clinical entity. Most of the time treatment is aimed at deformity rather than function. 
This paper has attempted to identify available resources on these issues. Clearly they 
are lacking. A nonscientific survey was added as a means of reporting on some 
current available services. The primary conclusion that can be drawn from it is that 
the needs are great. There is need of infrastructure, education, and public awareness. 
All of these take money. The most concerning need however was the expressed need 
for a societal change in attitude to over come stigma of cerebral palsy for specific and 
disabled persons in general. We must not lose sight of the goal for this workshop as 
we consider the medical needs of persons with cerebral palsy, the importance of 
inclusion of those persons in their society as a whole.   
WHO Definition of Disability 
“Any limitation in performing tasks, activities and roles to levels expected within 
physical and social context”
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CEREBRAL PALSY IN THE 21ST CENTURY: WHAT’S NEW? 
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for Childhood Disability Research, Canada Research Chair in Childhood 
Disability, Director, McMaster Child Health Research Institute 
 
Cerebral palsy (CP) has often been considered the prototype childhood 
‘neurodisability’ 1 (Rosenbaum 2003).  It is usually identified as the most common 
physically disabling condition seen and managed by child health professionals, with a 
prevalence of 2.0-2.5 per 1000 live births that has remained relatively stable over 
many decades 2.  In the past 40 years a number of thoughtful clinicians, researchers 
and epidemiologists have contributed to an ever-improving understanding of CP, in 
part through collaborative efforts among CP registers that have enabled researchers to 
discern epidemiological patterns using the very large databases that such registers 
make possible.  Causal pathways that lead to the development of CP are increasingly 
being explicated.  There have been important advances in understanding what CP 
looks like clinically, and how it can be defined and characterized.  At the level of 
‘treatment’, as will be described in this Workshop, research developments are helping 
to identify the benefits (and the limitations) of a host of specific interventions, using 
increasingly thoughtful and methodologically sound study designs and tailor-made 
outcome measures.  In addition, a number of secular influences have encouraged both 
service providers and researchers to expand our conceptual horizons to consider and 
accommodate new thinking. 
 
In this paper I shall offer a somewhat idiosyncratic perspective on what I see as some 
of the most important developments in the field of CP at the clinical and 
epidemiological levels.  In doing so I will discuss several significant conceptual and 
technical factors that have allowed (or forced) us to consider CP in a new light.  Thus, 
rather than attempt to undertake a comprehensive review of the literature and risk 
missing specific studies, let me offer instead a 50,000 foot overview as an opening 
perspective on ‘cerebral palsy’.    
 
Many of the fundamental issues and concerns about CP have been thoughtfully 
presented and discussed in an excellent series of papers in the Supplement to 
Developmental Medicine and Child Neurology  (Definition and Classification of 
Cerebral Palsy, 2007) 3 by a number of the world leaders in CP.  Several of these 
papers will be alluded to throughout, because any attempt by this author to improve 
on what was written in that excellent series of papers would be inappropriate. 
 
 
DEFINITIONS OF CP – AND WHY THEY MATTER 
 
An excellent historical perspective on cerebral palsy was provided by Morris in his 
2007(a) introduction to the Supplement to DMCN referred to above 4.  There he offers 
readers a brief review of thinking during the less than 200 years during which this 
constellation of findings (‘cerebral palsy’, by many names) has been identified and 
considered as a specific clinical entity.   
 
Moving ahead in time very quickly, we arrive at what might be considered the 
‘modern’ era of CP, in which the Bax definition has usually been considered the 
classic: simply put, CP is “a disorder of posture and movement due to a defect or 
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lesion in the immature brain” 5.  The emphasis that was taken from this brief 
statement and repeated regularly by others to the present time was that CP was a 
‘motor disorder’ (though in fairness to Bax and his colleagues there were more words 
in the full account of the consensus meeting he reported).   
 
Subsequent efforts by others to refine or improve the definition have generally been 
subtle.  These included the Mutch et al. definition of CP as “an umbrella term 
covering a group of non-progressive, but often changing, motor impairment 
syndromes secondary to lesions or anomalies of the brain arising in the early stages of 
development” 6. This definition emphasized the ideas of the condition as a collection 
of clinical pictures, non-progressive at the level of CNS pathology but potentially 
evolving clinically.  During this period leaders in CP research in the UK 7,8 and 
Western Australia 2 strove to consider how best to classify and describe the clinical 
dimensions of this neurodevelopmental disorder.   
 
Building on these and related ideas, the Surveillance of Cerebral Palsy in Europe 
(SCPE, 2000) group endorsed the notion of CP as an umbrella term that describes 
permanent but not unchanging functional impairments involving a disorder of 
movement and/or posture and of motor function, due to a non-progressive 
interference, lesion, or abnormality in the immature brain 9.  They have also promoted 
the use of a simple classification of CP into three broad groupings based on the 
predominant motor manifestations (spastic, dyskinetic, and ataxic [along with the 
term ‘mixed’ when it is difficult to identify a single predominant motor pattern]).  
They further separated spastic CP into bilateral and unilateral, and discourage the use 
of the classic topographical terms ‘diplegia’ and ‘quadriplegia’.   
 
Before turning to the most recent effort at defining CP, it is important to emphasize a 
point identified by Rosenbloom 10 and Cans et al. 11 regarding the purposes for which 
any definition or classification might be created.  It seems likely that at least some of 
the arguments surrounding attempts to define and classify CP concern what 
function(s) the definition and categorization are meant to serve.  From an 
epidemiological (population) perspective it is essential to identify all legitimate cases, 
of all ‘severities’, but to exclude those that do not belong in the defined entity 12.  
Accurate data may help us to identify temporal patterns in the appearance of the 
condition, perhaps associated with changes in the availability and use of health 
services, as Robertson et al. have so clearly shown about CP with a 30-year regional 
perspective 13.  Similarly, data from epidemiological studies may help us to recognize 
possible causal pathways 2 related to factors such as birth-weight and gestational age 
or the presence of multiple births as a risk factor for CP 14.  Policy-makers need to 
know about both incidence (new cases per year) and prevalence (how many people 
have ‘it’ at any specific time) in order to plan services for the population.  On the 
other hand clinicians are concerned with individuals, and wish to know whether the 
specific person they are currently assessing may have ‘it’, how severe the condition is, 
what additional manifestations of the condition may be present, and what 
management strategies are important at any stage of that person’s development.   
 
It is therefore apparent, and problematic, that clinical and epidemiological definitions 
may be rather different to serve these different purposes.  The difficulty arises when 
these perspectives collide.  As discussed by Blair et al. 15 the epidemiological focus 
adopted in Western Australia includes every child who has “…presence of 
neurological signs of the motor impairment. These neurological signs may or may not 
be associated with limitations in normal activities of daily living but are likely to limit 
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the potential for physical performance. Those in whom the motor impairment is so 
minor that it may not be apparent to an untrained eye are classified as ‘minimal CP’.”  
Note that this definition makes a presumptive prognostic judgment (‘…are likely to 
limit the potential for physical performance’) despite apparently having no 
‘…limitations in normal activities of daily living’.  Many clinicians would not agree 
that children without any apparent functional limitations should be labeled with the 
term CP, even though their inclusion might serve an epidemiologist’s needs.  It thus 
becomes apparent that there can be an important mismatch between what these two 
groups are referring to when the term ‘cerebral palsy’ is discussed! 
 
In 2007, following three years of meetings, commentary, feedback and discussion 
across the world, a proposed new, more detailed annotated definition of CP was 
published.  The full definition reads: “Cerebral palsy (CP) describes a group of 
permanent disorders of the development of movement and posture, causing activity 
limitation, that are attributed to non-progressive disturbances that occurred in the 
developing fetal or infant brain. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, perception, cognition, communication, and 
behaviour, by epilepsy, and by secondary musculoskeletal problems”.16 
 
As the lead author of the consensus definition I am aware of both the thinking that 
went into literally every word, and the areas of this statement that generated the most 
discussion within the committee and among critical colleagues who offered 
comments.  Most of these latter ideas have been collated in the DMCN Supplement 3, 
and will not be discussed here.  Rather, in this paper I wish to reflect on what I believe 
is, for clinicians at least, a new phase in our conception of CP.  At the clinical level I 
hope to encourage people to see CP in a fresh and expanded light, because in so doing 
I believe that we will modify some of our traditional thinking and probably be able to 
serve children and families even more effectively than we have done until now. 
 
Before turning to these modern perspectives it is important to comment briefly on the 
challenges of making a diagnosis of CP.  From a clinical perspective is it obviously 
important to identify children whose motor (and other) development is in some way 
aberrant, and to offer appropriate developmental intervention as soon as problems are 
recognized.  At the same time clinical investigations should be undertaken, and 
continued observation of the evolution of the child’s development is essential to track 
the evolution of the developmental difficulties.   
 
One challenge in making a formal ‘diagnosis’ of CP is the reality that, like most 
neurodevelopmental disorders, CP ‘develops’ over the early months and even years of 
the child’s life.  The early presentation of motor difficulties may include a 
combination of ‘qualitative’ and ‘quantitative’ signs (Rosenbaum 2006), the evolution 
of which may require long-term follow-up over the first few years 17.  The SCPE 
group supports the ascertainment of children with developmental motor difficulties at 
any age, but recommends that a formal assignment of the diagnosis ‘cerebral palsy’ 
only be given after the age of four years, when it is clear that the earlier signs and 
developmental difficulties have persisted but have not shown evidence of progression 
that would suggest another (usually more serious) diagnosis.9 
 
Most people in the field would recognize the classic forms of CP – predominantly 
(80%) associated with spasticity, impaired gross (and usually fine) motor control, 
variously affecting one side of the body (‘unilateral’ CP) or both sides (‘bilateral’ 
CP), with variations in the degree of functional limitations of lower and upper 
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extremities.  The traditional topographical descriptions of CP include unilateral CP 
(described by the interchangeable terms ‘hemiplegia/hemiparesis/hemisyndrome’); 
and bilateral CP (‘diplegia’, referring to CP affecting the lower extremities more that 
the upper; and ‘quadriplegia/tetraplegia’ in which all four limbs are equally (and by 
implication more ‘severely’) involved).  Bleck has recommended calling this 
distribution of CP ‘total body involvement’ to acknowledge the reality that this form 
of CP usually affects trunk and bulbar musculature, such that it has a pervasive impact 
on many areas of function. 
 
The problem with these terms is that, while the classic examples of each are easily 
recognizable, there is simply too much imprecision at the ‘edges’ to be able to be 
precise in how to define these patterns with these classic terms.  At what point does 
‘diplegia’ merge into ‘quadriplegia’?  How do we classify someone with 
predominantly unilateral CP who, on more careful examination, has ‘minor’ signs on 
the presumed ‘non-affected’ side?  No clear guidelines exist by which these nuanced 
distinctions can be made.  One of the few clinical studies of inter-observer reliability 
of the clinical classification of CP found relatively poor agreement 18.  On the other 
hand when classification is made on the basis of functional characteristics the 
reliability is somewhat stronger 19.  Gorter et al. 20 explored the relationships between 
topographical distributions of CP, or the predominant motor ‘types’, and functional 
classifications made with the valid and reliable Gross Motor Function Classification 
System (GMFCS) 21,22.  They showed clearly that traditional assumptions about these 
topographical-functional relationships were not nearly as sound as has usually been 
assumed.  For example, children with ‘diplegic’ CP were found in GMFCS Levels I 
through IV; and while the majority of children with ‘hemiplegia’ (88%) were 
classified in GMFCS Level I there were 12% in Levels II and III.  They also argued 
that in the absence of more reliable classifications of CP than are afforded by the 
GMFCS, GMFCS classification should be used to describe the function of people 
with CP, while the other topographical terms could not be expected to imply 
functional status. 
 
TWENTY-FIRST CENTURY THEMES 
 
CP as a ‘Developmental’ Disability 
The first theme that I want to discuss is that of CP as a ‘developmental’ disability and 
not simply a ‘motor’ disorder.  For me one of the significant points of emphasis in the 
2007 revised definition of CP was the identification of CP as ‘…disorders of the 
development of movement and posture’ (my emphasis).  In highlighting the 
developmental element of this ‘neurodevelopmental disability’ more explicitly than 
had heretofore been done, the new definition encourages people to recognize that CP 
affects the trajectories of the lives of developing beings from a very young age.   
 
I believe that this concept has at least two implications.  The first is that it is the 
development of movement and postural that is affected by the underlying motor 
disorders, meaning that whatever motor learning young children with CP are doing is 
likely to be in some ways atypical (I personally discourage people from using the 
imprecise and value-laden term ‘abnormal’).  The corollary of this notion is more 
subtle, but concerns the potential impact of disordered motor development on other 
aspects of child development.  One need only think of the amount and range of 
exploratory activity of a typical motor-minded two-year old to recognize how much a 
child with CP and motor restrictions may grow up ‘deprived’ as a consequence of 
limited motor (and by extension other early life) experience.  Thinking of CP as a 
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potential cause of childhood ‘deprivation’ may seem odd to many people, but 
considered in the light the challenge it poses to typical developmental I believe that 
framing CP in this way is conceptually logical. 
 
One of the therapeutic implications of this perspective on motor limitations is to 
consider the potential value and impact of the early and liberal use of ‘augmented 
(powered) mobility’, which both overcomes the mobility restrictions and can be 
associated with powerful changes in developmental function.  Butler’s 23 excellent 
studies illustrated how ‘empowering’ children 23 to 38 months of age led quickly to 
enormous changes in self-initiated interaction with objects, spatial exploration and 
communication with care-giver.  She also noted that these children, who were 
experiencing very significant restrictions in mobility, seemed to ‘discover’ and 
attempt to use their limited capacity more actively. 
 
In considering the formulation of CP as a developmental disorder, one of the 
significant changes to the classic definition of the condition is the addition of the 
second sentence: “The motor disorders of cerebral palsy are often accompanied by 
disturbances of sensation, perception, cognition, communication, and behaviour, by 
epilepsy, and by secondary musculoskeletal problems”.  The formal identification of 
this constellation of potential associated neurodevelopmental challenges serves to 
remind people that while the hallmark characteristic of CP is a “…permanent disorder 
of the development of movement and posture, causing activity limitation…” other 
aspects of neurological function may also be impaired and may create functional 
limitations.  In fact one might easily argue that at times many of these so-called 
‘secondary’ problems are more functionally important than the motor limitations by 
which CP has traditionally been characterized.   
 
These issues are important both philosophically and in practical terms.  From a 
developmental perspective the functional motor difficulties of a child with CP will 
almost always present at a younger age than problems in language, cognition or 
behaviour.  It is then too easy to assume that these later-emerging developmental 
difficulties are ‘secondary’ to the motor problems, when in fact they may co-vary as 
additional manifestations of the underlying “nonprogressive disturbances that 
occurred in the developing fetal or infant brain”.  At the same time, as discussed 
above, some of these associated developmental challenges may indeed literally be 
‘secondary’ to the deprivation and related challenges imposed by mobility restrictions, 
or to the consequences of functional impairments (e.g., contractures secondary to 
limited range of joint motion associated with spasticity).  Thus from a clinical 
perspective it behooves thoughtful service providers to identify all the developmental 
challenges that a child may experience (including those that emerge over time) 
without automatically assuming that these are either inevitable or ‘secondary’ 
difficulties.  In practical terms they all need to be addressed, though it is possible that 
some may indeed be preventable (as suggested by Butler’s work 23). 
 
The International Classification of Functioning, Health and Disability (ICF) 
In 2001 the World Health Organization published a revision and expansion of its 1980 
International Classification of Impairment, Disability and Handicap 24.  The new 
framework 25 incorporates concepts that include the structural underpinnings of a 
condition (originally ‘impairments’, now collectively labelled ‘body structure and 
function’); the impact of these impairments on ‘activity’ (what people can do and 
restrictions thereof); and the idea of ‘participation’ (engagement in life, and possible 
restrictions in this aspect of life).  In addition, the contextual elements of  ‘personal 
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factors’ and ‘environment’ have been added, to reflect the reality that within a social 
model of disability these latter factors, outside the person, can be important 
contributors to whether or not a problem with body structure and function becomes a 
‘disabling’ challenge. 
 
For people working with youngsters with CP these concepts give us ‘permission’ to 
think about ‘treatment’ outside the confines of impairments of body structure and 
function implied by the ICF framework 26,27.  In many therapeutic traditions it was 
assumed (usually implicitly rather than formally) that one needed to remediate the 
basic problems of CP – e.g., excess muscle tone, reflex abnormalities, obligatory 
motor patterns, etc. – if the person were to achieve ‘normal’ function.  In some 
traditions children were actively discouraged from standing and waking ‘abnormally’, 
and as a consequence were perhaps restricted not only by their impairments by but our 
beliefs about how function should be achieved! 
 
The 2007 revised definition of CP 16 speaks of ‘activity limitation’, with the clear 
identification of activity as a valued aspect of child development.  Nowhere are words 
like ‘normal’ or ‘typical’ used or even implied.  Rather, this version of the definition 
identifies the impact of the underlying impairments on ‘activity’.  This idea contrasts 
importantly with that developed by the Western Australia group 15, in which, for 
epidemiological purposes, even the presence of neurological signs without limitations 
in function is enough to qualify someone for inclusion under the CP label. 
 
The ICF appears to have considerable heuristic value and seems to have caught on 
much more extensively, in a few years, than the ICIDH ever did.  Among the 
challenges posed by thinking about ‘activity’ (what people can do) and ‘performance’ 
(what people actually do) is the need to recognize the essential difference between 
these related ideas.  To these concepts has now been added the notion of ‘capability’ – 
blending capacity with opportunity and inclination to perform the activity 28.  Why are 
these ideas important?  In clinical assessments we often try to elicit best abilities 
(‘capacity’) as an indication of what might be possible for that person, and what we 
might want to focus on in treatment programs.  One need only think about how we 
assess the mobility of a child with CP in the clinic – removing physical obstacles, 
watching them move on smooth floors, providing lots of verbal encouragement, etc.  
However, we may not think to take account of whether the child actually wants (and 
is encouraged) to do those activities we see that they have the capacity to perform 
during an assessment.  We can too easily assume that this is what the child ought to 
do ‘out there’ on crowded, slippery or uneven surfaces – and be disappointed by 
reports of less functional ‘performance’ than we know to be within the child’s 
repertoire.  These three related but distinct concepts regarding what people can and do 
achieve represent an important new way to think about how we evaluate children and 
what they actually do, and how we help them achieve their goals rather than ours. 
 
Modern Developments in CP 
In the past quarter century a number of technical as well as clinical and research 
developments have had a considerable impact on our emerging understanding of CP.  
These will be alluded to briefly to remind people of the fluid and still-developing 
nature of this fascinating story. 
 
The traditional belief was that perinatal difficulties were the ‘cause’ of CP.  One 
might be inclined (perhaps unfairly) to lay at least some of the responsibility for this 
idea at the feet of the ‘father’ of cerebral palsy, John Little, whose 1862 signal paper 
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on the subject 29 was entitled “On the incidence of abnormal parturition, difficult 
labour, premature birth and asphyxia neonatorum on the mental and physical 
condition of the child, especially in relation to deformities".  While he may have been 
partly correct in ascribing CP to perinatal misadventure (especially before the era of 
modern obstetrical care), Little can, of course, be forgiven for making a classic error 
in logic by assuming that because the child’s difficulties followed a difficult birth they 
were caused by it (‘post hoc, ergo propter hoc’).  Modern imaging techniques are 
making it possible to characterize the nature and location of the brain impairments 
that underlie CP, and with increasing precision to link the timing and location of 
specific impairments to particular phases of intrauterine development 30.  It has 
therefore become possible to recognize that many people with CP have impairments 
in brain structure (and almost certainly in brain function 31) prior to their delivery.  In 
fact it is likely that a significant proportion of people who have CP experience 
perinatal difficulties secondary to pre-existing CNS difficulties that make perinatal 
and immediate adaptations challenging.  These new insights into the timing of the 
insults to brain formation are important to parents, to the accoucheurs who have 
traditionally been blamed for obstetrical failures, and to neurobiologists seeking to 
understand brain ontogeny in order to prevent the developmental problems that 
underlie CP and related disabilities from occurring. 
 
Another important ‘technical’ development in the field has been the creation of 
purpose-built classification tools and standardized clinical assessments that enable 
people to speak the same language and evaluate our interventions using consistent and 
valid instruments 32,33.  Furthermore, these recent developments have been created to 
assess function (with ‘criterion-referenced’ measures) rather than deviations from 
‘normal’ (the latter assessed with so-called ‘normative’ measures).  Classifications of 
gross motor function (Gross Motor Function Classification System 21, 22) and manual 
abilities (Manual Abilities Classification System 34) among individuals with CP have 
enabled people to communicate with each other, and with parents, who appear to find 
these ‘levels’ of function both acceptable and useful in understanding their child’s 
status 35-37.  Morris recommends using the GMFCS levels as one of the frameworks 
for planning orthotic management of children and youth with CP 38,39.  Colleagues in 
Munich 40 (Heinen and Berwick) and Australia (Graham, personal communication 
2007) have also begun to outline approaches to the management of motor function by 
GMFCS levels. 
 
Without discussing specific measures in detail, it is important to note that the 
application of measurement science to the creation and validation of clinical measures 
has helped to move the field forward considerably.  Developments have included the 
creation and appropriate validation of measures specifically developed to assess 
change (e.g., PEDI 41, GMFM 42, QUEST 43, and GMPM 44,45).  These tools are 
criterion-referenced instruments that assess function against preset criteria, rather than 
misapplying norm-referenced measures that almost always fail to detect (real) change 
by virtue of their structural and functional properties 46 .  New measures have made it 
possible to assess whether, and to what extent, change happens ‘naturally’ 47 or as a 
function of interventions 48. 
 
Another research advance has been the undertaking of prospective longitudinal 
studies in which it is possible to observe within-person change over time in various 
aspects of function and well-being (e.g., gross motor function 47,49  or quality of life 
50,51).  Unlike cross-sectional studies which, in effect, ‘join the dots’ of the functional 
status of different individuals at different times (‘between-subject’ variability), this 
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research design makes it possible to observe how the same individuals develop and 
change over time (‘within-person’ variability).  While more expensive in time and 
effort, these perspectives are essential and are adding new levels of understanding to 
the field. 
 
As but one illustration of how prospective longitudinal studies can be useful, the 
extensive research from CanChild’s Motor Measures Group has enabled us to learn 
about patterns of gross motor development in children and youth with CP by GMFCS 
levels, and to offer an evidence-informed prognosis for gross motor development into 
the early adult years 47,49.  This was made possible by studies that followed and 
assessed the same large number of children and youth over almost 10 years, plotting 
their individual ‘motor growth curves’ and aggregating these curves with appropriate 
statistical modelling techniques.  The findings represent patterns of motor 
development associated with current mixed modalities of functional intervention, and 
may well change (and hopefully improve) as our therapeutic techniques become more 
refined.  However, at a minimum we are in a position to offer parents evidence-based 
answers to questions such as “Will our child walk?”. 
 
CP as a life-long condition – transition to adulthood and what it means for child 
health 
One concern about CP that has been discussed for years but seems finally to be 
gaining serious traction is the notion of ‘transition to adulthood’, and the recognition 
that there are increasing numbers of adults with this ‘childhood’ disorder 52.  Like so 
many neurodevelopmental conditions CP presents very early in life, and has 
traditionally been managed within the child health orbit.  Parents report that when 
their children reach 18 years they and their youth ‘fall off the cliff’ – a metaphor that 
has been heard in many countries.  We are at last starting to acknowledge and address 
the reality that CP does not disappear when children outgrow children’s services.  
People have begun to explore what happens to the lives of adults with CP.  (One 
should add as well that mortality in CP is relatively low in all but those people most 
complexly affected, and even in this group mortality is decreasing 53.  This means that 
premature death in childhood and adolescence is not the anticipated end for most 
children with CP born in the past two decades.) 
 
A detailed discussion of these important issues is beyond the scope of this report.  
Suffice to say that there are enormous opportunities to develop effective transition 
services, and to undertake research and careful delineation of the life circumstances 
and life quality of adults with CP who may too easily be ignored by the world of adult 
services to whom the life experiences of people with CP are alien.  At the same time it 
is very important to note that opportunities for gainful employment of adults with CP 
remain significantly limited.  There also appears to be evidence of ‘premature’ loss of 
motor function in adults who have previously been more capable 54.  Of course, 
findings like these latter observations may, to some extent, represent self-fulfilling 
prophecies about what has always been assumed was the fate of adults with CP.  It is 
quite reasonable to ask whether, with more effective attention and preparation early in 
the transition years (e.g., focusing on fitness and ‘participation’), careful planning 
toward adult independence, and more community-based opportunities and services the 
current picture can be enhanced considerably. 
 
The reason for raising these issues in this essay is simply to argue that those of us who 
work in the child and youth field need to take a much longer view of CP than has been 
our tradition with our focus on childhood.  There are almost certainly important 
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lessons to be learned from adults who have received our services as children, and 
equally important opportunities for ‘feed-forward’ of these experiences to parents of 
young children with CP, youth with CP, and professionals in our many fields 
regarding how best to offer advice, interventions and supports to young children 
starting on the CP ‘journey’ though life.  
 
CP as a condition that affects a whole family 
Another ‘modern’ concept about CP and other neurodevelopmental disabilities is the 
recognition that these conditions usually have a significant impact on families as well 
as children.  This in turn leads to a focus on the needs and well-being of families in 
what is usually referred to as ‘family-centred service’ 55.  One of the many reasons to 
be concerned about the well-being of parents is that there is documented evidence 
that, as a group, their physical and mental health is compromised 56-58.  There is also 
evidence that links ‘processes’ of service delivery to parental ‘outcomes’ (satisfaction 
with services, stress and mental health) 59.  Thus, the way that services are organized 
and delivered to families of children with CP actually matters to parent well-being, 
with the obvious assumption that this in turn matters to children! 
 
‘Quality of Life’ (QoL) and CP – what does this concept mean in CP? 
Finally, it is important to comment briefly on a ubiquitous concept – ‘quality of life’ – 
that has begun to move from a popular buzz phrase used in the community to an 
evolving set of concepts in health care that have both philosophical and academic 
importance.  Like many of the ideas discussed in this paper, it is challenging to define 
quality of life precisely.  One definition that is often cited states that QoL is the 
“individual's perceptions of their position in life in the context of the culture and value 
systems in which they live, and in relation to their goals, expectations, and concerns” 
60.  The idea of situating a person’s quality of life status within their culture and values 
speaks to the importance of understanding people’s realities from their internal 
vantage point rather than exclusively from the perspective of outside observers 
(judges). 
 
There are many reasons why it is usually assumed that the QoL of people with 
disabilities must be poorer that that of able-bodied citizens 61.  These include the 
assumption, on the part of many outside observers that if they were in the predicament 
they perceive to be experienced by people with CP their lives would be diminished in 
some way.  It is also the case that in many research studies ‘quality of life’ is 
measured with norm-referenced tools, developed to encompass the whole population, 
that ask about or assess functional status with able-bodied function as the standard 
(e.g., HUI3 62, PedsQL 63).  Since by definition people with CP have “…permanent 
disorders of the development of movement and posture, causing activity limitation…” 
it should be obvious that by the usual functional yardsticks used in these evaluations 
people with CP will score lower than people without CP! 
 
The reason to bring this concept into focus in a paper primarily about cerebral palsy is 
to remind us to consider the broad goals of our treatments, therapies, interventions, 
management strategies – whatever words we use for the roles and activities of 
professional service providers.  At the end of the day I believe that our overarching 
goal in working with young people with cerebral palsy ought to be to enhance their 
life quality.  This of course includes efforts to promote functional well-being and 
capability using the best of our impairment-directed interventions, and to prevent the 
secondary consequences of functional limitations.  These secondary consequences 
may include physical challenges associated with issues such as limitations in strength 
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and fitness; psychological difficulties associated with challenges in self-actualization; 
and social difficulties related to limited opportunities for meaningful employment and 
independence in the broad community.  Thus, perhaps one guiding principle in all our 
therapeutic initiatives ought to be to ask whether, how, and in what ways these efforts 
will contribute to supporting or enhancing the quality of life of the people with whom 
we work. 
 
It is exciting to realize that we are beginning to learn that the ‘quality of life’ of 
people with ‘disabilities’ is not as dismal as has often been assumed 64, nor is it 
inversely proportional to the level of externally visible disability.  Both Dickenson et 
al. 65 and Rosenbaum et al. 66 explored ‘quality of life’ using measures that ask about 
aspects of people’s inner lives rather than their functional status.  When this lens is 
used to explore how people view their life situation, the findings are very different 
from the way that QoL has usually been assessed and reported 61.  This reframing of 
the nature and quality of the lives of people with ‘disabilities’ is encouraging in itself; 
it also challenges those of us privileged to work with these people and their families to 
consider how we think and act in offering advice about the development of children 
and youth with CP. 
 
TO SUMMARIZE, in the 21st century there are increasing opportunities to 
(re)consider cerebral palsy as a developmental condition with clear biomedical 
underpinnings, affecting children and their families across their life course, requiring 
the best of both our biomedical therapies and our guidance to families and young 
people to make the most of their lives with whatever abilities they have and can 
develop.  I strongly believe that the glass is currently at least half full, and that these 
new perspectives, technical advances and conceptual thinking are empowering us to 
continue the process of filling the glass completely! 
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CLASSIFICATION OF GAIT IN PERSONS WITH CEREBRAL PALSY 
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“Gait Classification” refers to the assignment of a subject’s overall walking pattern to 
one of several defined categories or types of gait.  For persons with cerebral palsy 
(CP), sub groups of gait patterns are generally identified based on their type of 
cerebral palsy, e.g. spastic hemiplegia.  The work in gait classification can be traced 
back to the 1980’s when it was more-commonly referred to as “gait pattern 
recognition.”  Two contributions from that era illustrate the two approaches used in 
development of gait classification strategies today:  groups formed qualitatively by 
experienced clinical practitioners [1] and groups identified based on statistical 
methods.[2]  As these two early studies illustrate, gait classification approaches 
generally rely upon quantitative data provided through clinical gait analysis.[3] 
 
Motivations to develop and use gait classification approaches in CP vary.  At the very 
least, an effective gait classification approach can provide concise terminology to 
describe a patient’s complex set of gait abnormalities.  If used clearly and 
consistently, then this lexicon can facilitate communication between researchers and 
clinicians.  Sutherland and Davids [4] concluded that an understanding of common 
pathological gait patterns can also “facilitate accurate and detailed analysis of the 
individual patient with gait abnormalities.”  Winters et al. [1], followed in more detail 
by Rodda and Graham [5], broadened significantly the clinical application of gait 
classification by explicitly connecting gait patterns with specific treatment 
recommendations.  McDowell and her colleagues at the Musgrave Park Hospital 
(Belfast, Ireland) sidestepped this controversy with the opening statement in their 
recent article, “While there has been much debate as to the usefulness of classification 
systems for interpreting pathological gait, many clinicians still find them useful for 
minimising the complexity of kinematic gait data.”[6] 
 
The purpose of this report is twofold.  First, the pertinent literature associated with 
gait classification in CP will be examined and critiqued.  This will focus on the 
comprehensive review published by Dobson et al. [7] in 2007.  Several contributions 
associated with gait classification in CP, not included in or published since the 
Dobson review, will be considered.  In the second part of this report, gait 
abnormalities commonly seen in persons with CP will be described.  This synopsis is 
intended as foundation to subsequent reviews and discussions pertaining to the 
clinical management of ambulatory persons with CP.  This manuscript will conclude 
with a discussion regarding the challenge of gait classification in the context of a 
disease that presents a continuum of gait deviation and propose recommendations that 
might yield a more comprehensive gait classification approach. 
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REVIEW OF THE GAIT CLASSIFICATION LITERATURE 
 
In 2007, Fiona Dobson along with colleagues Meg Morris, Richard Baker and Kerr 
Graham from the Hugh Williamson Gait Laboratory & Murdoch Children’s Research 
Institute at the Royal Children’s Hospital (Parkville, Australia) published a 
systematic, carefully-designed review [7] of 18 published works [1, 2, 4, 8-22] that 
described strategies to classify the gait of persons with CP.  The studies were 
identified from a search of nine literature databases and included abstracts and full 
manuscripts published from 1966 through March, 2005.  For the most part, the 
identified studies focused on the gait of persons with CP aged 0–18 years.  Dobson’s 
review qualified the validity of the bases of these classification schemes through an 
evaluation of the studies with respect to their subject selection, classification 
construction, psychometric properties (i.e. degree to which a particular gait 
classification approach can actually classify gait, for example, considerations of 
reliability, construct validity, discriminant validity, basis of the classification 
construction, criterion validity, and concurrent validity). 
 
Adequate subject descriptions and inclusion criteria were provided in only four [1, 17, 
20, 21] of the 18 studies, thereby immediately limiting the utility of the resulting gait 
classification algorithm.  For example, it was unclear in a number of the studies if the 
research cohort included subjects with a history of previous orthopaedic surgery.  A 
retrospective convenience sample method was used in five [8, 13, 16, 21, 22] of the 
18 studies and not stated for the other 13 investigations.  This sampling method leaves 
open the question of whether the study cohort adequately represented the entire 
population.  For example, a study group comprised only of patients referred to a 
clinical laboratory for gait analysis and treatment planning may not adequately sample 
those subjects with milder CP-related gait abnormalities. 
 
With respect to classification construction, the majority (12) of the gait classifications 
were based on sagittal plane kinematics (and/or kinetics) despite the availability of 
three-dimensional quantitative gait data in 15 studies.  This simplification may limit 
the reliability of the classification scheme in patients with femoral and/or tibial 
torsion, i.e. transverse malalignment may impact sagittal plane motion.   
 
Nine [1, 4, 9, 12, 15, 17, 18, 20, 21] of the gait classification methods relied on groups 
formed qualitatively by experienced clinical practitioners, described by Dobson as 
“qualitative pattern recognition using quantitative data.”  As Dobson pointed out, “A 
potential advantage of qualitative methods is enhanced clinical relevance as groups 
are partitioned using clinical reasoning and rely on identifiable patterns of movement 
observed by clinicians. Therefore, they may be more meaningful in terms of clinical 
diagnosis and treatment planning.”  This reviewer agrees fully with this assertion.  
The fundamental problem, however, with these nine “qualitative” classification 
approaches is the lack of quantitative information provided in each article pertaining 
to how the groups were determined, e.g. how were the number of groups settled upon, 
how were subjects assigned to groups, are the identified groups different statistically.  
For example, Winters et al. [1] found four gait patterns for a cohort of children with 
spastic hemiplegia. The magnitude of the first standard deviation associated with the 
mean kinematic curves (refer to figure 1 in reference [1]) suggests that additional sub 
groups exist within the four identified groups.  Hullin et al. [9] investigated this same 
clinical population and found five gait patterns. 
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Nine of the gait classification approaches employed several different quantitative 
pattern recognition techniques:  cluster analysis [2, 10, 11, 13, 14, 19], hidden Markov 
models [8], generalized dynamic neural network [22], and support vector machine 
[16].  A fundamental advantage of the cluster analysis technique is that it requires 
objective specification by the user in setting up the analysis.  The challenge with 
cluster analyses is that they can yield different results depending on those a priori 
specifications and definitions.  As Dobson et al. [7] succinctly characterized it, 
“Cluster solutions may impose a structure on the data set rather than finding naturally 
occurring groups.”  The other analytical techniques (hidden Markov models, neural 
networks, and support vector machines) are used widely in pattern recognition (e.g. 
analysis of speech) and machine learning (e.g. data mining, machine vision).  These 
approaches allow the underlying pattern relationships to be established (supervised or 
unsupervised machine learning depending on technique) with relatively large, 
coherent training sets.  Basically, the model is provided enough “answers” so that it 
can probabilistically identify a new “unknown” pattern.  The utilization of these 
approaches in gait classification is promising, but challenged by the availability of the 
required training data, particularly as related to comprehensive gait patterns.  The 
more focused effort by Zwick et al. [22] (i.e. the characterization of plantar flexor 
muscle function with a neural network) appears to be a more plausible approach at 
this time. 
 
Information pertaining to psychometric properties provided in the studies included in 
the Dobson review was limited.  None of the articles associated with the nine 
qualitative-based classification approaches provided sufficient detail in this area.  
Somewhat amazingly, only two of the studies [15, 18] reported on inter-rater and/or 
intra-rater reliability.  Three of the quantitative studies [8, 14, 16] included 
classification cross-validation.  Dobson also reported that seven studies [2, 8, 13, 14, 
16, 19, 22] demonstrated construct validity and five studies [2, 8, 14, 16, 22] 
demonstrated discriminant validity.  Her review also qualified seven of the articles [1, 
10, 13-16, 22] as adequately describing clinical utility, with another eight studies [2, 
4, 8, 11, 12, 17, 19, 20] providing a “limited description.” 
 
Dobson et al. [7] abstracted her analysis of the 18 classification approaches in her 
review as follows:  “Many did not provide adequate guidelines or evidence of 
reliability and validity of the classification system. No single classification addressed 
the full magnitude or range of gait deviations in children with CP. Although gait 
classification in CP can be useful in clinical and research settings, the methodological 
limitations of many classifications restrict their clinical and research applicability.” 
 
Published subsequent to the Dobson review article, Toro et al. [23] described the 
application of hierarchical cluster analysis of sagittal (hip, knee, ankle) gait 
kinematics associated with 54 children with CP (hemiplegia (n = 25), diplegia (n = 
24), quadriplegia (n = 4), monoplegia (n = 1)) and 11 typically-developing children.  
The investigators’ goal was to objectively determine the optimal number of gait 
pattern clusters associated with this non-homogeneous study cohort.  The 
investigators used the following criteria define optimal number of gait pattern 
clusters:  1) distinct identification of the gait pattern associated with the typically-
developing children, 2) minimized hip, knee and ankle kinematic standard deviations 
within the clusters, and 3) for any given cluster, at least one kinematic curve (hip, 
knee or ankle) distinctly different from its neighboring cluster.  The investigators 
found 13 gait pattern clusters, four that they qualified as crouch gait type, four as 
equinus gait type, four as an “other gait” type, and one as “normal gait” type.  It is not 
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entirely clear that the objective analysis satisfied the first criteria as data for one 
typically-developing subject was associated with an “other gait” type cluster.  
Moreover, the investigators arrived at 13 clusters from a 14-cluster solution by 
eliminating one of two merged clusters, discarding what they qualified as an unstable 
cluster, and including a cluster identified in a 15-cluster solution.  These adjustments 
illustrate the challenge associated with defining objectively the number of clusters 
within non-homogeneous collection of gait patterns. 
 
Three publications were identified that exercised the Winters [1] classification 
approach.  Riad et al. [24] considered 112 pediatric patients with spastic hemiplegia 
CP (without prior orthopaedic surgery).  Twenty-six patients (23%) of 112 could not 
be classified in any of the four Winters classifications.  The gait deviations in these 
patients were slight relative to a laboratory normative reference, but were still 
qualified by the investigators as abnormal.  The authors proposed that a “Group 0” be 
added to the Winters 4-type classification approach to accommodate this additional, 
mildly-involved group. 
 
McDowell et al. [6] also investigated the validity of the Winters [1] classification 
approach through the examination of 91 pediatric subjects with spastic hemiplegia CP 
recruited from the community (30/91 with prior orthopaedic surgery) and 49 
typically-developing children.  Consistent with Riad et al. [24], McDowell and her 
colleagues found that the Winters classification approach failed to classify the most 
mildly-impaired children with CP (38/91, 30/61 children with no previous surgical 
history, 8/30 children with previous surgical history).  The classification rules utilized 
by McDowell differ from those employed by Riad, although both papers sought to 
employ the Winters classification system.  McDowell spoke to the challenge of 
creating explicit quantitative classification rules based on the somewhat ambiguous 
description provided by Winters et al. [1], a criticism that Dobson et al. [7] had of all 
of the qualitative CP gait classification schemes. 
 
The last evaluation of the Winters [1] CP gait classification method was provided by 
Dobson et al. [25].  In this study, 16 experienced clinicians (from six established gait 
laboratories) sought to classify 34 children with spastic hemiplegia CP into one of the 
four Winters types based on video and/or quantitative gait data and limited physical 
examination values (even though physical examination data were not incorporated 
into the Winters classification algorithm).  Although weighted kappa scores were 
sufficiently high for the investigators to conclude that there was acceptable overall 
clinician agreement using the Winters classification tool, the authors also reported 
actual agreement values as low as 32% (when using quantitative gait data and limited 
physical examination values) and 35% (when using video records and limited physical 
examination values).  Dobson and her colleagues recommend that the Winters gait 
classification approach be refined to define more explicitly the groups and to possibly 
include transverse and coronal gait kinematics. 
 
COMMON GAIT ABNORMALITIES SEEN IN PERSONS WITH CEREBRAL 
PALSY 
 
For detailed descriptions of the gait of the typically-developed individual, including 
terminology associated with gait events and phases of the gait cycle (e.g. initial 
contact, the three foot/ankle rockers) and definitions associated with segment and 
joint kinematics and intersegmental kinetics, readers are referred to the reference texts 
by Perry [26] and Rose and Gamble [27].  The Perry text is also an excellent resource 
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on pathological gait.  Davids [28] provides a description of common foot deformity 
seen in individuals with CP and its consequence with respect to gait, a topic that is not 
included here. 
 
Despite the significant limitations identified in the review by Dobson et al. [7], two of 
the “qualitative” CP gait classification approaches (Winters et al. [1], Sutherland and 
Davids [4]) cited in that review are commonly-referenced clinically and provide a 
starting point for describing routinely-seen gait deviations in CP.  Colleagues from 
Melbourne (Rodda et al. [5] and later Rodda et al. [15]) build on these earlier 
classifications and provide a framework for this presentation. The gait patterns 
described in all of these articles include a consideration of simultaneous changes in 
ankle, knee, hip, and pelvic sagittal plane motion.  This complete lower extremity 
presentation allows an opportunity to appreciate the dynamic relationships between 
joints and segments. 
 
Spastic Hemiplegia CP (refer to Figure 1) 
 
Type 0 (described by Riad et al. [24]) – milder than Winters Type 1, ankle 
dorsiflexion in mid swing with excessive ankle plantar flexion in terminal swing, 
increased knee flexion in terminal swing and at initial contact associated with a toe or 
foot flat landing at initial contact 
 
Winters Type I – excessive ankle plantar flexion throughout swing (drop foot), 
increased knee flexion in terminal swing and at initial contact associated with a toe or 
foot flat landing at initial contact; commonly-seen compensations for foot drop 
include a vault (premature heel rise) on the sound side and/or lower limb 
circumduction on the involved side 
 
Winters Type II – excessive ankle plantar flexion over the entire gait cycle, full knee 
extension in midstance (Melbourne Type 2a) or knee hyperextension (recurvatum) in 
midstance (Melbourne Type 2b), increased knee flexion in terminal swing and at 
initial contact associated with a toe or foot flat landing at initial contact (seen in the 
data presented by Riad et al. [24]) 
 
Winters Type III – excessive ankle plantar flexion over the entire gait cycle, increased 
knee flexion in terminal swing and at initial contact, full knee extension or recurvatum 
in midstance, reduced peak knee flexion in swing (resulting in reduced knee range of 
motion over the gait cycle) 
 
Winters Type IV – excessive ankle plantar flexion over the entire gait cycle, increased 
knee flexion over entire gait cycle, reduced knee range of motion over the gait cycle, 
lack of full hip extension in terminal stance, increased pelvic lordosis in terminal 
stance and pre swing (resulting in increased pelvic range of motion over the gait 
cycle, “single bump” pattern [29]) 
 
Spastic Diplegia CP (refer to Figure 2) 
 
Melbourne Group I, True Equinus – excessive ankle plantar flexion over the majority 
of the gait cycle (with possible “inverted second rocker,” refer to the description 
presented below), increased knee flexion in terminal swing and at initial contact, full 
knee extension (or mild recurvatum) in mid stance, full hip extension in terminal 
stance, anterior pelvic tilt with low amplitude bi-modal (“double bump”) pattern [29] 
 44          © International Society for Prosthetics & Orthotics 
 45          © International Society for Prosthetics & Orthotics 
Melbourne Group II, Jump Gait – excessive ankle plantar flexion over the majority of 
the gait cycle (with possible “inverted second rocker”), significantly increased knee 
flexion in terminal swing and at initial contact, excessive knee flexion in mid stance, 
knee range of motion may be reduced, lack of full hip extension in terminal stance, 
hip flexion bias overall, anterior pelvic tilt with double bump pattern 
 
Melbourne Group III, Apparent Equinus – ankle range of motion over the entire gait 
cycle within normal limits but with a “flat second rocker” indicative of limited ankle 
motion during single support, knee and hip pattern similar to Jump Gait, distinguished 
from True Equinus and Jump Gait by the neutral or dorsiflexed ankle angle, i.e. a toe-
toe foot contact pattern misleads the observer to conclude ankle equinus, anterior 
pelvic tilt with double bump pattern 
 
Melbourne Group IV, Crouch Gait – peak dorsiflexion in stance elevated and delayed 
until opposite initial contact (as described by Sutherland) or excessive ankle 
dorsiflexion over the entire gait cycle (shown in the Melbourne data, Rodda et al. 
[15]), excessive knee flexion over the entire gait cycle, reduced knee range of motion, 
lack of full hip extension in terminal stance, hip flexion bias overall, normal to 
posterior pelvic tilt with double bump pattern. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Mean kinematics associated with 
Winter Groups I-IV for spastic hemiplegia 
CP gait.  Approximated from data presented 
in Winter et al. [1].  The gray band 
represents the first standard deviation about 
the mean for the laboratory normative 
reference (Shriners Hospitals for Children, 
Greenville). 
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Figure 2.  Mean kinematics associated with 
the Melbourne gait classes for spastic 
diplegia CP gait.  Approximated from data 
presented in Rodda et al. [15]. 
The gray band represents the first standard 
deviation about the mean for the laboratory 
normative reference (Shriners Hospitals for 
Children, Greenville).
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Additional Kinematic and Kinetic Details 
 
First or heel rocker (heel contact at initial 
contact) is commonly absent in the gait of 
persons with CP.  More common is a 
forefoot/toe or foot flat pattern at initial 
contact.  With respect to sagittal plane ankle 
kinematics, immediately following initial 
contact (where the ankle can be excessively 
plantar flexed), the ankle begins to dorsiflex 
and continues to dorsiflex in loading 
response.  This brief dorsiflexion wave is 
followed in mid stance by a plantar flexing 
motion that can continue for the remainder o
stance.  This is referred to variously as 
“inverted second rocker” or “disrupted 
second rocker.”  Alternatively, this plantar 
flexion wave may end, to be replaced by a 
dorsiflexing motion, creating a bimodal 
ankle kinematic curve (Figure 3). 
f 
 
There are changes in ankle kinetics 
associated with the absence of first rocker as 
well.  In cases of mild to moderate equinus, a 
forefoot landing at initial contact causes the 
ground reaction point of application (or 
center of pressure) to be shifted well in front of 
the ankle center.  This results in an elevated 
internal ankle plantar flexor moment in mid 
stance with possibly a bimodal pattern (Figure 
3).[29, 30]  Premature ankle power generation is 
seen with this kinetic response as well as 
reduction in ankle power generation in terminal 
stance (Figure 3).  In cases of severe equinus, the 
ankle position shortens the moment arm between the center of pressure and the ankle 
center, thereby reducing the internal ankle plantar flexor moment in mid stance. 
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Figure 3.  Illustration of inverted second 
rocker kinematics with associated 
deviations in ankle kinetics.  The gray 
band represents the first standard 
deviation about the mean for the 
laboratory normative reference 
(Shriners Hospitals for Children, 
Greenville). 
 
In cases of excessive knee flexion in single support (i.e. crouch gait), an elevated internal 
knee extensor moment can result.  If the subject’s trunk is leaning forward, the internal 
knee extensor moment may be reduced and the internal hip extensor moment may be 
elevated to support the excessive knee flexion. 
 
Commonly associated with pathological hip involvement (motor control, spasticity) is a 
reduction and possible delay in hip power generation during the stance-to-swing 
transition. 
 
In addition to the sagittal plane kinematic deviations associated with spastic hemiplegia 
CP described above, transverse gait deviations may include pelvic retraction/protraction, 
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internal hip rotation secondary to femoral anteversion and internal foot progression 
secondary to femoral anteversion and/or tibial torsion.  Note that internal hip rotation 
with simultaneous knee and hip flexion may present as hip adduction in a coronal plane 
view of the walking subject.  Moreover, in a coronal plane view of the walking subject, 
pelvic retraction may “hide” internal hip rotation on the retracted side while “falsely” 
identifying or exaggerating internal hip rotation on the protracted side (i.e. misled by 
internal knee progression and/or internal foot progression).  These transverse plane gait 
deviations are also seen bilaterally (often asymmetrically) in persons with spastic diplegia 
CP as well and are best sorted out through quantitative gait analysis. 
 
 
CONCLUSION – GAIT CLASSIFICATION IN CP 
 
Motivations in support of the development of an accurate and reliable gait classification 
system for persons with CP include:  to assist in diagnosis, clinical decision-making and 
communication.[7]  Perspectives on the use of gait classification in clinical decision-
making in CP varies.  Dr. James Gage [1] and Professor Kerr Graham [5, 15] and their 
respective colleagues offered explicit guidance as to how specific groups of patients with 
gait abnormalities associated with spastic hemiplegia CP and spastic diplegia CP could be 
managed clinically.  Drs. David Sutherland and Jon Davids [4] qualify the clinical 
application of their observed patterns more conservatively, “It is not the intention of this 
paper to suggest that every patient with spastic diplegic-type cerebral palsy can be 
conveniently classified into one of the four groups described.  Rather, it should be 
recognized that although there are common types of pathological gait, a patient may often 
exhibit combinations of the primary patterns.  Each patient is an individual and should be 
evaluated as such.  Careful attention to the detailed analysis of the patient’s gait, in 
conjunction with an understanding of the most common pathologic patterns, should lead 
to an individualized treatment plan.”  At the Seventh Annual East Coast Clinical Gait 
Laboratory Conference in Richmond, Virginia, USA in 1991, Dr. Murali Kadaba (then at 
Helen Hayes Hospital, West Haverstraw, New York) presented pattern recognition 
research findings associated with the gait of 30 patients with CP.  Following the 
presentation, Dr. Jacquelyn Perry (Rancho Los Amigos Hospital, Downey, California) 
came to the floor and commented, “30 patients, 30 patterns.”  Dr. Perry’s succinct 
statement captures the fundamental challenge of placing a patient’s gait pattern into one 
of several groups.  The variance in neuromuscular deficits associated with cerebral palsy 
results in a continuum of ambulatory impairment associated with a broad range of 
primary gait abnormalities (type, magnitude) and secondary and compensatory 
deviations. 
 
All of these clinicians have advocated the use of quantitative gait analysis in decision-
making and treatment planning in this clinical population, e.g. Novacheck and Gage [31].  
Quantitative gait analysis produces an abundance of gait-related information which can 
be extremely challenging to interpret, particularly in cases where the complex three-
dimensional gait deviations are significantly different from normative references.  
McDowell et al. [6] pointed to the utility of gait classification as “minimising the 
complexity of kinematic gait data.”  In this sense, a “whole-body” gait classification 
strategy may provide a framework for the interpretation of this data, a way of 
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“organizing” the complexity of the gait data by promoting not only a joint-by-joint 
analysis, but also the examination of the relationships between anatomical levels.   
 
But a consideration of gait kinematic patterns alone is not sufficient.  Hullin and his 
colleagues in Edinburgh make this point in their proposed gait classification approach 
that extends the analysis of kinematic patterns by exploring the underlying kinetic 
relationships associated with the identified kinematics.  A more comprehensive 
understanding of the underlying biomechanical relationships between particular 
kinematic and kinetic variables may be the key in more effective use of quantitative gait 
data for clinical decision-making and treatment planning. 
 
For example, factors often included in consideration of the surgical transfer of the rectus 
femoris muscle in children with CP are the magnitude and timing of peak knee flexion in 
swing, shape of knee flexion wave in early swing, and the electromyographic (EMG) 
activity of the rectus femoris muscle in swing.[32-36]  Drs. Perry, Sutherland and Gage 
appreciated the relationship between a pathological muscle force (thought to be 
associated with a spastic reflex to the quick stretch of the muscle) and a kinematic deficit 
(insufficient magnitude and/or timing of peak knee flexion in swing).  These factors 
(magnitude and timing of peak knee flexion in swing, shape of knee flexion wave in early 
swing, and the EMG activity of the rectus femoris muscle in swing) represent a specific 
“pattern of treatment indicators” and serve to illustrate an approach that may prove more 
useful than the “whole limb” gait classification approaches included in the Dobson 
review.  The clinical and biomechanical intuition of these orthopaedists provided a 
starting point in identifying the pattern of indicators associated with rectus femoris 
transfer.  Biomechanical gait simulations point to other potential indicators as well.  For 
example, the modeling work of Piazza and Delp [37] highlighted the possible influence 
of the hip flexors at toe-off on swing phase knee flexion as well as simulating the 
impediment to swing phase knee flexion associated with rectus femoris muscle 
overactivity.   
 
A gait classification system can offer a framework for organizing the complex data 
associated with the walking impairment of a patient with CP.  An understanding of the 
kinematic and kinetic relationships associated with the common patterns can augment the 
interpretation of an individual patient’s data.  Any future gait classification algorithm 
should integrate gait kinematics (including all three planes of motion and trunk 
kinematics as well as lower extremity kinematics), kinetics, and EMG with clinical 
examination measures and observational gait qualifiers.  The investigator(s) must provide 
a complete description of the gait model used in processing the gait data, explicit group 
or type criteria, and demonstrated internal/external validity.  Comprehensive gait analysis 
also requires that the underlying relationships between specific clinical examination, 
kinematic, kinetic, and EMG parameters be identified and considered in the context of 
reliable patterns of treatment indications and contraindications. 
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Physiotherapy has been a mainstay of the rehabilitation management of children with 
cerebral palsy (CP) for decades1.  There are many therapy approaches to the 
management of CP however despite some attempts to evaluate effectiveness of 
therapy interventions there are still many questions left unanswered. Many agree that 
therapy is beneficial for the child with CP, however there is still limited evidence on 
which to base clinical practice2. 
 
For the child with CP the main aim of therapy should be to improve their quality of 
life with three general aims of: 1) increasing or improving the skill repertoire, 2) 
maintaining functional level and 3) the general management and minimization of 
contractures and deformities2. Common interventions usually address; the reduction 
of the effects of abnormal muscle/postural tone, musculoskeletal problems (muscle 
weakness and muscle length), working for activity in a functional context and 
providing opportunities for practice2.  
 
Activity-based approaches aim to prevent secondary musculoskeletal impairments and 
maximise physical functioning, foster cognitive, social and emotional development of 
the child and develop, maintain and perhaps restore neural structures and pathways1.   
 
Two components of physical function are muscle strength and cardio-respiratory 
fitness and limitations in these are a major problem affecting the function and health 
of children with CP3. Impairments such as weakness, spasticity and balance problems 
make it difficult for children with CP to participate in sport and activities at a level of 
intensity sufficient to develop and maintain normal physical fitness levels3.  
 
There has been a resurgence in the late 1990’s of treatments based on perspectives of 
motor control in physiotherapy management4. The concern in the past has been that 
performing strengthening exercises to address muscle weakness would increase 
spasticity and produce abnormal movement patterns, however this concern appears to 
be unfounded3; 4. Strengthening has been a popular treatment in more recent times and 
there has been an increase in the number of studies examining strengthening in the 
past 10 years. Another area that has increased in popularity is supported treadmill 
training which is designed to train walking.  
      
A common treatment approach that has been used in the past and is still used is 
Neurodevelopmental Treatment (NDT), also known as the Bobath approach. This is a 
therapy approach originating from the work of Berta and Karel Bobath, and aims to 
facilitate normal motor development and function and to prevent development of 
secondary impairments due to contractures and deformities focusing on sensorimotor 
components5. The approach has changed over the years to incorporate carryover into 
activities of daily life and preparing for specific functional tasks. This makes it a little 
harder to define, especially when used in conjunction with other techniques6.  
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Because there is a range of interventions that a physiotherapist might use to treat a 
child with CP, it is difficult to assess physiotherapy overall. Research is best directed 
to examining the effectiveness of individual specific types of therapy or exercise. 
Other recent reviews of the effectiveness of passive stretching7, conductive 
education8, aquatic interventions9, casting10 and static weight-bearing exercises11 have 
all shown the low levels of evidence for these interventions and the need for further 
studies with improved methodology. As well as individual treatment interventions, the 
dosage of physiotherapy generally impacts its effectiveness. A small body of literature 
has attempted to answer the question of what is the optimal intensity and duration of 
physiotherapy intervention that is most beneficial for the child with CP.  
 
A review of changes in the scientific quality of therapeutic motor interventions studies 
on children with CP over the decade 1990-2001 showed an increase in intensity of 
treatment, increase in number of home-based treatment and a definite improvement in 
methodological quality with higher levels of evidence seen12. This review was 
conducted to update the literature on physiotherapy interventions for children with 
CP. 
 
The aim of this review was to identify the common conventional physiotherapy 
interventions utilised in the past 10 years and to critically appraise the evidence of 
these. The focus was on recent trends in physiotherapy management and on those 
interventions relevant to orthotic management for the child with CP.  
 
The research question was: “what level of evidence exists for the effectiveness of 
common physiotherapy interventions for children with CP utilised in the past 
decade?” 
 
METHOD 
 
Search Strategy 
 
The search was conducted in May 2008. An electronic search was performed of the 
following databases: MEDLINE (1996 – May 2008), Embase (1980-May 2008), 
CINAHL (1983-May 2008), PubMed, Database of Reviews of Effectiveness (DARE), 
the Physiotherapy Evidence Database (PEDro), and Cochrane Database of Systematic 
Reviews.  Keywords used in the search included ‘cerebral palsy’, ‘treatment 
outcome’, ‘physical therapy (specialty)/or physical therapy modalities/ or 
physiotherapy.mp’. Terms were exploded or searched as a keyword where 
appropriate. Targeted hand searching was also employed to minimize the chance of 
missing key studies, including searching reference lists in key studies and review 
articles.  
 
Two reviewers were involved in the process of reading the abstracts independently to 
determine eligibility of inclusion into the review. Once the abstracts had been 
reviewed, the full text papers were retrieved and read. In some cases it wasn’t clear 
until the full paper was read whether it was to be included.    
 
Inclusion criteria 
 
The focus of this review was on common physiotherapy interventions utilised in the 
past 10 years for children with CP aged 4-18 years. The inclusion criteria were 
focused and precise. The interventions included were; strengthening (progressive 
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resisted strength training, task-related training and strengthening through cycling), 
functional training, supported treadmill training, NDT and other general forms of 
physiotherapy. The inclusion criteria for the interventions were those considered to 
impact on orthotic intervention. 
 
Studies examining the above interventions were included if they included children 
with CP aged between 4-18 years, if they assessed the effectiveness of these 
interventions using outcome measurement, were published from 1995 onwards and 
were full text papers in peer reviewed journals. 
 
Exclusion criteria 
 
The interventions excluded were those considered not “standard” physiotherapy 
including alternative and adjunct treatments. Excluded were; hydrotherapy, 
hippotherapy, electrical stimulation and other electrotherapy and biofeedback 
modalities, conductive education and other forms of educational based therapy, 
casting and splinting and taping. Also excluded was treatment focusing on early 
intervention because the focus of the review was treatment relevant for orthotic 
interventions. Studies were excluded if they; were descriptive studies not examining 
the outcomes of interventions, were single case studies (n=1), had a sample of 
children less than 4 years or older than 18 years, focused on the upper limb only, did 
not have children with CP in the sample and were published prior to 1995. Also 
excluded were abstracts and conference proceedings.  
 
Studies were included if they were examining the effects of physiotherapy after 
interventions such as surgery or selective dorsal rhizotomy but were excluded if the 
aim was to examine the effect of the surgery rather than the physiotherapy.   
 
Data extraction and quality assessment 
 
An individualised data extraction form was devised for this review and was pilot 
tested on 3 articles prior to use. The themes of the form were study aims, study 
design, subject characteristics, recruitment and sampling, interventions and outcome 
measures used, and clinical significance and relevance. The same form contained 
quality assessment items that were matched to the corresponding thematic items of 
data extraction. Two reviewers reviewed all the included articles independently using 
the data extraction and quality assessment form. Following this a consensus meeting 
was held where any disagreement between reviewers was discussed using a third 
person until consensus was reached. 
 
As well as the individualized quality assessment form, the Oxford Centre for 
Evidence-based Medicine Levels of Evidence (May 2001) were used to assign a level 
of evidence for each article. These levels were assigned for the different categories of 
interventions and an overall score.  
 
For the purposes of this review: 
1. A randomised controlled or clinical trial (RCT) involved randomly allocating 
participants to a treatment or control group 
a. a RCT was considered high quality if both groups had the same baseline 
treatment and the intervention group had the treatment in question, confidence 
intervals (CI’s) were stated and the CI’s were narrow   
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b. a RCT was considered low quality if the 2 groups had 2 different treatments, 
there were no confidence intervals, the sample size was very small or 
extraneous factors were not well controlled for 
2. A cohort study involved 2 groups matched as closely as possible where one group 
was exposed to the treatment and one was not (i.e. not randomised)13 
3. A case series involved one group only, assessed at baseline and then reassessed 
following the intervention, i.e. observational studies.  
 
For this review the question was the effects of treatments in children with CP, 
therefore studies that used normally developing children as a control group were not 
considered RCT’s, they were considered case series of children with CP. Also for this 
review, within participant designs (including if children acted as their own controls) 
were considered to be case series because there was not two groups allocated into 
different interventions. 
 
 
RESULTS 
 
The initial electronic search yielded 786 studies. After reviewing the titles there were 
42 articles thought to be relevant. From these nine studies were excluded because they 
did not fit the inclusion criteria. Another six articles were found through hand 
searching. This left a total of 39 articles included in the main review.    
 
Of the 39 articles included, 34 were studies and 5 were reviews. The numbers of 
articles in each category were: 
1. strengthening; 20 articles (18 studies, 2 reviews) 
2. functional training; 1 study 
3. treadmill training; 6 articles (all studies) 
4. NDT; 4 articles (3 studies, 1 review) 
5. frequency of physiotherapy; 4 articles (all studies)  
6. general/mixed; 4 articles (2 studies, 2 reviews) 
 
 
Table 1 displays the articles included in the review and summarises aspects of the 
study design and subject characteristics. This excludes the reviews.
Table 1 Studies on physiotherapy for children with CP (excluding systematic reviews) 
Study Study Type Study PT 
category 
Sample 
size 
Power 
analysis 
Age  
Gender M:F 
Classification 
of CP 
Recruitment Sampling Inclusion 
Exclusion 
Damiano14 CP: case 
series 
strengthening CP: 14 
ND: 25 
N 9.1 (6-14) 
10:4 
All SD NS NS Incomplete 
Damiano4 Case series strengthening 14 N 9.1 (6-14) 
10:4 
All SD Rehabilitation 
centre 
NS Vague 
Damiano15 Case series strengthening 11 Y 8.81 (6-12) 
NS 
SH 5 SD 6 Rehabilitation 
centre 
convenience Inclusion ? 
Exclusion NS 
MacPhail16 Case series strengthening 17 N 15.8 
7:10 
SQ 1 SD 7  
SH 9 
NS NS Inclusion ? 
Exclusion NS 
Seniorou17 RCT strengthening Rx 1: 11 
Rx 2: 9  
N 13 (7-16) 
10:10 
I: 3, II: 13, 
III: 4 
NS Random 
allocation 
Complete 
Patikas18 RCT strengthening Rx: 19 
C: 20 
N 9.75 
NS 
NS 1 hospital Random 
allocation 
Inclusion ? 
Exclusion NS 
Patikas19 RCT strengthening  Rx: 19 
C: 20 
Y 6-16 
27:12 
I: 12, II: 18,  
III: 9 
I hospital  Random 
allocation 
Complete 
Fowler20 Cohort strengthening CP: 24 
ND: 12 
N 11.5 (7-17) 
NS 
SD 1 hospital NS Inclusion ? 
Exclusion NS 
Lee21 RCT strengthening Rx: 9 
C: 8 
N 6.3 
10:7 
SD 9 SH 8 1 clinic Random 
allocation 
Complete 
Engsberg22 RCT strengthening 12: 4 Rx 
groups 
N 9.9 
3:9 
I: 5, II: 5 
III: 2 
Local PT’s Random 
allocation 
Complete 
Crompton23 RCT strengthening Rx: 8 
C: 7 
N 10.6 (6-14) 
6:9 
I: 12, II: 2  
III: 1 
CP register NS Complete 
Liao24 RCT strengthening Rx: 10 
C: 10 
Y 5-12 
12:8 
I 10, II 10 Numerous 
centres 
Stratified & 
randomised 
Complete 
Eagleton25 Case series strengthening 7 N 12-20 
NS 
NS NS NS Complete 
Williams26 Case series  strengthening 11 Y 12.6 (11-15) 
1:10 
SQ 10,  SD 1 1 special 
school 
NS Complete 
McBurney27 Case series strengthening 11 N 12.7 (8-18) 
4:7 
I: 2, II: 2, III: 7 From another 
RCT 
NS Inclusion ? 
Exclusion NS 
Dodd28 RCT strengthening Rx: 11 
C: 10 
Y 13.1 (8-18) 
10:11 
I: 7, II: 5, III: 9 1 hospital Random 
allocation 
Complete 
Morton29 Case series strengthening 8 N 8.5 (6-12) 
4:4 
All III 2 special 
schools 
convenience Complete 
Blundell30 Case series strengthening 8 N 6.3 (4-8) 
7:1 
SD 7   SQ 1 1 school convenience Complee 
Table 1 Studies on physiotherapy for children with CP (continued) 
 
Ketelaar31 RCT functional 
training 
Rx: 28 
C: 27 
N 55mo (24-87) 
33:22 
SH 32, SD 11 
SQ 12 
PT’s Stratified & 
randomised 
Inclusion ? 
Exclusion NS 
Cherng32  Within 
participant 
treadmill 8 N 3.5-6.3yrs 
6:2 
II: 2, III: 6 Not fully 
stated 
NS Inclusion ? 
Exclusion NS 
Phillips33 Case series treadmill 6 N 10.6 (6-14yrs) 
4:2 
I: 6 
SH 4,  SD 2 
rehabilitation 
centres 
NS Complete 
Begnoche34  Case series treadmill 5 N 2.3-9.7yrs 
4:1 
I: 2, III: 1, IV: 2 
SD 4,  SQ 1 
Outpatient 
clinic 
convenience Incomplete 
Dodd35 Matched 
pairs 
treadmill Rx: 7 
C: 7 
N 9rs 
10:4 
III: 4,  IV: 10 2 schools convenience Complete 
Provost36 Case series treadmill 6 N 6-14yrs 
4:2 
All I 
SH 4,  SD 2 
Part of larger 
study 
NS Complete 
Schindl37 Case series treadmill 10 N 11.5 (6-18) 
4:6 
SD 3, SQ 4, 
Ataxia 3 
Outpatient 
clinic 
NS Complete 
Tsorlakis38 RCT NDT Rx 1: 17 
Rx 2: 17 
Y 7.3 (3-14) 
22:12 
I: 10, II: 10,  
III: 14 
1 centre Stratified & 
randomised 
Inclusion ? 
Exclusion NS 
Adams39 Case series NDT 40 N 6 (2.6-10.2) 
45%:55% 
incomplete 1 centre convenience NS 
Knox40 Case series NDT 15 N 7.4 (2-12) 
9:6 
I: 1, II: 4, III: 5, 
IV: 4, V: 1 
3 centres convenience Complete 
Christiansen41 RCT frequency Rx 1: 10 
Rx 2: 14 
Y 1-9 
16:9 
NS 1 centre Stratified & 
randomised 
Incomplete 
Bower42 RCT frequency 44: 11 in 4 
groups  
Y 3-11 
NS 
All SQ 14 health 
districts 
Stratified & 
randomised 
Inclusion ? 
Exclusion NS 
Bower43 RCT frequency 56: 13-15 in 
4 groups 
Y 3-12 
31:25 
NS 33 health 
districts  
Stratified & 
randomised 
Inclusion ? 
Excusion NS 
Steinbok44  RCT frequency Rx 1: 14 
Rx 2: 14 
N NS NS NS – part of 
larger study 
NS Complete 
Shumway-
Cook45 
Case series Other (balance 
training) 
6 N 9.2 (7-13) 
4:2 
I: 2, II: 4 Local schools NS Complete 
 
Butler46 Case series Other (trunk 
training) 
6 N 4.7 (2-8) 
4:2 
SQ 5, SD 1 1 centre consecutive Complete 
RCT: randomised controlled/clinical trial, CP: cerebral palsy, NDT: neurodevelopmental treatment, Rx: treatment, C: control, NS: not stated, Y: yes, N: no,  
ND: normally developing, SD: spastic diplegia, SH: spastic hemiplegia, SQ: spastic quadriplegia, I II III IV & V: GMFCS levels, PT: physiotherapist  
 
Of the 34 studies, 11 had sample sizes of 10 or less. The largest sample sizes were in 
the NDT and frequency studies and the smallest were in the treadmill training and 
general studies. Fourteen of the 18 strengthening studies had adequate sample sizes. 
There were power calculations or justifications of sample size in only 9/34 studies (3 
frequency studies, 5 strengthening and 1 NDT study). The recruitment and sampling 
procedures were inadequately or incompletely described in 21/34 studies. They were 
well described in 8/18 strengthening studies, 1/6 treadmill training, 1/3 NDT and 3/4 
frequency studies. Subject characteristics were inadequately or incompletely 
described in 8 studies (4 strengthening and 4 frequency).  
 
The inclusion and exclusion criteria were vague or inadequately described in 16 
studies (4 frequency, 10 strengthening, 1 NDT and 1 treadmill). Often the inclusion 
criteria were stated but not the exclusion. There was blinding of assessors in only 16 
of the studies42; 43; 46; 32; 41; 23; 14; 28; 31; 24; 27; 29; 19; 37; 44; 38. There were co-interventions 
(other treatment as well as that under study) in at least 18 studies (10 strengthening, 4 
treadmill, 1 NDT, 2 frequency and 1 other), in 10 it was not stated and there was no 
co-intervention in 6 studies only. There was a follow-up assessment (ie to assess 
carryover effects) in 15 of the 34 studies (10 in strengthening, 2 in frequency studies 
and 1 each in NDT, treadmill and general). In 18 studies the limitations of the study 
were explored adequately.  
 
Table 2 displays all studies in the review with the study type and the Oxford EBM 
level of evidence. This table shows that overall there were 14 RCTs; 3 were rated as 
high quality (level 1b)24; 19; 18 and 11 rated as low quality (level 2b)17; 21-23; 31; 28; 35; 38; 44; 
41-43. The study by Liao was particularly well designed and performed. The Dodd 
study 28 was also well designed with tight inclusion and exclusion criteria and 
reported clearly, but was graded down because there were no confidence intervals. 
There was one true cohort study 35 and 19 case series4; 14-16; 20; 25-27; 29; 30; 34; 32; 33; 36; 37; 
39; 40; 45; 46. There were no case control studies. Overall there were 3 level 1b studies, 
12 level 2b studies, 19 level 4 studies and the 5 reviews were classified as level 5 
because they did not consist of all RCT’s.  
 
The level of evidence per physiotherapy category was: 
1. strengthening; 8 RCT’s (3 level 1b, 5 level 2b) and 10 case series (level 4) 
2. functional training; 1RCT (level 2b) 
3. treadmill training; 1 cohort study (level 2b) and 5 case series (level 4) 
4. NDT; 1 RCT (level 2b) and 2 case series (level 4) 
5. frequency; all 4 were RCT’s (level 2b) 
6. general other; 2 case series (level 4) 
 
There were 2 studies in the strengthening category that were graded as case series20; 14 
despite the authors considering them to be RCT’s. This decision was made based on 
the review question which was the effect of physiotherapy on children with CP. Both 
of these studies used typically developing children as the control group.  
 
Overall there were 8 strengthening studies rated as level 2b or higher. The functional 
training study was also level 2b. All studies addressing intensity of PT were level 2b 
and one of the treadmill training studies was level 2b. Despite the body of evidence 
containing a number of observational case series, there was also a number of studies 
with higher levels of evidence (level 2b or higher).   
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Table 2 Strength of the evidence 
 
Study Study Type PT category Oxford 
EBM 
Level  
Additional Information 
 
Damiano14 
 
Case series (CP) 
 
strengthening 
 
4 
 
Used TD children for controls 
Damiano4 Case series strengthening 4  
Damiano15 Case series strengthening 4  
MacPhail16 Case series strengthening 4  
Seniorou17 RCT strengthening 2b 2 different Rx’s compared, no CI’s 
Patikas18 RCT strengthening 1b  
Patikas19 RCT strengthening  1b  
Fowler20 Cohort/case series strengthening 4 Used TD for control 
Lee21 RCT strengthening 2b 2 different Rx’s, small sample 
Engsberg22 RCT strengthening 2b  
Crompton23 RCT strengthening 2b  
Liao24 RCT strengthening 1b  
Eagleton25 Case series strengthening 4  
Williams26 Case series  strengthening 4  
McBurney27 Case series strengthening 4  
Dodd28 RCT strengthening 2b No CI’s 
Morton29 Case series strengthening 4  
Blundell30 Case series strengthening 4  
Dodd47 SR strengthening 5  
Darrah48 review strengthening 5  
     
Ketelaar31 
 
RCT functional training 2b PT’s randomised not participants 
Cherng32 Case series treadmill 4  
Phillips33 Case series treadmill 4  
Begnoche34  Case series treadmill 4  
Dodd35 Matched pairs/cohort treadmill 2b  
Provost36 Case series treadmill 4  
Schindl37 Case series treadmill 4  
     
Tsorlakis38 RCT NDT 2b 2 different Rx’s compared 
Adams39 Case series NDT 4  
Knox40 Case series NDT 4  
Butler5 SR NDT 5  
     
Christiansen41 RCT frequency 2b 2 different Rx’s compared 
Bower42 RCT frequency 2b No strict controls, wide CI’s 
Bower43 RCT frequency 2b No strict controls, wide CI’s 
Steinbok44  RCT frequency 2b  
     
Shumway-Cook45 Case series Other (balance) 4  
Butler46 Case series Other (trunk) 4  
Lannin49 SR Therapy post Botox 5  
Harris50 SR Postural control 5  
     
Total PT   B-C 1b=3  2b=12   4=19 
 
TD; typically developing     Rx; treatment    CI; confidence intervals  
RCT; randomised controlled/clinical trial      SR; systematic review 
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Table 3 summarises the various regimes of treatment within each physiotherapy 
intervention category, the outcome measurement used and overall results. For each 
category there were similarities and differences with the treatment regimes. The 
strengthening studies often used a frequency of 2-3 times per week for 6 weeks. The 
treadmill training studies used either a 2 week intensive program or a 6-12 week 
program of 2-3 times weekly. For the NDT studies the participants had more 
individualised treatments based on goal setting due to the nature of the intervention. 
The frequency studies examined the effects of different intensities of treatments.  
 
There was a range of outcome measures used overall. The most common was the 
GMFM which was used as an outcome in all categories. Dynamometry was common 
in strengthening studies. Functional tests such as timed 10m walk, and 6 and 10 
minute walk tests were used as outcome measures in the treadmill training and 
strengthening studies. The measures used covered various aspects of the ICF but more 
commonly activity and body structures and function. There were very few studies that 
used outcomes to measure changes in participation.   
 
The study designs were strongest in the strengthening and frequency studies, i.e these 
categories had higher quality studies thus providing more evidence to accept their 
findings. For strengthening the results varied but overall the studies found that 
strength was improved in selected targeted muscle groups as measured by 
dynamometry, but not always significantly. Gross motor function also improved after 
strengthening in some studies. The three level 1b studies comparing strengthening to 
other treatments or standard treatment showed that both groups tended to improve 
with no significant differences between the groups24; 19; 18. Strengthening did not 
increase spasticity. The four frequency studies for general physiotherapy found no 
significant differences in GMFM scores for different intensities of treatment. This 
contradicts the Tsorlakis study38 which found that both intensities of NDT improved 
gross motor function with significantly more improvement in the more intense 
program.      
 
Both the treadmill training and NDT categories contained primarily case series 
studies. The treadmill training resulted in variable outcomes with no clear indication 
of significant gains, although improvements in standing and walking parameters were 
seen. Improvements on the GMFM were seen after various intensities of NDT.    
Table 3. Interventions and outcomes 
 
Category Regimes Outcome measures used and results 
 
Strengthening 
 
 
 
 
 
PRST programs: 4-5 reps, 3 x weekly for 6-8 weeks4; 14-16; 22; 25; 
27; 29; 28 usually starting at 65% maximum isometric strength. 
Functional based programs used a number of exercise stations, 1 
hour, 2 x weekly for 4-6 weeks23; 30 or repetitive practise31 
Post-operative strength studies used a set of exercises, 3 x 
weekly for 6 weeks17 and 9 months18; 19 
Others were 6 week programs of loaded sit-stand24, general 
strengthening21 or exercise bike26  
 
GMFM used in 10 studies with; significant improvements24; 15, non-significant 
improvement28; 29; 26, no difference between strengthening and control groups with both 
improving17; 18; 31, and no changes seen on GMFM21; 22. 
Dynamometry showed; significant increases after strengthening quads4; 16, combined 
muscle strengths28, and other muscle groups30; 29; 22; 21. Non-significant increases17; 15; 14; 23 
and no differences between groups also seen19; 24.  
Gait parameters: no change  in energy expenditure15; 16, no significant change seen in 
velocity or cadence16; 14; 22; 24, improvements in some gait parameters25; 18. 
Significant increases in timed walk tests30; 25. No increase in spasticity29; 20; 19. 
Treadmill 
training 
 
 
 
All used motorised treadmill with support harness 
Amount of support given arbitrary in some studies, others began 
at 30% of body weight and reduced support to 0% over study 
period33; 36. 
Some were 20-30 mins, 2-3 x weekly for 6-12 weeks37; 35; 32. 
Others 2 x daily, 6 x weekly for 2 weeks33; 36  
 
GMFM used in all studies except Dodd with variable results. Significant increases in 1 
study only32. Other studies show improvements in dimension D & E. 
Timed 10m walk used in 4 studies33-36 with improvements, but only 1 significant36. 
Endurance (10 and 6 minute walk tests) showed either no change33, non significant 
improvement36; 35; 34.   
Other gait parameters showed no changes in velocity or cadence32; 34  
NDT Treatments individualised for each participant with; 1) 1 hour, 2 
x weekly for 6 weeks39, 2) 75 mins, 3 x weekly for 6 weeks40 
and 3) 50 mins 2 x weekly compared with 5 x weekly for 16 
weeks38 
GMFM used in 2 studies38; 40: 1) significant increases in dimension C and E and total 
score maintained at follow up40 and 2) both intensities of treatment improved38  
PEDI – improvements in functional skills self-care and caregiver assistance40 
Pedographs – significant increases in stride & step length & velocity (large SD’s)39 
 
Frequency 
 
 
 
 
 
2 assessed 4 groups combining aims or goal directed therapy 
with routine or intense frequency for 2 weeks42 and 6 months43.  
One compared intermittent bursts with continuous PT41. 
One examined effects of pre-SDR intense PT program44. 
 
GMFM primary outcome measure in all studies. There were no significant differences in 
GMFM between different intensities in any study. 
 
Other 
 
 
 
 
One examined effect of individualised targeted trunk training 
using specialised equipment for 1-2 trunk joints at a time46. 
One assessed effects of 5 consecutive days of balance training 
using movable force plate system45  
 
 
All children gained independent sitting within 12-25 weeks but other results not analysed 
clearly46. 
Significant improvements seen in centre of pressure and reduced time to recovery of 
balance perturbation45.  
There were 2 reviews on strengthening48; 47, one on NDT5, one on the effect of therapy 
after botulinum toxin injections49 and one on postural control50. One of the 
strengthening reviews was performed in 199748 and included only 7 studies with 6 of 
them low quality studies (level V evidence). The difference between this review and 
the later one on strengthening47 is encouraging with the more recent one involving 11 
studies from 23 that fitted the inclusion criteria (1 RCT, 9 observational studies and 1 
review). Despite overall the studies having low levels of evidence, there have been 
improvements in study design and quantity of studies over the time period. The 
review on NDT5 included 21 articles (not restricted to PT) and found 4 were level I 
evidence, 10 were level II, 2 were level III, 4 were level IV and 1 was level V. 
However of the 14 that were level I-II, many had small sample sizes thus 
compromising power. The review on the effects of all types of therapy after botox 
injections included 9 studies; 1 RCT on electrical stimulation (level II), 3 on casting 
(level II and V) and 4 others level IV. None were high quality RCT’s and thus the 
authors concluded that there was a paucity of evidence of the effect of therapy after 
botox injections. The review on the effects of postural control included 12 studies, 
most were level III-V (8 studies) and 4 were level II. More research is required in this 
area also.    
 
 
DISCUSSION   
 
This review found overall that in the past 10 years there has been an increased interest 
in using strengthening, functionally based programs and functional training for 
children with CP. There were more RCT’s in the recent strengthening studies with 
some good evidence of effects of strengthening targeted muscles for children with CP 
as measured by dynamometry, however carryover into improvements in activity and 
participation are not clear.  
 
More recently the use of supported treadmill training has been investigated. Clinically 
this might be an appropriate form of endurance training for children, particularly for 
those more severely involved who in the past have not been able to participate in this 
type of exercise. However, most of the studies examining this were case studies with 
low levels of evidence and small sample sizes and further work is required. 
 
There have been advances in the field over the past 10 years with greater numbers of 
studies performed and improved study designs. Despite this, the strength of the 
evidence overall still remains lower than is desired for clinicians to accept that these 
interventions are positively impacting children with CP. A number of the studies were 
observational case studies with low levels of evidence. A number of the RCT’s were 
low quality RCT’s because of the study design or methodology. The strongest study 
designs were in the intensity studies; however these 4 studies showed no difference in 
intensity. Many of the strength studies used a follow-up assessment to determine if 
there was a carry-over effect and to examine the long term effect of the intervention, 
however many of the others did not. A number of studies in this review did not report 
all aspects of their trials or series and there was missing information, particularly in 
the recruitment and sampling procedures. This makes it difficult to generalise the 
results. This issue of insufficient reporting has been shown previously in a study that 
examined the quality of reporting trials in CP, whereby only a small number of trials 
included were sufficiently reported51. This poor reporting jeopardizes judgements on 
clinical implications.  
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Conducting research in children with CP is a challenging task due to the heterogeneity 
of the population and small sample sizes12. Physiotherapy is a complex intervention 
with a diversity of facets such as type and intensity of therapy, using standardised or 
individually tailored approaches and the skills and experience of the therapists, 
therefore the specific ingredient responsible for the effect is frequently hard to discern 
and difficult to measure52. The clinical heterogeneity of CP is a major challenge in the 
performance and interpretation of clinical trials, and clinical interpretation of observed 
change has been widely omitted in trials52. Good quality RCT’s to assess effectiveness 
of physiotherapy in this population are both feasible and necessary, however well 
designed observational studies can also provide important information.  
    
The most common confounder in many of the studies in this review was the impact of 
children having “usual” or “standard” physiotherapy either as a control or in 
conjunction with the intervention in question. It was often not clearly stated what and 
how much this was. This highlights the issue of what the ideal control group is in this 
population. The nature of clinical research often means that it is not ethical for 
children to have “no treatment” as a control group. In the studies in this review it was 
often difficult to determine whether both groups received similar baseline treatments. 
The impact of the “usual” physiotherapy on the findings remained unclear in many 
studies. In the NDT studies each participant had individualised therapy based on goal 
setting and it is very difficult to control the study conditions in such situations. It is 
difficult to evaluate effectiveness of treatments when there is no discrete dosage 
administered under specific invariable procedures in conditions that are held 
constant5. Evaluating the effects of NDT is confounded further because the skill level 
of the therapists is seldom clear5. In one study in this review the study took place 
during a NDT training course where the therapists are likely to be inexperienced and 
with instructors present it was not representative of usual therapy conditions39.   
 
Other influences that may have impacted the results were participant numbers and 
dosage of treatment employed. Many of the studies were pilot studies with small 
sample sizes, thus limiting power. Treatment dosage may not have been effective with 
many studies choosing a 6 week period of treatment, with little evidence to support 
this decision. It is possible that longer treatment periods are required before beneficial 
results become evident.   
 
A focused review of systematic reviews on the effectiveness of physiotherapy and 
conductive education interventions in children with CP showed that the high quality 
reviews found evidence supporting strength training, constraint-induced movement 
therapy or hippotherapy, and insufficient evidence on comprehensive physiotherapy 
interventions53. Because of the poor quality of primary studies many reviews drew no 
conclusions on the evidence of effectiveness of particular interventions.   
 
A recent systematic review of the effectiveness of physiotherapy interventions (both 
upper and lower extremity) for children with CP that included only RCT’s found that 
of 22 trials only 4 were high methodological quality54. The evidence for upper limb 
therapy was better. The evidence was limited due to low methodological quality and 
the statistically insignificant results of the studies54. Further well-defined trials with 
clear clinical questions that control for extraneous factors are still required.  
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Clinical significance 
 
The evidence for strengthening shows that targeted strength training can improve the 
strength of particular muscle groups as measured at the body function and structure 
level without provoking increases in spasticity. There is evidence of more 
improvements in muscle strength than gait or functional parameters, thus carryover 
into activity and participation has not been shown using the dosages employed in the 
studies in this review.  
 
Treadmill training may be clinically applicable in this population, however the results 
were mixed and there was a lack of evidence of significant changes for the better. 
Further evidence is required before it is used as a routine treatment for children with 
CP. There was some evidence of NDT improving gross motor function in children 
with CP but once again further high level evidence is required. The literature for 
intensity of physiotherapy showed that there was no difference in outcome for 
different intensities of general physiotherapy treatment; however a more intense 
program of NDT did show more significant improvements in gross motor function. 
 
Many of the treatments outcomes were quantified using measures based around the 
ICF domain of body functions and structures such as muscle strength, spasticity, gait 
parameters, or activities such as gross motor function and gait function. Not many 
studies considered the effect of the intervention on the participation of the child. Some 
of the studies considered the effect of the environmental setting such as home 
programs27; 28 or group based programs23; 30. This highlights the issue of matching 
appropriate outcome measures for the stated research question. Covering all ICF 
domains with selected tools is often difficult and a particular focused intervention 
may not impact all domains. Some studies that used particular outcome tools may 
have missed changes in other domains not measured in their studies.      
 
There are many areas of physiotherapy practice that are not routinely measured. This 
includes family advocacy, the organisation of assistive devices and other equipment 
and education of the child and family. These are very important roles of the 
physiotherapist and attempts to quantify them should be made.     
 
Limitations of this review 
 
In considering the results of this review, the limitations need to be also considered. 
The review focused on common treatments utilised in the past 10 years relevant to 
orthotic management. It did not cover all treatments used by physiotherapists and did 
not consider adjunct therapies such as hydrotherapy, hippotherapy, electrical 
stimulation and conductive education. The inclusion criteria were focused and did not 
include single case studies, studies not published in peer review journals or abstracts. 
There is a chance that some key studies were omitted from this review.    
 
Implications for orthotics  
 
Although none of the studies in this review directly examined the effect of 
physiotherapy on orthotic management of the child with CP, clinical experience 
suggests they work hand in hand. With the increased use of interventions including 
strengthening and treadmill training, physiotherapists need to make decisions with 
respect to the role orthoses play with each intervention. Many children with CP have 
improved stability in stance and better gait function and endurance with AFO’s on. 
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This suggests they would play an important part in treadmill training and 
strengthening programs, except when strengthening the foot and ankle. Physiotherapy 
and orthoses are often used in conjunction and complement each other. With less 
focus on normal movement and more on functional improvements in recent years, 
orthoses play an integral role in most physiotherapy interventions.  
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Physical therapy or physiotherapy (PT) as a profession has a long history in providing 
habilitative and rehabilitative services to children and adults diagnosed with cerebral 
palsy going back to the early 1900’s.  The model practice act of the Federation of 
State Boards of Physical Therapy (www.fsbpt.org) describes practice of PT as 
follows: 
 
1. Examining, evaluating and testing individuals with mechanical, physiological 
and developmental impairments, functional limitations, and disabilities or 
other health and movement-related conditions in order to determine a 
diagnosis, prognosis and plan of treatment intervention, and to assess the 
ongoing effects of intervention. 
2. Alleviating impairments, functional limitations and disabilities by designing, 
implementing and modifying treatment interventions that may include, but are 
not limited to: therapeutic exercise, functional training in self-care and in 
home, community or work integration or reintegration, manual therapy 
including soft tissue and joint mobilization/manipulation, therapeutic massage, 
prescription, application and, as appropriate, fabrication of assistive, adaptive, 
orthotic, prosthetic, protective and supportive devices and equipment, airway 
clearance techniques, integumentary protection and repair techniques, 
debridement and wound care, physical agents or modalities, mechanical and 
electrotherapeutic modalities, and patient-related instruction. 
3.  Reducing the risk of injury, impairment, functional limitation and disability, 
including the promotion and maintenance of fitness, health and wellness in 
populations of all ages. 
4.  Engaging in administration, consultation, education and research. 
During the past two decades, since the last Consensus Conference of the International 
Society of Prosthetics and Orthotics (ISPO), a significant expansion in research has 
seen the publication of randomized clinical trials and a number of systematic reviews 
on the topic of PT and the interventions commonly used by therapists.  Highlights of 
these developments will be discussed in this paper. 
 
This is one of two papers to be presented at the 2008 ISPO Consensus Conference on 
the topic of PT.  The purposes of this paper are to provide; 1) an overview of efficacy 
literature on PT and 2) to focus on select interventions commonly used by therapists.  
The interventions to be reviewed include exercise interventions to promote motor 
control for gait including neurodevelopmental treatment (NDT), the use of electrical 
stimulation and biofeedback for gait training and lastly, to review the efficacy of 
casting and stretching to promote flexibility.     
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METHODS 
 
The following electronic databases were searched for articles up through June of 
2008; Pubmed, CINAHL, the American Physical Therapy Association database 
Hooked on Evidence, the Physiotherapy Evidence Database PEDro, the American 
Academy of Cerebral Palsy and Developmental Medicine on-line database of 
Evidence Reports and the Cochrane Controlled Trials Register. The reference lists of 
the identified studies and reviews were screened for additional references. Study type 
inclusion criteria included published, full-length articles or full written reports of 
randomized clinical trials (RCTs) or systematic reviews published since 2000.  If no 
RCTs or systematic reviews were identified then additional references were reviewed. 
The Oxford Centre for Evidence-based Medicine Levels of Evidence 1  was used to 
grade the evidence that was reviewed and also used as a basis for the author 
recommendations.   
 
 
RESULTS 
 
Meta analyses are the accepted highest level of evidence in support or refutation of 
interventions.  No meta analyses were found on the topic of PT or interventions 
commonly used by PT related to CP.  The next highest level of support are systematic 
reviews and a number of reviews have been published in the past decade related to PT 
and interventions for CP. 
 
Methodological Issues  
 
Two recent systematic reviews have focused attention on methodological quality of 
research on the topic of PT 2 and motor intervention programs 3 for children or adults 
with cerebral palsy.  Kunz and colleagues 2 identified issues in performing 
randomized clinical trials (RCTs) to assess how the trials handled study design, 
methodology and analysis in working with a very complex patient population.  
Fourteen (14) RCTs were reviewed and the authors found that good to fair 
methodology was used in the studies.  The article by Kunz et al 2 more specifically 
outlines the methodological characteristics of each of the studies in regards to study 
size, setting, randomization method, use of stratification and concealment.  The 
authors concluded that despite the challenges, “good quality RCTs in physiotherapy 
for children with CP are feasible and currently being done”.  Siebes et al, 3 similarly 
reported that a significant improvement in methodological design was seen in articles 
published from 1990 to 2001 in contrast to previously documented findings of 
Vermeer and Bakx 4 who reviewed the literature in the prior decade.  Siebes and 
colleagues identified a sample of 49 studies, of which 13 were classified as Sackett 
level one 5, 19 as level two and 15 as level four with the remaining studies as case 
studies and level five.  An increase in the percentage of studies at level one or two 
doubled, from 32 to 66%, in comparing the two time frames.  
 
Physical Therapy Interventions – Global Consideration 
 
A recently published systematic review of the effectiveness of PT interventions for 
children with CP provides an overview of the topic 6.  The authors reviewed RCTs 
published between 1990 and 2007.  Twenty two (22) trials were identified that 
included eight intervention categories typically reported in the literature.  Overall the 
studies represented PT services provided to children age seven months to 18 years on 
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an overall cohort of 255 children with spastic diplegia, 238 with hemiplegia, 180 with 
quadriplegia and 20 with ataxic or mixed involvement.  The levels of disability were 
represented using the Gross Motor Function Classification System (GMFCS) 7 with 
21% at level one, 20% level two, 33% level three, 21% level four and 5% in level 
five.  Eight intervention categories were identified with 53 outcome measures across 
the studies and only eight of the measures being used in more than one study.  No 
strong evidence was found for the reviewed interventions.  Moderate evidence on 
effectiveness was found for upper extremity treatment and constraint induced therapy.  
Moderate evidence on ineffectiveness was found on strength training for walking 
velocity or stride length and conflicting evidence was reported for strength training 
with the Gross Motor Function Measure (GMFM) 8 as an outcome measure.    
 
Two additional RCTs were identified in the literature, more recently published than 
the systematic reviews listed above 9,10.  Weindling et al 9 randomized children with 
spastic CP to a PT only, PT with additional therapy provided by a physical therapist 
assistant or PT with additional services provided by a family support worker.  Seventy 
six (76) families completed the intervention period with 43 children available for 
reassessment  six months following intervention and 34 at one year post intervention.  
While  improvement in motor functioning was seen following the six month 
intervention period, no difference was found with addition of the either the physical 
therapist assistant nor family support worker services.  Christiansen & Lange 10 
studied the effect of two delivery schedules for PT services.  Twenty five children 
were stratified by GMFCS level and then received intervention sessions of 45 minutes 
four times per week for six weeks followed by a six week, no intervention phase.  
This schedule was repeated three times for a total intervention period of 30 weeks and 
a total of 48 intervention sessions.  The other group of children was received 45 
minute sessions once or twice per week for 30 weeks, also receiving a total of 48 
sessions.  Both groups significantly increased their GMFM-66 scores post 
intervention without difference between the groups other than better compliance with 
the group receiving four time-per-week intervention scheduling.  It should be noted 
that neither of these studies included a no intervention control group so the effect of 
only the PT service as not assessed.  These two additional RCTs provide further 
evidence to physical therapy as a global intervention for children with CP. 
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Table 1 Listing of Randomized Clinical Trials from Kunz et al 2 & Siebes et al 3 
 
Author, year Topic Level of 
Evidence1 
Bower et al, 1996  11 Goal type and PT intensity  1  
Bower et al, 2001  12 Goal type and PT intensity  1  
Bumin and Kayihan, 2001  13 Center based vs home PT 1  
Chad, 1999  14 Weight bearing on bone density 1  
Girolami and Campbell, 1994  15 NDT vs regular PT 1  
Hazlewood et al, 1994  16 Electrical stimulation 1  
Jonsdottir et al, 1997   17 NDT 1  
Ketelaar et al, 2001  18 Functional vs standard PT 1  
Kuczynsky and Slonka, 1999  19 Hippotherapy 1  
Law et al, 1991  20 NDT and casting 1  
Law et al, 1997  21 NDT and casting 1  
MacKinnon, 1995  22 Hippotherapy 1  
Mayo, 1991  23 NDT intensive vs home 1  
O’Dwyer et al, 1994  24 Physiologic study on muscle tone 1  
Palmer et al, 1990  25 NDT vs infant stimulation 1  
Reddihough et al, 1998  26 Conductive education vs PT 1  
Steinbok et al, 1997  27 Rhizotomy and PT vs PT alone 1  
Steinbok and McLeod, 2002 28 Rhizotomy and PT vs PT alone 1  
1Oxford Centre Criteria, 2001 
 
 
Neurodevelopmental Treatment Approach  
 
Two systematic reviews 29 and 30 have been published on the topic of  
neurodevelopmental  treatment (NDT) used by therapists working with children with 
CP.  Butler and Darrah 29 participated in an American Academy of Cerebral Palsy and 
Developmental Medicine evidence report project on the topic.  Four level one studies 
20, 21,  25, 31 and eight level two studies 32, 33, 34, 35, 36, 37, 38,39 were reviewed.  The authors 
reported that inconsistent evidence was available for the effect of NDT on motoric 
responses, more consistent positive results on handling to active range of motion, 
spasticity and discomfort and no advantage favoring NDT in the area of motor 
development.  There was no evidence regarding the effect of NDT on cellular 
structure or function.  Results in favor of an infant stimulation program over NDT 
were reviewed in the area of functional limitation / activity and no difference in 
parental report of satisfaction between NDT versus other intervention programming 
that was offered when a contrast was available to families.  The report does provide 
more detailed information regarding subgroups of children who have shown benefit 
from the intervention.  Brown and Burns 30 reported on 17 articles on NDT as an 
intervention.  The authors also reported largely inconclusive evidence in support of 
NDT. 
 
Functional Approach Contrasted to NDT or Vojta 
 
Ketelaar and colleagues 18 randomly assigned a group of 55 children with CP to either 
a functional group intervention program or a reference group that included 
continuation of current therapy which was predominately NDT or Vojta.  The 
intervention lasted for six months with an average of 3-4 PT sessions per month for 
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both the intervention and reference group.  The main features of the functional 
approach were functional goals, repetitive practice on the motor ability in context of 
the functional activity, active participation by the children in motor planning and 
execution and active participation of the parents in goal setting, decision making, 
implementation of the program and evaluation of the goals.  The program was 
evaluated pre, post .  Follow up assessment were completed at six and 18 months 
following pretesting. The authors reported a significant improvement in GMFM at 
post-test for both groups, but on the group receiving the functional approach 
intervention improved on the PEDI with post testing.  The authors concluded that 
using this approach greater functional improvement is seen over more traditional 
approaches to PT intervention.   
 
Balance Training 
 
Harris and Roxborough  40 published a systematic review of 12 studies examining the 
efficacy and effectiveness of physical therapy postural control interventions for 
children with CP.  The authors reported on limited evidence, Sacket levels three to 
five, for all studies reviewed.  Individual studies have since been reported by Ledebt 
et al 41 & Woollacott et al 42 that provide further evidence.  Ledebt and colleagues 41 
demonstrated improved gait symmetry and balance in children with hemiplegic 
involvement following a six week intervention program of three sessions per week.  A 
multiple baseline design was used with randomization to treatment versus control 
phase.  Woollacott et al 42 and Shumway-Cook et al 43 also used a single-subject, 
multiple baseline experimental design to examine massed practice effects of balance 
training on muscle activity and stability in six children with hemiplegic and diplegic 
CP.  A moveable foreplate system (NeuroCom) was used to deliver 100 pertubations 
per day over a five days of intensive training schedule.  Improvements in the standing 
subsection of the GMFM and select measures of balance from the force platform were 
reported. providing additional support for balance training for children with CP.   
 
Neuromuscular Electrical Stimulation  
 
Kerr et al 44 published a systematic review to examine the efficacy of electrical 
stimulation for strengthening or to improve motor function of children with CP.  
Eighteen (18) articles were reviewed with six of the articles classified as RCTs.  
Twelve (12) of the articles examined the use of neuromuscular electrical stimulation 
(NMES) and six (6) threshold e-stim (TES).  The differentiation between the two is 
that NMES is applied to obtain a palpable contraction where TES is applied 
subthreshold to a muscle contraction.  The RCTS reported by Kerr are listed in Table 
2.  Kerr reported evidence from three RCTs that NMES has been shown to improve 
motor control through an increase in GMFM scores but that conflicting and 
inconclusive evidence from three RCTs is seen for TES for either improvement of 
muscle strength or motor function in children with CP.    More two additional RCTs 
45, 46 have been published on the use of either NMES or TES in CP.  Kerr and 
colleagues 45 examined the efficacy of NMES and TES in strengthening of the 
quadriceps and did not find any significant findings.  Ho and colleagues 46 examines 
NMES applied to the gastrocsoleus complex to reduce muscle stiffness and to study 
the effect on select gait temporal-distance measures.  The authors reported significant 
results in improving select walking measures, but not muscle stiffness.   
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Table 2: Electrical Stimulation Reference Articles 
 
Topic Level of Evidence1Author, year  
Dali et al, 2002   47 TES and PT 1  
Hazelwood et al, 1994  16 NMES and PT 1  
Park et al, 2001 48 NMES and PT 1  
Sommerfelt et al, 2001 49 TES, stretching and PT 1  
Steinbok et al, 1997 27 TES and PT 1  
Van der Linden et al, 2003  
50
NMES and PT 1 
 
1Oxford Centre Criteria, 2001 
 
 
Biofeedback   
 
No systematic reviews or RCTs were identified addressing the issue of biofeedback 
and gait training in children with CP.  Table 3 lists eight articles that were found on 
the topic and the level of evidence of each.  The use of auditory and visual surface 
EMG biofeedback has limited evidence with no studies identified who randomized the 
intervention to a non-intervention control group.  Only the Dursun article 51 included 
randomization of treatment assignment in their study design and that was to contrast 
the use of biofeedback to the use of conventional exercise. Biofeedback was used by 
the authors to treat dynamic equinus with a cohort of 21 children receiving both 
exercise and biofeedback in comparison to an exercise only group.  Both groups 
significantly improved gait function, but it was the biofeedback group that 
significantly improved muscle tone and active ankle range of motion.  The authors 
concluded that biofeedback was an effective intervention for dynamic equinus in 
children with CP.  
 
Table 3: Biofeedback Reference Articles 
 
Topic Level of Evidence1Author, year  
Bolek, 2003  52 Surface EMG (SEMG) for 
dorsiflexion 
4  
Colborne et al, 1994  53 PT or SEMG for 
plantarflexors 
3  
Dursun et al, 2004  51 SEMG for equinus 2  
Flodmark, 1986 54 SEMG for gait training 4  
Kassover et al, 1986  55 Auditory EMG for heelstrike 4  
Seeger et al, 1981 56 & 1983 
57
Auditory EMG for gait 
symmetry 
4 
 
Toner et al, 1998  58 SEMG, strengthening & ROM 
for ankle function  
4  
1Oxford Centre Criteria, 2001 
 
 
Casting 
 
In 2007, AACPDM published an evidence report which included a systematic review 
of casting, either alone or in combination with botulinum toxin type A on equinus in 
children with CP 59.  Of the 22 articles reviewed, 12 reported on casting as a sole 
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intervention with only one being a level two RCT and the others providing level four 
evidence.  Table 4 lists the articles.  The small level two RCT by Bertoti 60 examined 
10 weeks of intervention in 16 children with CP where were randomly assigned to a 
NDT only or NDT plus casting group.  A significant percent increase in stride length 
was found, but other gait variables were non-significant between groups post 
intervention.  In reviewing all casting literature in the study review, Blackmore and 
colleagues 60 concluded that there was little evidence to support casting versus no 
casting, but that a no-intervention control group has not been used in any RCT on the 
intervention.  Many of the studies demonstrate a return to baseline values at follow up 
and it is unclear whether the improvement seen in range of motion is improved stretch 
tolerance or actual increased range due to the outcome measurement methodology that 
is typically used.   
 
Table 4: Casting 
 
Topic Level of Evidence1Author, year  
Bertoti 1986 60 Inhibitive casts & PT 2  
Brouwer et al, 1998 61 & 2000 62 Serial casting 4  
Cameron and Drummond, 1998 63 Serial casting and PT 4  
Cottalorda et al, 2000 64 Serial casting 4  
Dvir et al, 1991 65 Serial casts & NDT 4  
Hinderer et al, 1988 66 Bivalved casts & NDT 4  
Otis et al, 1985  67 Bivalved casts 4  
Sussman and Cusick, 1979 68 Inhibitive casting & 
PT 
4  
Tardieu et al, 1982  69 Serial casting 4  
Watt et al, 1986  70 Inhibitive casts & PT 4  
1Oxford Centre Criteria, 2001 
 
 
Stretching 
 
Two systematic reviews  71, 72 have recently been published examining the effect of 
passive stretching to improve range of motion or to affect spasticity in children with 
CP.  Pin and colleagues 71 identified 10 studies, of which, four were RCTs on the 
topic.  Overall the authors reported limited evidence for passive stretching to improve 
range of motion.  The authors reported some evidence for increased range of 
movement following stretching and decreased spasticity, but no lasting effect.  
Sustained stretching was preferred to manual stretching.  Wiart 72 reported on seven 
studies with three RCTs and the paper overlapped the findings of Pin and colleagues.  
The RCTs from both reviews are listed in Table 5.  The findings of Wiart also 
reported limited evidence for passive stretching, active stretching or for positioning to 
improve range of motion in children with CP.   
 
Table 5: Stretching References 
Topic Level of Evidence1Author, year  
Miedaner & Renander, 1987  73 Passive stretching 2  
O’Dwyer et al, 1994  24 Passive stretching 2  
Richards et al, 1991  74 Single prolonged stretch 2  
Tremblay et al, 1990  75 Single prolonged stretch 2  
1Oxford Centre Criteria, 2001 
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RECOMMENDATIONS 
 
Based on the information reviewed in this paper the following recommendations are 
made: 
 
• While there is some evidence, it is not consistent evidence (Grade A) for PT as 
an intervention for children with CP. 
• Moderate evidence (Grade B) is present on effectiveness of upper extremity 
treatment, constraint-induced therapy, use of a functional approach to 
improving gross motor skills and use of NMES to improve gait function.   
• Limited evidence (Grade C) for NDT as a treatment approach, the use of 
balance training to improve sitting or standing balance, the use of biofeedback 
to improve gait and the use of casting to improve equinus. 
• Inconsistent evidence (Grade D) or moderate evidence for the ineffectiveness 
of strength training for walking velocity or stride length and for passive 
stretching to increase range of motion and for the use of TES to improve gait. 
 
It is reported widely in the literature that the lack of evidence-based support for an 
intervention does not negate the clinical effectiveness or efficacy of that intervention 
if limited research on the subject has been completed and that there is clinical 
consensus that the intervention is effective.  Physical therapy and many of the 
interventions used by therapists are in this situation with limited high quality research 
currently available to guide practitioners toward sound evidence-based decisions.  The 
practitioner is left with the need to discriminate where beginning evidence of a lack of 
support for an intervention, for example passive stretching to improve range of 
motion, is seen in the literature pending the completion of more definitive research.  
This will be a long term process as certainly part of the issue lies in the heterogeneity 
of children with CP and difficulty in gaining the information, although significant 
strides have been made in this area over the past decade as reported by Kunz et al 2 
and Siebes et al 3.   
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 PHYSICAL THERAPY MANAGEMENT: POINTS FOR DISCUSSION 
WHAT DO WE KNOW, WHERE SHOULD WE GO? 
 
Dianne J. Russell PhD 
CanChild Centre for Childhood Disability Research 
McMaster University, Canada 
 
I want to start by acknowledging Dr. Harvey and Dr. Stuberg for undertaking the 
synthesis and review of this literature.  I realize what a big task it was. It is interesting 
how they both took a very different approach to their reviews.  In addition to focusing 
on different interventions,  Dr. Stuberg focused on collating evidence from systematic 
reviews and RCT studies where possible as the highest level of evidence, whereas  Dr. 
Harvey relied more on individual studies (which included RCTs) and rated the 
systematic reviews as low level evidence. This brings to light one of the challenges 
with using and interpreting the Oxford CEBM guidelines for the review of the 
evidence and recognizing the inconsistencies which may occur in the application of 
the guidelines.  This is in addition to the challenges with interpreting the strengths and 
limitations of individual articles.  It was recognized throughout this meeting that the 
Oxford guidelines were challenging to apply in our area, where randomized controlled 
trials are the exception rather than the rule.  Dr. Harvey did a nice job describing 
individual studies documenting specific information about child characteristics and 
outcomes, making it easy to tease out the generalizability of the findings from the 
tables.  However, when summarizing the evidence for a particular intervention across 
studies, Dr. Harvey averaged the levels of evidence rather than weighting those 
studies with higher methodological rigour as providing stronger evidence.  I have used 
their two reviews along with a recent systematic review of randomized trials by 
Anttila et al.1 to guide this discussion and identify important questions to consider.   
 
As with many areas in rehabilitation medicine, the evidence for the effectiveness of 
physical therapy interventions for children with cerebral palsy is sadly lacking.  While 
there has been a lot of work done in the area, we still don’t know what interventions 
work, for whom, and under what conditions.  The methodological challenges we face 
are great.  We have no high level (Grade A) evidence for any of our interventions 
from high quality randomized controlled trials.  We have limited Grade B evidence 
from Marjolijn Ketelaar’s well done RCT 2 for the value of a functional approach to 
therapy (defined as physical therapy with an emphasis on practicing functional 
activities) to improve capability and performance of functional skills in daily life as 
measured by the Pediatric Evaluation of Disability Inventory (PEDI) in children with 
CP primarily in GMFCS levels I and II.  While these results are promising, further 
studies replicating this work are needed.  Law et al.3 are currently conducting a RCT 
of a functional approach to therapy or “task/context approach” compared with  a 
“child-focused approach” and measuring outcomes at all levels of the International 
Classification of Functioning, Disability and Health (ICF) 4 which should help with 
our understanding of the generalizability of the results for functional therapy.  Dr. 
Stuberg  also identifies Grade B evidence from several RCTs evaluating 
Neuromuscular Electrical Stimulation (NMES) to improve gait; however without 
going back to the original articles and describing  the details of the individual study 
participants in terms of ages and GMFCS levels it is difficult to know to whom these 
results are generalizable.  There is evidence from systematic reviews that strength 
training programs can increase muscle strength in children and young adults with CP 
without increasing spasticity, however the evidence from four lower quality RCTs 
indicate that strength training is not effective in changing gait parameters such as 
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walking speed and stride length.  There is inconclusive evidence regarding its effect 
on gross motor function as measured with the GMFM. All other areas of 
physiotherapy that were reviewed have limited or conflicting evidence. 
 
This review of the evidence for physical therapy interventions raises many questions 
and my job is to highlight some issues that we could consider for discussion.  I think 
the first one is what do we have to do in order to get the quality evidence we need?  
Assuming that the RCT is the gold standard for determining evidence of effectiveness, 
is it necessary and is it feasible to conduct a high quality RCT in this area? Unlike 
work in the area of drug trials, where RCTs are relatively straightforward in terms of 
randomizing and controlling for important variables, we face incredible challenges 
related to the difficulty in “blinding” therapists and children to their treatment 
interventions, compliance, fidelity to the prescribed treatment(s), defining and 
describing our treatments specifically enough so they can be administered consistently 
and replicated by others. Families may have difficulties consenting to randomization 
(especially if it means changing therapists) and may choose not to participate.  Is our 
field in a place where we have enough good lower level evidence with good outcomes 
to justify the cost and resources needed for an RCT? Whether or not we decide that 
RCTs are necessary, how will we overcome the methodological challenges associated 
with doing research in the area of cerebral palsy?  I’m going to use the PICO 
framework (Patient, Interventions, Comparison, and Outcomes) to highlight a few of 
these challenges. 
 
1)  Patient: Patient heterogeneity makes it particularly challenging to get large enough 
samples in research studies to have the power to detect statistical and clinically 
important differences between interventions.  In studies of general therapy 
approaches, we may include children from a spectrum of GMFCS levels in order to 
get large enough samples, perhaps diluting the effects of the intervention if it is only 
effective for a subgroup of children.  Do we need to narrow our focus to determine 
what works best for children in specific GMFCS levels or at least stratify by GMFCS 
levels so we can start to tease this out?  On the other hand, when samples only include 
children in limited GMFCS levels, it is important when summarizing the evidence that 
we are explicit about to whom these results apply.  
 
2) Interventions: Physical therapy “management” or intervention is dependent on the 
goals of the child and family in consultation with evidence-based, family-centred 
service providers.  Children with CP are extremely variable in their functional 
capabilities and goals, making the target of intervention challenging.  PT interventions 
as with many rehabilitation interventions are diverse and often a mix of several 
different approaches making the “active” ingredient difficult to tease out.  Thus while 
it may be artificial to try to “standardize” a treatment approach if we can’t clearly 
describe what it is we do, then how can we evaluate and replicate the results?  And if 
we do find an effective approach, will we have described it in enough detail in order 
to be able to teach it to others?  Have we done a good enough job defining the content 
and the process of our treatments that will facilitate research, replication and 
dissemination of treatments into practice?  
 
3) Comparisons: Another interesting dilemma that arises when reviewing the evidence 
concerns what should be the appropriate control or comparison group?  Does it make 
sense to compare two different intensities of a treatment that has no evidence of 
effectiveness?  How do we interpret the results?  Several authors criticize studies for 
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not having a “no treatment” control group.  Is it necessary or ethical to have a no-
treatment control? 
 
4) Outcomes: Are we measuring the right outcomes?  If our goals are to improve 
activity and participation of children, we should not only be measuring impairments 
and assume that improvements will carry over into functional activities.  We need to 
ensure that our outcomes match our goals.  Do we have good outcome measures for 
what we want to evaluate at all levels of the ICF or do we need to focus more effort 
on developing and validating clinically appropriate, responsive, psychometrically 
sound outcome measures?  Should we be trying to come to consensus on common 
outcomes? Do we need more multi-centre collaboration with common methods and 
measures to allow us to combine data sets for meta-analyses?  If so, how do we move 
forward on this?  And finally, with limited health care dollars and limited evidence of 
effectiveness for most of what we do, what is the take home message for evidence-
based clinicians, parents and families, and funders of health care? 
 
It is encouraging to note that the methodological quality of studies of motor 
interventions for children with CP has greatly improved over the years 5,6 however the 
evidence is still not there and we need to decide what are the important next steps in 
getting the evidence we need to ensure we are providing children and families with 
the most cost effective, family-centred, evidence based care.   
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The primary role of occupational therapists is to enable individuals to participate in 
meaningful occupations of their everyday life. Occupational therapy practice focuses 
on enhancing occupational performance in self-care, productivity and leisure activities 
and overcoming the obstacles that limit the ability to participate in these occupations 
[1]. Occupational therapy is holistic by definition, and includes minimizing 
impairments, maximizing functioning in all facets of life, and facilitating participation 
in all life roles. This may be achieved through remediation and training (to acquire or 
improve abilities and skills), and compensation and adaptation (by modifying the task 
or the environment to improve functioning). Many new outcome measures are 
enhancing the therapist’s ability to objectively assess children with disabilities and 
monitor changes over time.  
 
Recent advances in pediatric occupational therapy practice have been prompted by a 
number of theoretical frameworks and concepts [2] [3] [4]. These include: 
* Client-centred practice (personal autonomy and choice, life satisfaction) 
- What are the child’s preferences and goals that are intrinsically motivating? 
* Family-centred care (collaboration on goals and priorities) 
- What are the family’s priorities and concerns at this time? What resources and 
supports are available to them? 
* Biopsychosocial framework of the ICF (International Classification of 
Functioning, Disability and Health; a holistic view of functioning and health) 
- What areas should be considered in the evaluation and the intervention process 
to ensure that therapeutic strategies are holistic and encompass all aspects of 
an individual’s functioning? Which contextual factors are either enhancing or 
inhibiting functional capacities? 
* Person-Environment-Occupation Model (transactive model) 
- In what way are the impairments and activity limitations of the individual 
influenced by characteristics of everyday tasks, and by the environment in 
which these activities are performed? At what level(s) should the OT intervene 
(person, environment and/or occupation) to promote function? 
* Lifespan approach (key transition points in development) 
- What are the current challenges for the child at this point in development? 
When should the occupational therapist re-evaluate the child’s needs and 
concerns in the future? 
* Evidence-based practice (graduate level education) 
- What new research evidence needs to be considered, in the context of clinical 
expertise and clients values, to ensure best practice? 
* Life-long learning (knowledge transfer and exchange) 
- Which new scientific discoveries need to be transferred and used in clinical 
practice? Which areas of occupational therapy practice need to be investigated 
through scientific inquiry? 
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This paper provides a brief overview of the evidence on the effectiveness of selected 
OT interventions for children with cerebral palsy (CP). Interventions used by OTs are 
diverse and may focus either on elements of body structure and function, activity, 
participation and/or the environment. The areas of intervention selected were those in 
which there is a body of evidence to review, and are discipline-specific (typically 
performed by occupational therapists). We chose to organize the literature according 
to the classification proposed by the ICF. For body structure and function, we 
reviewed the evidence on: 1) casting and splinting of the upper extremity, and 2) 
seating and positioning. These are devices or adaptations used as tools to prevent or 
minimize deformity and to facilitate abilities and capacities. For activity and 
participation, we reviewed the evidence for three occupational performance domains; 
1) productivity (hand use), 2) self-care (feeding) and 3) play (virtual reality). 
Facilitation of the use of the upper extremities through constraint therapies was 
specifically reviewed. Promoting bimanual hand use in children with CP is critical for 
the successful execution of everyday tasks and activities (ref). With respect to 
independence in self-care, feeding challenges are a common area of concern for this 
population and is associated with respiratory and gastrointestinal health risks. Safe 
and efficient feeding is essential for nutrition and growth, positive parent-child 
interactions and personal autonomy. Therefore the effectiveness of feeding 
interventions was reviewed [5]. Play is a primary occupation of children and is an 
important source of skill development (motor, social, cognitive) and social 
participation. Specifically, we focused on virtual reality as a new modality for 
intervention to enhance motivation, mastery and self-efficacy (Rizzo et al, 1998). For 
each of the areas reviewed, we formulated a primary PICO research question 
(Population, Intervention, Comparison, Outcome) according to the domains of body 
structure, body function, activity and participation. Although, we provide a 
systematic review of discrete OT intervention approaches (as outlined above), each of 
these approaches should not be performed in isolation, but rather, should be integrated 
within the concepts and frameworks highlighted above.   
 
 
SPLINTING AND CASTING 
 
Search strategy: 
The electronic databases that were searched included CINAHL, CIRRIE, the 
Cochrane Library, EMBASE, ERIC, HealthSTAR, Health and Psychosocial 
Instruments, MEDLINE, OTSeeker, PEDro, PsycINFO and RehabData, using the key 
words: tetraplegi* (ie. tetraplegia or tetraplegic), spastic*, quadriplegi*, quadrapare*, 
pes equinus*, monoplegi*, little* disease, hypotonic*, hemiplegi*, hemipare*, 
dystoni*, diplegi*, dyskine*, choreoathe*, cerebral palsy, atheto*, ataxi*, cast*, 
splint*. Only English or French manuscripts were included, for publications up to and 
including December 2007. All age groups between newborn and 18 years of age were 
included. Articles on stroke, traumatic brain injuries, adults, and very poorly designed 
studies were excluded (e.g. anecdotal reports, single subject observations). The search 
was completed by a research assistant trained in the appropriate search strategies. 
 
Definition of terms: 
Orthotic management would include the use of splints or casts to improve function. 
They may be used alone or in conjunction with other rehabilitation interventions 
(Kurtz, 2002). Splints are devices designed to maintain parts of the limb in a 
particular position, stabilize one or more joints, and/or facilitate specific movement 
patterns [6]. Splints may be either static (rigid) or dynamic (movable parts), and are 
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made of moldable plastic. Casts are used to maintain a body part in a fixed position, 
and are typically made of plaster or fiberglass. They may or may not be removable. 
Serial casts involve a series of casts that are changed periodically to progressively 
increase the stretch on a muscle, whereas inhibitive casts are designed to decrease the 
effect of reflexes [6]. 
 
SPLINTING 
 
Purpose 
Static resting splints are used primarily to maintain muscle length and prevent 
deformities for children with spasticity. They can be used while sleeping or 
periodically during the day, when the child is less active. A biomechanical (to support 
body part) and /or neurophysiological (to decrease spasticity) framework is applied, 
with the primary purpose of maintaining or increasing muscle length so as to improve 
position, flexibility and quality of  movement, and preventing contractures. In 
addition, prolongation of muscles may decrease spasticity. Other possible benefits are 
to reduce pain, support weak muscles, minimize involuntary movements or reflexes, 
and immobilize part of the body. In some cases splints serve as a base for attachments 
of other devices such as self care aids or toys [6]. The overarching goal is to improve 
hand function. For example, the wrist may be stabilized in a neutral (slightly 
extended) position to facilitate a more functional grasp pattern. 
 
Primary PICO research question: Does daily use of a hand splint in children with 
cerebral palsy result in enhanced hand movement patterns and more functional use of 
the hand? 
P: Infants, children and/or youth with cerebral palsy 
I: Hand splint, typically for several hours per day, over several weeks 
C: Compared to baseline (prior to use of splint) or compared to a control group 
O: Measures of body structure (somatosensory evoked potentials), body function 
(spasticity, range of motion, grip strength, arm posture, visual-motor control, visual-
perception, motor skills such as grasp) and activity and participation (hand use, 
functional activities); body function measures predominate. 
 
Primary findings: 
Nine studies described the effectiveness of upper extremity splints for children with 
cerebral palsy. Descriptive information regarding these studies appears in Table A and 
B [7-15] . Children were of varying ages (infants to adolescents) and most had either 
quadriplegia or hemiplegia. Sample size for 8/9 studies was small (1-12 subjects). 
Interventions typically involved pre- and post-testing after a period of weeks to 
months of daily use of a hand splint, with no RCTs. A variety of hand splints were 
used in these studies, with the primary goal of maintaining the hand and wrist in a 
well-aligned neutral position and/or to inhibit spasticity. Outcome measures were 
predominantly observational, with one study using a three-dimensional tracking 
system. Results suggest improvements in hand and arm use, including grasp, better 
range of motion and hand positioning, and decreased spasticity. Muscle strength did 
not improve. Only one study found no positive effects. Some studies did not apply 
formal statistical analyses, and these studies are indicated in the Table. Improvements 
in functional activities were not supported by these studies. 
 
Review articles: 
Autti-Ramo et al [16] conducted a systematic review of all review articles on the 
effectiveness of upper and lower limb casting and orthoses in children with cerebral 
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palsy. This includes the review article by Teplicky et al [6] in which 3 articles on 
splinting are included. The conclusion of these reviews is that hand splints appear to 
improve grasp but the ability to use the hand more functionally in everyday tasks 
remains unclear. Existing studies suggest that splints may be more helpful in children 
with more severe limitations, however this requires empirical support. Furthermore, 
the choice of the type of splint needs to be task-specific.  
 
Conclusions and future directions: 
The literature in this area is sparse. Studies indicate that following a period of use of 
upper extremity splints, spasticity may be inhibited and there are improvements noted 
in range of motion, grasp pattern and general hand use. The long-term effects are 
unknown. Objective, quantitative measures of hand function have not been used, 
therefore improvements in grasp and hand use require empirical validation in the 
future. Use of splinting in conjunction with more functional, task-specific approaches 
may be warranted to enhance functional gains and should therefore be examined in 
future studies. Grade of Recommendation: C 
 
CASTING 
 
Purpose: 
Casting may be used on the upper or lower extremities for short periods of time to 
stretch a shortened muscle, and thus, to increase range of movement. Therefore, 
casting may either prevent or correct deformities, decrease spasticity, and possibly 
also decrease pain and discomfort. Supporting normal alignment and greater range of 
movement may help promote greater function [6, 16, 17]. 
 
Primary PICO research question: Does daily use of an upper extremity cast in 
children with spastic cerebral palsy result in enhanced upper extremity movement 
patterns and more functional use of the hand? 
P: Infants, children and/or youth with spastic cerebral palsy 
I: Upper extremity inhibitive casting, typically for several hours per day, over weeks 
to months 
C: Compared to baseline or compared to randomized control group 
O: Measures of body function (spasticity, range of motion, grip strength, quality of 
upper extremity movements, fine motor skills such as grasp) and activity and 
participation (hand use, functional activities); body function measures predominate. 
 
Primary findings:  
Eight studies described the effectiveness of upper extremity casts for children with 
cerebral palsy. Descriptive information regarding these studies appear in Table C and 
D [18-25]. Children were of varying ages although most were preschoolers or early 
school-age, and subjects had one of three spastic subtypes (diplegia, quadriplegia, 
hemiplegia). Sample size for 6/8 studies was small (1-12 subjects), typically involving 
pre- and post-testing after an extended period of daily use of casts. Two studies by the 
same group [21, 26] involved larger samples (50+) and implemented a randomized 
controlled trial. Casts were predominantly inhibitive, with the primary goal of 
inhibiting spasticity and maximizing range of motion. Casts were worn several hours 
per day, for weeks to months. Casting was viewed as an adjunct to other rehabilitation 
treatment approaches. Outcome measures included observational data, measurement 
of range of motion, and in some cases, application of standardized measures of quality 
of upper extremity movement and motor skills. Results suggest improvements in 
passive and active range of motion, and decreased spasticity. There is some 
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suggestion of improvements in upper extremity movement quality, but this is unclear. 
Improvements are not sustained on follow-up assessment. The positive effects on 
quality of movement noted in the first randomized trial [21] were not replicated in the 
second  trial[26]. Authors suggest that this may have been because the first study 
included older children (4-8 years) who may exhibit greater benefits than younger 
children (<4 years). The influence of age remains to be determined in future studies. 
 
Review articles: 
In addition to the systematic review of all review articles on the effectiveness of upper 
and lower limb casting and orthoses in children with cerebral palsy conducted by 
Autti-Ramo et al [16], there are two review articles that focus predominantly on 
casting. This includes the review article by Teplicky et al [6] in which 3 articles on 
casting are included, as well as the review by Lannin et al [17] which included articles 
in children and adults with brain injury. The conclusion of these reviews is that upper 
limb casting improves range of motion with some possible effect on decreasing 
muscle tone. The effect on quality of arm movement and hand function remains 
unclear, although there is some suggestion of improved movement quality in the 
short-term. It is uncertain if such improvements are merely cosmetic or have a 
functional impact [16, 17]. 
 
Conclusions and future directions: 
Casting appears to transiently improve range of motion, with some possible effects on 
decreasing spasticity and improving quality of movements. The lack of high level 
evidence limits the ability to strongly support or refute the short and long-term 
effectiveness of upper limb casting. Clinical indicators for casting appear to be 
presence of soft tissue contracture, spasticity and limited joint range [17]. The type or 
severity of cerebral palsy or the possible effects of age were not examined as 
determinants of effectiveness of casting. In future studies, outcome measures need to 
focus not only on the direct impact on range of motion and spasticity, but the possible 
concurrent benefits on hand function. Casting in conjunction with particular task-
specific training may prove beneficial in optimizing functional gains, and should 
therefore be examined in future studies. Grade of Recommendation: C 
 
 
SEATING AND POSITIONING 
 
Search strategy: 
The electronic databases that were searched included MEDLINE, CINAHL, the 
Cochrane Library, OTSeeker, PEDro, and PsycINFO, using the key words: cerebral 
palsy, quadriplegia, children, posture, position, orthotic device, equipment design, 
wheelchairs interior design and furnishing, infant equipment, rehabilitation, sitting. 
Only English language manuscripts were included. All age groups between newborn 
and 18 years of age were included. Case studies, methodological articles and basic 
science articles were excluded as well as articles earlier than 1980. Thus, all relevant 
papers between 1980 until July 2008 were included. 
 
Definition of terms: 
Seating is an important though complex issue for children with cerebral palsy. It is 
presumed that good seating: 1) promotes normal development by maintaining of 
postural alignment and reducing undesirable tone and reflexes; 2) enhances postural 
stabilisation of the trunk as a prerequisite to functional performance of upper limb; 3) 
helps to prevent or delay development of deformity or muscle contractures; 4) 
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optimises the child’s position for feeding, respiratory and digestive function; 5) assists 
exploration of the child’s environment; and 6) improves head control which is 
essential for orientation and socialisation and to help the child to develop cognitive 
and communication skills. In short, a seating system is usually chosen with the aim to 
improve posture and enhance function. It is believed that the seating position affects 
the potential for future development and independence in daily life. Finally, other 
important but often neglected factors are the utility and comfort for the children and 
the seating system’s compatibility with the needs of families and transportation 
arrangements.  
 
Primary PICO research questions: The following research questions were 
addressed: 
1. Does changing sitting ability using special chairs and other devices (Intervention) 
improve upper extremity function (Outcome) in children with severely impaired 
CP (Population) compared other positions or chairs (Comparison intervention)  
2. Does changing sitting ability using special chairs or other device (Intervention) 
improve posture (Outcome) in children with severely impaired CP (Population) 
compared other positions or chairs (Comparison intervention)  
3. Does changing sitting ability using special chairs or other devices (Intervention) 
improve pulmonary function (Outcome) in children with severely impaired CP 
(Population) compared other positions or chairs (Comparison intervention)  
 
Primary findings:  
Four review articles and 22 research articles were selected. In general, the studies 
were small and many of them published before 2000. Hence the level of evidence to 
support intervention using seating systems is weak. 
 
1. Does sitting ability by special chairs and other device improve upper extremity 
function?  
The review by Stavsness [27] investigated the possibility of finding a seating position 
for children with CP which improved the control of their upper extremity. Sixteen 
articles were found, all of them were published before 1997. Two of the articles were 
based on small RCTs, and the other studies used before and after designs. The review 
investigated the influence of seating position, mainly backward-neutral-forward 
orientation. All but one study supported the neutral to slightly forward orientation (0-
15 degree). The seating angle did not appear to influence upper limb function. 
Typically the seat orientation is suggested to be combined with Functional Sitting 
Position (FSP) including hip abduction, foot rests, hip belt, and a cut-out tray. The 
FSP are recommended to be determined for each individual. Reach and grasp were 
investigated by different methods, scoring systems, questionnaire, a hand function 
test, as well as motion analysis. The results were investigated over a short time period 
despite the fact that children spend many hours in their seating system. 
 
Other articles discussing improved upper limb function by special chairs and 
sitting device 
Ten articles were found focusing on upper limb function, only one was published later 
than 2000 [28]. Some of the articles investigating postural improvement also discuss 
upper limb function, like those written by Myhr and colleagues [29-31]. In these 
studies, the children were similarly investigated when positioned for short time 
periods, ranging from only seconds to a few minutes. Demonstrating improved task 
performance and satisfaction as well as reduced caregiver assistance are discussed in 
two studies reporting the difference when lap belts were replaced with rigid pelvis 
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stabilizer [28, 32]. On an individual level, adaptive seating was found to improve 
upper limb function, feeding and eating behaviour [33-35]. The control of reaching 
and grasping was not found to be influenced by sitting position, [36] using a saddle 
seat or flat bench, [37] different seating angles, [15, 38] or hip flexion [39, 40].    
 
2. Does sitting ability by special chairs and other device improve posture?  
Articles were selected because posture was evaluated, however these papers often 
reported other outcomes. One review investigated the effect of tilt-in-space seating 
[41](16). It included adults and children with different neurological and 
neuromuscular impairments. Nineteen studies were included, 10 studies from children 
with cerebral palsy, 5 were overlapped with the Stavnees review [27]. The studies 
investigated the immediate effect of tilting the seating. The over all result was that 
posterior tilt can reduce pressure at the interface under pelvis. The implications for 
children with CP were unclear. 
 
Does seat inclination affect the function of children with cerebral palsy 
The review of McNamara and Casey [42] aimed to evaluate if postural control, 
muscle activity and upper extremity function was influenced of the seat inclination. 
Ten studies were included published 1990-2006. There were four single case studies, 
two studies were longitudinal and four studies were between group comparisons. In 
general the numbers of subjects were small. For postural control, anterior tilt resulted 
in reduction in sway for hypertonic children and increased sway for hypotonic 
children. Upper extremity function improved when sitting in the functional sitting 
position compared to posterior seat inclination. The conclusion is that anteriorly 
tilting the seat appears to improve function and that seating systems should be adapted 
to needs of the individual. 
 
Other articles discussing improved posture by special chairs and other sitting 
device 
Nine articles were found that investigated different types of chairs and adaptations. 
The quality of the articles improved over time. Almost all studies included profoundly 
impaired children. Investigation of the Seating Buggy wheelchair shows that if it was 
well adjusted for each child, the sitting balance was improved [43]. Static correction 
of scoliosis can be improved with an arrangement of lateral pads on a seating system 
[44] or by thoraco-lumbar-sacral orthosis [45]. An adaptive seating device 
incorporating a thoracic lumbar sacral orthosis had a positive outcome effect on 
feeding and posture in a fairly large prospective study [46]; a finding supported by 
another older study [47]. Individualized fitting seemed to be important. The functional 
sitting position with or without a cut-out tray tends to reduce pathological movement 
and improve upper extremity [29, 30]. For some children the ‘saddle seat’ appears to 
improve postural control but not upper extremity function [48]. Overall posture was 
not improved by only using knee blocks [49].  
 
3. Does sitting ability by special chairs and other device improve pulmonary 
function?   
The review by Barks [50] analysed how pulmonary function was affected by 
positioning of persons with CP who lack trunk control. Twenty-eight references 
published from 1966 -2003 were included. All reflected either a physiologic or 
therapy-based model involving function in activities of daily living, but no other 
health outcomes.  
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Other articles: Three articles describe the effect on pulmonary function of two 
different sitting positions. A study of six children demonstrated that the anterior-tilted 
position does not improve respiratory function compared to horizontal sitting [51]. 
Children increased their vital capacity and forced expiratory volume in one second 
and expiratory time when seated in an adaptive seating system compared to a sling 
wheelchair [52]. A soft TLSO, did not have a negative impact on pulmonary 
mechanisms in persons with severe cerebral palsy [53].  
 
Conclusion and future directions 
Seating position is clearly important to optimising child’s experience. However, on 
the basis from current evidence, it is difficult to come to any rigorous conclusions 
about the effect of particular seating positions on function. In general the research 
questions need to be more explicitly defined and build on recent theories for treatment 
and management. Research on this topic would benefit from larger sample sizes, 
longer follow up, greater precision in describing independent variables of positioning, 
and where possible the participation of children in assessing key outcomes.  
Grade of Recommendation: C 
 
 
HAND USE: CONSTRAINT-INDUCED MOVEMENT THERAPIES 
 
Search strategy: 
The electronic databases MEDLINE, CINAHL, the Cochrane Library, OTSeeker, 
PEDro, and PsycINFO were searched using the terms: cerebral palsy, hemiplegia, 
hemiparesis, constraint-induced movement therapy, constraint-induced therapy, 
CIMT, CIT, CI-therapy, forced use, MCIT, MCIMT, upper extremity. Only English 
language manuscripts were included. All age groups between newborn and 18 years 
of age were included. Articles including children with traumatic brain injuries were 
included only when they were grouped with children with congenital hemiplegia. 
Case studies and methodological papers were excluded. The search was completed by 
a research assistant trained in the appropriate search strategies. 
 
Definition of terms: 
The main principle of Constraint-induced movement therapy (CI therapy) is restraint 
of the uninvolved hand and intensive practice with the involved hand, i.e. hemiplegic 
hand, during a specified time period. The principle of CI therapy was developed 
through neurophysiological research by Dr Edward Taub during the 1950s.[54] 
Somatic sensation was unilaterally abolished in monkeys using dorsal rhizotomy. This 
caused the monkeys to stop using the affected arm unless the intact limb was 
restrained, in combination with practicing tasks using the deafferented limb, for one to 
two weeks. The monkey experiments formed the basis for intervention in adult 
humans who had sustained a stroke. Gradually the intervention was refined and 
eventually termed ‘constraint-induced movement therapy’ [55]. Subsequent studies of 
CI therapy have examined the efficacy of this intervention for improving involved 
upper extremity use. There has been experimentation with various types of restraint, 
interventions and outcome measures, and provided for people with chronic, acute and 
sub-acute stroke. [56] Today, for adults, restraint for 90% of waking hours is typically 
used, together with a structured training program.  
 
The primary PICO research question: 
This review will address if CI therapy, modified CI therapy and Forced Use 
(Intervention) will improve hand function (Outcome) in children with hemiplegic CP 
 94          © International Society for Prosthetics & Orthotics 
(Population) compared to contemporary intervention (Comparison intervention). The 
question is formulated according to the PICO model. In addition the differences in 
treatment protocol, age and restraint will be discussed. 
 
Primary findings  
There have more than 30 articles describing CI therapy in children since late nineties. 
There are many case reports and small studies but recently, there have been somewhat 
larger studies as well. Twelve of them meet the inclusion criteria for this review 
(Table 1). One Cochrane review was published in 2008. 
 
Cochrane Review  
In the Cochrane review by Hoare et al. [57], three articles met the inclusion criteria. 
These were two RCTs and one controlled clinical trial (CCT) comparing CI therapy, 
modified CI therapy and Forced Use with traditional service or no treatment. The 
review includes articles published before August 2006. One RCT showed a trend for a 
positive effect for one subscale of the QUEST , [58] also partly described by [59]. The 
other assessments used, without reported psychometric properties, were also positive. 
The second RCT, [60] demonstrated improvement only on the self-care component in 
WeeFIM using Forced Use protocol. The other assessments used, without reported 
psychometrics, were also positive. The CCT was the largest study and demonstrate 
good effect by using Assisting Hand Assessment (AHA). In conclusion, although 
there was a positive trend from the four RCTs and one CCT, there is still weak 
evidence to support CIMT. An adequately powered RCT is recommended to provide 
further evidence.        
 
Other articles 
Four studies used a randomized design [59, 61-63]. These studies can be designated 
Level I [64] although they were small trials. One study was prospective with a control 
group [65] consistent with Level III. The remaining papers were level IV studies, 
three with an ABAA design, [65-68] two with pre and post treatment design [69, 70] 
and one study with repeated treatments [71]. All these studies reported positive 
results. However, despite the potential benefits of CIMT, the evidence to date, while 
promising, is still tentative.  
 
Other results and ongoing studies 
In adults, there have been studies reporting reorganization of hand motor pattern from 
functional magnetic resonance brain imaging. The first article in children with 
cerebral palsy was published 2007 [69], reporting increased cortical activation in 
some cases. One study, combining CI therapy with botulinum A toxin, showed no 
additional effect (Eliasson et al, submitted). There is at least one ongoing study which 
is further exploring this topic. Likewise there is one study in press combining CI 
therapy with intensive bimanual training demonstrating similar results (Hoare et al, 
personal communication). CI therapy has so far been compared to conventional 
therapy but the issue of intensity (frequency and duration or ‘dosage’) is yet to be 
resolved.  
 
Conclusion and future directions 
Large well controlled studies are lacking. Multi-centre studies are recommended since 
the prevalence of hemiplegic CP is fairly low. The evidence is still tentative but there 
are no studies reporting negative results. The training methods need further 
investigation, especially in relation to other types of intensive training programmes 
and with a longer follow up periods. No studies have so far been using orthoses in 
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combination with CI therapy and this might be an interesting avenue for further 
research. 
 
 
SELF-CARE: FEEDING INTERVENTIONS 
 
Search strategy: 
The electronic databases that were searched included CINAHL, CIRRIE, the 
Cochrane Library, EMBASE, ERIC, HealthSTAR, Health and Psychosocial 
Instruments, MEDLINE, OTSeeker, PEDro, PsycINFO and RehabData, using the key 
words: tetraplegi*, spastic*, quadriplegi*, quadrapare*, pes equinus*, monoplegi*, 
little* disease, hypotonic*, hemiplegia*, hemipare*, dystoni*, diplegi*, dyskine*, 
choreoathe*, cerebral palsy, atheto*, ataxi*, feed*. Only English or French 
manuscripts were included, for publications up to and including December 2007. All 
age groups between 0 and 18 years of age and all study designs (e.g. RCTs, quasi-
experimental, case series, case studies) were included. Medical interventions such as 
medications, nasogastric feeding, fundoplication or use of a GE tube were not 
included. Interventions to decrease drooling were also specifically excluded. Articles 
that were excluded focused predominantly on individuals with stroke, traumatic brain 
injuries, physical disabilities and adults. Studies with a heterogeneous sample of 
children with a variety of developmental disabilities to include cerebral palsy (but less 
than 50%) were excluded. 
 
Definition of terms: 
Feeding interventions (i.e. treatments) that are part of this review included 
individualized sensori-motor approaches, food consistency alterations, positioning 
techniques, oral orthodontic appliances and adapted equipment. Sensori-motor 
approaches include sensory stimulation (e.g. thermal application-typically cold, 
vibration around the mouth, stretch pressure to the oricularis oris, olfactory input) and 
oral-motor facilitation (e.g. massage gums, apply pressure to the teeth and tongue, 
maintain jaw control, side-placement of textured bolus) [72, 73]. Alteration in the 
consistency of food textures has been used as an intervention to optimize feeding 
performance [74]. Positioning techniques incorporate neurodevelopmental treatment 
principles and adapted equipment to optimally position the child for safe and effective 
task training and/or feeding [75]. Oral appliances are orthodontic removable plates 
that may be prescribed to improve oral-motor performance. They can include a tongue 
stimulator (a button-like protrusion or beads), a tongue shield in the midline or at the 
side, a lip stimulator with mobile beads over the front teeth, and/or vestibular pads 
[76, 77]. The occupational therapist carefully evaluates oral-motor abilities prior to 
and with daily use of the appliance, and monitors the potential benefits on feeding 
efficiency[78]. In terms of adapted equipment, the effectiveness of the Handy 1 
Robotic Aid to Eating has been tested. Using a single switch device, food is presented 
in a controlled or consistent method using this assistive device [79, 80]. 
 
Purpose:  
Feeding disorders (eating, swallowing) are a common associated condition in children 
with CP. These difficulties are often associated with poor oral motor control. As a 
result, these children are at high risk of aspiration, which may cause chest infections 
or can be potentially life threatening [81, 82]. Growth failure and inadequate caloric 
intake are important clinical concerns as well [83]. Feeding may take up to 6 hours or 
more each day for caregivers, and therefore contributes to burden of care [84]. A wide 
variety of intervention strategies have been evaluated to improve oral motor skills, so 
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as to be able to feed more safely and efficiently. These include impairment-based 
treatments (sensori-motor, positioning) as well as the application of modifications and 
adaptations (oral appliance, food consistency, electric feeder). The purpose of sensori-
motor techniques is to decrease or increase tone and inhibit abnormal reflexes that are 
interfering with safe feeding, thus enabling training and strengthening of the oral 
musculature, and providing greater opportunities to learn and practice feeding skills 
[85]. Sensori-motor approaches are used to facilitate lip closure, tongue lateralization 
and rotary chewing, to inhibit tongue thrust and decrease tactile hypersensitivity and 
encourage swallowing [85, 86]. Solid soft versus mashed food consistency can 
influence chewing and swallowing abilities in children with CP.[87] Positioning 
techniques such as stabilization of the neck and trunk, forward neck flexion or 
supported recline positions may be used to promote more effective feeding behaviors. 
Optimal positioning techniques have been guided by videofluoroscopy images of 
eating and swallowing while in different positions [82, 88]. Oral appliances such as 
the Innsbruck Sensori-motor Activator and Regulator (ISMAR) [89] are used to 
improve orofacial sensori-motor functions such as sucking, coordination of chewing 
and swallowing. This appliance is used for jaw stabilization in the initial phase, 
followed by activation and mobilization of the oral and pharyngeal structures in the 
second phase. These removable plates may also improve facial expression. Use of an 
electronic feeding device (Handy 1 Robotic Aid) may be helpful in promoting 
independent self-feeding. This aid provides a predictable presentation of the food, but 
demands active participation of the child in removal of the food from the spoon. 
 
Primary PICO research question: Does regular application of feeding interventions 
{sensori-motor, consistency of textures, positioning, oral appliance, adapted device} 
improve feeding efficiency (mastication, swallowing) and safety (decrease 
aspirations) and result in enhanced weight gain in children with cerebral palsy? 
P: Children (most school age and/or adolescents) with cerebral palsy 
I:   Impairment-based interventions or modifications/appliances/equipment, 
regular/daily, either immediate effects or over several months 
C: Compared to baseline or to a control group 
O: Highly variable: measures of body structure (videofluoroscopy), body function 
(anthropometric measurements, pathologic reflexes, oral-motor observations), activity 
and participation (feeding performance, speech skills). 
 
Primary findings: 
Seventeen studies that described the effectiveness of particular feeding interventions 
in children with cerebral palsy were reviewed. Descriptive information regarding 
these studies appear in Table E and F. Children were typically of school age or 
adolescence and had moderate to severe motor impairments, although type and 
severity of CP were often not described. Sample size for 13/17 studies was small (up 
to 20 subjects). Statistical approaches were primarily descriptive in most studies. 
Designs were predominantly quasi-experimental (with comparison or control groups) 
or case series with pre-post testing, with only one randomized controlled trial 
(although randomization method was not specified). Sensori-motor interventions and 
oral appliances were typically applied daily for several months, whereas interventions 
that focused on positioning, consistency changes or adapted equipment involved 
observations over single or multiple sessions only. Only one study incorporated a 
multi-modal approach to include oral-motor interventions, behavioral techniques, 
positioning and caregiver education [90]. Outcome measures were highly variable but 
often included anthropometric measures, videofluoroscopy, feeding observations with 
video, and standardized feeding measures. Results to date provide preliminary 
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evidence supporting the effectiveness of feeding interventions. Specifically, sensori-
motor approaches improved oral-motor skills and reduce aspirations, especially in 
more impaired children (i.e. those who aspirated) [85, 86, 91-93] A single study 
demonstrated that mashed foods were ingested more rapidly and more safely than 
semi-solid foods [87]. Individualized positioning programs guided by 
videofluoroscopy improved eating and swallowing skills [82]. Furthermore, 
positioning helped to promote successful self-feeding behaviors when accompanied 
with task training (practice, physical assistance) of self-feeding components such as 
reach, grasp, and hand to mouth movements [94]. However, for some children, 
positioning does not facilitate safe feeding and therefore tube feeding or gastrostomy 
may be necessary [82]. Use of the ISMAR oral appliance for children with moderate 
dysphagia enhanced mastication and swallowing skills in most children, improved 
sensibility of the oral cavity, facilitated tongue mobility and lip and jaw control, 
improved resting posture of the tongue and lips. In addition, there were improvements 
noted in generalized motor control and facial expression was enhanced as well ([76, 
84, 95, 96]. Use of an electronic feeder (assistive device) enabled children to feed 
independently, although feeding rate was slower for children with some speech skills, 
when compared to being fed by a caregiver. It was suggested that in higher 
functioning children, the device may be interfering with conversation and social 
interaction. While the investigators noted that oral-motor skills improved with this 
consistent feeding presentation approach, however the device cannot handle all food 
types therefore limiting the feasibility of use for all meals [97, 98]. For all these 
feeding interventions, no significant changes to weight gain were noted (except for 
Clawson et al [90]), therefore caloric supplementation for “catch-up” is often still 
needed to maximize growth. Improvements in most studies were often not maintained 
on follow-up (post-intervention). These interventions appeared to be well tolerated 
overall. 
 
Review articles: 
To our knowledge, there are no “systematic” reviews in this topic area. Rogers [5] 
published a review article on feeding interventions in children with CP. Oral sensori-
motor interventions are noted as the most common therapeutic strategy used 
clinically. Evidence suggests that this intervention approach improves oral-motor 
skills but not airway protection, feeding efficiency or weight gain. In terms of medical 
interventions, gastrostomy tube feeding remains an important alternative approach for 
this population, to prevent growth failure. Gisel (in press) also provides an overview 
of feeding interventions for children with dysphagia. She concludes that sensori-motor 
interventions and oral appliances are both effective in improving oral-motor skills and 
enhancing the efficiency of food intake. 
 
Conclusions and future directions: 
Feeding disorders can impact on nutrition, growth and development, respiratory and 
gastrointestinal functioning, parent-child interactions and family burden [5]. Sensori-
motor interventions provided regularly over weeks to months may improve oral-motor 
skills such as food retention, biting and chewing. Individualized positioning 
techniques can also optimize oral-motor control. Preliminary evidence would indicate 
that adjusting food consistency (e.g. thickening of liquid foods) may also be helpful in 
improving feeding performance. Use of an oral appliance enhances oral sensory 
perception, jaw stabilization and tongue mobilization with subsequent improvements 
in feeding skills. Of importance, use of the oral appliance may be associated with 
improved facial expressions and mouth closure, which has social benefits [84]. 
Results of a pilot study on preschoolers with spastic diplegia suggested that biological 
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(oral-motor, positioning), behavioural (positive reinforcements, extinction of negative 
behaviours) and environmental (parent education) aspects of feeding disorders are 
mutually interactive. This recent study [90]  is the only intervention that applies a 
multi-modal approach. Interestingly, improvements noted on descriptive analysis 
included improved oral-motor skills, enhanced caregiver abilities and most 
importantly, percentile improvements for weight and height. In contrast, weight gain, 
a marker of feeding efficiency, did not improve in all other feeding interventions 
studied to date.  
 
Oral feeding experiences, even if difficult, are important to the child and family. 
Single-modality approaches such as sensori-motor stimulation or positioning yield 
modest improvements in feeding ability. Consideration of complementary medical 
interventions such as caloric supplementation with commercial products or use of 
gastrostomy tubes may be necessary to ensure adequate nutrition and growth [5, 99]. 
While there are some indications for placement of feeding G-tubes (e.g. children with 
malnutrition, moderate to severe aspiration, and/or aversive behaviour during oral 
feeding), a recent Cochrane systematic review (2004) [99] concludes that considerable 
uncertainty remains regarding the effectiveness of gastrostomy for children with 
cerebral palsy. Future studies should evaluate the effectiveness of multi-modal 
(medical, oral-motor, behavioural and environmental interventions and adaptations) 
approaches to improve feeding performance, growth and development. Clearly, well 
designed randomised controlled trials with long-term outcomes should be undertaken 
to evaluate the effectiveness of these multi-modal approaches. Grade of 
Recommendation: B-C  (note: evidence was not consistent enough to warrant a 
grade of B for any one category, although somewhat stronger evidence than for other 
interventions) 
 
 
PLAY: VIRTUAL REALITY 
 
Search strategy: 
The electronic databases that were searched included CINAHL, CIRRIE, the 
Cochrane Library, EMBASE, ERIC, HealthSTAR, Health and Psychosocial 
Instruments, MEDLINE, OTSeeker, PEDro, PsycINFO and RehabData, using the key 
words: tetraplegi*, spastic*, quadriplegi*, quadrapare*, pes equinus*, monoplegi*, 
little* disease, hypotonic*, hemiplegia*, hemipare*, dystoni*, deplegi*, dyskine*, 
choreoathe*, cerebral palsy, atheto*, ataxi*, virtual reality. Only English or French 
manuscripts were included, for publications up to and including December 2007. All 
age groups between and 18 years of age and all study designs (e.g. RCTs, quasi-
experimental, case series, case studies) were included. Articles that were excluded 
focused predominantly on individuals with stroke, traumatic brain injuries, physical 
disabilities and adults. 
 
Definition of terms: 
Virtual reality (VR) is a virtual environment system that uses a range of computer 
technologies that present virtual or artificially generated sensory information in a 
format that enables the user to perceive experiences that are similar to real-life events 
and activities [100]. A three-dimensional simulated environment of objects and 
activities is created and presented either on a computer monitor, or projected on a 
large screen or within a helmet-mounted display. Specific input devices (e.g. 
dataglove) allow the user to interact actively with the virtual environment. VR 
provides the user with the opportunity not only to sense the virtual environment, but 
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also to interact and explore the environment, relatively free of limitations imposed by 
their disability. Multi-user formats, which are becoming increasingly commercially 
available, can provide new social and recreational opportunities to enhance 
participation for individuals with functional limitations [100]. With respect to 
rehabilitation, VR is used to create an interactive play environment to achieve 
particular occupational therapy treatment goals. Note that the outcomes may include 
improved play skills or play attitudes, but for several studies, also include 
improvements at other levels (see below). This modality can be used either to evaluate 
level of performance within a simulated task, or more commonly as a treatment 
approach. For the latter, VR can incorporate motor learning principles such as 
repeated practice and positive feedback, so that play-based training of everyday 
functional activities can occur. Precise laboratory measurements may be made to 
quantify performance over time. Furthermore, the task demands (e.g. speed, accuracy, 
complexity of the task) and the type and frequency of feedback can be manipulated 
and graded, so as to grade performance requirements [101-103]. In addition, benefits 
of this novel, animated treatment approach include enhancement of creativity and 
pleasure, a greater degree of control and increased mastery motivation (i.e. persistence 
with tasks) [102]. 
 
Purpose: 
VR has been used primarily in research as a new treatment modality for children and 
youth with cerebral palsy. Motor learning concepts to include the use of feedback and 
practice are applied as facilitators of motor performance. Through virtual games, 
children engage in multiple trials of a specific task with ongoing feedback on 
performance success. The children see themselves on a screen within a virtual 
environment that responds to their movements [104]. The primary purpose is to 
improve competence and confidence in motor-based activities [105] and also to 
engage in play-based activities that are otherwise inaccessible in the real world [106]. 
Research studies demonstrate that this modality is feasible, highly enjoyable and non-
threatening [107]. VR can be used for task training (e.g. electric wheelchair mobility), 
by initially simplifying the task and subsequently grading the complexity of the task 
demands. This modality is also advantageous for children with cerebral palsy as it 
enables the subject to spatially explore complex environments that would be 
otherwise impossible due to mobility restrictions. VR provides the opportunity to 
overcome existing obstacles to navigating and exploring the environment safely, thus 
promoting visual-spatial and perceptual-motor concept formation [101]. Furthermore, 
spatial and motor learning through virtual environments have been shown to transfer 
into real environments in adults and in children with other disabilities [100, 101]. 
 
Primary PICO research question: Does weekly repetitive training using a play-
based VR intervention improve {brain reorganization/ motor skills/ spatial skills/ 
motivation and playfulness/ functional everyday self-care and leisure activities} in 
children with cerebral palsy? 
P: Children (4-14 years; most 8-12 years) with cerebral palsy 
I: Virtual games, weekly sessions, for 4-8 weeks 
C: Compared to baseline or to a control group 
O: Highly variable: measures of body structure (fMRI), body function (motor skills, 
quality of movements, visual-spatial skills), activity and participation (self care and 
leisure activity performance, playfulness), personal factors (motivation, self-
perception, self-efficacy). 
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Primary findings: 
Eight studies described the effectiveness of VR for children with cerebral palsy. 
Descriptive information regarding these studies appear in Table G and H. Children 
were typically of school age (4-14 years) and had cerebral palsy, although type and 
severity were often not described. When specified, studies included children who 
were non-ambulatory, but not exclusively. Sample size for 6/8 studies was small (1-16 
subjects). Statistical approaches were primarily descriptive in most studies. Designs 
varied from observational studies (2), case studies with pre-post testing (4), an 
experimental study with a control group (1) and one randomized controlled trial. 
Interventions typically involved weekly VR sessions for 1-2 months. A variety of 
virtual games were used in these studies, with different goals. As a result, outcome 
measures were variable and included measures of brain structure and function, motor 
and cognitive ability, activity limitations in self care and leisure, enjoyment of play 
and self-perception. Preliminary results indicate that intense use and practice provided 
by VR may contribute to improved neuroplasticity by facilitating neural motor 
pathways that are under-utilized. This reorganization seems to be closely associated 
with the enhancement of age-appropriate skills in the affected limb [108].  The 
primary objective of the VR training used by Akhutina et al [101] was to enhance 
spatial skills in children with limited navigation experiences. Children were assigned 
to an experimental (with VR training) or control group and a wide range of computer-
based and standardized outcome measures were used. The first experiment yielded no 
significant effects, possibly due to differences in level of motor impairment between 
experimental and control groups, as well as the complexity of the training task. In 
experiment two, simpler and more varied spatial cognition tasks to include training of 
spatial terminology was used on larger and more functionally comparable children 
assigned to experimental and control groups. The experimental group showed 
significant improvements in visual-spatial abilities following VR training. With 
repeated practice (e.g. about 100 reaches per 3-minute session), Chen et al [102] noted 
improvements in accuracy and quality of reaching and in fine motor skills. On follow-
up, some maintained changes or continued to improve but this was not consistent in 
all subjects. VR environments stimulated playfulness (motivation, control, suspension 
from reality, framing) except for games that were too challenging [106], was highly 
motivating for children [104, 109] and improved self-perceptions and self-efficacy 
[104, 107].  
 
Review articles: 
No review articles on VR were found that focused specifically on the target 
population (cerebral palsy). 
 
Conclusions and future directions: 
The literature in this area is now emerging (since 2002) and remains fairly 
preliminary, however evidence to date suggests that VR may prove to be a useful 
therapeutic modality for children with cerebral palsy. A wide range of potential uses 
of VR are being proposed and tested, therefore validation of findings is needed. 
Practice effect and lack of use of blinded evaluators may in part explain 
improvements on outcome measures. Studies suggest that repetitive training offered 
by VR play-based activities can facilitate motor and visual-spatial skills, and may 
influence brain plasticity and reorganization. Furthermore, this modality is highly 
motivating and engaging, therefore if widely available, compliance and potential 
benefits are likely to be high. The long-term benefits are unknown. Randomized 
controlled trials on large samples are needed to ascertain whether this approach is 
better than traditional rehabilitation interventions [101, 102]. In addition to improving 
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function, this modality may prove useful in promoting social participation through 
virtual environments. Greater clarity is needed with respect to which children (type 
and severity of CP, level of cognitive function required) and which treatment 
outcomes should be targeted. Grade of Recommendation: C 
 
 
LINKING OCCUPATIONAL THERAPY AND ORTHOTICS: 
 
Orthoses are devices that are applied externally to the child in order to modify 
structural and functional attributes of the neuromuscular and musculoskeletal systems 
. Occupational therapists may also use a variety of devices and adaptations, such as 
upper extremity splinting and casting, seating devices and oral appliances. The use of 
orthoses may be linked to lessons learnt from Occupational Therapy intervention 
studies in a number of ways: 
 
• Clinically, these devices (used by orthotists and/or OTs) are helpful in 
providing stability around joints, facilitating movement, and preventing 
deformities. As such, they provide biomechanical improvements that may help 
to overcome limitations in activity and restrictions in participation. However, 
promotion of activity and participation must be explicitly facilitated 
(concurrent with use of these devices) with prescribed intervention strategies, 
and these outcomes need to be measured, in determining the effectiveness of 
orthotic use. This has been largely lacking in the OT literature. 
 
• Child (client-centred practice) and family (family-centred care) preferences 
should be considered in the selection and use of devices and adaptations. In 
order to maximize compliance, the child must be willing to apply the device. 
Furthermore, family members need to understand the underlying mechanisms 
and potential benefits of the device, so as to ensure that they incorporate its 
use as part of daily life activities. Any negative consequences of use of the 
devices (e.g. self-image, sleep disturbances, discomfort) need to be “solved” 
by the treatment team, in partnership with the child and family. 
 
• Most OT intervention studies we reviewed focused on a single treatment 
modality (e.g. a specific device or a particular intervention approach). In 
reality, clinicians apply multi-modal (remediation, compensation, adaptation) 
strategies, intervening at the body function, activity/participation and/or 
environmental levels, with direct treatments (e.g. to increase hand reach, learn 
to eat with a spoon, recognize socially acceptable feeding behaviors) and with 
application of particular adaptations or devices (e.g. seating device, oral 
appliance, less distracting environment). For example, a recent feeding study 
or current randomized trials using Botox that incorporate function-based 
interventions using activities preferred by the child, can serve as models. 
 
In summary, disability is the product of characteristics of the individual, such as 
impairments and activity limitations and personal factors, as well as attributes of the 
individual’s physical, social and attitudinal environment. Therefore, future trials 
should adopt an integrated “multi-modal” approach with emphasis on the child and 
family’s needs, and selection of interventions with greater focus on maximizing 
community integration and participation, either by enhancing abilities (e.g. at body 
function and activity level) and/or by modifying the task or environment. Orthotic 
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devices are one piece of that puzzle. Many possible approaches may be considered to 
address functional challenges, and the home, school and community environments 
may each require different strategies to ensure optimal functioning. Goals of treatment 
need to be individualized rather than prescriptive, that is, developed with 
consideration of the family’s priorities and the child’s preferences.  
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TABLE A: Upper Extremity Splinting 
 
Authors, year Title Oxford score Splint type 
McPherson, 
1991[15] 
 
Objective evaluation of a splint 
designed to reduce hypertonicity 
4 Snook’s spasticity reduction 
splint 
Exner & Bonder, 
1983 [7] 
 
Comparative effects of three 
hand splints on bilateral hand 
use, grasp, and arm-hand 
posture in hemiplegic children: A 
pilot study 
2b 3 types: orthokinetic cuff, 
short opponens thumb 
splint, MacKinnon splint 
Currie & Mendiola, 
1987 [8] 
 
Cortical thumb orthosis for 
children with spastic hemiplegic 
cerebral palsy 
4 Cortical thumb orthosis 
Flegle & 
Leibowitz, 1988 
[9] 
 
Improvement in grasp skill in 
children with hemiplegia with the 
MacKinnon splint 
4 MacKinnon splint 
Goodman & 
Bazyk, 1991l [10] 
 
The effects of a short thumb 
opponens splint on hand function 
in cerebral palsy: A single-subject 
study 
4 Short thumb opponens 
Kerem et al, 2001 
[11] 
 
Effects of Johnstone pressure 
splints combine with 
neurodevelopmental therapy on 
spasticity and cutaneous sensory 
inputs in spastic cerebral palsy 
2b Johnstone pressure splint  
Reid, 1992 [12] 
 
An instrumentation approach for 
assessing the effects of a hand 
positioning device on reaching 
motion of children with cerebral 
palsy 
4 Hand positioning device 
(aligns hand with forearm, 
resting position of wrist and 
fingers) 
Reid & 
Sochaniwskyj, 
1992 [13] 
 
Influences of a hand positioning 
device on upper-extremity control 
of children with cerebral palsy 
4 Hand positioning device 
(wrist slightly extended, 
thumb abducted and 
opposed, and MCP joints 
and fingers in slight flexion) 
Kinghorn & 
Roberts, 1996 [14] 
 
4 The effect of an inhibitive weight-
bearing splint on tone and 
function: A single-case study 
Inhibitive weight-bearing 
splint 
 
 
Oxford Score: 
1b: Individual RCT study 
2b : Experimental cohort study with well-defined control group, or low quality RCT 
3b: ABA design 
4: Quasi-experimental  =  to include either a pre-post design or descriptive cohort study
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TABLE B: Upper Extremity Splinting 
 
Authors, year Subjects; sample 
size; age range 
Methodology Outcome 
measures / 
Variables * 
Main findings 
McPherson, 
1981[15] 
 
Increased wrist flexor 
tone;  
N=5 (7 hands); 10-18 
years 
Quasi-experimental; 
Incremental exposure 
(0-60 min., 2x/day), 5 
weeks (compared to 
pretest) 
Hypertonicity  Reduction in 
hypertonicity with 
increased exposure to 
splint. No permanent 
changes noted. 
Results were tested 
statistically.  
Exner & Bonder, 
1983 [7] 
Hemiplegia;  
N=12;   3-16 years 
Randomized control 
trial; 8 hrs/day, 6 
weeks per splint, 2 
week rest periods 
Bilateral hand use, 
grasp skill, arm-hand 
posture 
Improvements over time 
in orthokinetic cuff 
(41.6% bilateral skills) 
and MacKinnon (58.3% 
improved bilateral hand 
use and/or grasp; no 
differences between 
splints used. More 
impaired children had 
greater changes noted. 
Results were tested 
statistically. 
Currie & Mendiola, 
1987 [8] 
Hemiplegia (moderate);  
N=5;   20-26 months 
Quasi-experimental, 
compared to 
baseline;  
1 week (pre-post) 
Observation of the hand 
position and function 
Improved position of the 
thumb, improved 
prehension and 
function. 
Conclusions were 
based on descriptive 
data. 
Flegle & Leibowitz, 
1988 [9] 
Hemiplegia;  
N=3;   2.5-7.5 years 
Multiple baseline;  
8 hrs/day 
(Grasp skill test) Improvements in grasp 
skills, especially for 
those with poor grasp 
initially. 
Conclusions were 
based on descriptive 
data. 
Goodman & Bazyk, 
1991 [10] 
Quadriplegia 
(moderate);  N=1; 4 
year old 
A-B single subject;  
3 hrs, 2x/day and 
overnite, 4 weeks 
baseline, 4 weeks 
splinting 
Active range of motion, 
grip and pinch strength, 
(Box and Block tests) 
stacking cubes, lateral 
pinch 
Improvements in areas 
assessed except 
palmar and tip pinch 
strength.  
Conclusions were 
based on descriptive 
data. 
Kerem et al, 2001 
[11] 
Diplegia;  
N=34, 36-82 months  
Experimental;  
20min/day, 3 months 
(compared to NDT) 
(Goniometry, Modified 
Ashworth Scale, 
somatosensory evoked 
potentials) 
Improvements in range 
of motion, spasticity and 
SEP. 
Results were tested 
statistically. 
Reid, 1992 [12] 
 
Spastic quadriplegia, 
athetoid, dyskinetic; 
N=5;   5.8-11.1 years 
Quasi-experimental; 
1 hr/day, 6 weeks 
(3D tracking system for 
upper extremity 
reaching) 
Differing improvements 
in upper extremity 
reaching in individual 
children, but no 
significant differences 
for group data. 
Results were tested 
statistically. 
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TABLE B Upper Extremity Splinting (continued): 
 
Authors, year Subjects; sample 
size; age range 
Methodology Outcome 
measures / 
Variables * 
Main findings 
Reid & 
Sochaniwskyj,  1992 
[13] 
Spastic and athetoid 
cerebral palsy; N=10; 
5-12 years old 
Before-after trial; 3 
sessions 
(EMG, 3D motion 
analysis, “home-made” 
visual-motor 
performance test 
[based on Beery 
Development Test of 
VMI, Frostig 
Developmental Test of 
Visual Perception,] 
Miller Assessment for 
Pre-schoolers and 
BOTMP) 
While wearing the 
splint, differences noted 
in the average velocity 
of movement, 
movement time, 
movement units in 8/10 
individuals; muscle 
activation patterns 
resembled  
normal patterns in 
several children. Scores 
on visual-motor tests 
were not statistically 
significant (group). 
Results were tested 
statistically. 
Kinghorn & Roberts, 
1996 [14] 
Quadriplegia; 
N=1; 20 months 
Single-subject;  
3 x 8 weeks 
Hand tracing, arm-hand 
posture, functional 
activities (block play for 
active grasp, voluntary 
release, ball play) 
No effects. 
Conclusions were 
based on descriptive 
data. 
Hr(s): hour(s);    min.: minutes;   EMG: electromyography;    
VMI: Visual Motor Integration;    BOTMP: Bruininks-Oseretsky Test of Motor Proficiency 
• Outcome measures/Variables: when studies specified actual measures used, these are indicated in the column, 
otherwise the variables observed and documented are specified. 
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TABLE C: Upper Extremity Casting 
 
Authors, year Title Oxford score Cast type  
Smith & Harris,  
1985 [18] 
 
Upper extremity inhibitive casting 
for a child with cerebral palsy 
4 Upper extremity inhibitive 
casting (elbow) 
Smelt, 1989 [19] 
 
Effect of Inhibitive weight-bearing 
mitt on tone reduction and 
functional performance in a child 
with cerebral palsy 
4 Inhibitive weight bearing mitt 
(removable plaster cast of 
hand) 
Yasukawa,  
1990 [20] 
 
Upper extremity casting: Adjunct 
treatment for a child With cerebral 
palsy hemiplegia 
4 Long arm cast on impaired 
extremity (elbow, wrist, hand) 
and short arm cast on 
unimpaired (wrist, hand) 
Law, et al. 
1991 [21] 
 
Neurodevelopmental therapy and 
upper-extremity inhibitive casting for 
children with cerebral palsy 
2b Upper extremity inhibitive bi-
valve cast (wrist) 
Tona & Schneck, 
1993 [22] 
 
The efficacy of upper extremity 
inhibitive casting: a single-subject 
pilot study 
4 Upper extremity inhibitive 
casting  
Copley, et al. 
1996 [23] 
 
Upper limb casting for clients with 
cerebral palsy: a clinical report 
4 Upper limb serial casting (wrist 
and/or elbow) 
Law, et al. 
1997 [26] 
 
A comparison of intensive 
neurodevelopmental therapy plus 
casting and a regular occupational 
therapy program for children with 
cerebral palsy 
2b Upper extremity inhibitive 
casting (wrist) 
Yasukawa, 
Malas, &  
Gaebler-Spira,  
2003 [25] 
 
Efficacy for maintenance of elbow 
range of motion of two types of 
orthotic devices: A case series 
4 Serial casting of both elbows 
(bi-valve vs. Ultraflex casts) 
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TABLE D: Upper Extremity Casting 
Authors, year Subjects; sample 
size; age range 
Methodology Outcome measures / 
Variables * 
Main findings 
Smith & Harris,         
1985 [18] 
Severe spastic 
quadriplegia;  
N= 1; 5.5 years old 
Case study;  
3 hrs/day, 13 months 
Range of motion 
(goniometry) 
Helped maintain range of 
motion in both elbows and 
prevented the increase of 
contractures at the elbow 
joint. 
Conclusions were based 
on descriptive data, 
observed over time. 
Smelt,  
1989 [19] 
Spastic hemiplegia; 
N=1; 17 months 
Single subject ABA 
design;  
twice/week for 15 
minutes,13 weeks 
Passive range of motion of 
hand, tone of hand, 
Erhardt Developmental 
Prehension Assessment 
Increase in grip 
circumference (passive 
range of motion), hand 
weight-bearing surface 
area (tone in hand) and 
hand use. However, the 
two latter gains were lost 
at follow-up. 
Time series: Descriptive 
analysis; C statistic 
Yasukawa,   
1990 [20] 
Spastic diplegia;  
N=1; 2 years, 9 months  
Single subject case 
study; casted for 4 
weeks 
Observation Elbow extension and 
forearm supination 
improved, strength of right 
arm also increased. 
Statistical analysis for 
single subject designs. 
Law, et al. 
1991 [21] 
Quadriplegia and 
hemiplegia;  
N=73; 1.5-8 years  
Randomized control 
trial (casting with or 
without NDT); 
minimum 4 hrs/day, 6 
months 
Peabody Developmental 
Motor Scales–Fine Motor, 
Quality of Upper Extremity 
Skills Test (QUEST) 
Casting in combination 
with neurodevelopmental 
therapy program resulted 
in improved upper 
extremity movement 
quality and wrist extension 
Descriptive and statistical 
analyses. 
Tona & Schneck,  
1993 [22] 
Cerebral palsy; 
N= 1; 8.5 years 
Single subject (AB 
withdrawal);  
11 days  
Observation, Modified 
Ashworth Scale, Biodex 
system 
Reduced tone and gains 
in active and passive 
range of motion. However, 
these gains were not 
maintained at follow-up. 
Statistical analysis for 
single subject designs. 
Copley, et al. 
1996 [23] 
Spastic quadriplegia 
and hemiplegia;  
N= 11; 5.3-17.8 years  
Quasi-experimental; 
4-6 weeks 
Range of motion 
(goniometry), 
Spasticity (patterns of 
tome reduction observed), 
Achievement of functional 
goals 
Spasticity was reduced in 
all and ROM improved 
after treatment. 
Improvements were 
maintained on 6-month 
follow-up. Improved  
function associated with 
less spasticity. 
Percentage change noted. 
Law, et al. 
1997 [26] 
Diplegia, hemiplegia, 
quadriplegia;  
N=50; 1.5-4 years 
Randomized 
controlled trial 
(crossover);  
at least 4 hrs/day, 
4 months 
No improvement was 
noted in hand function, 
quality of upper extremity 
movement or parents’ 
perception of hand 
function after treatment. 
Peabody Developmental 
Motor Scales –Fine Motor, 
Quality of Upper Extremity 
Skills Test, Canadian 
Occupational Performance 
Measure, parent’s 
perception of improvement Descriptive and statistical 
analyses of results. 
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TABLE D Upper Extremity Casting (continued): 
Authors, year Subjects; sample 
size; age range 
Methodology Outcome measures / 
Variables * 
Main findings 
Yasukawa, Malas, &  
Gaebler-Spira,  
 2003 [25] 
Quadriplegia (spasticity 
at elbows); 
N= 3; 7 years  
Case series;  
4 hrs/day and at night 
Modified Ashworth Scale, 
passive range of motion, 
caregiver questionnaire        
The Ultraflex cast proved 
to better maintain the 
range of motion at the 
elbows and facilitated 
length-tension 
adjustments. 
Descriptive statistics, 
changes over time. 
hr(s): hour(s);    min.: minutes 
* Outcome measures/Variables: when studies specified actual measures used, these are indicated in the column, otherwise the 
variables observed and documented are specified. 
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Table E Seating & positioning  
Authors, 
year 
Title Oxford Type 
2007, 
Vekerdy [46] 
Management of seating posture of children with cerebral 
palsy by using thoracic-lumbar-sacral orthosis with non-
rigid SIDO frame. 
2b 
 
 
Thoracic-lumbar sacral 
orthosis with rigid SIDO 
frame 
2007, 
McDonald and 
Surtees [49] 
Longitudinal study evaluating a seating systems using 
sacral pads and kneeblocks  for children with cerebral 
palsy  
3b Kneeblock,  
2007, 
Hatta et al [43] 
 
Evaluating the relationships between the postural 
adaptation of patients with profound cerebral palsy and 
the configuration of the Seating Buggy's seating support 
surface. 
2b wheelchair fitting in the 
Seating Buggy 
2007, 
Michael et al 
[41] 
Tilted seat position for non-ambulant individuals with 
neurological and neuromuscular impairment: a 
systematic review. 
2b Systematic review 
2007, 
McNamara & 
Casey [42] 
Seat inclinations affect the function of children with 
cerebral palsy: A review of the effect of different seat 
inclines 
2b Systematic review 
2006, 
Stavness [27] 
The effect of positioning for children with cerebral palsy 
on upper-extremity function: a review of the evidence 
2b Systematic review 
2004, Barks 
[50] 
Therapeutic positioning, wheelchair seating, and 
pulmonary function of children with cerebral palsy: a 
research synthesis 
2b Systematic review 
2004, Shoham 
et al [45] 
The influence of seat adjustment and a thoraco-lumbar-
sacral orthosis on the distribution of body-seat pressure 
in children with scoliosis and pelvic obliquity. 
3b orthosis 
2003, 
Holmes et al 
[44] 
Management of scoliosis with special seating for the non-
ambulant spastic cerebral palsy population--a 
biomechanical study 
3b Special seating 
2001, Rigby et 
al [110] 
Effects of a wheelchair-mounted rigid pelvic stabilizer on 
caregiver assistance for children with cerebral palsy 
3b wheelchair-mounted rigid 
pelvic stabilizer 
1999, 
Leopando et 
al [53] 
Effect of a Soft Boston Orthosis on pulmonary mechanics 
in severe cerebral palsy.  
4 Soft Boston 
1999, 
Reid et al [32] 
Functional impact of a rigid pelvic stabilizer on children 
with cerebral palsy who use wheelchairs: users' and 
caregivers' perceptions.  
 
3b chair mounted rigid pelvic 
stabilizer compared with a 
traditional wheelchair lap 
belt 
1996, Reid 
[48] 
The effects of the saddle seat on seated postural control 
and upper-extremity movement in children with cerebral 
palsy. 
2b saddle seat 
1995, Myhr et 
al [31] 
Five-year follow-up of functional sitting position in 
children with cerebral palsy. 
4 Abduction orthosis and 
Functional Sitting 
Adaptation 
1993, Myhr 
and von 
Wendt [30] 
Influence of different sitting positions and abduction 
orthoses on leg muscle activity in children with cerebral 
palsy. 
4 
 
Abduction orthosis and 
Functional Sitting 
Adaptation 
1993, 
Miedaner and 
Fiore [35] 
Effects of adaptive positioning on psychological test 
scores for preschool children with cerebral palsy 
1b Fitted wheelchair 
1992, 
McClenaghan 
[38] 
Effects of seat-surface inclination on postural stability and 
function of the upper extremities of children with cerebral 
palsy. 
2b seat-surface 
1991, 
McPherson 
[15] 
Analysis of upper extremity movement in four sitting 
positions: a comparison of persons with and without 
cerebral palsy 
2b Seat angle 
1991, Myhr 
and  von 
Wendt [30] 
Influence of different sitting positions and abduction 
orthoses on leg muscle activity in children with cerebral 
palsy. 
4 Abduction orthosis and 
Functional Sitting 
Adaptation  
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Table E Seating & positioning (continued) 
Authors, 
year 
Title Oxford Type 
1991, Reid 
and 
Sochaniwskyj 
[51] 
Effects of anterior-tipped seating on respiratory function 
of normal children and children with cerebral palsy 
2b Seat angle 
1989, 
Noronha et al. 
[36] 
The effect of positioning on the hand function of boys 
with cerebral palsy. 
3b Standing sitting  and 
prone 
1987, Hulme 
et al [34] 
Effects of adaptive seating devices on the eating and 
drinking of children with multiple handicaps.  
4 Adaptive sitting device 
1987, Nwaobi 
[40] 
Seating orientations and upper extremity function in 
children with cerebral palsy. 
4 Seat angle 
1986, Colbert 
et al [33] 
DESEMO seats for young children with cerebral palsy.  
 
4 DESMO seat 
1986, Nwaobi 
and Smith [52] 
  Effect of adaptive seating on pulmonary function of 
children with cerebral palsy. 
 
4 Adaptive seating system 
1984, Seeger 
BR. [39] 
Will increasing hip flexion above 90 degrees would 
improve hand function in seated cerebral-palsied children 
4 Seat angle 
 
 
 
Table F Seating & positioning 
 Aim Subject, age Outcome  Main finding Methodology 
Reviews 
2006, 
Stavsnees [27] 
Investigating the effect of positioning on 
upper-extremity function: A review of the 
evidence 
16 articles after 
1980 up to? 
 The evidence supports the positive effect of 
a neural to slightly forward orientation 
Small studies , few RTC 
2007, Michael 
et al [41] 
Does tilted seat position have an effect 
for non-ambulant individuals  
19 articles, 10 for 
CP 
 Posterior tilting can reduce pressures at the 
interface under the pelvis 
Small studies , few RTC 
2007, 
McNamara 
and Casey 
[42] 
A review of how Seat inclinations affect 
the function 
10 articles 
1990-2006 
 Neutral and anterior seat do positively 
affect function and individual adaptation are 
preferable  
Small studies , few RTC 
2004, 
Barks [50] 
Does the seating effect pulmonary 
function 
28 articles  Not possible to sum up the result Small studies , few RTC 
Improved posture by adapted seating and special device 
2007, 
Vekerdy [46] 
To investigate the effects of a special 
seating device by using thoracic-lumbar-
sacral orthosis with non-rigid SIDO 
frame. 
47 children  
mean age of 53.2 
months +/- 30.1 SD 
 X-ray 
questionnaires about 
daily activities 
Regular application of the TLSO-SIDO had 
a beneficial effect on feeding problems and 
on posture. 
Experimental prospective study, 
pre- and post-intervention 
2007, 
McDonald and  
Surtees [49] 
Evaluation of Adaptive seating systems 
using sacral pads and kneeblocks for 
improving the posture and stability in 
sitting.  
23 children, 7 - 14 
years  
Measure of force  The seating systems using a sacral pad 
and kneeblock may not improve overall 
posture but may improve hip position in 
with cerebral palsy. 
Single-subject design Repeated 
measure (6 times) 
2007, 
Hatta et al [43] 
 
Evaluating of the relationships between 
postural adaptation and the 
configuration of the Seating Buggy's 
seating support surface. 
21 children 
 
Active Balanced 
Seating scale and by a 
seating expert. 
Properly adjusted depth of thoracic support 
and distance of the lumbar support were 
related to satisfactory head-neck alignment 
and sitting balance of the patients with 
profound cerebral palsy. 
Experimental Comparative  study. 
Postural adaptation were 
compared for 11= appropriate or 
nearly appropriate fitting, 10= ill 
fitting 
2004, 
Shoham et al 
[45] 
To determine the effect of a thoraco-
lumbar-sacral orthosis (TLSO) on the 
distribution of body-seat interface 
pressure in children with concomitant 
scoliosis and pelvic obliquity  
15 children with CP 
and scoliosis and 
pelvic obliquity 
when seated 
Measure maximum 
pressure, mean 
pressure and contact 
area 
X-ray  
Application of a TLSO significantly reduced 
the spinal curvature and interface sitting 
pressure. Manipulation of sitting by use of 
wedges under the pelvis had no significant 
effect on pressure 
Descriptive study 
Data collection at baseline and at 
10 degrees 'push up' and 10 
degrees wedge insertion, with and 
without the TLSO.  
2003, Holmes 
et al [44] 
To investigate the effects of special 
seating on lateral spinal curvature in the 
non-ambulant spastic cerebral palsy 
population with scoliosis. 
?? The shape of the 
spine was measured 
Significant static correction of the scoliotic 
spine can be achieved. By the careful 
configuration of the lateral pads, significant 
correction of a scoliosis can be obtained. 
Descriptive 
 
Table F Seating & positioning (continued) 
 Aim Subject, age Outcome  Main finding Methodology 
1999, 
Reid et al [32] 
Evaluation of the functional 
impact of a Rigid Pelvic 
Stabilizer (RPS) compared 
with a wheelchair lap belt 
6 children mean 
age 10,4 
COPM, a structured weekly 
interview  
Clinically significant changes in task performance 
and satisfaction when the RPS was worn as 
compared to the lap belt for all subjects. 
ABA design 
1995, Myhr et 
al [31] 
A five year follow up of 
functional sitting position 
10 children Scoring of video-filmed sitting 
position 
8 of the 10 who had used the functional sitting 
approach had slightly improvement 
Comparative Study 
1993, Myhr and  
von Wendt [30] 
Influence of different sitting 
positions and abduction 
orthosis on leg muscle 
activity 
 
8 children with 
CP and  
controls 
 
EMG  Abduction orthosis and horizontal and forward-
leaning seats might decrease lower-extremity muscle 
activity, and improve upper-extremity function. 
Comparative Study. 
1991, Myhr and  
von Wendt [29] 
Investigation of best sitting 
position 
23 children Scoring of video-filmed sitting 
position 
Pathological movements were minimised, postural 
control and arm and hand function improved with a 
forward-tipped seat, with a firm backrest supporting 
the pelvis, arms supported against a table and feet 
permitted to move backward. 
Descriptive AB 
Seating and pulmonary function  
1999 
Leopando et al 
[53] 
Effect of a Soft Boston 
Orthosis on pulmonary 
mechanics in severe 
cerebral palsy. 
 
12 children 
5-23 yr 
Pulmonary resistance, compliance, 
tidal volume, minute ventilation, 
work of breathing, oxygen 
saturation, and end-tidal CO2 
tension were measured  
Soft Boston Orthosis does not impact negatively on 
pulmonary mechanics and gas exchange in young 
people with severe cerebral palsy. 
Comparative study, AB 
with and without the 
orthosis and in the supine 
position without the 
orthosis. 
1991, 
Reid and 
Sochaniwsk 
[51] 
Effect on anteriorly-tipped 
seating on respiratory 
function 
12 children, 6 
control 6 CP, 
mean age 6 
years 
respiratory parameters of tidal 
volume, respiration rate, and minute 
ventilation 
No significant differences in respiratory parameters 
could be attributed to seat base position 
Experimental Prospective 
control 
1986, Nwaobi 
and  Smith [52] 
Effect of adaptive seating on 
pulmonary function of 
children with cerebral palsy. 
8 children. 5-12 
yr 
The vital capacity (VC), forced 
expiratory volume in one second 
(FEV1) and expiratory time (ET) 
Increase in VC, FEV1 and ET in the adaptive seating 
system compared with the standard wheelchair.  
Comparative study, AB 
Does sitting ability by special chairs and other device improve upper extremity function  
2001, 
Rigby et al 
[110] 
Investigation of the impact of 
a Rigid Pelvic Stabilizer 
(RPS) compared with a 
traditional lap belt.  
 
6 children Five bimanual or reaching tasks was 
evaluated using a six-point scale by 
parents. 
The RPS appeared to impact directly on reducing 
caregiver assistance for 30% of the tasks,  
ABA design 
Table F Seating & positioning (continued) 
 Aim Subject, age Outcome  Main finding Methodology 
1996,  
Reid [48] 
Evaluate upper extremity 
movement using the saddle 
seat versus flat bench 
 Time and path length to reach No significant difference Experimental cross 
over design 
1993, 
Miedaner and 
Finuaf  [35] 
Evaluation of the relation 
between unsupported sitting 
versus fitted  
N= 12 Cognitive test with reach and grasp item Improved upper limb function for fitted seated in 
tilted wheelchair 
RTC 
1992, 
McClenaghan 
et al [38] 
Relation between seat angel 
and functional use of upper 
extremity 
N=10 CP 
N=10 control 
Time and accuracy Seat angle do not affect upper extremity motor 
performance 
Prospective Case 
Control study 
1991, 
McPherson [15] 
Relation between seat angel 
and functional use of upper 
extremity 
N=10 
adolescents 
Number of movement segments to 
complete reaching task 
No significant difference in quality of arm 
movements 
Experimental cross 
over design 
1989, Noronha 
et al. [36] 
  The effect of positioning on 
the hand function of boys 
with cerebral palsy. 
 
10 boys (mean age 
= 12.5 years, SD = 
1.2 years) 
Jebsen-Taylor Hand Function Test, A 
scale modified from Hohlstein (1982) was 
used to measure quality of grasp on each 
subtest of the Jebsen-Taylor test. 
No significant improvement for between sitting 
and standing, Improved ability for feeding and 
reaching/ handle small objects   
Randomized 
Controlled Trial. 
1987, Hulme et 
al [34] 
To explore the effects of 
adaptive seating on oral-
motor functioning 
11 children 
1-4 yr 
An assessment instrument with a 
behavioural base was used for the seven 
direct observations 
Sitting posture and head alignment during eating 
and drinking improved, children progressed from 
bottle to cup drinking and from eating blended to 
chopped or cut-up food.  
Repeated 
measurements 
1987, Nwaobi 
[40] 
To explore the how sitting 
orientation affect upper 
extremity 
N=13 Time in second to activate a switch Significant difference between neutral position 
and all other position  
Repeated measure 
cross sectional 
1986, Colbert 
[33] 
Investigate the effect of the 
custom-molded DESEMO 
seat for posture and function.  
12 children 
18m-8 yr 
 Feeding improved dramatically for 2 children. 3 
children showed no improvement or progression 
of their curves. The positioning device assisted 
head control for 10 children but failed in 2.  
Comparative, AB 
1984, Seeger 
[39]  
Testing if increasing hip 
flexion above 90 degrees 
would improve hand function 
in those seated   
12 children Time and accuracy Increasing hip-flexion angle in seating  and 
extensor spasticity appears to have no effect on 
hand function. 
Prospective Case 
control study 
TABLE G Constraint-Induced Movement Therapy (CIMT) 
 
Authors, 
Year 
Title Participants Oxford 
2002 Willis  
et al.[62] 
 
Forced use treatment of childhood hemiparesis Hemiplegia 
(stroke, CM, 
trauma, 
unknown 
etiology) 
1b 
2004, Taub et 
al.*[59] 
2002, DeLuca* [58] 
Efficacy of constraint induced movement therapy for children with 
cerebral palsy with asymmetric motor impairment 
Intensive therapy with casting for children with hemiplegic 
cerebral palsy: A randomized controlled trial (Dissertation) 
Hemiplegia 
(CP)  
1b 
2005, Eliasson 
et al. [111] 
Effects of constraint-induced movement therapy in young children 
with hemiplegic cerebral palsy: an adapted model 
Hemiplegia 
(CP) 
2b 
2005,  Naylor & 
Bower [66] 
Modified constraint-induced movement therapy for young children 
with hemiplegic cerebral palsy: a pilot study 
Hemiplegia 
(CP) 
4 
2005, Sung et al 
[61] 
Efficacy of forced use therapy in hemiplegic cerebral palsy Hemiplegia 
(CP) 
2b 
2006, Bonnier et al 
** [67] 
2003, Eliasson et 
al ** [65] 
Effects of constraint-induced movement therapy in adolescents 
with hemiplegic cerebral palsy: a day camp model 
Clinical experience of constraint induced movement therapy in 
adolescents with hemiplegic cerebral palsy - a day camp model 
Hemiplegia 
(CP) 
4 
2006, Charles 
et al. [63] 
Efficacy of a child-friendly form of constraint-induced movement 
therapy in hemiplegic cerebral palsy: a randomized control trial 
Hemiplegia 
(CP) 
1b 
2006, Gordon 
et al. [68] 
Efficacy of constraint-induced movement therapy on involved 
upper-extremity use in children with hemiplegic cerebral palsy is 
not age dependent 
Hemiplegia 
(CP) 
3b 
2007, Charles et al  
[71] 
A repeated course of constraint-induced movement therapy 
results in further improvement 
hemiplegia 3 
2007, Juenger et al  
[69] 
Cortical neuromodulation by constraint-induced movement 
therapy in congenital hemiparesis 
Hemiplegia due 
to MCA and 
preserved 
contra lateral 
motor projection  
4 
2008, Wallen et al  
[70] 
Modified Constraint-induced therapy for children with hemiplegic 
cerebral palsy: A feasibility study 
Hemiplegia 
(CP) 
4 
2008, Hoare et al 
[57] 
 
Constraint-induced movement therapy in the treatment of the 
upper limb in children with hemiplegic cerebral palsy: a Cochrane 
systematic c review  
Congenital 
hemiplegia 
1a 
* and ** the same data are reported in both articles  
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TABLE H Constraint-Induced Movement Therapy (CIMT) 
 
Authors, 
Year 
N Ages Intervention Research Design 
 Outcome 
measures 
Main finding 
2002, 
Willis et al.[62] 
25 
Tx=12 
Cont.= 13 
1–8 y 1 month, no 
training 
 
 
RTC 
Pre–and 1 mo post–
intervention & 6-mo follow–
up 
Short arm 
cast 
Modified PDMS 
and parent 
interview 
Improvement on both modified PDMS 
and parent report, positive result of 
half of the group who returned for 
follow up 
2004, 
Taub et al. [59] 
2002,  
DeLuca [58] 
18 
Tx=9 Cont=9 
7–96 m 3 weeks, restraint 
during waking 
hours, including 
shaping, 6 h/d 
RTC with cross over design 
Pre- & post–intervention & 3 
mo follow-up 
Bi-valved full 
arm cast 
EBS, PMAL, 
TAUT 
Significant improvement on  all but 
non validated tests  
2005, 
Eliasson et 
al.[111] 
41 
Tx. =21 
Cont.=20 
18 mo-
4y 
8 weeks, Training 
and restraint 2 h/d   
Prospective + control 
Pre- & post- intervention, 6 
mo follow-up  
Stiff glove AHA Significant improved bimanual 
performance (AHA), sustained at 
follow up 
2005, 
Naylor & Bower 
[66] 
9 21-61 
mo 
4 weeks, training 
2x1 h/wk and 1h/d 
in home program. 
Case-series design 
ABAA 
Pre- & post-intervention 
4-wk follow-up 
Gentle 
physical 
restraint + 
verbal 
instruction 
QUEST Significant improvement, sustained at 
follow up 
2005, 
Sung et al 
[61] 
31 
Tx =18 
Cont =13 
>8y 6 weeks, training 
2x30min/w for 
both groups 
RTC 
Pre- & post-intervention 
short arm 
cast, 
Box and blocks 
WFIM 
EDPA 
Improvement of all assessment, 
although questionable, since it 
occurred in both hands 
2006, 
Bonnier et al 
[67] 
2003,  
Eliasson et al 
[65] 
 
9 13–18 y 2 weeks, training 
and restraint 7 h/d, 
group intervention 
Case-serie design 
Pre–and post–intervention 
5-mo follow–up tests 
Stiff glove B–OS, J–T Test, 
AMPS, grip 
strength, in–hand 
manipulation, 
Novel MotorTask 
Performance 
Significant result of B-OS, J-T test, in 
hand manipulation, novel Motor Task, 
sustained at 6-month 
 
 
TABLE H Constraint-Induced Movement Therapy (CIMT) (continued) 
Authors, 
Year 
N Ages Intervention Research Design 
 Outcome 
measures 
Main finding 
2006, 
Charles et al. 
[63] 
22 
Tx.=11 
Cont.= 11 
4-8 y 2 weeks, restraint 
and training 6 h/d 
RTC 
Pre- & post-intervention. 1& 
6-mo follow-up 
Sling J-T Test 
B-Os 
CFUS, Strength, 
tactile sensation, 
muscle tone  
Significant improvement for J-T test, 
B-Os and CFUS, sustained at 6-month 
2006, 
Gordon et al. 
[68] 
19 
Younger =11 
Older=8 
 
4-8 y 
 
9-14 y 
2 weeks, restraint 
and training 6 h/d  
Prospective single group 
design 
Sling J-T Test 
B-Os 
CFUS 
Strength, tactile 
sensation, muscle 
tone 
Significant improvement in both group 
for J-T test, B-Os and CFUS, no 
difference between groups, sustained 
at 6-month 
2007, 
Charles et al 
[71] 
8 5-11 y 2 weeks, restraint 
and training 6 h/d 
ABABA design sling J-T Test 
B-Os 
CFUS  
Significant improvement on all test 
both after first and second period of 
treatment, sustained at 6-month  
2007, 
Juenger et al 
[69] 
10 
 
10-30 y 12 days restraint 
and training 10 h 
/day 
Before and after  fMRI 
WMFT 
All participants improved at WMFT 
4 showed increased activation in 
primary sensori-motor cortex 3 
unclear, 2 no changes 
2008, 
Wallen et al 
[70] 
10 6m-8y 8 weeks, restraint 
and training 2h 
/day, 
Prospective pre-post 
feasibility study 
Mit COPM, GAS, 
PMAL, AHA, MUL 
COPM, PMAL and GAS improvement 
 
Abbreviations: CP=cerebral palsy, CM= cerebral malformation, Tx.= treatment, J-T Test= Jebsen-Taylor Test of Hand Function, PDMS= Peabody Developmental Motor 
Scales, AMPS= Assessment of Motor processing Skills, B-Os= Bruininks-Oseretsky Test of Motor Proficiency, AAUT= Actual Amount of Use Test, MAL= Motor Activity 
Log, PMAL= Pediatric Motor Activity Log, TAUT= Toddler Arm Use Test, EBS= Emerging Behavior Scale, AHA= Assisting Hand Assessment, QUEST= Quality of Upper 
Extremity Skills Test, CFUS= Caregiver Functional Use Survey. EDPA=Erhardt Developmental Prehension Assessment, fMRI =  functional Magnetic Resonance 
Imaging,  WMFT = Wolf Motor Function Test, COPM = Canadian Occupational Performance Measure, GAS= Goal Attainment Scale, MUL= Melbourne Upper Limb Test
TABLE I Feeding Interventions 
 
Authors, year Title Oxford 
score 
Feeding treatment approach 
Haberfellner & 
Rossiwall, 1977   
[89] 
                                 
 
Appliances for treatment of oral sensori-motor 
disorders 
 
4 ORAL APPLIANCE:  Innsbruck Sensori-motor Activator 
 and Regulator (ISMAR) 
Banerdt & Bricker,           
1978 [94] 
 
 
A training program for selected self-feeding skills for 
the motorically impaired 4 
POSITIONING/TASK-TRAINING: Proximal and trunk 
support, midline orientation, coupled with task training 
(self-feeding) and adapted equipment 
Helfrich-Miller et al, 
1986 [81] 
 
Dysphagia: Its treatment in the profoundly retarded 
patient with cerebral palsy 4 
ORAL SENSORI-MOTOR FACILITATION: Thermal 
stimulation, oral motor treatment and dietary 
modification 
Ganz, 1987 [73] 
 
Decreasing tongue thrusting and tonic bite reflex 
through neuromotor and sensory facilitation 
techniques 
3b ORAL SENSORI-MOTOR FACILITATION: desensitize oral region, inhibition of abnormal oral and postural 
reflexes, facilitation of muscle tone 
Fischer-Brandies 
et al, 1987 [95] 
 
Therapy of orofacial dysfunctions in cerebral palsy 
according to Castillo-Morales: First results of a new 
treatment concept 
4 ORAL APPLIANCE: Orthodontic palatal plates (stimulates tongue and upper lip), with oral-facial 
physiotherapy (e.g. Vojta, Bobath)  in one third 
Croft, 1992 [74] 
 
What consistency of food is best for children with 
cerebral palsy who cannot chew? 2b 
FOOD CONSISTENCY: Soft solid versus mashed food 
Morton et al, 1993 [82] 
 
Videofluoroscopy in the assessment of feeding 
disorders of children with neurological problems 4 
POSITIONING/CONSISTENCY AND OTHER 
TECHNIQUES: Recommendations for changes in trunk 
position (forward flexion or reclined position), as well as 
utensils, consistency (based on videofluoroscopy) 
Larnert & Ekberg, 
1995 [91] 
 
 
Positioning improves the oral and pharyngeal 
swallowing function in children with cerebral palsy 4 
POSITIONING: Extended versus flexed neck with 30 
degrees reclined sitting 
Gisel et al, 
1995 [72] 
 
 
Effect of oral sensori-motor treatment on measures 
of growth, eating efficiency and aspiration in the 
dysphagic child with cerebral palsy 
2b ORAL SENSORI-MOTOR FACILITATION: Stimuli used for tongue lateralization, lip control, chewing vigor; use 
of textures 
 
Gisel et al, 
1996 [83] 
 
 
Oral-motor skills following sensori-motor therapy in 
two groups of moderately dysphagic children with 
cerebral palsy: Aspiration vs nonaspiration 
2b ORAL SENSORI-MOTOR FACILITATION: Stimuli used for tongue lateralization, lip control and vigor of 
chewing; use of textures  
 
Pinnington & 
Hegarty, 1999 [80] 
 
Effects of consistent food presentation on efficiency 
of eating and nutritive value of food consumed by 
children with severe neurological impairment 
4 ADAPTED EQUIPMENT: Handy-1 Robotic Aid to Eating 
Gisel et al,        1999 
[77] 
The Innsbruck Sensori-motor Activator and 
Regulator (ISMAR): Construction of an intraoral 
appliance to facilitate ingestive functions 
 
4 ORAL APPLIANCE:  Innsbruck Sensori-motor Activator 
and Regulator (ISMAR) 
 
Gisel et al, 
2000 [76] 
 
 
"Whole body" mobility after one year of intraoral 
appliance therapy in children with cerebral palsy 
and moderate eating impairment 
2b ORAL APPLIANCE:  Innsbruck Sensori-motor Activator 
and Regulator (ISMAR) 
 
Gisel et al, 
2001 [78] 
 
 
Impact of oral appliance therapy: Are oral skills and 
growth maintained one year after termination of 
therapy? 
2b ORAL APPLIANCE:  Innsbruck Sensori-motor Activator 
and Regulator (ISMAR) 
Pinnington & 
Hegarty, 2000 [79] 
 
Effects of consistent food presentation on oral-
motor skill acquisition in children with severe 
neurological impairment 
3b ADAPTED EQUIPMENT: Handy-1Robotic Aid to Eating 
Gerek & Ciyiltepe, 
2005 [112] 
         
Dysphagia management of pediatric patients with 
cerebral palsy 4 
ORAL APPLIANCE: Castillo-Morales Device (CMD) 
coupled with speech language therapy and oral-motor 
range of motion exercises 
Clawson et al, 2007 
[90] 
 
4 Use of behavioral interventions and parent education to address feeding difficulties in young 
children with spastic diplegic cerebral palsy 
ORAL SENSORI-MOTOR FACILITATION: oral-motor 
exercises (range, strength)  followed by feeding; 
coupled with positioning and behavioral techniques 
(positive reinforcement, extinction of negative 
behaviors); parental involvement 
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TABLE J Feeding Interventions  
 
Authors, 
year 
Subjects; 
sample size; 
age range 
Methodology Outcome 
measures / 
Variables* 
Main findings 
I. ORAL SENSORI-MOTOR FACILITATION 
Helfich-Miller et 
al, 1986 
[81] 
Severe CP (spastic 
quadriplegia, cerebral 
encephalopathy, 
microcephaly); 
N=6; 10-31 years 
Case series, intermittent 
repeated measures; 
3x/day but thermal increased 
to 6x/day, everyday for 12 
months 
Modified barium swallow, 
ENT exam, 
in depth oral-motor 
examination, videotaping 
of feeding 
Improvements made in efficiency and speed (especially 
pharyngeal transit times) of swallowing. 
Important reductions in aspirations. 
Decreased incidence of upper respiratory tract infections for 
those who remained on thermal stimulation program. 
Percentage change over time. 
Ganz, 1987 
[73] 
Severe cerebral palsy;  
N=1; 8 years old 
 
Single-subject ABA design; 
daily/14 weeks 
at meal time followed by 4 
weeks without treatment 
 
Morris Pre-Speech 
Assessment Scale (oral-
motor function), number of 
tongue thrusts and tonic 
bites between 6th -15th  
presentation of food during 
a meal 
 
Decreased tongue thrust with both solid and semi-solid 
foods.                                                  
Other positive changes included: merging tongue 
lateralization, stable jaw movements with the cup, decreased 
tongue protrusion with liquids, better suck-swallow-breathing 
coordination, decreased associated movements such as 
head extension, decreased stereotyped phasic bite and 
release pattern in chewing, beginning to chew with lips 
closed.                                                                                    
However, poorer elevation of tongue with jaw separation for 
liquids and solids. 
Results were tested statistically. 
Gisel et al, 1995 
[72] 
Moderate to severe 
cerebral palsy with 
moderate eating 
impairment 
n=27 ; mean age= 5.1 
(2-10 years) 
 
Experimental; 
Group 1: 20 weeks treatment, 
Group 2 & 3: 10 weeks 
control then 10 weeks 
treatment; 
(group 1/2: non-aspirators, 
group 3: history of aspiration); 
5-7 minutes/day,5x week 
before lunch/snack 
Modified Functional 
Feeding Assessment- 
subtest of the 
Multidisciplinary Feeding 
Profile, 
Gisel Video Assessment, 
Videofluoroscopy 
Eating efficiency in non-aspirators did not change markedly 
in response to oral sensori-motor therapy. 
In the aspirating group, eating efficiency improved with 
puree, but decreased with solids.  
Children maintained their percentile rank in weight- and 
skinfold-for-age measurements.  
Findings suggest that eating efficiency is not a good 
estimator of treatment outcome 
but rather related to severity of eating impairment. 
Results were tested statistically. 
Gisel et al, 1996 
[83] 
Cerebral palsy 
(moderate to severe 
motor impairment) 
n=27; 2.5-10 years 
 
Experimental; 
10 control followed by 10 
weeks treatment; 
5-7 minutes/day, 5 
days/week, prior to lunch or 
snack; 
(group 1 : 20 non-aspirators, 
group 2 : 7 aspirators) 
Weight and skinfold 
measures, Modified 
version of the Functional 
Feeding Assessment 
subtest of the 
Multidisciplinary Feeding 
Profile, Gisel Video 
Assessment, 
Videofluoroscopy 
There were significant improvements in spoon feeding (lip 
control and swallow pattern), chewing (lateralization of the 
tongue), and swallowing. 
Children that aspirated performed significantly worse 
(baseline) than those that did not aspirate. 
There were no significant changes in rotary chewing or 
drinking skills. 
Children maintained their pretreatment weight-age percentile 
but did not show any catch-up growth. 
Results were tested statistically. 
Clawson et al, 
2007 
[90] 
Spastic diplegia, half 
required nutritional 
supplementation; 
N=8; 18 months-4.7 
years 
Quasi-experimental with 
pre/post testing; Primarily 
descriptive analyses; 4x/day; 
Average duration: 5.8 weeks, 
with follow-up for 1 year 
Beckman Oral-motor 
Assessment, 
Anthropometric measures 
More efficient (shorter time) chewing and swallowing, faster 
transit time from intake to swallow. 
Greater caloric consumption, less need for supplementation. 
Greater height and weight gain (percentile ranks increased). 
Caregivers were more effective in administering feeding, 
(after behavior program: instruction, prompts, 
consequences). 
Descriptive analysis. 
II. CONSISTENCY 
Croft, 1992 
[74] 
Cerebral palsy (all 
types); 
N=67 CP, 64 controls; 
3-18 years 
 
 
 
Experimental; 
2 sessions over 6 week 
period;  
Group 1:normal to near-
normal speech,  Group 2: 
poor speech; Group 3: no 
speech 
Video observation, time to 
complete feeding portion 
Children who had no speech took significantly longer to eat 
non-mashed than mashed potato; 
Children with CP were more likely to cough or choke while 
eating more solid foods, especially those in Group 3. 
Study suggests that mashed foods are safer and eaten more 
quickly than soft solid foods in children with poor oral motor 
skills. 
III. POSITIONING 
Banerdt &              
Bricker, 1978         
[94] 
Cerebral palsy’ 
N=1; 2.5 years 
 
Case study;  
Training sessions 3 
days/week, 4 months, 
at morning and afternoon 
snack time 
Observation, Recording of 
independence, cueing, 
prompting, mandate 
(assistance) 
Number of independent responses from the child increased 
throughout treatment.                
New self-feeding behaviors were maintained with minimal 
assistance 5 months after termination of treatment. 
Results were tested statistically. 
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TABLE J Feeding Interventions (continued) 
 
Authors, 
year 
Subjects; 
sample size; 
age range 
Methodology Outcome 
measures / 
Variables* 
Main findings 
Morton et al, 
1993 
[82] 
 
Most had cerebral 
palsy, all were 
malnourished; N=14; 4-
16 years 
 
Case series; 
Observations on 
videofluoroscopy  
 
Videofluoroscopy with 
multidisciplinary review 
 
 
Children with difficulties mainly in the oral phase fed best in 
the reclined position, those with difficulties mainly in the 
pharyngeal phase fed best in the erect position, particularly if 
they had upper-esophageal sphincter spasm with tonic 
labyrinthine reflex. 
Seating and positioning recommendations were made for 
feeding which parents found to be helpful, however they 
reported no changes in terms of weight gain. 
Descriptive analysis. 
Larnert & 
Ekberg, 1995 
[91] 
 
Tetraplegia with 
dystonia (aspiration, 
recurrent pneumonia); 
N=5;  3-10 years 
 
Quasi-experimental; 
Videofluoroscopy 
observations when sitting 
upright compared to 30 
degrees reclined and neck 
supported and flexed; Single 
session 
Videofluoroscopy 
 
In the reclined position with neck flexed, aspiration 
decreased in all subjects, oral leak diminished in 2 children, 
retention of puree improved in one child. 
Descriptive analysis. 
 
IV. ORAL APPLIANCE 
Haberfellner & 
Rossiwall, 1977 
[89] 
 
 
 
Mixed forms of 
spasticity, athetosis 
and/or ataxia 
N=9; 6-12 years  
 
Quasi experimental, pre-post 
testing with descriptive 
analyses only;  
Progressively increased use 
of appliance; 18 months 
 
Clinical observations: oral 
sensibility to touch, oral 
stereognosis, phonation 
and articulation, position of 
tongue tip during swallows, 
mastication, deglutation, 
speech, lip seal, drooling, 
nasal breathing 
Normalization of sensibility, lip seal, transport of saliva, nasal 
breathing. 
Improvement of speech articulation. 
Descriptive analysis. 
Fischer-
Brandies et al, 
1987 [95] 
Cerebral palsy; 
N=71; l 4-14 years  
 
Quasi experimental, pre-post 
testing with descriptive 
analyses only;  
Several hours/day except 
when eating or sleeping; 
average duration:15 months 
(0.5-3.0 years) 
Oral sensory-motor 
functions via formal 
neuropediatric examination 
 
Improvements noted in spontaneous tongue position and 
coordination of tongue movement, food intake, speech 
development and drooling (in at least half of the children). 
In 5 children, treatment was discontinued due to no apparent 
improvements. 
Spontaneous position of lips and the constant open mouth 
remained unchanged in most cases. 
The positive effects of physiotherapy versus the appliance 
could not be differentiated in this study. 
Descriptive analysis. 
Gisel et al, 1999 
[77] 
Moderate spastic 
quadriplegia; 
N=1; 12 years, 10 
months 
 
Case study; 
6 months control, 12 months 
with appliance (stabilization, 
then mobilization phases) 
 
Anthropometric measures 
(weight, skinfolds), Video 
observation during feed, 
Functional Feeding 
Assessment 
 
Change in facial expression (jaw more retruded in resting 
position; more relaxed facial musculature).                                 
Improved functional feeding skills (spoon feeding, biting, 
chewing, cup drinking, straw drinking) and visible aspects of 
the swallow.                                                                  
Improved eating efficiency of 3 standard textures, with catch-
up of weight during treatment phase.                                           
Able to self feed.                        .                                                 
Concurrent improvements in ambulation and upper extremity 
functions (possibly related to improved nutritional state 
and/or better postural control) 
Descriptive analysis. 
Gisel et al, 2000 
[76] 
Tetraparesis with 
moderate motor 
impairment; 
N=20; 4-13 years 
 
Randomized controlled trial, 
Group A: 12 months ISMAR, 
Group B: 6 months standard 
rehab-control, followed by 
ISMAR for 12 months; worn 
daily; 
Randomization method not 
specified. 
Formal video observation: 
postural and ambulatory 
skill measurements, Sitting 
Assessment Scale, 
Pathologic reflexes and 
movements, Video facial 
expression analysis 
Significant improvement in sitting postural control (axial 
skeleton) and upper extremity control after one year of 
ISMAR therapy. Ambulatory status in children who relied on 
wheelchair mobility also significantly improved, above the 
level of maturation. These changes were not observed in the 
control period. 
These changes were associated with improvements in jaw 
stabilization and oral-motor control.  
Half of the children showed marked improvement in oral 
posture (e.g. lip closure, closed mouth) but not tongue 
position. 
Results were tested statistically. 
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Authors, 
year 
Subjects; 
sample size; 
age range 
Methodology Outcome 
measures / 
Variables* 
Main findings 
Gisel et al, 2001 
[78] 
 
Tetraparesis with 
moderate motor 
impairment; 
N=17; 6-15 years 
Experimental, 
Group A: 2 years with ISMAR 
(n=9), Group B: 1 year with 
ISMAR, 1 year without (n=8). 
(note: sample from Gisel 2000 
study, however some children 
were  non-randomly 
reassigned to different groups 
Anthropometric 
measurements, 
Functional Feeding 
Assessment  
 
Prolonged use of ISMAR was tolerated without 
complications. 
No significant differences were found in the 7 domains of 
functional feeding or in weight gain on follow-up (18-24 
months).  
Maturation was equally effective as ISMAR therapy after the 
first year of use.  
Results were tested statistically. 
Gerek & 
Ciyiltepe, 2005 
[112] 
Cerebral palsy; 
N=7, 8-17 years 
 
Case series (descriptive),  
6-8 hours/day with rest 
periods to all day by week 4; 
for 12 weeks; 
With Vojta and oral-motor 
range of motion exercises 
Deglutition skills, Lip and 
tongue position, 
Goniometric measures of 
labial movements, 
Phonation time 
Improvements noted in bilapial lip control and lip closure. 
Most obvious changes noted in degluition skills (higher 
consistency in food intake, decreased risk of aspiration, 
better saliva control).                                                                    
Parents expressed satisfaction with the results of therapy. 
Descriptive analysis.                                               
V. ADAPTED EQUIPMENT 
Pinnington & 
Hegarty,  
1999 [80] 
 
Most (17) had cerebral 
palsy, 3 traumatic brain 
injury, Lesch-Nyhan 
syndrome or 
encephalitis; all 
dependent feeders, 
wheelchair users; 
N=20; 7-17 years; but 4 
withdrew - could not 
use device  
Quasi-experimental (AB 
within-subject design); 
Use of electric feeder 
(consistent method), when 
feasible for selected meals 
compared to delivered by 
hand (standard method); 9 
months 
 
Dietary analysis program 
(for energy and protein 
content), Diary recordings 
over 5 days for intake and 
eating efficiency, Duration 
of meals and rate 
compared to 
quantity of food eaten, 
Anthropometric 
measurements 
 
Food intake and weight gain can be maintained using 
assistive device compared to feeding by a caregiver. No 
change in the amount of energy or protein consumed. 
Efficiency of eating is reduced  (slower) with use of the 
assistive device, particularly for children with some speech 
who performed more poorly with the device when compared 
to children with no speech.  
Results were tested statistically. 
 
 
Pinnington & 
Hegarty, 
2000 [79] 
 
Most cerebral palsy, 3 
other diagnoses 
(above); 
N=16; 7-17 years 
 
 
Quasi-experimental (ABA 
within-subject design); 
baseline, intervention and 
postintervention phases- 3 
months each;  
selected meals;  
9 months 
 
Video recording/ analysis, 
Schedule for Oral-motor 
Asessment (oral-motor 
behavior and postural 
control during eating) 
 
 
Statistically significant improvements in components of oral-
motor behaviour (e.g. mastication, swallowing) were found 
when a consistent method of food presentation was 
employed.  
Improvements were not always retained on follow-up in the 
post-intervention phase. 
Children with more limited speech skills appeared to benefit 
more. Results were tested statistically. 
* Outcome measures/Variables: when studies specified actual measures used, these are indicated in the column, otherwise the 
variables observed and documented are specified. 
 
TABLE K Virtual Reality 
 
Authors, 
year 
Title Oxford 
score 
VR type 
Reid, 2002 
[107] 
 
 
Benefits of a virtual play rehabilitation 
environment for children with cerebral 
palsy on perceptions of self-efficacy: A 
pilot study 
 
4 Virtual reality (Mandala Gesture Xtreme VX 
technology, 1996) 
- Games* to promote trunk midline and 
lateral movement and control  
Reid, 2002 
[105] 
 
 
The use of virtual reality to improve 
upper-extremity efficiency skills in 
children with cerebral palsy: a pilot study 
 
4 Virtual reality (Mandala Gesture Xtreme VX 
technology, 1996) 
- Games* to encourage arm reaching 
Akhutina et al,  
2003 
[101] 
 
 
 
Improving spatial functioning in children 
with cerebral palsy using computerized 
and traditional game tasks         
2b 
Experiment 1 
Virtual environments (Super Scape VRT 3-
D construction package)       
- Desk-top activities and training tasks (e.g. 
moving through a maze) 
Improving spatial functioning in children 
with cerebral palsy using computerized 
and traditional game tasks        
Experiment 2 
- Games (e.g. sorting, matching, naming 
cards; figure construction) 
 
Reid, 2004 
[106] 
 
The influence of virtual reality on 
playfulness in children with cerebral 
palsy: a pilot study 
 
4 Virtual reality (Mandala Gesture Xtreme VX 
technology, 1996) 
- Games*  
Harris & Reid, 
2005  
 [109]         
 
The influence of virtual reality play on 
children's motivation 
 
4 Virtual reality (Mandala Gesture Xtreme VX 
technology, 1996) 
- Games* to encourage motivation and 
engagement in play activities 
You et al, 2005  
    [108]                
 
Cortical reorganization induced by 
virtual reality therapy in a child with 
hemiparetic cerebral palsy 
 
4 Virtual reality (IREX VR therapy system) 
- Games involving manipulation of objects, 
to encourage movement  
Reid & 
Campbell, 2006  
[104] 
 
The use of virtual reality with children 
with cerebral palsy: A pilot randomized 
trial 
 
2b Virtual reality (Mandala Gesture Xtreme VX 
technology, 1996) 
- Games* requiring arm reaching  
Chen et al, 
2007  
[102]     
  
 
Use of virtual reality to improve upper-
extremity control in children with 
cerebral palsy: A single-subject design 
 
4 2 VR systems: VR-based hand 
rehabilitation training system and EyeToy-
Play system 
- Target and tracking games (e.g.butterfly, 
pegboard, bubbles, boxing, kungfoo) to 
improve goal-directed and anticipatory 
reaching 
 
*examples of games: volleyball, drumming, soccer, snowboarding, juggling, painting, bubbles 
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TABLE L Virtual Reality 
Authors, 
year 
Subjects; 
sample size; 
age range 
Methodology Outcome measures  / 
Variables* 
Main findings 
Reid, 
2002a 
[107] 
Spastic 
quadriplegia or 
diplegia;  
N=3; 8-12 years  
 
Case study, pre/post 
test design                        
two 90 minute sessions 
per week, 4 weeks 
Canadian Occupational 
Performance Measure (COPM) 
-mainly self-care and leisure 
activities were identified 
Performance and satisfaction scores were rated 
higher at post-test for all participants (clinically 
significant). 
Suggests beneficial effects with respect to self-
efficacy.    
Descriptive analysis.      
Reid, 
2002b 
[105] 
 
Spastic 
quadriplegia or 
diplegia; 
N=4; 8-12 years  
Case study, pre/post 
test design; 
1.5 hrs/week, 8 weeks 
 
Quality of Upper Extremity Skills 
Test (QUEST), BOTMP (item 6 
of subtest 5- motor accuracy) 
 
Scores improved on the BOTMP accuracy score.   
Change in quality of upper extremity movements 
was variable (no consistent effect). 
Descriptive analysis.      
Akhutina 
et al,  
2003 
[101] 
 
Cerebral palsy; 
N=21; 7-14 years;  
12 experimental, 
9 control 
Experimental design; 
30-60 min/session,  
6-8x over a one month 
period  
Computer-based: Koos Block 
Design Test, Clown Assembly 
Test                       Other tests: 
Decentration of Viewpoint Test, 
Directional Pointing to Hidden 
Object Test, Raven Progressive 
Matrices, Benton Judgment of 
Line Orientation Test, Arrows 
subtest of the Nepsy-
Neuropsychological Test 
Battery for Children, Roads Test 
 No significant changes were observed
(Most children in experimental group were non-
ambulatory whereas most controls were 
ambulatory) 
Results were tested statistically. 
Cerebral palsy 
(most diplegia); 
N=45; age not 
specified; 
23 experimental, 
22 control 
Experimental design; 
30-60 min/session,  
6-8x over a one month 
period  
 
Visual-spatial abilities of the children in the 
treatment group improved more compared to the 
control group 
Results were tested statistically. 
Reid, 2004 
[106] 
Cerebral palsy 
N=13; 8-12 years 
 
Observational study 
(videotape analysis) 
8 1-hour sessions 
 
Test of Playfulness 
 
Children exhibited all elements of playfulness 
(intrinsic motivation, internal control, suspension of 
reality, and framing) while playing the VR games.     
Playfulness varied with the type of virtual 
environment, some being more engaging than 
others. Descriptive and qualitative analyses. 
Harris & 
Reid, 2005   
[109] 
Cerebral palsy; 
N=16;  8-12 years 
 
Observational study 
(videotape analysis) 
1 hr/week, 8 weeks  
 
Pediatric Volitional 
Questionnaire (measures 
motivation, level of 
engagement) 
VR play is a motivating activity, therefore of interest 
as an intervention tool. 
Level of volition was influenced by the type of 
virtual environment (e.g. degree of variation in the 
game, degree of challenge, competition. 
You et al, 
2005   
[108]             
 
 
Hemiplegia; 
N=1; 8 years 
 
Case study; 
60 min/day, 5x/week 
for 4 weeks 
fMRI, BOTMP, modified 
Pediatric Motor Activity Log 
Questionnaire, Upper Limb 
subtest of the Fugl-Meyer 
assessment 
 
Improved functional motor skills (use) and better 
quality of movement (control, coordination) in 
affected upper limb.  
Post intervention, spontaneous reaching, self-
feeding and dressing were noted (not possible prior 
to VR). Concurrently, there was greater activation 
of the contralateral sensori-motor cortex (as 
opposed to ipsilateral or bilateral). Descriptive 
analysis. 
Reid & 
Campbell, 
2006  
[104] 
Cerebral palsy; 
N=31; 8-12 years 
19 experimental, 
12 control 
(standard care) 
Randomized controlled 
trial; 1.5 hours/week, 
8 weeks 
 
Canadian Occupational 
Performance Measure (COPM), 
Quality of Upper Extremity Skills 
Test (QUEST), Harter Self-
Perception Profile for Children 
(SPPC) 
Significantly increased scores for the social 
acceptance subscale favoring the experimental 
group. VR appears to increase motivation in 
experimental group. Many children in the control 
group were lost to follow-up. 
Descriptive and statistical analyses. 
Chen et al, 
2007   
[102]         
 
 
Spastic cerebral 
palsy; 
N=4; 4-8 years 
 
Single-subject design, 
AB with 2-4 week 
follow-up; 
2 hrs/week, 4 weeks 
 
Reaching kinematics, Fine 
Motor Domain of PDMS-2 
(subtests: grasping, visual-
motor integration) 
3/4 children showed improvement in some aspects 
of quality of reaching which was partially 
maintained 4 weeks after treatment.  
Scores on the PDMS-2 increased (1-11 points) for 
all children; scores on the visual-motor integration 
subtest improved for 3/4 subjects.  
 
Statistical analyses (single subject design).      
* Outcome measures/Variables: when studies specified actual measures used, these are indicated in the column, otherwise the 
variables observed and documented are specified. 
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OCCUPATIONAL THERAPY MANAGEMENT: POINTS OF DISCUSSION  
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The reviewers did a marvellous job in reviewing the whole range of occupational 
therapy papers in a very systematic way, using the PICO system to formulate the 
research questions. An important aspect to focus on in the discussion is on the 
outcomes. All research questions have been formulated in terms of different 
outcomes, using ICF terminology. For example, for Virtual reality the PICO question 
was formulated (p17): Does weekly repetitive training using a play-based VR 
intervention improve: (1) brain reorganization, (2) motor skills, (3) spatial skills, (4) 
motivation and playfulness, (5) functional everyday self-care and (6) leisure activities 
in children with CP? This means that for virtual reality, which is just an example, but 
illustrative for the other topics, in fact there are 6 research questions, all focusing on 
another outcome. 
 
I think it is important to distinguish these outcomes explicitly in the conclusions and 
recommendations. For example looking at the different papers and the different 
outcomes, it was found that in one study with an Oxford level of 4 there were 
significant improvements on the performance and satisfaction levels of the COPM. 
There was another study, also with an Oxford level of 4, which found no change in 
quality of movement, and you found a third study, Oxford level 2b, in which it was 
found that social acceptance improved of the children training with virtual reality 
games compared to a control group. 
 
I think it makes sense to differentiate between outcomes when concluding on the 
levels of evidence. From this respect I think it is fair to conclude that there is no 
evidence that virtual reality may improve quality of movement (grade of 
recommendation C), and that there is some evidence that it may improve social 
acceptance (grade of recommendation B).  
 
The second topic I think is important to discuss relates to the steps in leading to the 
grades of recommendation. When looking at these tables I felt the Oxford level was 
not very easy to use. And in the PT chapter I recognized the same struggle. When do 
you give a paper a level of I, IIa, IIb, or IV? IN the PT chapter, two reviewers 
described a paper on an RCT I am very familiar with, and the first reviewer gave it an 
Oxford level of IIb, and the other one gave it an Oxford level of I. When I looked at 
the tables fr the OT studies I recognized the same struggle; for example looking at the 
papers on splinting there was a paper with a quasi-experimental design of McPherson 
and colleagues, described as Oxford level 4. Another paper with a quasi-experimental 
design (Kerem and colleagues) was assigned a level of 2b, and an RCT of Exner & 
Bonder received a level of 4. 
 
Why do I think this is important? Well, at the end of the conference we want to 
summarize the recommendations, and base them on the Grades of Recommendation 
A-D, which in turn are based on the Oxford levels. But are we really sure about the 
levels of evidence? So, to put it another way, from a research perspective I would be 
interested to know how another reviewer would rate the same papers and what is the 
reliability of this classification system. 
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The third topic I would like to emphasize is the topic of subgroups. This came up 
yesterday as well. The GMFCS and the MACS are very helpful classification systems 
to describe the children in a study. If a study for example included children with 
MACS levels I and II, it should be explicitly described in the Recommendations that 
follow in the guidelines. For splinting and casting some first indications were 
presented that it might be useful, especially for specific subgroups, based on severity 
and age. From the review it became clear that severity was rarely mentioned. I see it 
as a major challenge for the coming years to distinguish subgroups for different 
interventions. 
 
This brings me to my last point which has to do with working mechanisms. When I 
look at the papers that have been reviewed I see two different ways of thinking. First, 
interventions focusing on improving body function or body structure with the implicit 
assumption that improvements in these areas will lead to improvements of activities 
and participation. And second, interventions that focus directly at optimising activities 
and participation. Right now there is some evidence that changes at the level of body 
function do not relate very strongly to changes at the level of activities.  
 
This means it becomes very important to become explicit in our thinking in terms of 
working mechanisms and to think about our major outcomes (again). Yesterday we 
discussed the statement if social inclusion/participation should be the overarching 
goal for health care. If we agree with that it has important consequences for the 
outcomes we should study, and even more importantly to make clear what is the 
theoretical perspective, what’s the theoretical pathway or mechanism to reach that 
goal?  
MEDICAL MANAGEMENT 
 
Jules Becher MD PhD 
Professor of Paediatric Rehabilitation Medicine 
VU University Medical Center 
& 
Deb Gaebler-Spira MD 
Professor, Departments of Physical Medicine and Rehabilitation & Pediatrics 
Rehabilitation Institute of Chicago & Northwestern Feinberg School of Medicine 
 
 
The definition of cerebral palsy has been expanded to incorporate aspects of the 
condition that affect activities or functional abilities (1). This definition is in keeping 
with the World Health Organization’s concepts of participation, abilities, and body 
structure and function (2).  Optimizing the medical condition of the child with 
cerebral palsy aims to improve body structures and function and increase 
participation. Children with cerebral palsy represent a heterogeneous group of 
children with varying medical co-morbidities and secondary musculoskeletal 
impairments. Medical co-morbidities represent impairments of body structure and 
function. The use of the Gross Motor Functional Classification System (3) allows a 
reliable way of classifying and predicting gross motor function and provides a useful 
stratification to base realistic habilitation and rehabilitation goals on. The GMFCS 
represents a continuum of the severity of motor disorder. Current literature shows that 
medical conditions have a significant relationship with the child’s GMFCS level.This 
paper will review interventions based on the use of the GMFCS classification. 
 
 The children in GMFCS I, II, and III are anticipated to walk with different levels of 
competencies. The goals for this group include i) the development of basic and higher 
gross motor skills such as standing, walking, running and jumping, ii) improvement of 
the efficiency of gait and iii) maintenance and prevention of deterioration in gait. 
More concrete treatment goals are decreasing gait deviation by improving alignment, 
improving range of motion, improving strength, and decreasing the related issues that 
may interfere with walking. 
 
The children in GMFCS classes IV and V will have limited abilities to move around 
at home, at school and in the community. Mobility and self-care goals are for sitting 
and comfortable positioning, transfers, dressing, changing diapers and – in general - 
maximizing the interaction with the environment. Improving general health status and 
decreasing medical complications have a high priority in this group. For all children, 
doing their best depends on the child having a base of rest, nutrition, and medical 
well-being. As about 85% of the children has a spastic motor disorder, this paper is 
focused on the treatment of spastic Cerebral Palsy (4).   
 
The first part of this paper will provide focused systematic reviews highlighting areas 
that affect medical conditions that affect life expectancy, nutrition, and bone health 
will be reviewed for children in GMFCS classes IV and V, as well spasmolytic 
therapy as oral medications and Intra-Thecal Baclofen therapy (ITB) to improve care 
and comfort. Although most interventions lack randomized control studies of 
adequate size, sufficient cross-sectional information exists to define problems that are 
in need of trials.  
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THE NON-AMBULANT CHILD (GMFCS level IV and V) 
 
This chapter considers those children who are non-ambulatory (Level IV, ability 
function in supported sitting; Level V, severe limitations in head and trunk control 
with need for extensive assistance for care and mobility). Rehabilitation goals are 
directed toward sitting and comfortable positioning, transfers, and maximizing 
interaction with the environment. In addition to  functional impairments, children with 
GMFCS Levels IV and V are also likely to have comorbid medical problems. 
Preventing and/or treating medical complications and improving overall health status 
are a high priority in this group. For all children, optimal function depends on a base 
of rest, nutrition, and medical well-being. 
Of the many medical issues that affect children and families, we consider three that 
are of major importance to families and also have implications for orthotic practice: 
life expectancy, nutrition, and bone health. We also review two commonly used 
treatments for improvement of care and comfort: intrathecal baclofen (ITB) and oral 
spasmoytic medication.  Treatments on single muscle level are not reviewed (e.g. 
adductor spasticity with botulinumtoxin A). Although most interventions lack large 
randomized control studies, sufficient cross-sectional information exists to define 
problems that are in need of trials. 
 
METHODS  
 
The following databases were searched for randomized clinical trials (RCTs) and 
systematic reviews: Medline, the Cochrane Library, the Cumulative Index to Nursing 
and Allied Health Literature (CINAHL), the Physiotherapy Evidence Database 
(PEDro), the Center for International Rehabilitation Research and Information and 
Exchange (CIRRIE), and the National Rehabilitation Information Center (NARIC). If 
RCTs and systematic reviews were not available, additional references were 
reviewed. The Oxford Center level of evidence-based medicine was used to grade the 
evidence of each study.  
The literature was analyzed focusing on a PICO question (Patient population, 
Intervention, Comparison, Outcome). The authors used the information to discuss the 
implications for orthotics.   
 
What factors are important for limited life expectancy in children with cerebral 
palsy? 
 
Life expectancy is the average survival time of a population; it is convenient measure 
of the health of a population but it cannot predict the lifespan of an individual. It is a 
way of looking at trends in general health, and it is important  in planning health 
services and systems of care such as school, rehabilitative services, and social support 
services. 
Population-based life expectancy is calculated using statistical tools that incorporate 
complex statisticsl using complex statistical relationships. Large longitudinal 
databases, such as those in the U.K. and Australia, have demonstrated consistent 
findings relating the number and severity of functional disabilities to survival.2,3 
Survival curves were calculated and are available (Figure 1).2,3 
 
Life expectancy is negatively related with severe motor involvement, cognitive 
impairment and visual impairment (Figure 1). 
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 Figure 1 Predicted survival from the age of 2 years  
Normal bw, >2500 grams, low bw, <2500 grams.  
(from: Hutton JL, Pharoah PO. Effects of cognitive, motor, and sensory disabilities on 
survival in cerebral palsy. Arch Dis Child 2002;86:84-9.)  
 
In a study in the U. S., pooled repeated observations were analyzed with logistic 
regression for 28,513 children (4 to 14 years) and 30,185 adults, yielding 407,895 
person-years of follow-up.  Life expectancy is limited for  persons without head 
control (between 10-20 yrs), and better for persons fed by others than tube fed. 
However, they found a steady decline in mortality in severely affected children and in 
those fed with gastrostomy tubes over the previous 20 years. 4  
Strauss also reviewed the databases from the U.K. and Australia and concluded that 
the findings were quite consistent with each other and with the findings in the U.S. 
study.5 The authors of these studies of cerebral palsy and life expectancy stress the 
need for consistency in definitions of disabilities and in methods for calculating life 
expectancy. They also emphasize the importance of stratifying data to calculate life 
expectancy for those least severely affected by cerebral palsy, the need to take secular 
trends into account when comparing life expectancy between countries  
Countries that have instituted registries are beginning to provide longitudinal data that 
informs our ability to estimate survival. 
Severity of impairment (motor, cognitive and visual) is associated with decreased life 
expectancy. Studies have consistently shown that the association of motor disability is 
greater than the effect of cognitive disability in this regard. 
Recommendation: Orthotist should use the GMFCS classification to classify a 
child’s ability to move around and being aware of a limited life expectancy. Orthotists 
can also assist in improving health status by monitoring weight and height . 
Implications for orthotics: The overall life expectancy of children with CP is – in 
general – very good, but is at risk in those children with severe impairments (motor, 
cognition and visual). More than 90% of all children with CP become adults with CP. 
Interventions of the orthotist should always be put into this life-span perspective. 
 
 
Does gastrostomy improve body structure and function in children with cerebral 
palsy? 
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A major concern for children with severe cerebral palsy is adequate nutrition a
growth.
nd 
nt.7 
llow, poor GI motility, gastroesophageal reflux, and 
ifficulty positioning for feeding.8 Inadequate caloric intake then leads to poor growth 
ss 
ge 
s). 
 
 high 
 
e ethical issues in 
an subjects review scrutiny. 
ch 
areness of 
wallowing difficulties and knowing the method of feeding may help the orthotist 
nticipate the frequency of need for modification and refabrication.  
 
ring. 
f 
udies 
 risk of 
ver, one cross-sectional multicenter 
ngitudinal study by Stevenson, who concluded that disease severity was not an 
6 The ability to sustain weight and growth is essential to further developme
Factors leading to lengthy feeding and inadequate caloric intake include poor 
coordination of suck and swa
d
and poor nutritional status.  
 
A search was performed for systematic reviews of gastrostomy feeding in children 
with Level IV and V cerebral palsy performed since 2004. There have been no 
randomized controlled trials; but there have been eight studies showing that children 
fed by gastrostomy tubes show greater gains in weight, height, and skinfold thickne
than children without gastrostomy tubes. The levels of evidence in these studies ran
from 2c to 3b. Other studies, however, with evidence levels of 2b and 2c, provide 
multicenter cross-sectional and prospective longitudinal cohort data. These studies 
consistently demonstrated improved growth and increased fat mass index (see table
In addition, one study with 2c evidence with small numbers showed that best growth 
was associated with fewest days of health care use and more social participation.8  
Although it now appears that gastrostomy tubes can lead to increased growth, it is not
clear how much weight is appropriate. Low energy expenditure may result in a
fat content, raising the possibility of relative overfeeding and excessive weight gain,
causing difficulty for parents in transferring and positioning their child.9,10,11  
The level of evidence remains poor quality for impact of growth and size on ability 
for caregivers to continue to care for the child; however, th
performing a large-scale well-designed study with such a vulnerable population will 
require expert input and hum
Recommendation: Optimal weight is unclear but children can grow with attention to 
adequate nutritional intake. 
Implications for orthotics: Orthotic fit and function are affected by weight; resear
for tolerance of orthoses related to change in growth is necessary. Aw
s
a
 
 
Does bone health affect body structure and function? 
 
Bone health—structure, composition, density, and strength is a source of concern in
children with cerebral palsy. There is good evidence that children with cerebral palsy 
are at risk of fractures, particularly children who are older and non-weight bea
Several factors that may contribute to risk have been suggested, including severity o
disease, bone mineral density, nutritional status, and use of anticonvulsants.  
A systematic search of electronic databases was performed. No systematic reviews 
were found. Most relevant studies had evidence levels ranging from 2c to 3b.  
Eight studies of fractures in children with cerebral palsy were identified. These st
were generally case control studies and demonstrated consistent findings: the
fracture increases in older children, those with greater disease severity, and non–
weight bearing status. There was, howe
lo
independent risk factor for fracture.12  
 
Bone mineral density (BMD) has been studied in nine recent articles. Study results 
showed some inconsistencies, but the most persuasive information was provided by 
Henderson in a prospective longitudinal observational study, showing that BMD in 
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the distal femur decreased with greater severity of disease, and increasing age.13 Th
have not been consistent findings about the role of anticonvulsants or abou
ere 
t the use of 
d 
e in 
predict which patients with cerebral palsy will benefit from 
ems to 
 
lates BMD in healthy 
ith orthotists regarding proper alignment and the 
bility of equipment and orthoses to provide sufficient weight bearing (standing or 
upported walking) for bone health. 
o oral medications improve body structure and function for children with 
view 
s 
um in four studies, baclofen in three, diazepam in two, 
nd gabapentin in one. Most studies were small, of short duration, and had no 
 to 
ent in 
 
lated 
 As with other 
reas of study discussed in this paper, consensus is difficult to establish because of the 
scle tone is decreased when using baclofen, Dantrium, 
serum markers, such as parathyroid hormone, alkaline phosphatase, and inorganic 
phosphorus as predictors of decreased BMD or increased risk of fracture. 
The scientific evidence at present supports the conclusion that bone health is affecte
by weight bearing status, poor nutrition, and severity of disease. Evidence also 
supports the notion that fractures are partially a failure of bone health. There is less 
evidence regarding nutritional status and anticonvulsant therapy and little evidenc
support of serum factors as predictors of risk. The relationship of BMD and fractures 
remains to be determined. Many studies are limited by their retrospective nature, 
small sample size, and use of bone mineral density (BMD) instead of fracture rate as 
outcome. It is difficult to 
treatment (specifically bisphosphonates, and Vitamine D), increased weight bearing, 
and improved nutrition.  
Recommendations for treatment are not yet available because of the absence of firm 
evidence; larger, appropriately designed studies are needed. Weight bearing se
be an important factor and could be encouraged in non-ambulatory children with CP.
Implications for orthotics: Since weight bearing stimu
children, orthoses may enhance weight bearing in non-ambulatory children with CP 
and – by this – may be beneficial to their bone quality. 
Research is needed in collaboration w
a
s
 
 
D
cerebral palsy? 
 
Oral medications are frequently used in children with cerebral palsy, although there 
have been few large randomized studies to evaluate this practice. A systematic re
of oral antispastic drugs published in Neurology in 2004 found twelve studies—six on 
stroke, three on spinal cord injury, and three on cerebral palsy.14 Tizanidine wa
assessed in four studies, Dantri
a
consistent efficacy variables.  
 
Review of published articles since 2004 on diazepam, Dantrium, and baclofen show 
few RCTs. One RCT involved administration of a single bedtime dose of diazepam
114 children with cerebral palsy. This study demonstrated subjective improvem
parent report of well-being and burden of care for children receiving treatment.15 
Another study involved use of two different dose regimens of diazepam in 174
children; the two-dose regimen had poorly defined outcomes but showed dose-re
improvements in sleep and decreased resistance to movement, not defined as 
spasticity.16 Another RCT was performed using oral baclofen with 15 children; 
medication was more effective than placebo in tasks such as transfers and positioning, 
although there were inconsistent results in other assessment tools.17
a
variety of methodologies, outcomes, and assessment tools used.  
 
Studies support the use of diazepam for reducing tone, improving nighttime 
discomfort, and improving motor activity. Other medications have conflicting 
outcomes for function, but mu
 138          © International Society for Prosthetics & Orthotics 
and tizanidine. Subjective improvement in comfort and well-being may be at least a
important as other outcomes. 
Recommendation: The need to decrease spasticity and improve comfort and well-
being is an appropriate indication for oral medications. Oral anti-spasticity 
medications lend themselves to use in RCTs. Such s
s 
tudies are warranted and should 
fined positioning and wearing goal. Collaborative 
search efforts with orthotists are warranted to evaluate the role of orthotic tolerance 
 the management of spasticity.  
oes intrathecal baclofen improve body structure and function in children with 
 
 
e 
rable 
lts 
evaluate 
e for 
. 
e 
losely 
. Functional gains and changes in quality of life 
ance 
nd application and may potentially affect patterns of deformity. Orthotic 
anagement will be altered by ITB, requiring close observation and follow-up. 
ies. 
ack of 
vidence-based practice in combination with a defined habilitation plan that considers 
e child, family, and community defines state of the art medical management. 
involve larger numbers and better outcome tools than those in previous studies. 
Outcome studies should include orthotic tolerance. 
Implications for orthotics:  The use of oral medications is relevant to orthotists, 
since reducing tone can affect a de
re
in
 
 
D
cerebral palsy? 
 
The use of intrathecal baclofen (ITB) for reducing spasticity associated with cerebral
palsy has grown over the past decade. Baclofen is most frequently administered as a 
continuous infusion through a programmable delivery system. In a recent article, 29 
studies published between 2000 and 2007 were systematically reviewed.18 Almost all
studies were case series, case control studies, cohort studies, or case studies; evidenc
levels were low, and assessment tools were inconsistent. Nevertheless, conside
evidence supports the use of ITB for reducing hypertonia. This affects orthoses and 
positioning for children with GMCFS Levels IV and V. Some studies suggest 
subjective improvement in functional mobility and caregiver burden, but these resu
are not based on statistically significant data. Few studies have attempted to 
activities, and almost none have looked at participation.  
The complications of CITB are most often related to surgical procedur
implantation of the drug delivery system or the function of the drug delivery system
Complications are frequent and demand expert and immediate care.19 
Considerable evidence supports the use of ITB in reducing spasticity, although its 
effect on activities , participation, and quality of life has not been established. 
Recommendation: Spasticity management should include ITB if hypertonia is sever
and warrants aggressive management. Children using ITB should be followed c
for complications by an expert team
and caregiver burden should be measured in controlled studies with consistent 
definitions and assessment tools.    
Implications for orthotics: Modifying severe spasticity will affect orthotic toler
a
m
 
 
CONCLUSIONS FOR THE NON-AMBULANT CHILD  
 
Developing a treatment plan for a child with GMCFS Level IV or V is complicated, 
since this group of children presents complex and variable medical comorbidit
Using evidence-based practice is desirable but not always possible, given the l
randomized controlled trials and the variety of methodologies, outcomes, and 
assessment tools used in published clinical studies. However, using available 
e
th
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THE AMBULANT CHILD (GMFCS level I, II & III) 
 
This part of the paper will also review interventions based on the use of the GMFCS 
classification (5).  The children in GMFCS I, II and III are anticipated to walk with 
different levels of competencies. The goals for this group include decreasing gait 
deviation by improving alignment, improving range of motion, improving strength, 
and decreasing the related issues that may interfere with walking.  
 
Since the last consensus report of the ISPO (6) about the treatment of children with 
Cerebral Palsy, new medical treatment options to reduce the effect of spasticity has 
become available.  According to the International Classification of Functioning (7), 
effect of treatment can be described on the level of body function and structure, and 
on the level of activities and participation. This paper will provide focused systematic 
reviews highlighting areas that affect activity level for children in GMFCS level I, II 
and III, by reviewing spasmolytic therapies (Botulinumtoxin A and selective dorsal 
rhizotomy) for improvement of the level of activities.  The efficacy of these 
treatments on the level of body function and structure (decrease of spasticity / muscle 
tone) has been demonstrated (8-10).  
Botulinum toxin A is a drug, which can be used for intramuscular injections. It blocks 
the acetylcholine dependent synaptic transmission from the nerve to the motor unit 
temporary (3 to 6 months). Selective dorsal rhizotomy is a surgical procedure in 
which sensory roots at the intrathecal space  at lumbar level (from S1-S2 to L2) 
partially are cut bilaterally (11).  
 
Methodology 
 
Keywords for the search in digital medical literature databases were “cerebral palsy 
and (clinical trial or review) and (botulinum toxin or rhizotomy )“, from November 
2003- November  2008, in PubMed, Embase and the Cochrane Library. The data from 
an Evidence based guideline for the diagnosis and treatment of Cerebral Palsy in the 
Netherlands (2007) are also used 
(www.cbo.nl/product/richtlijnen/folder20021023121843/rl_cerebrale_parese_07.pdf/v
iew).  Only the results of systematic reviews and randomized clinical trials are 
considered. The literature was analyzed focusing on a PICO question (Patient 
population, Intervention, Comparison, Outcome). 
 
 
Does treatment with Botulinum toxin A improve walking ability in children with 
CP? 
 
Results of the analysis of the literature are summarized in Table 8. Although many 
case reports and pre-post studies have reported statistically significant improvement 
of gross motor function in spastic Cerebral Palsy by means of the Gross Motor 
Function Measure (GMFM), the evidence in randomized clinical trials is still 
inconclusive.  The selection of patients for treatment is a key issue in the treatment 
with BTX-A: should all muscles with spasticity be treated or should only limiting 
impairments for mobility  (e.g.  pain in an Ankle Foot Orthosis by high muscle 
tension, crouch gait with fatigue)  be treated with a goal oriented rehabilitation 
program?  In the study of Moore, all muscles with spasticity has been treated 
repeatedly after recurrence of spasticity. In the study of Bjornson, only young 
bilaterally involved children have been treated in the Gastrocnemius Muscle (GM). At 
this age, hyperactivity of the GM is a more common problem, while the weakness can 
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cause limitations at an older age (12). Children with a flexion gait pattern with 
functional problems, treated with a comprehensive rehabilitation program (physical 
therapy, orthoses) improved significantly, but criteria for selection are still unclear 
(13). In this study, the specific  contribution of  Botulinumtoxin A treatment in the 
improvement in gross motor function is not clear. The study of Reddihough addressed 
a heterogeneous group of children and was not based on treatment of functional 
problems. 
Recommendation: Treatment with Botulinumtoxin A can potentially improve 
walking ability in a selected population of children with spastic CP. Selection criteria 
for treatment are still unclear.  
Implication for orthotics: Botulinumtoxin A is effective in reducing spasticity, and 
should be considered in case of limitation in the use or in the potential effect of an 
Ankle Foot Orthosis to improve gait by spasticity related problems.  Botulinumtoxin 
A treatment should be seen as one component of a comprehensive rehabilitation 
program (physical therapy, exercises, orthoses). 
 
 
Does treatment with Botulinumtoxin A improve bilateral hand function? 
 
In children with upper limb involvement (hemiparesis, GMFCS level I, II or III), only 
improvement of bilateral hand function is important to improve the level of activities, 
as the least involved upper limb will be used as the dominant upper limb.  Therefore, 
the  the level of activities is the relevant outcome to assess the improvement of 
abilities (as dressing, drawing, scribing) by treatment of upper limb function.  
In Table 9, the results of systematic reviews and recent randomized clinical trials are 
summarized.  Combined treatment of occupational training and botulinum toxin A 
treatment showed  significant improvement  only on subjective goals for treatment, 
not on capacity and performance assessment tools(14).  The secondary trial analysis 
had not been published for the effect of each therapy modality at the time of this 
review. Looking to the effect sizes, it is not very likely that each therapy alone could 
achieve a significant improvement. The study of Russo (15) found comparable results. 
Recommendation: There is no scientific evidence for improvement of bilateral hand 
function by Botulinumtoxin A treatment of the upper limb in children with spastic CP 
and unilateral involvement. 
Implications for orthotists: Botulinumtoxin A is effective in reducing spasticity, and 
should be considered for the upper limb, only if there are complaints  in the use of 
orthoses on the level of body functions and body structures (pain, contracture, thumb 
in palm deformity).  
 
 
Does Selective Dorsal Rhizotomy improve walking ability? 
 
Selective Dorsal Rhizotomy, a neurosurgical procedure to reduce spasticity, is the 
only well studied medical treatment for children with spastic CP (16). A small but 
significant improvement in mobility (GMFM-66) has been demonstrated in a meta-
analysis , based on 3 Randomized Clinical Trials (Table 10). Moreover,  in a long 
term follow up study the gait improvement after SDR in children with CP turned out 
to be stable. The criteria for selection of the patients has been described (17;18).   
Recommendation: Selective Dorsal Rhizotomy is a treatment option for a selected 
group of children with bilateral spastic CP to improve mobility. 
Implications for orthotics:   Selective Dorsal Rhizotomy is effective in reducing 
spasticity, and in improving mobility.  Limitation of the use or effect of an Ankle Foot 
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Orthosis to improve gait by spasticity related problems can be improved by Selective 
Dorsal Rhizotomy in a selected group of patients. 
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Table 1. What factors are important for life expectancy in children with CP? 
Author year 
/LoE 
Research design Subjects Interventi
on 
Outcome measures Main findings 
Strauss 2008 
/1b 
Def of life expectancy and how 
calculated; revised estimates based 
on improved analytical methods; 
issues regarding quality of care; 
comparison of life expectancies 
among countries 
People with CP 
receiving services 
from state of CA 
between 1983-2002 
(as below in Strauss, 
2007) 
None Life expectancy using 
adjusted statistical methods 
Consistent findings in life expectancy in large 
databases in US, UK, and Australia; need to stratify 
data for least severely affected pts; need to adjust for 
secular trends in survival. 
Strauss 2007 
/1b 
Statistical analysis using pooled 
repeated observations method, with 
logistic regression analysis. Based 
on data collected by CA (US), 
including survival, severity of CP, 
mode of feeding, mobility  
People with CP 
receiving services 
from state of CA 
between 1983-2002: 
28,513 children (4-14 
y) and 30,185 adults 
(≥15 y)→407,895 
person-years.  
None Death rates by age, 
mobility, feeding status 
Declining mortality in those fed by gastrostomy over 
20 years (decline of 3.4% per year); increased 
longevity in most severely disabled. 
Hutton 2006 
/1b 
Analysis of Mersey Cerebral Palsy 
database (UK); discussion of 
statistical methods needed for valid 
assessment of life expectancy. 
1647 people with CP 
registered 
None Survival curves by 
functional disability 
More severe disability associated with poorer 
survival; severity of motor disability has greater 
predictive power than severity of cognitive disability. 
But valid estimation will depend on cohort with 
accurate birth and death data and clear definitions of 
functional disability. 
 
Hutton 2002 
/1b 
Analysis of Mersey Cerebral Palsy 
database (UK); statistical analysis 
1942 individuals 
registered 
None Survival curves associated 
with cognitive, motor, and 
sensory deficits, and 
birthweight 
Survival varies by number and severity of disabilities 
and birthweight. Poorest prognosis for those with 
severe motor, cognitive, and visual disability, and 
normal birthweight. 
 
 
Table 2. Does gastrostomy improve body structure and functional outcomes in children with CP? 
Author  
year/LoE 
Research design Subjects Intervention Outcome measures Main findings 
Henderson 
2007 /2c 
Multicenter, cross-sectional 
single observational 
assessment 
75 children <19 y with CP 
in residential care, 205 
with CP living at home 
None Anthropometric measures Use of feeding tube → ↑weight, height, skinfold 
thickness. Pts in residential care older; significantly 
higher percentage with feeding tube 
Campanozzi 
2007 /3b 
Prospective case series 21 consecutive children 
(mean age 5.8 y) with CP 
and severe MR 
Caloric 
increase 
(20%), treated 
w/ omeprazole 
if + for GERD 
Measurement of growth and 
motor function before and 
after 6 mo nutritional tx.  
15 (71%) had ↓ FBM; of these, 73% + for GERD and 
60% + for CC. 14/15 completed 6-mo tx. BMI ↑ 
(P=0.08); GMFM signif  ↑ in 9/14, unchanged in 5 
Day 2006 /2c Cross-sectional study, 
multiple measurements 
24,920 with CP (ages 2-
20 y) receiving svcs from 
the state of CA from 
1987- 2002; 11,496 had 
Grade V CP  
None 141,961 ht/wt 
measurements→developed 
growth curves stratified by 
severity of disability. 
Compared BMI of pts with 
grade V CP with and 
without G-tube 
Those with feeding tubes had ↑ height and weight 
compared to those without (2-5 kg heavier) 
Increase in weight attributable to use of feeding tubes; 
most pronounced at 10 y (M and F) and 15 y (M) 
Stevenson 
2006 /2c 
Multicenter, region-based 
cross-sectional study; 
cluster analysis 
methodology  
273 children (2-18 y) with 
CP GMFCS III-V 
None Anthropometric measures; 
health care use; and social 
participation over previous 
4 weeks 
Best growth associated with fewest days of health care 
use and fewest days of social participation missed. 
Smaller children more likely to have more severe 
GMFCS grade. Children with Grade V without feeding 
tube more likely to be in smallest group than those with 
feeding tube (4% vs 20%) 
Sullivan 2006 
/2b 
Prospective, longitudinal, 
observational.  
40 children with CP 
(median age 8.5 y): 39 
GMFCS IV-V; 22 with G-
tube feeds, 18 fed orally. 
Compared patients with 
each other and with 1990 
British ref. centiles 
(without disabilities) 
None Measures of body fat and 
energy expenditure: resting 
metabolic rate, total energy 
expenditure, lean body 
mass, fat mass; fat mass 
index, fat-free mass index  
Both CP groups had higher body fat and less energy 
expenditure than ref pop. RMR and TEE lower in G-tube 
group than orally fed group, but G-tube group had 
significantly (P<0.02) larger fat mass index than orally 
fed group. G-tube group 2.41 kg/m2 >ref; orally fed 
group 1.15 kg/m2 >ref standard. Orally fed group had 
3.74 kg/m2 less FFM than ref; G-tube group had 4.58 
FFM than ref. (trend, NS) 
Craig 2006 
/2c 
Prospective case series 76 children <18 y (median 
age 40 mo); 32 with CP, 
25 with genetic abn 11 
with degenerative disease, 
8 w/o dx  
Gastrostomy± 
anti-reflux 
procedure 
Growth; surgical 
complications; change in 
symptoms. Growth and sx 
assessed preop and 3 or 6 
mo postop. 
Two-thirds had catch-up growth (P=0.001). Major postop 
complications in 17%. Significant improvements in 
drooling, vomiting, and constipation  
 
Table 2. Does gastrostomy improve body structure and functional outcomes in children with CP? (continued) 
Author  
year/LoE 
Research design Subjects Intervention Outcome measures Main findings 
Kong 2005 
/2c 
Cross-sectional 110 children-CP 
(nonambulatory); 48 tube-
fed, 62 orally fed, 119 
normal controls 
None Measurement of weight and 
height (height est. from 
ulnar length in CP), skinfold 
thickness 
Weight-for-height z scores nl in tube-fed group; signif ↓ 
in orally fed pts w/ CP compared to tube-fed grp and 
normal controls. Skinfold thickness in CP most reliable at 
triceps; unreliable in LE (muscle atrophy)   
Sullivan 
2005/ 2c 
Longitudinal, prospective, 
cohort study; no controls 
(ref data) 
57 children ≤18 y (median 
age 52 mo) with poor 
weight gain; 77% Grade 
V. 
Gastroscopy ± 
fundoplication 
Growth/ complications/ 
health at baseline, 6 mo, 12 
mo 
Weight gain at 12 mo (z=+1.24, P <0.0001; mid-upper 
arm z=+1.02, P <0.0001.) One serious complication 
(peritonitis). 
No change in frequency of chest infxn, but ↓ 
hospitalizations. 
 
BMI, body mass index; CP, cerebral palsy; FBM, fat body mass; FFM, fat-free mass; FMI, fat mass index; FFMI, fat-free mass index; G-tube, gastrostomy tube; 
GERD, gastroesophageal reflux disease; GMFCS, Gross Motor Function Classification System; RMR, resting metabolic rate; TEE, total energy expenditure 
 
Table 3. Systematic studies of gastrostomy 
 
Author year Search strategy Intervention Comparison Methodology of 
individual studies 
Main findings 
Vernon-Roberts 2007 Cochrane, Medline, 
EMBASE, CINAHL ISI Web 
of Science, Child Health 
Library; include only RCT 
Gastrostomy + 
anti-reflux tx 
Effectiveness 
of anti-reflux 
surgery and 
anti-reflux 
meds in pts 
w/neurologic 
impairments 
and GER 
No studies met 
criteria 
No RCT 
Sleigh 2004 (Arch Dis Child) Cochrane, Medline, 
EMBASE, CINAHL, 
LILACS, databases of theses: 
include CT, systematic 
reviews, published 
observational studies; 
exclude nonsystematic 
reviews, qualitative studies 
Gastrostomy / 
jejunostomy 
Death rate, 
growth, GER, 
complications 
/ caregiver 
wellbeing 
2 cohort studies, 15 
case series, 8 case 
reports 
Inconsistent criteria for same 
outcomes; little robust evidence re: 
gastrostomy 
Sleigh 2004 (Cochrane 
Database) 
Cochrane, Medline, 
EMBASE, CINAHL, 
LILACS, databases of theses; 
include only RCT 
Gastrostomy / 
jejunostomy 
Nutritional 
status for 
children with 
CP ≤16 y 
No studies met 
criterial 
No RCT 
Samson-Fang 2003 Medline, CINAHL, 
HealthSTAR, ClinPSYC, 
Cochrane Database: include 
clinical studies comparing 
gastrostomy with oral feeding  
Gastrostomy Effectiveness 
in children <18 
with CP  
10 studies, all with 
levels of evidence IV 
and V  
Most show improvement after 
gastrostomy. Low levels of 
evidence; few controls; little 
statistical data, little info about 
caloric intake or body composition 
 
Table 4. Bone Health: Risk factors for fracture in children with CP 
Author year 
/LoE 
Research design Subjects Intervention Outcome measures Main findings 
Khoury 
2007/3b 
Case-control Non-ambulatory, (2-20 
y/o, mean 11 y) 
None Fracture  Risk of fx ↑ in those with BMI >17; risk factors: 
combination of BMD of femur + BMI 
Presedo 2007 
/3b 
Case-control 156 with fx,150 
without; 55% with 
spastic quadriplegia 
None Fracture 82% fx lower extremity; trauma was cause of 32% of fx; 
45% fx with unknown cause. Significant risk factors: 
severity of CP, ↓ ambulatory status, anticonvulsants 
Ko 2006 /3b Case-control Children living at a 
disabilities unit in Hong 
Kong, 4-19 y/o (mean 
10 y); 19 with fx, 90 
without 
None Fracture  Risk factors: Lower weight for age, longer duration of post-
surgical immobilization 
Leet 2006 /3b Case-control 50 children with fx, 368 
without fx (1.3-18 y/o, 
mean 10.6 y), 58% 
quadriplegia  
None Fracture  Increased risk for fx in older pts, those with mixed tone, 
feeding tube, sz, valproate, use of standing equipment 
Stevenson 
2006 /2c 
 
Longitudinal, cross-
sectional, multicenter 
297 children with CP, 
GMFCS III-V (2-19 
y/o, mean 9.3 y). 
Baseline: 46 w/ fx, 251 
without fx 
None Fracture Follow-up: 24 fx among 260 pts followed for 605 person-
years. Estimated fracture rate 4.0% per year. Disease 
severity not significant. 
King 2003 
/3b 
Case-control Non-ambulatory pts, 5-
48 y/o (mean 15 y) with 
spastic quadriplegia  
None Fracture  Lower BMD z-score (–2.81 vs. –2.11) 
Bischof 2002 
/3b 
Case-control Pts living in care 
facility in South Africa, 
6-29 y/o (mean 17.5 y), 
20 with fx, 20 without 
fx 
None Fracture  Anticonvulsant use, higher ALP, PTH, lower Pi 
Henderson 
1997 /2b 
Retrospective cohort 43 children (3.3-17.2 
y/o, mean 7.9 y) with 
spastic CP. Baseline 
BMD measurements 
taken; followed for 162 
person-years 
None Fracture 9 fx; most involved femur; most occurred with minimal 
trauma. Previous fx and hip spica casting significant for 
predicting future fx. BMD z-score not significant in 
predicting fx. 
ALP, alkaline phosphatase; BMD, bone mineral density; BMI, body mass index; CP, cerebral palsy; fx, fracture; GMFCS Gross Motor Function; Classification 
System; Pi, inorganic phosphorus; PTH, parathyroid hormone; sz, seizure 
Table 5. Bone Health: Effect of bone mineral density in children with CP 
 
Author, year Research design Subjects Interventi
on 
Outcome 
measures 
Main findings 
Henderson 
2005 /2c 
Prospective 
longitudinal, 
observational 
69 patients (55 observed >2 
years, 40 observed >3 
years); GMCFS III-V; 2-
17.7 y/o (mean 9 y) 
None BMD  Total body BMD increased with age but distal femur BMD decreased. Risk 
factors for low BMD: greater severity of disease, poorer growth/nutrition, 
advancing age. No variable at baseline was a predictor for change in BMD 
 
Henderson 
2004 /3b 
Cross-sectional 107 with CP, GMCFS III-V, 
2-21 y/o (mean 12 y) 
None BMD  Additive risk factors. Weight z-score best predictor of BMD z-score. Risk factors: 
lower weight z-score, increasing age, greater disease severity, prior fractures, 
anticonvulsant use, feeding difficulties. 
King 2003 
/3b 
Case-control 48 pts (42 w/ CP), non-
ambulatory with spastic 
quadriplegia, 5-48 y/o 
(mean 15 y); number of 
controls not reported 
None BMD  Lower BMD in patients. Age, weight, or height, serum analysis, anticonvulsant 
use not significant 
Nakano 2003 
/2c 
Cross-sectional 123 institutionalized adults 
with CP, 21–46 y/o  
None BMD  Risk factors: use of anticonvulsant in both male and female, higher ALP in men, 
decreased ambulation in women 
Unay2003 /3b Case-control 67% tetraplegic, 55% non-
ambulatory, 2.7-14.2 y/o 
(mean 5.1); 40 with CP, 40 
without 
None BMD  Tetraplegic patients had lower BMD than hemiplegic; ambulatory status and 
physical therapy not significant 
Henderson 
2002 /3b 
Case-control 117 with CP, >250 without; 
GMCFS III-V, age 2-19 y/o 
(mean 9.7 y) 
None BMD  Osteopenia in most non-ambulatory children by 10 y. Risk factors: neurological 
impairment, feeding difficultly, anticonvulsant use, lower triceps skinfold 
Tasdemir 
2001 /3b 
Case-control 63% non-ambulatory, 50% 
malnourished, 10 mo to 12 
y/o, (mean 4.1 y); 24 with 
CP, 19 without 
None BMD  BMD less in all patients, even less in non-ambulatory patients. Risk factors: 
higher Ca and P levels. Malnutrition, anticonvulsant use not significant 
Chad 2000 
/3b 
Case-control 17 with spastic CP, 894 
without, good nutritional 
status, 76% non-
independent ambulators, 
7.6-13.8 y/o (mean 10.9 y) 
None BMD  Risk factor: non-independent ambulation 
Henderson 
1995 /3b 
Case-control 139 children (3-15 y/o, 
mean 9 y) with spastic CP; 
95 controls 
None BMD  BMD nearly one SD greater in controls than pts. Risk factors: ambulatory status, 
nutritional status, pattern of involvement, duration of immobilization, low Ca 
intake. Previous fx, anticonvulsant use, vit D levels not significant 
ALP, alkaline phosphatase; BMD, bone mineral density; BMI, body mass index; CP, cerebral palsy; fx, fracture; GMFCS Gross Motor Function; Classification 
System; Pi, inorganic phosphorus; PTH, parathyroid hormone; sz, seizure 
Table 6. Do oral medications improve body structure and function for children with cerebral palsy? 
Author 
year/LoE 
Research design Subjects Intervention Outcome measures Main findings 
Murphy 2008 
/2 
Randomized, double-blind, 
crossover trial 
8 children (mean 
age 11.5 y) 
GMFCS Level 
III-V 
Modafinil vs. 
placebo 
Modified Ashworth; Caregiver 
Priorities and Child Health Index 
of Life with Disabilities 
(CPCHILD), 
No improvement in spasticity or quality of life 
Lubsch 2006 
/2b 
Retrospective chart review 87 children (<18 
y/o) with 
spasticity due to 
CP (80%) or TBI 
(20%) 
Oral baclofen 
and/or clonidine 
To calculate mean dosages of 
baclofen and clonidine based on 
the duration of spasticity 
postinjury. Secondary objectives: 
determining correlations between 
dosage and age, injury type, 
location of spasticity, comorbid 
seizures, or concomitant 
antispasticity meds. 
86 on baclofen, 31 on clonidine; 33% of those on baclofen 
also on another antispasticity med.  
Strongest predictor of both baclofen and clonidine dosage 
in children with CP or TBI is time since injury. Patterns: 
baclofen dosages for age, 2 y: 10-20 mg/day (max 40 
mg/day), 2-7 y: 20-30 mg/day (max 60 mg/ day), 7 y: 30-40 
mg/day (max 200 mg/day) and clonidine maintenance 
dosage of 0.4 mg/day (max 1.8 mg/day). 
Scheinberg 
2006/ 2 
Double-blind, randomized 
crossover study 
15 children (7.4 
y ± 2.7 y) with 
CP, GMFC IV-V 
baclofen Modified Tardieu Scale Goal 
Attainment Scale, Pediatric 
Evaluation of Disability Inventory 
Improvement in GAS; No change in Tardieu, PEDI, 
inconsistent parent responses. 
Vásquez-
Briceño, 
2006/2 
6-month double-blind RCT 10 children with 
CP, 30 controls 
Tizanidine vs. 
placebo 
spasticity, Ashworth scale, posture 
tone scale, reflex scale and liver 
function test 
Significant ↓ Ashworth scale and reflex scale vs placebo (p 
= 0.0001); no abnormalities in liver function tests  
Mathew 
2005/ 2 
RCT 114 children 
with CP  
Single bedtime 
dose of diazepam 
vs placebo 
Well being of child (reported) 
Burden of care (reported) 
Behavior profile of child 
(observed) 
59 children diazepam, 55 placebo Statistically significant 
changes with diazepam: 
Improved well being 
Lessened burden of care 
Improved behavior 
Mathew 
2005/ 2 
RCT 173 children 
(<12 y/o) with 
CP 
2 different doses 
of diazepam 
(half-dose vs 
full-dose) vs 
placebo 
MAS, goniometry  Statistically significant improvements in movement and 
spasticity. Full dose much more effective than half-dose 
Vargus-
Adams, 
2004/ 4 
Prospective, uncontrolled 
case series 
11 children (51 
mo ± 11 mo) 
Grade II-IV CP 
baclofen GMFM, MAS No significant change n MAS, GMFM; improved parent 
report 
Montane 
2004/  
Systematic review of 
double-blind RCT PubMed, 
Medline, Cochrane  
469 patients; 67 
(3 studies) with 
CP 
Dantrium-37 
Baclofen-20 
Placebo-57 
Crossover 
Crossover 
Parallel groups 
Improvement in Ashworth scale 
No functional change 
 
CITB, continuous intrathecal baclofen; CP, cerebral palsy; DDS, drug delivery system; GMFCS, Gross Motor Function Classification System; ITB, intrathecal baclofen; LE, lower 
extremity; MAS, modified Ashworth Scale; QALY, quality-adjusted life-years; ROM, range of motion
Table 7. Does intrathecal baclofen improve body structure and function in children with cerebral palsy? 
 
Author year Search strategy Subjects (description, number, etc.) 
Interventi
on  Comparison  
Methodology of 
individual studies 
(RCT, case study etc)  
Main findings 
Kolaski 2008 Electronic 
databases 2000-
2007; people with 
CP and ITB 
29 studies (including 
4 studies with ≤50% 
subjects with CP who 
were not analyzed 
separately) 
ITB (TD 
or CITB) 
Spasticity, neurophysiologic 
assessment, dystonia,  
ROM, orthopedic deformity, 
ADL,  
Care/comfort, caregiver burden  
29 studies: one level 
II, all others level IV 
or V; no consistent 
assessment tools.   
Spasticity: decreased in UEs/ LEs 
Neurophysiologic: ↓ tibial nerve H reflex and 
LE nerve flexor reflexes 
Dystonia: ↓in mean BADS in 63/69; in smaller 
study no significant differences 
Comfort/pain/sleep: Improved pain and comfort 
in multiple anecdotal studies 
Orthopedic deformities ↓hip migration; 
accelerated scoliosis in some studies—possible 
↑ asymmetrical paraspinal muscle relaxation 
Motor function: Mixed findings on GMFCS, 
functional mobility 
Caregiver burden: anecdotal improvement, little 
statistical data. 
Kolaski 2007 Electronic 
databases 2000-
2007; people with 
CP and ITB 
36 studies 
documenting 
complications, non-
controlled case series 
or single case reports, 
plus 21 other reports 
with relevant 
information  
ITB 
BADS, Barr Scale; CITB, continuous intrathecal baclofen ; DDS, drug delivery system; GMFCS, Gross Motor Function Classification System; 
ITB, intrathecal baclofen; LE, lower extremity; QALY, quality-adjusted life-years; ROM, range of motion; RSV, respiratory syncytial virus; TD, test dose; UE, upper extremity 
y-Albright Dystonia ; CP, cerebral palsy
Adverse effects of medication; 
surgical complications; 
complications related to 
presence and function of drug 
delivery system; complication 
trends  
Non-controlled case 
series, single case 
reports 
Variable adverse reports (CNS, GI). Surgical 
complications in 25% to 40%. DDS problems in 
≤15%. Most common problems = infections, 
catheter problems, CSF leaks. Problems seen 
short-term and long-term after placement. Probs 
more common in pts ≤8 y/o than older patients.  
de Lissevoy 2007 15 studies of ITB 
in children with 
CP—health utility 
index developed by 
physicians; cost 
calculated based on 
insurance claims; 
bootstrap 
modelling applied 
 484 with severe CP ITB Cost-effectiveness analysis with 
effectiveness measured in 
quality-adjusted life-years 
(QALY) 
Variable 
Incremental cost (total cost of 
ITB minus total cost of usual 
care) divided by quality adjusted 
life-year (QALY ITB minus 
QALY usual care) 
Benefit of ITB in children = $42,000 per QALY 
(cochlear implant = $12,774; Palivizumab 
prophylaxis of RSV in children with congenital 
heart disease =$114,337) 
 
Table 8. Does treatment with Botulinum toxin A improve walking ability in children with CP? 
 
Author year 
/LoE 
Research design Subjects Intervention Outcome measures Main findings 
(19) 2008 / 1c RCT, placebo controlled 64 CP children, mean 
age 5.3 / 4.8  years 
intervention and 
placebo group . Mean 
GMFM (88?) scores 
66.5 / 69.1 
At most 3-monthly 
Bont-A injections at 
different sites of the 
lower limb during 2 
years 
GMFM (88?), PEDI NS 
(20) 2007 / 1b RCT, placebo controlled  33 diplegic CP children 
(mean age 5.5 yrs), 
GMFCS 1-3 
12 IE Bont-A in 
Gastrocnemius M. 
bilateral 
GMFM-88/66, ECI, COPM, 
GAS 
GMFM-88 difference score at 24 weeks 
(P<.001), GMFM-66 (P<.03); CPOM score at 
12 weeks (P<.04), NS at 24 weeks. ECI NS. 
(21) 2007 /1b RCT, control group usual 
care 
46 CP children, 
GMFCS 1-4 
Multilevel Bont-A, 
SC, AFO, PT  
GMFM-66, EC GMFM-66 at 24 weeks (P<.01). EC NS. 
(22) 2006 / 1a Systematic review 
Cochrane, Medline, 
Embase, Cinahl, DARE, 
PEDro, SCI, Australasian 
Medical index 
CP children  Bont-A injections 
Lower and Upper 
Limb in combination 
with other therapies 
Gait Insufficient evidence to support or refute the use 
of therapy interventions after Bont-A injections. 
(23) 2002/ 1b RCT cross over, Bont-A 
with PT or only PT. 
49 CP children (mean 
age  4yrs 1mth) 
GMFCS 1-4 
Bont-A injections 
Lower Limb, PT 
GMFM-88 NS 
((24) 2006/2a Systematic review of  all 
available avidence 
CP children Bont-A injections  in 
Upper and Lower 
Limb in combination 
with other therapies 
Gait, GMFM, COPM, GAS Expert opinion based recommendations 
 
RCT = Randomized Clinical Trial; CP = Cerebral Palsy;GMFCS =  Gross Motor Function Classification System; Bont-A = Botulinum toxin A; GMFM = Gross Motor Function 
Measure; COPM = Canadian Occupational Performance Measure; EC(I)= Energy Cost (Index); GAS = Goal Attainment scaling; SC = serial casting; AFO = Ankle Foot Orthosis; PT 
= Physical Therapy; NS = not significant difference. LoE = Level of Evidence  Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001). 
 
Table 9 Does treatment with Botulinumtoxin A improve bilateral handfunction? 
 
Author year 
/LoE 
Research design Subjects Intervention Outcome measures Main findings 
(25) 2007 / 1c RCT 4 treatment groups 
(Bont-A + OT, Bont-A, OT, 
control) 
72 CP children, 33 
unilateral, 39 bilateral, 
mean age 5 yrs 11mth 
Bont-A  
injections upper 
limb,  OT. 
COPM,GAS, MA, QUEST 
of treated limb, PEDI 
COPM and GAS significant improvement Bont-A 
+OT group versus control.# ; MA, QUEST, PEDI 
NS 
(26) 2007 / 1b RCT Bont-A + OT, OT only 43 unilateral CP 
children, mean age 8.6 
yrs. 
Bont-A 
injections upper 
limb , OT 
AMPS, PEDI, PEDsQL, 
GAS 
At 3 mth  GAS (p=.001), at 6 mth NS; others NS 
(27) 2006 /1a Systematic review of 
PUBMED, CINAHL, 
PICARTA, EMBASE, 
PEDRO, and the Cochrane 
Controlled trial register. 
64 CP children Bont-A 
injections of the 
upper limb 
Heterogeneous sets of 
outcome measures were 
used in  3 RCT’s . 
NS effects on functional outcome measures. 
(28) 2004 /1a Cochrane systematic review 
Cochrane, Medline, 
Embase, Cinahl databases. 
14 and 29 CP children Bont-A 
injections of the 
upper limb 
PEDI, QUEST No evidence to support or to refute the efficacy of 
Bont-A injections of the upper limb. 
((29) 2007/1a RCT, comparing 3 Bont-A 
treatments with 2, in 
combination with OT. 
42  unilateral CP 
children (4 yrs, sd 
1.61), GMFCS 1. 
OT, Bont-A 
injections upper 
limb. 
QUEST, COPM,PEDI, 
GAS  
NS between the 2 groups 
 
RCT = Randomized Clinical Trial; CP = Cerebral Palsy; Bont-A = Botulinum toxin A;  COPM = Canadian Occupational Performance Measure; QUEST = Quality of Upper Extremity 
Skills Test; PEDI = Pediatric Evaluation of Disability Inventory; GAS = Goal Attainment scaling; MA = Melbourne Assessment of Unilateral Upper Limb Function; AMPS = 
Assessment of Motor and Process Skills; PEDsQL = Pediatric Quality of Life Inventory; OT = Occupational Therapy; NS = not significant difference. # = no adequate statistical trial 
analysis. LoE = Level of Evidence  Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001).  
 
Table 10 Does Selective Dorsal Rhizotomy  improve walking ability? 
 
Author year 
/LoE 
Research design Subjects Intervention Outcome measures Main findings 
(30)2002 / 1a Meta analysis of 3 RCT’s 90 CP GMFCS 1-4; 
mean age 5,5 yrs 
SDR surgery 
with PT versus 
PT only 
GMFM-66 GMFM-66 + 2.66 (P=.0002) 
(31) 2007 / 1b Prospective cohort study 11 of 14 ambulatory CP 
children 10 years after 
surgery, mean age 27.9 
yrs. 
SDR surgery and 
PT 10 years ago 
Gait NS change in gait. 
 
RCT = Randomized Clinical Trial; CP = Cerebral Palsy; GMFCS =  Gross Motor Function Classification System;  GMFM = Gross Motor Function Measure;  SDR 
= Selective Dorsal Rhizotomy; PT = Physical Therapy; LoE = Level of Evidence  Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001). 
 
 
 
 
MEDICAL MANAGEMENT: POINTS OF DISCUSSION  
 
Jan Willem Gorter, MD PhD  
CanChild Centre for Childhood Disability Research 
McMaster University, Canada 
 
Since the first publication on ‘cerebral palsy’ by Little (1862) up to the most recent 
publication on the revised definition of CP (Rosenbaum, 2007) the picture of children 
and adults persons with CP has changed from a child with deformities due to asphyxia 
(a good example of the medical model) to a developmental childhood onset disability 
requiring a lifespan perspective in the context of the family (a developmental and 
social model). The framework of the International Classification of Functioning, 
Disability and Health (ICF, 2001) goes beyond the health condition (CP) and the 
direct impairments in body function and structure. It also shows the person’s 
functioning in terms of activities / participation and the interaction (bidirectional) 
between the level of functioning and environmental factors (family) and personal 
factors. Unfortunately, the framework does not show the paediatric perspective, in 
which growth and development are the key factors.  
 
In last decades two major shifts in the medical management of CP can be observed: 
 
1. A shift from impairment based medicine (i.e. cure or fix the problem) to a 
habilitation approach in order to enhance a person’s developmental capabilities and 
performance (activities and participation). 
 
2. The shift from patient-centered to a family-centered approach, i.e. i) the 
acknowledgement of the unique strengths, resources and needs of all family members, 
and ii) the emphasis on partnership between the patient, the family and service 
providers.  
 
The functional classification of a heterogeneous condition like CP by the Gross Motor 
Function Classification System (GMFCS) helps us to make meaningful distinctions, 
(functional) prognosis (e.g. prediction of gross motor function, associated 
impairments) and to set realistic goals given a certain level of functioning. The 
authors of this section used the GMFCS levels as a framework for planning medical 
management (GMFCS level I-III, potential walkers versus IV & V, potential 
wheelchair users). In clinical practice, however, the service provider is often 
challenged by the variability in children with CP and the complexity in individual 
cases. The central question in medical management therefore is: what works best for 
whom and when?  
 
In the beginning of the 21st century we must accept that, although attempts are being 
made to prevent and to cure CP (the ultimate goal), the reality is that CP is a lifelong 
condition both for the child and the family. In general the following goals in the 
medical management in CP can be distinguished: 
 
1. To prevent additional impairments (e.g. life threatening complications, 
malnutrition/ obesity, secondary musculoskeletal impairments) 
2. To Cure impairments (e.g. relieve of current distress) 
3. To Improve / optimize activities and participation (optimizing daily 
functioning) 
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4. To Manage a life with CP in society (e.g. maintenance, respite care, self-
management)  
 
The most recent and high-level evidence papers (systematic reviews) were used if 
available. The search method of the literature is missing and should be stated in the 
method section. A good point is that the authors addressed issues of medical 
management following the PICO framework (patients, intervention, control and 
outcome). The majority of the studies lack a long term follow-up (except from the 
survival studies, studies on nutritional status and 1 study on the long term follow=u 
after SDR) and information on side-effects / complications.  Given the complexity and 
heterogeneity of CP it would be helpful to identify the children who might benefit 
most of the intervention and who do not. I think that we need a better understanding 
of the natural course and determinants of functioning in children, youth and adults 
with CP. Longitudinal studies (e.g. the PERRIN program in the Netherlands, Move & 
Play study in Canada, Australia) are currently underway.  
 
Points for discussion  
 
Life expectancy 
- Overall good life-expectancy leads to an increasing number of adults with CP. 
There is a need for epidemiological studies. 
- Implications for orthotics: long-term use in a developmental /realistic perspective 
(person, parent & professional).  
 
Nutritional status / Gastrostomy 
- Optimal weight is unknown. Recommendation: (at least annual) documentation of 
body weight and length (BMI) 
- Orthotics: adaptations (cost issues?) 
 
What treatment works best for who? When to start and for how long? What 
information do we have about cost-effectiveness of medical interventions (in terms of 
direct and indirect costs, think of all the time and effort of the parents!)? 
 
Botulinum Toxin-A – walking ability 
- What do we know about timing and duration of BTX-A treatment: in relation to the 
development of gross motor skills (1-7 years), efficiency of walking (7-10 years) and 
maintenance (10 – older) 
- Effects of BTX-A in combination with AFO’s are suggested to prevent secondary 
musculoskeletal impairments. Are we able to find evidence for this statement? 
- Outcome measurement issues:  
o Selecting the most appropriate measure  GMFM-88 with and without orthosis, 
quality of movement (Quality-FM), efficiency of gait?  
o Interpreting the data (what is a clinically relevant difference?) 
 
Selective Dorsal Rhizotomy – walking ability 
- SDR is effective in the short term. Think of the lifespan perspective: is it worth the 
effort? (perspectives of person, parent and professional) 
 
 
 
Botulinum Toxin A bilateral handfunction 
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- Indication is more specified: prevention of deformities, relieve of distress, 
optimizing function (no evidence), ease of care? 
- Outcome measures: with orthosis? 
- Combination with intensive therapy? 
 
Spasmolytica / tone reduction 
 
• Oral 
o Side-effects, dosage and duration 
o Goal setting 
o Focal versus generalised spasticity/ hypertonia 
 
• ITB (GMFCS level IV-V) 
o Indication criteria: ease of care/handling 
o Long-term side effects (safety) 
o Organisation of care (operation, follow-up) 
 
In line with other interventions I can see the knowledge and evidence growing on 
medical interventions in CP: to prevent impairments, to cure impairments, to optimize 
functioning and to manage problems in CP. Also in this field there are more questions 
than answers. Directions for further discussion/ future research are: 
 
Organisation of medical care 
 
o How do we organise our health care in children with complex lives, do children 
and youth have access to multidisciplinary teams or the services they are looking 
for? Do we give youth a voice and evaluate their perception of the services they 
get? 
o How do we take care of the medical management transition into the adult world 
(is there a formal link between paediatric and adult services, but also is there a 
link between paediatric services and family doctors / community services?)  
o Do we address issues as the availability of services / medical expertise required 
for specific interventions (e.g. dorsal rhizotomy, ITB) 
 
Clinical practice 
 
o Do we really incorporate a lifespan perspective in our medical management? 
o Are we ready to reconsider our way of thinking: from impairment based therapy 
towards an approach focussing on activity / participation? 
o How good are we in informed shared clinical decision making in medical 
management (do we know what information should be shared, and how we do 
make decisions?) Do we deal with the different perspectives (person (patient), 
parent, professional) in the short and in the long term? 
 
 
 
 
 161          © International Society for Prosthetics & Orthotics 
ORTHOPAEDIC SURGERY IN THE MANAGEMENT OF CEREBRAL 
PALSY 
 
H. Kerr Graham MD FRCS (Ed) FRACS 
Professor of Orthopaedic Surgery, University of Melbourne 
Murdoch Childrens Research Institute, Australia 
 
 
Percutaneous tenotomy of the Achilles tendon was the first orthopaedic operation, 
introduced in the early part of the 19th Century in Germany by Louis Stromeyer.  
Although the initial application of percutaneous Achilles tendon tenotomy was for 
equinus associated with club foot or polio, the English physician, William John Little, 
who himself had a clubfoot deformity, travelled to Germany to observe Dr 
Stromeyer’s work.  Dr Stromeyer performed an Achilles tenotomy on Dr Little who 
was so impressed with the results that he introduced the technique in England and 
became such an advocate for research into the causes of cerebral palsy and treatments 
based on tenotomies, that in England cerebral palsy is still referred to as “Little’s 
disease”. Despite the nearly 200 years which have passed since the introduction of 
tenotomy for equinus deformities in cerebral palsy, controversy still exists as to the 
best method for the correction of fixed equinus deformity in children with cerebral 
palsy.   
 
Animal Models in Cerebral Palsy  
A significant restraint in basic research in the understanding of deformities in cerebral 
palsy is the lack of a suitable animal model.  Many researchers have attempted and 
failed to develop a reproducible model for human cerebral palsy.  Two studies have 
used the hereditary spastic mouse. The first confirmed the imbalance between the 
longitudinal growth of the gastroc-soleus muscle tendon unit in relation to tibial 
growth as the primary cause for fixed equinus deformity1.  A later study showed that 
the equinus deformity could be prevented by the injection of Botulinum toxin A 
within the first few days of life, implicating spasticity as a causative factor in the 
development of fixed equinus deformity2. 
 
Natural History  
In the absence of a suitable animal model, the study of the natural history of the 
development of fixed musculoskeletal deformities assumes even greater importance. 
The development of cerebral palsy registers, the development of a common language 
for the classification of gross motor function (GMFCS) and the development of new   
measurement tools has improved our understanding of the natural history of 
musculoskeletal deformities in contemporary populations of children with cerebral 
palsy. These studies suggest that diminished voluntary activity may have a greater 
impact on the severity of musculoskeletal deformity than spasticity or muscle 
imbalance. 
 
 
SINGLE LEVEL SURGERY TO SINGLE EVENT MULTILEVEL SURGERY 
 
A key development in strategic thinking of how to manage fixed musculoskeletal 
deformity in cerebral palsy has been the move from single level surgery, repeated at 
frequent intervals throughout childhood, to single event multilevel surgery (SEMLS).  
The weakness of repeated surgery at single anatomic levels (ankle, knee, hip) was 
identified by Rang, Gage and others but it was Rang who characterised this approach 
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as the “birthday syndrome”3.  As the surgeon starts surgical correction at the ankle 
level for equinus deformity, followed one to two years later by surgery at the knee 
level for flexion contracture, followed by surgery at the hip level for hip flexion 
contracture, the child undergoes repeated hospitalisation and spends each birthday 
either in hospital, in cast or in rehabilitation.  A second major development has been 
the emphasis moving from soft tissue surgery (lengthening of contracted muscle 
tendon units and tendon transfers) to an emphasis on bony reconstructive surgery.  
The concept of lever arm deformities has been articulated by Gage and others and 
includes torsional deformities of long bones, typically medial femoral torsion and 
lateral tibial torsion as well as joint instability including hip displacement and mid 
foot breaching4.  Lever arm deformities have been linked to lever arm disease.  
Specifically, if the already weakened muscle tendon units are unable to generate 
adequate extensor moments, progressive crouch gait will ensue.  With the 
development of multilevel surgery as a practical reality, the need for objective 
measurement to identify gait deviations and measure the outcomes of multilevel 
procedures became self evident.  The development of practical instrumented gait 
analysis has been pivotal in the development of multilevel surgery and in assessing 
outcomes.  The majority of publications in the field of surgery focus on the surgical 
procedure and its outcome and the commonest publication is a retrospective cohort 
study describing the outcome of a specific surgical procedure. The weakness of this 
approach in cerebral palsy has become increasingly recognised with publications 
detailing widely different outcomes for surgery for equinus deformity according to the 
cerebral palsy subtype (hemiplegia versus diplegia) as well as by GMFCS.  The 
ability to describe cerebral palsy by movement disorder, topographical distribution 
and gross motor function has resulted in new thinking in the application of surgical 
techniques, the design of surgical trials and the reporting of outcomes5. 
 
The reporting of surgical outcomes is also in the process of rapid change.  The earliest 
studies in the literature focus on the morbidity and mortality of surgical procedures 
and report outcomes in the broadest terms, usually in the impairment domain.  Over 
time, standardised goniometric measurements and observational gait scales became 
more widely used.  The development of instrumented gait analysis has been pivotal in 
the assessment of gait before and after intervention in a valid and reliable manner.  
With the introduction of the International Classification of Functioning by the World 
Health Organisation, a much broader perspective is now being employed in the 
measurement of outcomes of orthopaedic procedures particularly single event 
multilevel surgery (SEMLS).6  In this area the remaining challenges include the 
development of responsive measures for the measurement of participation, quality of 
life and cost effectiveness of combined orthopaedic, orthotic and rehabilitation 
measures. 
 
Orthopaedic surgeons have gradually embraced a multidisciplinary context for the 
application of orthopaedic surgery in the management of children with cerebral palsy.  
Such approaches may include spasticity management, optimising nutrition, 
strengthening programs, and the use of orthoses in the context of orthopaedic surgery 
for the correction of fixed musculoskeletal deformities. 
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ORTHOPAEDIC SURGERY: REVIEW OF EFFECTIVENESS 
 
Orthopaedic Surgery for children and adolescents with cerebral palsy may be 
classified as follows: 
 
• Upper limb surgery    
 
• Lower limb surgery:  
o Single-level surgery 
o Multi-level surgery - unilateral SEMLS 
  - bilateral SEMLS 
• Surgery for hip displacement: 
o Preventative 
o Reconstructive 
o Salvage 
 
This review paper concentrates provides an overview of upper limb surgery, hip 
surgery and lower limb surgery; the subsequent paper examines the current evidence 
base specifically for the surgical management of equinus deformity in cerebral palsy 
 
 
UPPER LIMB SURGERY 
 
Surgery for the upper limb in cerebral palsy is performed much less frequently than 
surgery for the lower limb and there are enormous variations in practice around the 
world.  As with lower limb surgery, the multidisciplinary context including the need 
for movement disorder management, strengthening, and the use of orthoses is 
increasingly recognised. In addition as with the lower limb there has been a move 
from the use of single level procedures to a more integrated multilevel approach.  This 
has included the need for more global outcome measures including validated 
functional scales.  However kinematic analysis for upper limb movements lags well 
behind gait analysis in the lower limb.  This is principally because the upper limb has 
such a wide repertoire of movements and lacks the single stereotypical pattern of gait.  
 
A systematic review of interventions for the upper limb in children with cerebral palsy 
was conducted by Boyd and colleagues and reported in 20017. The development of 
the Manual Ability Classification Scale (MACS) as the equivalent of the GMFCS is a 
major step forward in upper limb assessment.  Other scales such as the Melbourne 
Assessment of Unilateral Limb Function are very useful. 
 
As with lower limb surgery, increasing numbers of surgeons are moving from a single 
level approach to a “single event multilevel surgery” approach in reconstructive 
surgery of the hemiplegic upper limb.  One of the few recent reports in the literature 
detailing outcomes of a true multilevel surgery report is that by Johnstone and 
colleagues in 20038. In this study a true multilevel surgery protocol was applied and a 
useful analysis of outcomes included cosmesis scores, functional scores, hygiene 
scores and dressing scores before and after surgery. 
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ORTHOPAEDIC SURGERY IN THE MANAGEMENT OF HIP 
DISPLACEMENT: REVIEW OF EFFECTIVENESS 
 
The natural history of hip displacement in children with cerebral palsy has become 
clearer following large population based studies. The study from the south of England 
by Scrutton and colleagues is unique because the data collection was longitudinal, 
objective (based on serial hip radiographs) and involved both a large data set as well 
as high levels of ascertainment9. These authors have confirmed the high incidence of 
hip displacement in children with cerebral palsy, the timing and rate of displacement 
and have espoused the need for regular clinical and radiological hip surveillance. The 
concept of hip surveillance has been employed by other centres and recently 
reviewed12,13.  Additional studies on the natural history of hip displacement in 
children with cerebral palsy have focused on population based studies based on 
cerebral palsy registers and the use of the GMFCS10,11.  These studies confirm that the 
incidence of hip displacement in children with cerebral palsy is approximately 33% 
and is directly related to GMFCS but not related to the type of movement disorder10,11. 
Taken together these studies make a pervasive case for hip surveillance and early 
preventative surgery12,13. 
 
A key concept in hip surgery has been the development of a simple classification by 
Miller and colleagues suggesting that hip surgery be classified as preventative, 
reconstructive or salvage14. Preventative surgery refers to procedures principally 
adductor releases, which are designed to prevent progressive hip displacement in 
children who show early signs of hip displacement on hip radiographs.  When 
preventative surgery fails or children present with very displaced or dislocated hips, 
reconstructive surgery may be employed. This refers to various combinations of 
adductor releases, femoral osteotomy and pelvic osteotomy.  This is being developed 
into the concept of one stage hip reconstruction with reports from several centres 
detailing good results15,16,17.   
 
Some older children and adolescents who present with severe hip displacement 
combined with severe femoral head and/or acetabular deformity may not be suitable 
candidates for reconstructive surgery.  If severely destroyed hips are symptomatic, 
some form of salvage surgery may be required all of which involve loss of the hip 
joint.  These procedures include various forms of excision of the femoral head, valgus 
osteotomy, arthrodesis, and arthroplasty. 
 
Prevention of Hip Displacement  
 
The prevention of hip displacement has been attempted by a variety of methods 
including orthoses, interventions for spasticity, and surgery or combinations of the 
above. 
 
Given that the risk factors for progressive hip displacement in children with cerebral 
palsy are now reasonably well known, early prevention by abduction bracing using 
either bracing at the hip level or a more extensive bracing system including the trunk 
and pelvis, would seem to be an attractive option.  Isolated bracing or postural control 
systems have been reported in pilot studies but have not been studied in adequately 
powered randomised trials. There are good grounds to suggest that orthoses alone 
might not be effective including poor tolerance and the developing understanding of 
proximal femoral geometry as a major contributor to hip displacement in children 
with cerebral palsy. 
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Spasticity Interventions Combined with Bracing    
 
Because of the reservations outlined above, that bracing children with high levels of 
adductor tone might not be well tolerated, Graham and colleagues studied the effects 
of combining injections of Botulinum toxin A to the hip adductors and hamstrings, 
combined with the SWASH brace (Sit Walk And Standing Hip Orthosis) in a large 
multicentre randomised clinical trial18.  The principal findings of their study was that 
the combined intervention was relatively well tolerated and did result in a measurable 
decrease in the rate of hip migration.  However hip displacement continued in both the 
treatment and control group but simply at a lower rate.  In a follow up study, it was 
determined that although fewer patients had proceeded to hip surgery during the trial, 
after exit from the trial, the majority of children in both the treatment and control 
groups required extensive surgery to keep their hips in joint including both adductor 
surgery as well as bony reconstructive surgery.  They concluded that the combination 
of injection of Botulinum toxin and the SWASH brace had such a minimal effect on 
hip displacement that it could not be recommended either in terms of safety or 
efficacy.  
 
It is important to note that neither selective dorsal rhizotomy (SDR) nor intrathecal 
Baclofen (ITB) have been effective in preventing hip displacement in children with 
cerebral palsy and there is some evidence that SDR may increase the risk of hip 
displacement. 
 
The failure of interventions for spasticity to prevent hip displacement in children with 
cerebral palsy and the increasing recognition of the high incidence of abnormalities in 
the proximal femur led Robin and colleagues to conduct a population based study of 
proximal femoral geometry in children with cerebral palsy.  This study found a very 
high incidence of both increased femoral neck anteversion (FNA) across all GMFCS 
levels as well as progressive increase in neck shaft angle (NSA) which was directly 
related to GMFCS level19.  They concluded that the shape of the proximal femur is 
largely determined by gross motor function as determined by GMFCS and suggests 
that bony reconstructive surgery might be required to stabilise the hips in many 
children with cerebral palsy.  The results of this study led Yu and colleagues to 
investigate the effectiveness of hip adductor surgery for the prevention of hip 
displacement in children with cerebral palsy. 
 
In 2004 Stott and Piedrahita reported on the effects of surgical adductor releases for 
hip subluxation in cerebral palsy, an AACPDM evidence report20.  This was an 
extensive, systematic, structured review which followed AACPDM guidelines.  It 
provides a detailed over view of the extensive literature in the field with an excellent 
summary of the findings of the principal studies and a useful commentary on the 
strengths and weaknesses of the evidence.  They concluded that “the body of evidence 
for adductor surgery comprises very low levels of evidence.  There is no level I or II 
study of hip adductor release for hip subluxation and most studies were coded as level 
IV.  Small sample sizes, heterogenous interventions, poorly defined outcome 
measures and lack of statistical analysis were common reasons for the judgement of 
weak internal validity”. 
 
Yu and colleagues embarked on a single centre, long term, retrospective analysis of 
the outcomes of adductor surgery in children with cerebral palsy in which they 
stratified their analysis by GMFCS level in the form of Kaplan Mier survivorship  
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analysis. Additional factors investigated were age at index surgery, migration 
percentage (MP) at initial surgery, type of surgical procedure and experience of the 
surgeon.  They found that the success of adductor releases in the prevention of hip 
displacement and the need for additional surgery, was determined principally by 
GMFCS level.  Children at GMFCS level II had a very high success rate and children 
at GMFCS V a very low success rate.  They concluded that studies investigating 
adductor releases must be analysed by GMFCS level and that the abnormal shape of 
the proximal femur might be the most plausible explanation for the high failure rate at 
GMFCS levels IV and V21. 
 
Reconstructive Surgery for Hip Displacement  
 
Reconstructive surgery refers to various combinations of adductor releases when 
combined with bony reconstructive procedures such as femoral osteotomy (varus 
derotation osteotomy of the femur) and pelvic osteotomy ( Para-Ilial, Dega or San 
Diego osteotomies).  In recent years there has been a move towards “one step hip 
reconstruction” in which adductor releases, femoral varus derotation osteotomy and 
pelvic osteotomy are combined in one sitting.  Several centres have reported 
promising early results from such approaches15,16,17.  However the outcome measures 
in most of these studies have been in the impairment domain mainly focusing on 
radiographic measures such as migration percentage before and after surgery.   
 
There has been limited information on range of motion, function, or quality of life.  In 
this regard it should be noted that a validated quality of life tool for children at 
GMFCS level IV and V has been developed by Nararayan and colleagues22 and may 
well be the ideal tool in studies in this complex area. 
 
In addition there has been no agreed system for classifying the morphology of the hip 
joint in broad categorical terms in adolescents with cerebral palsy.  Robin and 
colleagues have recently published a cerebral palsy hip classification which may be 
useful in both natural history and outcome studies23. (Figure 1) 
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Figure 1 Classification of hip subluxation/dislocation 
 
 
 
 
 
GAIT CORRECTION SURGERY 
 
The majority of surgical procedures in the lower limbs in children with cerebral palsy 
are designed to improve gait and function.  Lower limb surgery can be classified as 
single level, multilevel, unilateral or bilateral.  The number of procedures is very 
extensive and the possible combinations almost infinite.  For the purposes of this 
review it was felt appropriate to concentrate on two key areas: 
1. Surgery for equinus deformity 
2. Single event multilevel surgery (SEMLS) 
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Equinus deformity is the most common deformity in children with cerebral palsy and 
surgery for equinus was not only the first orthopaedic operation recorded but has the 
longest continuous history in medical history, approximately 200 years.  In addition, 
surgery for equinus deformity is the most common component of single event 
multilevel surgery. 
 
Single Event Multilevel Surgery (SEMLS) 
 
The concept of multiple operations on both lower limbs in one surgical session seems 
to have developed simultaneously in both North America and Europe about 20 years 
ago.  One of the clearest descriptions of the concept was by Rang who described 
single level surgery repeated on multiple occasions as the birthday syndrome and 
advocated correction of all deformities simultaneously3.  However one of the first 
reports was by Norlan and Tkaczuk in 198524.  They reported commencing their 
multilevel surgery program in 1975 and reported the outcome of multilevel surgery in 
40 children claiming an 80% success rate.  As would be expected from a report from 
that era, they classified the children as having spastic diplegia, spastic tetraplegia or 
spastic hemiplegia.  In addition, the emphasis in the surgical program was on 
lengthening contracted flexor muscles including the hip flexors, the knee flexors, and 
the ankle plantar flexors.  Additional procedures included adductor releases, transfer 
of tibialis posterior, subtalar arthrodeses and plantar fasciotomies.  However the study 
also included children who could not walk, requiring obturator neurectomies and 
femoral osteotomies.  Again as typical of studies from this era, the principal outcome 
measures were the rate of complications, recurrence rates and the need for 
supplementary osteotomies with almost no objective data on functional outcomes. 
 
The first report utilising objective outcome measures was that by Nene and colleagues 
in 199325.  They reported on the outcome of simultaneous multiple operations in 18 
children with spastic diplegia utilising the Physiological Cost Index (PCI) of walking.  
They reported that 14 patients had a measurable reduction at one year and that the 
more severely affected patients took up to two years to reach a new functional plateau.  
Again the surgical program was essentially muscle tendon lengthenings including 
intramuscular psoas tenotomy, fractional lengthening of the hamstrings and transfer of 
the rectus femoris.  Significantly fewer gastrocsoleus lengthening procedures were 
performed and they also employed bony reconstructive surgery including femoral 
osteotomies, tibial osteotomies and stabilisation of the foot by either subtalar 
arthrodesis or triple arthrodesis. 
 
In 1984 Gage and colleagues reported on the value of pre and postoperative gait 
analysis in patients with spastic diplegia who underwent multilevel surgery.  Although 
the emphasis in the paper was on the use of computerised gait analysis, this may be 
the first report on the outcome of multilevel surgery in children with cerebral palsy, 
certainly the first with objective outcome measures26.  In 1987 Brown and McManus 
reported on the outcome of 57 children with spastic diplegia who had a bilateral 
combined adductor and proximal hamstring lengthening which in some cases was 
combined with a lengthening of the Achilles tendon.  They reported changes in hip 
and knee range of motion.  In addition they attempted a functional classification (non-
ambulant, ambulant plus aids, independent) which showed that a significant 
improvement in ambulatory status was recorded in many children after surgery27.  
 
With the increased use of three dimensional gait analysis, there is more objective 
information on the natural history of gait changes in children with cerebral palsy have 
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been published form several centres.  Three studies which utilised motion analysis all 
confirmed broadly similar findings.  These include deterioration in gait velocity and 
temporospatial characteristics, increased dorsiflexion at the ankle with concomitant 
increased flexion at the hip and knee as well as increased stiffness28,29,30. 
 
The more recent literature in multilevel surgery follows two main trends.  Firstly there 
has been greater emphasis on detailed analysis using instrumented gait analysis as 
typified by Saraph and colleagues in 200231. They reported on the outcome of 25 
ambulatory children with diplegic cerebral palsy who had a mean of 8.2 lower limb 
procedures.  They reported on physical examination findings, kinematic and kinetic 
data in the sagittal plane before and at least three years after surgery.  They 
emphasised the need to integrate information from clinical, kinematic and kinetic 
data.  This concept was taken further by Davids and colleagues32 who promoted the 
idea of a diagnostic matrix for the comprehensive evaluation of children before and 
after multilevel surgery. 
 
The second trend has been the promotion of a broader assessment of children with 
cerebral palsy according to the National Centre for Medical Rehabilitation Research 
NCMRR and World Health Organization International Classification of Functioning 
Models. Oeffinger and colleagues reported a large multicentre study in which the 
relationships between Gross Motor Function Classification Systems (GMFCS), Gross 
Motor Function Measure (GMFM), Pediatric Orthopaedic Data Collection Instrument 
(PODCI) and instrumented gait analysis were reported.  GMFM sections D and E 
scores correlated with the largest number of the other tools and GMFM section E 
score can be used to predict GMFCS level with a high degree of accuracy.  They 
concluded that their study established justification for using the GMFCS as a 
classification system in clinical studies.  The relationships between functional 
outcome measures for assessing children with ambulatory CP were further explored in 
a large study by Sullivan and colleagues with important conclusions for the design of 
future studies33.  In a very large multicentre study, Oeffinger and colleagues34 and 
Bagley and colleagues35 reported on outcome assessments in children with cerebral 
palsy at GMFCS levels I-III as well as the discriminatory ability of outcome tools.  
The information from these studies is crucial in the design of balanced outcome 
studies in the future33-36. 
 
Despite studies reporting the outcome of multilevel surgery with emphases on various 
aspects such as the changes in rehabilitation during the first year or the duration of 
benefit, the majority of studies continue to be retrospective and uncontrolled37-41.  To 
date the only control study is by Zwick and colleagues in 2001 but the subjects were 
not randomised42.  Preliminary results of the first randomised control trial of SEMLS 
has recently been reported by Thomason and colleagues6.   
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Equinus is the most common deformity in cerebral palsy and may be defined as the 
inability to dorsiflex the foot above plantigrade, with the hindfoot in neutral and the 
knee extended.  However there are many other definitions for both equinus deformity 
and equinus gait which contribute to the difficulty in interpreting the extensive 
literature on the subject. 
 
Apart from the large number of original papers, there are a number of review articles 
of which two are noteworthy.  In 2001, Goldstein and Harper published an annotation 
in Developmental Medicine and Child Neurology entitled “Management of Cerebral 
Palsy: Equinus Gait”1.  This was the report of a multidisciplinary workshop convened 
to explore the current state of knowledge, best clinical practice and research needs for 
the management of equinus gait associated with cerebral palsy (CP).  This review 
provides a scholarly update on many aspects of equinus gait and was greatly 
strengthened by the multidisciplinary approach as well as an analysis of the evidence 
base.  The analysis compared the evidence base for physical therapy, orthoses, 
casting, Botulinum toxin A and surgery across the domains of treatment aims which 
had been suggested by Condie and reported by Stuberg2.  Condie and colleagues 
suggested that the aims of management of equinus in cerebral palsy were the 
prevention of deformity, correction of deformity, the promotion of a base of support, 
the facilitation of training skills and an improvement in the efficiency of gait.  When 
these aims of treatment were considered in the context of the evidence base, 
Botulinum toxin A was noted to have level 1or level 2 grading whereas surgery had 
consistently level 4 and 5 grading. 
 
In a more recent and more traditional review of surgical studies, Koman and 
colleagues reviewed recurrence of equinus deformity in cerebral palsy patients 
following surgery, in 20033.  This is a very useful review of 31 published articles from 
1938 to 2001 and focused mainly on the issue of recurrent equinus deformity.  The 
conclusions of the review were that age at first surgery is the number one predictor of 
recurrent equinus deformity.  For this reason temporising measures such as the use of 
Botulinum toxin A, casting and orthoses should be considered in younger children to 
postpone the age at first surgery for as long as possible.  
 
There is a very extensive literature on the management of equinus deformity in 
cerebral palsy by both operative and non-operative measures.  However despite the 
large volume of published studies, the review by Koman and colleagues3 and the 
annotation by Goldstein and Harper1 both found very poor levels of evidence to 
support surgical intervention for equinus deformity.  The complexity and evolving 
nature of cerebral palsy in children, coupled with the difficulties of designing and 
conducting randomised clinical trials, have led to a paucity of robust evidence to 
guide surgical practice.  This study was undertaken to examine the current evidence 
base for surgical management of equinus deformity in cerebral palsy. 
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Central to discussion of the surgical management of equinus is the issue of recurrent 
deformity and the need for additional surgery as well as the opposite outcome, over-
correction, calcaneus deformity and crouch gait.  However detection of these 
dichotomous outcomes requires studies of adequate power, appropriate duration and 
sensitive, appropriate and objective outcome measures.  In addition, the child and 
their cerebral palsy type was considered to be of great importance.  Cerebral palsy can 
be classified in the domains of movement disorder, topographical distribution and 
gross motor function4. Single-event multilevel gait improvement surgery (SEMLS) 
has become the standard of care in many institutions for the treatment of walking 
children with CP5,6,7,12. More recently, equinus surgery was preformed in the setting 
of multilevel surgery and these articles were considered in this review. Other factors 
to be considered in the review, having been suggested in previous studies to be 
important include the surgical procedure, the postoperative care, the use of orthoses 
and night splinting. 
 
 
METHOD 
 
Search strategy 
 
In March 2008, an electronic search was performed of MEDLINE (1966-March 
2008), Embase (1980-2006), and the Cochrane database.  Keywords used in the 
search strategy included ‘cerebral palsy’, ‘equinus’, ‘ankle’, ‘achilles’, 
‘gastrocnemius’, ‘gait analysis’, ‘contracture’ and ‘calf’.  Key terms were matched to 
Medical Subject Headings (MeSH) index, and exploded or searched as keywords. 
Surgical procedures identified as being used in the correction of equinus deformity 
were also searched as keywords. Targeted searching was undertaken from reference 
lists of the articles included for review, and other key articles concerning the topic. 
 
Inclusion and exclusion criteria 
 
Studies were shortlisted for inclusion if they pertained to the surgical management of 
equinus in a paediatric population with cerebral palsy, and were available in English. 
Where doubt existed, the article was shortlisted.  Additional inclusion and exclusion 
criteria were then applied to shortlisted articles. Articles were excluded where they 
examined a novel surgical intervention or had fewer than ten cases followed up. 
Articles included for review had a mean follow up period of greater than five years, or 
used instrumented gait analysis, with a mean follow up of greater than 12 months.  
 
Data extraction 
 
Included articles were examined in depth and key data extracted with the use of a 
custom data extraction form. This form focused on themes of sample characteristics, 
surgical intervention, outcome measures, data handling, follow up, and complication 
rates.  Oxford Centre for Evidence Based Medicine levels of evidence8 were used to 
grade the selected studies. In surgical research, randomization is not always possible 
or feasible9 and in this review all included articles were non-randomized. As a result, 
the methodological index for non-randomized studies (MINORS)10 was applied to 
further assess the quality of each article. 
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RESULTS 
 
Search strategy yield 
 
The initial electronic search identified 6905 articles for consideration, from which a 
short list was generated.  From this, two authors identified 49 possible inclusions for 
review.  These were examined in depth.  After applying inclusion and exclusion 
criteria, 35 studies were included.  Table One lists the articles included and their 
characteristics.  
 
Descriptive aspects of reviewed studies 
 
The studies which were reviewed ranged in sample size from 9 subjects30 to 156 
subjects29 with an average of 38.  It should be noted that in some papers, the number 
of “lower limbs” is reported rather than the number of subjects14.  Given that 
hemiplegic children are managed by unilateral surgery and diplegic children can be 
managed by either unilateral or bilateral surgery, this can be very confusing and is 
another mark of the low quality of many of the reports.  The mean age of subjects 
ranged from 4.8 to 19 years with many studies reporting a wide age range at index 
surgery.  The majority of studies reported the gender of the patients but many did not 
include this potentially important information. 
 
The type of cerebral palsy was in general poorly described.  Very few studies reported 
the type of movement disorder, not all included such basic information as the 
topographical distribution and only five referred to gross motor function11,19,22,26,27. 
Studies which gave a breakdown of either movement disorder or topographical 
distribution, frequently utilised out of date classifications. 
 
Outcome measures used included goniometry, observational gait analysis or rating 
scales, instrumented gait analysis, surgery for recurrence, bracing for calcaneal gait 
pattern, measures of spasticity, physician rating scale and parental satisfaction. Such 
measures were commonly used to derive an outcome scale rating the overall result 
from good to poor. The duration of mean follow up varied considerably, from 1 to 14 
years. For the purposes of this review, studies with less than five years follow up were 
only considered if they used instrumented gait analysis. Nineteen studies used 
instrumented gait analysis, with an average follow up of 2.8 years.  
 
Operative Intervention 
 
The surgical intervention was not always clearly identified by either a generic term or 
an eponym. Some studies reported on a single clearly described operative procedure 
such as the White slide tendo Achilles lengthening23.  Others compared multiple 
procedures and in these studies there was a tendency to refer to the original operative 
description15.  Some articles specified modifications of earlier procedures29.  Finally, 
some studies reported on combinations of surgical procedures for equinus for example 
the Strayer distal gastrocnemius recession combined with the slide lengthening of the 
Achilles tendon16. For clarification and consensus an ‘intramuscular lengthening’ was 
interpreted as a Baumann procedure, a ‘gastrocnemius recession’ was interpreted as a 
Strayer procedure and a ‘gastrosoleus aponeurotic lengthening’ was interpreted as a 
Vulpius procedure (Figure 1). 
From proximal to distal, the procedures which were included in the 35 selected 
articles were the Baumann procedure, the Strayer distal gastrocnemius recession, the 
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Baker and Vulpius gastrocsoleus lengthening, the White and Hoke slide tendo 
Achilles lengthenings (percutaneous and open), open Z tendo Achilles lengthening 
(TAL) and heel cord advancement (HCA).  The operative procedures are illustrated in 
relation to three specific zones of the triceps surae in Figure 1.  Zone 1 is from the 
gastrocnemius origin and ends at the most distal fibres of the medial belly of the 
gastrocnemius.  The operative procedures in Zone 1 are the Baumann procedure and 
the Strayer distal gastrocnemius recession.  Zone 2 is from the distal gastrocnemius 
belly to the end of the soleus muscle fibres and includes the Baker and Vulpius 
gastrocsoleus aponeurotic lengthenings.  Zone 3 is the Achilles tendon and includes 
all forms of lengthening of the Achilles tendon as well as heel cord advancement 
(HCA). 
 
Figure 1 Operative procedures categorised in three zones of the triceps surae 
 
 
 
 
Postoperative Care 
 
The immediate postoperative care was reasonably well described in most studies.  The 
older literature reported above knee casts for at least six weeks with long periods of 
restricted weight bearing14.  The more recent literature reports the use of below knee 
casts and much earlier weight bearing11,13,18,19,22,25,27,28,37.  The utilisation of ankle-
foot-orthoses after cast removal, the type of ankle-foot-orthosis and the utilisation of 
night splints varied greatly and were poorly described. 
 
The outcome measures reported were in order of frequency, clinical examination, 
clinical rating scales, gait rating scales, goniometry, three dimensional gait analysis, 
the Modified Ashworth Scale, radiographs, the Gross Motor Function Measure 
(GMFM) and the need for floor reaction AFOs to manage crouch gait.  Many studies 
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reported rates for recurrent equinus deformity or calcaneus gait/deformity.  However 
the definitions for both equinus/calcaneus gait and equinus/calcaneus deformity varied 
from study to study and were not always clearly defined. 
 
Effect of age at surgery on rates of recurrent equinus and calcaneus 
 
The effect of age at index surgery on the rates of recurrent equinus or calcaneus were 
reported in 10 of the 35 studies15,16,17,23,29,33,35,38,39,42.  Damron et al17 found no clear 
relationship between age and outcome.  Seven studies reported that a younger age at 
index surgery was associated with an increased risk of recurrent equinus 
15,16,23,29,33,39,42 but one study found that age was not related to recurrent equinus35.  
One study38 utilising gait analysis found that velocity and stride length improved most 
in younger patients.  Twenty five of the 35 studies made no comment on the effect of 
age on either the rate of recurrent equinus or calcaneus. 
 
Recurrent equinus deformity and type of surgery  
 
Twelve of the 35 studies stated explicit criteria for the definition of equinus deformity 
and/or recurrent equinus13,15,16,17,23,25,26,33,35,38,39,44.  Definitions for equinus deformity 
were either based on clinical examination and/or sagittal ankle kinematic data.  In an 
attempt to increase the relevance of this heterogenous body of evidence, results were 
grouped according to the surgical zone as illustrated in Figure 1.  Where results by 
sub-group were not specifically stated and could not be confidently derived from 
presented data, they are indicated to be not available.  Recurrence rates varied from 0-
43% overall but this increased up to 62% when specific sub-groups were considered.  
The majority of studies reporting three dimensional gait analysis had short term 
follow-up and reported much lower rates for recurrent equinus deformity than the 
clinical studies, which all included a mean follow-up of at least five years26,28,30,36,40,44.   
 
The rate of recurrent equinus deformity for procedures involving lengthening of the 
Achilles tendon were given in 13 studies14,15,17,23,25,26,28,32,33,35,39,41 (Table 2). 
 
Seven studies reported on the rates of recurrent equinus deformity following surgical 
lengthening in Zone 2 (the Baker and Vulpius procedures) 11,15,17,24,29,41,43 (Table 3). 
 
Eleven studies reported a Zone 1 procedure, three Baumann and eight Strayers. Six 
studies reported on the rates of recurrent equinus following surgery 16, 22, 25, 26, 36, 39 
(Table 4). No recurrent equinus was found at a mean follow-up of just over two 
years36. The only other Zone 1 procedure, the Strayer distal gastrocnemius recession 
was reported in combination with Achilles tendon lengthening or in sub-groups of 
studies reporting multiple surgical procedures. 
 
Outcome and topographical distribution of cerebral palsy 
 
Thirteen studies reported on the rate of recurrent equinus deformity in children with 
spastic diplegia11,15,22,24,26,28,29,33,35,36,39,42,43. Additionally the study by Kay et al, whilst 
not providing an overall recurrence rate in spastic diplegia, reported no significant 
difference in recurrence rates when children with diplegia who had gastrocnemius 
recession were compared to those who had tendo Achilles lengthening (Table 5). 
 
Ten studies reported on the rates of recurrent equinus deformity in children with 
hemiplegia15,23,24,26,29,33,35,39,42,43 (Table 6).  Again, Kay et al25 reported no difference in 
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the rate of recurrent equinus deformity in children with hemiplegic cerebral palsy who 
had either gastrocnemius recession or lengthening of the Achilles tendon. 
 
Calcaneus deformity, calcaneus gait and crouch gait by topographical 
distribution  
 
Nine of 35 studies reported explicit criteria for calcaneal gait, calcaneal deformity, or 
crouch gait15,17,18,20,25,26,36,38,44.  The definitions included the inability to passively 
plantarflex the foot to neutral as a definition of calcaneus deformity and the need for a 
floor reaction orthosis for crouch gait.  In terms of kinematic criteria, peak 
dorsiflexion in stance more than 2 standard deviations above the reference range was 
quoted in several studies and in kinetic terms, reduced push off or A2 power 
generation was also quoted.  Using these variable terms, the rates of calcaneus varied 
from 0 to 36% overall but up to 80% in specific sub-groups. 
 
Thirteen studies reported the rate of calcaneus for operative procedures in Zone 
315,17,18,23,25,28,26,32,33,35,39,41,42.  One study reported on the development of spastic flat 
foot and knee flexion deformity as postoperative complications42 (Table 2). 
 
Nine studies reported the rate of calcaneus following surgical procedures in Zone 2 
11,13,15,17,24,29,38,41,43 (Table 3). Five studies reported the rate of calacaneus following 
Zone 1 surgical procedures16,25,26,36,39 (Table 4). The report by Saraph et al36 on the 
Baumann procedure reported no calcaneus in 22 children and adolescents with spastic 
diplegia who had multilevel surgery including a Baumann gastrocsoleus lengthening. 
 
Twelve studies reported the rates of calcaneal gait in diplegic children 
15,17,18,19,24,28,29,33,36,38,43,44.  Kay et al25 reported no significant difference in the rates of 
calcaneus gait in children with spastic diplegia who had either a gastrocnemius 
recession or an Achilles tendon lengthening (Table 4). 
 
Thirteen studies reported the rates of calcaneus gait in hemiplegic children 
11,13,15,17,18,24,28,29,33,36,38,39,43 Again, Kay et al25 found no significant difference in 
calcaneus gait in hemiplegic children who had either a gastrocnemius recession or a 
lengthening of the Achilles tendon (Table 5). 
 
The majority of studies were scored at level 4 evidence according to the Oxford 
classification for evidence based medicine (Table 1). Only 4 studies met the criteria 
for 3b level of evidence, demonstrating a comparable control group for comparison. 
Therefore, the MINORS index was applied to each study. In this review, MINORS 
scores ranged from 3 to 16 demonstrating a significant amount of methodological 
heterogeneity and quality within the studies.  
 
Fifteen studies recorded results of equinus surgery in the setting of SEMLS (Table 6). 
On average, seven surgical procedures were preformed on each patient including calf 
lengthening. Overall trends demonstrated and increase in ankle dorsiflexion through 
initial contact and a decrease in the degree of knee flexion at initial contact (Table 6).  
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DISCUSSION 
 
Cerebral palsy type and outcome 
 
Given that the rate of calcaneus in children with spastic hemiplegia averaged only 1% 
(range 0-7%) and the rate of calcaneus in spastic diplegia averaged 15% (ranging 
from 0-41%) it would appear that the topographical distribution of cerebral palsy may 
well be the strongest determinant of outcome.  It is also of note that several of the 
studies utilising instrumented gait analysis reported high rates of calcaneus gait and 
the clinical studies with the longest to follow-up also reported the highest rate of 
calcaneus gait.  The outcomes in terms of recurrence versus calcaneus in children with 
hemiplegia versus children with diplegia are so different as to merit separate studies.  
 
There is very little information on the movement disorder.  It is very likely that a 
number of children with dystonia or mixed movement disorders have been included in 
these studies but have not been clearly identified.  The outcome of surgery including 
surgery for equinus deformity, in children with dystonia and mixed movement 
disorders is usually considered to be more unpredictable but no information from the 
studies which have been reviewed is available. 
 
The choice of studies for this review in two main groups, those with a mean follow-up 
of more than five years and those with instrumented gait analysis, give two quite 
different perspectives on both recurrent equinus deformity and calcaneus gait. 
 
Gait analysis is expensive and the majority of studies report a preoperative and a 
single postoperative study usually within 1-2 years after surgery.  Although the 
kinematic parameters are objective and sensitive in the definition of under-correction 
and over-correction, the brevity of follow-up, dramatically weakens the value of these 
studies.  The one study which combines instrumented gait analysis and a medium 
term follow-up is that by Segal et al38.  Segal and colleagues reported a 30% 
prevalence of calcaneal gait but there were only 20 children in their study and there 
were five different combinations of surgical procedures38. 
 
The two clinically based outcome studies with the longest follow-up and the largest 
number of cases of children with diplegia were the studies by Borton et al15 and Dietz 
et al18.  Borton and colleagues reported risk factors for both recurrent equinus and 
calcaneus in a large heterogenous population of children with cerebral palsy who were 
followed clinically for an average of seven years (range 5-10 years).  They found a 
very high incidence of calcaneus gait leading to crouch gait in both spastic diplegia 
and spastic quadriplegia especially after percutaneous lengthening of the Achilles 
tendons.  Dietz and colleagues confirmed these findings but added an objective 
measure of crouch gait, the need to prescribe a floor reaction brace18.  Their study 
reports a single surgeon, case series with a highly standardised operative protocol, 
follow-up programme and consistency in the diagnosis and management of crouch 
gait.  Again, results were best in patients with either hemiplegia or subjects who 
required lengthening on only one side.  They recommended consideration of non-
surgical treatment or more conservative surgical treatment such as gastrocnemius 
fascial lengthening18.  
 
There is a clear consensus from the studies that the type of cerebral palsy matters a 
great deal and should be carefully considered in the choice of surgical procedure and 
overall management.  Only four studies reported Gross Motor Function Classification 
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System (GMFCS) levels11.  In children with bilateral cerebral palsy, traditionally 
described as having spastic diplegia or spastic quadriplegia, the use of the GMFCS 
might well prove to be very valuable.  It is possible that outcomes might vary 
considerably across GMFCS levels and this would be worthy of examination in future 
studies. 
 
Effect of age at index surgery on rates of recurrent equinus deformity and 
calcaneus gait   
 
There was widespread agreement in the studies reviewed that early surgery was a 
major risk factor for recurrent equinus deformity and possibly for unpredictable 
outcomes in general14,15,18,29,39,44.  This led several authors to recommend delaying age 
at index surgery by the use of non-operative measures such as injection of Botulinum 
toxin A, serial casting and the use of orthoses1,3,15,18.  No study to date has reported on 
the outcome of sequential non-operative management of equinus using Botulinum 
toxin injections followed by surgical lengthening at appropriate age.  However several 
studies on the use of Botulinum toxin A have reported successful short term outcomes 
and the ability to delay surgery until age more than six years in the majority of 
children.  A more widespread application of this policy might well improve surgical 
outcomes by reducing the risk of recurrent equinus and perhaps calcaneus. 
 
Effect of surgical procedure on the rate of recurrent equinus deformity and 
calcaneus gait 
 
A total of 10 different operative procedures or combinations were reported in the 
articles in this review.  Some studies focused on a single operative procedure23,29,36, 
others on comparison of multiple procedures15,32,39 , and some in the setting of 
SEMLS 11,12,18,21,22,25,26,28,34,36,37,40,44.  The reason for choice of various procedures was 
often surgeon preference or frequently not clearly stated.  The operative procedures 
range from very proximal procedures in Zone 1 of the gastrocsoleus to very distal 
procedures on the Achilles tendon.  Despite a great emphasis on the importance of the 
differences in the surgical techniques, the evidence for difference in outcomes is 
weaker for surgical procedure than for cerebral palsy type or age at index surgery.  In 
particular, several studies utilising three dimensional gait analysis found little 
difference between Zone 2 surgical procedures (Baker and Vulpius) and surgical 
lengthening of the Achilles tendon.  Within the Achilles tendon, a wide range of 
procedures was utilised from open Z lengthening to percutaneous slide lengthening.  
There were no studies in which children were randomised to receive one surgical 
procedure versus another and the conclusions reported in most studies are 
questionable and highly susceptible to selection bias.  Despite the paucity of evidence, 
opinions on the appropriate choice of surgical procedure are highly polarised.  The 
lack of equipoise means that the design of randomised trials in which different 
procedures are compared is contentious and difficult. 
 
Only one of the included studies was prospectively designed and no studies were 
randomised with a blinded control group.  The majority of studies were Level 4 
quality of evidence according to the Oxford Centre for Evidence Based Medicine 
Levels.  Therefore, these results at best could lead to only a Grade C treatment 
recommendation. 
 
Given the well recognised difficulties of designing, recruiting, funding and 
implementing randomised surgical trials consideration should be given to designing 
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better cohort studies.  Improvements in study design might include improved 
definition of equinus gait and associated functional problems using a combination of 
instrumented gait analysis, functional testing and quality of life measures.  Surgical 
populations should be described much more rigorously in terms of cerebral palsy type 
(movement disorder, topographical distribution and GMFCS level).  The surgery for 
equinus deformity should be clearly described avoiding eponymous terms.  The need 
for a clear description of postoperative management, bracing and night splinting is 
also obvious.  In addition, for children with spastic diplegia it is essential to fully 
describe all additional procedures in multilevel surgical protocols. 
 
Prospective studies with balanced outcome measures at prescribed intervals would 
greatly improve the evidence base for equinus surgery.  A comparison of outcomes at 
baseline, 12 months and 5 years after surgery with appropriate outcome measures 
would be a major advance on the current poor evidence base. 
 
 
CONCLUSION 
 
Equinus deformity can be primary, secondary, either fixed or functional, and both 
impacts upon and is affected by the motor development of the child in question. A 
systematic review revealed the literature to be dominated by retrospective case series 
studies with no control groups, and a lack of prospective randomised controlled trials. 
The current literature is particularly weakened by the frequent treatment of patient 
groups with differing motor distributions as a homogenous population, and inadequate 
follow up to detect true complication rates. There is insufficient evidence to state 
clearly a preference for any single procedure over another. However, the literature 
indicates greater recurrence in children with hemiplegia regardless of procedure, and 
greater calcaneus in children with diplegia, particularly following procedures to the 
Achilles tendon. 
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TABLE 1 35 Articles Fulfilling Criteria for Systematic Review 
 
Author(s) 
 
Surgical 
Procedures 
SEMLS No of 
subjects 
Age (years)  
Mean (range) 
Gender 
M F 
CP Type 
H,D,Q 
Outcome 
Measures 
Follow-up 
(yrs/range) 
OX 
LOE 
MINORS 
Score 
 11Abel et al 
   (1999) 
Vulpius Yes 30 8.7 (4-20) - 30 D 3DGA, GMFM 
Goniometry 
2 (1.6-3.1) 4 10 
12Adolfsen et al 
(2007) 
Vulpius, 
TAL(NS) 
Yes 31 8.5 (5-15) - 10H, 20D, 1Q 3DGA, EMG, 
Clinical exam 
1.9 (0.7-6.4) 4 6 
 13Baddar et al  
   (2002) 
Vulpius No 34 7.2 (2.6-15.2) 17M 17F 34 D 3DGA/EMG 
Clinical exam 
1.3 (0.8-1.9) 4 8 
14Banks (1976) White TAL No 200 feet - - - OGA 10 ( - ) 4 3 
15Borton et al 
   (2001) 
Hoke TAL(Perc) 
Z TAL, Baker 
No 134 7.6 (2-18) 78M 56F 45H, 65D, 24Q 3DGA, PRS 
Goniometry 
6.9 (5-10) 4 11 
16Craig & Van   
Vuren (1976) 
Strayer + 
White TAL 
No 59 6 (1-15) 
 
- - Clinical exam 6 ( - ) 4 8 
17Damron et al 
   (1994) 
Z TAL,Baker, 
Vulpius 
No 59 4.8 (2-11) 31M 28F 2H, 18D, 28Q Goniometry 
Functional scale 
7 ( - ) 3b 9 
(14) 
18Dietz et al 
   (2006) 
Hoke TAL(O), Z 
TAL 
Yes 79 7.7 (2-47) - 23H, 34D, 15Q OGA 
GRAFO 
7 ( - ) 4 11 
19Engsberg et al 
   (2005) 
HCA, Vulpius, 
White TAL 
No 32 7 ( - ) 19M 13F 32D, (GMFCS I) Goniometry 
3DGA, GMFM 
* 1 ( - ) 4 11 
20Fabry et al 
(1999) 
TAL(O)(NS),  
TAL (P)(NS) 
No 15 15.7 8M 7F 15D 2DGA 
Clinical exam 
9.5 4 4 
21Gough et al 
(2004) 
Strayer Yes 12 9.8 8M 4F 12D 3DGA, EMG 
Clinical exam 
Functional status 
1.5 (-) 3b 9 
(15) 
22Gough et al 
(2008) 
Strayer Yes 13 6.4 (5.9-6.9) - 13D 3DGA, GGI, EMG 
Clinical exam 
2 (2-5) 3b 10 
(16) 
23Graham & 
Fixsen (1988) 
White TAL No 35 6.9 (3-15) 18M 17F 35H Goniometry 
VRS 
13 (9-16) 4 9 
24Javors & 
Klaaren (1987) 
Vulpius No 47 6.8 (2-14) - 15H, 23D, 9Q Clinical exam 5.7 (1-12) 4 3 
25Kay et al 
   (2004) 
Strayer, 
TAL(NS) 
Yes 54 9.8 (4-16) 28M 27F 23H, 26D, 6Q 3DGA, PRS, 
Ashwoth 
1.5 (1-2) 4 8 
26Lofterod & 
Terjesen (2008) 
Strayer, Z TAL No 15 8.8 (6-14) 8M 7F 6H, 9D  
(GMFCS I + II) 
3DGA 
Clinical Exam 
* 3 (1.1-4.6) 4 6 
27Lofterod & 
Terjesen (2008) 
Strayer Yes 47 11.5 (5-19) 29/18 13H  34D  
(GMFCS I+II+III) 
3DGA exam 
GMFCS FMS 
* 1.2 (.8-
1.5) 
4 8 
28Lyon et al 
   (2005) 
Z TAL, Hoke 
TAL 
Yes 14 9.1 (4-17)   6M  8F 14D 3DGA * 1.5 (0.5-
2.5) 
4 6 
29Olney et al 
   (1988) 
Baker No 156 5.5 (2-14) - 90H, 108D, 21Q Clinical exam 
Recurrence 
7.5 (3-14) 4 9 
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Author(s) 
 
Surgical 
Procedures 
SEMLS No of 
subjects 
Age (years)  
Mean (range) 
Gender 
M F 
CP Type 
H,D,Q 
Outcome 
Measures 
Follow-up 
(yrs/range) 
OX 
LOE 
MINORS 
Score 
30Orendurff et al 
   (2002) 
TAL (NS) No 9 - - - 3DGA 
Muscle length  
* 1 ( - ) 4 5 
31Park et al 
   (2006) 
Vulpius, Z 
TAL(NS)  
No 16 8 (3-16) 11M  5F 16H 3DGA * 1.25 (0.75 
– 2) 
4 5 
32Pierrot & 
Murphy (1974) 
HCA, White 
TAL, Z TAL 
No 41 7 (3-10) 23M 18F 16H, 9D, 13Q VRS  6 (3-10) 4 9 
33Rattey et al 
   (1993) 
Z TAL No 57 5.4 (1.4-14.7) - 27H, 30D Clinical exam 
Recurrence 
9.6 (5-15) 4 9 
34Rose et al 
   (1993) 
Baker Yes 20 6 (4-26) - 5H, 15D Clinical exam 
3DGA 
* 1 ( - ) 4 7 
35Sala et al 
   (1997) 
Hoke TAL No 27 5 (2-10) 15M 12F 4H, 17D, 6Q Clinical exam 
VRS, MAS 
(2-9) 4 9 
36Saraph et al 
   (2000) 
Baumann Yes 22 12.6 (7.4-16.6) - 
 
22D Clinical exam 
3DGA 
* 2 (2.1-4) 4 5 
37Saraph et al 
(2005) 
Baumann Yes 32 11.1 (8.7-13.5) - 32D Clincal exam, 
3DGA, EMG 
* 4.4(1.0-
5.4) 
4 9 
38Segal et al 
   (1989) 
 
Hoke TAL(P), 
White TAL, Z 
TAL, HCA, 
Vulpius 
Yes 20 5.2 (2.7-8.2) 9M 11F 20D Clinical exam 
3DGA 
5.8 (1.1-11) 4 11 
39Sharrard & 
Bernstein 
(1972) 
Z TAL, Strayer No 92 7 ( - )3 - 45H, 20D, 27Q Clinical exam 
OGA 
8.9 ( - ) 4 7 
40Steinwender et 
al (2001) 
Baumann Yes 29 14.4 ( - ) - 17D Clinical exam 
3DGA 
* 3.9 ( - ) 3b 5 
(13) 
41Truscelli et al 
   (1979) 
TAL(NS), 
Vulpius 
No 58 - - - Clinical exam 14 (2-27) 4 4 
42Uyttendale et 
al 
   (1984) 
Z TAL, Scholder  No 32 19 (14-30) - 13H, 19D/Q Clinical exam 
OGA 
- 4 5 
43Yoshimoto et 
al 
   (2005) 
HCA + Vulpius No 17 10 (5-17) 9M 8F 11H, 6D Clinical exam 
OGA, Xray 
8 (5.7-9.11) 4 11 
44Yngve & 
Chambers 
(1996) 
Z TAL, Vulpius Yes 33 9 ( - ) - 14H, 17D, 2Q Clinical exam 
3DGA 
* 1 ( - ) 4 8 
45Zwick et al 
 ( 2001) 
 Strayer  Yes 17  11.2 (5.7-16.4) - 17D Clinical exam 
3DGA 
* 3.8 (2.6-
5.7) 
4 9 
OX LOE – Oxford Levels of Evidence     HCA – Heel Cord Advancement         G/S – Gastrosoleus          3DGA- 3D Gait Analysis 
VRS – Visual Rating Scale     MAS – Modified Ashworth Scale      OGA – Observ 
TABLE 2: Zone 3:  Achilles Tendon Lengthening: Recurrent Equinus and Calcaneus 
 
Author Procedure Feet Hemis Dis Quads Recurrent 
equinus %  
Calcaneus      
% 
F/up 
 <5 yrs 
3DGA 
12Adolfsen et al TAL (NS)     6  - - - - -  x 
14Banks White TAL 200 - - - 27% -   
15Borton et al Z TAL   
Hoke TAL (P) 
40 
98 
- - - 23% 
20% 
35% 
39% 
 x 
17Damron et al Z TAL   80 - - - 2% 2%   
18Dietz et al  Hoke TAL (O) 
Z TAL 
 56 
 56 
- - - - 
- 
43% 
53% 
  
19Engsberg et al White TAL    10  0 10 0 - - x x 
20Fabry et al TAL (O)(NS) 
TAL (P)(NS) 
  11 
   6      
0 15 0 - - x x 
23Graham & Fixsen White TAL   35 35 0 0 43% 0   
25Kay et al TAL (NS)   17 11 4 2 29% 36% x x 
26Lofterod et al  JCP Z TAL   10 2 8 0 0% 0 %  x 
28Lyon et al 
 
Z TAL 
Hoke TAL  
  21 
    2 
0 
 
12 
2 
0 
 
35% Most * x x 
30Orendurff et al TAL (NS)   12 - - - - - x x 
31Park et al  Z TAL (NS)   13 13 0 0  - - x x 
32Pierrot &  
   Murphy 
White TAL 
Z TAL 
    9 
  13 
7 4 5 46% 0%   
33Rattey et al Z TAL   77 29 34 0 26% 5%   
35Sala et al Hoke TAL   27 4 17 6 22% -   
38Segal et al 
  
 
Hoke TAL (P) 
White TAL  
Z TAL    
    12 
    6 
    12 
     0  6 
3 
7 
 0 - 
 
 
 25% 
25% 
25% 
 x   x  
39Sharrard & 
   Bernstein 
Z TAL   77 37 12 24 23% 0%   
41Truscelli et al TAL (NS)   72 - - - 35% 3%   
42Uyttendaele et al Z TAL   25 10 15 0 20% -   
  44Yngve &           
Chambers 
Z TAL   27 11 16 0  - - x x 
 
* avg df in stance 24.1       x = <5 years average follow up 
 
TABLE 3:   Zone 2:  Mid Calf Gastrocsoleus Recession 
 
 
Author Procedure Feet Hemis Dis Quads Recurrent 
equinus % 
Calcaneus % F/up 
 <5 yrs 
Gait 
analysis 
11Abel et al  Vulpius 42 0 21 0 0% 0%  x 
12Adolfsen Vulpius 33 - - - - -  x 
13Baddar Vulpius 22 0 11 0 - 0% x x 
15Borton et al Baker  57 - - - 26% 32%  x 
17Damron et al Baker, Vulpius 38 - - - 12% 0%   
19Engsberg et al Vulpius  10  0 10 0 - - x x 
24Javors & Klaaren Vulpius 79 15 46 18 4% 4%   
29Olney et al Baker 219 80 108       21 48% 0%   
31Park et al  Vulpius 3 3 0 0  - - x x 
34Rose et al Baker 24 5 15 0 - - x x 
38Segal et al 
   
Vulpius 2 0 2 0 - 0% x  
41Truscelli et al Vulpius  22 - - - 23% 36%   
43Yoshimoto et al Vulpius (+HCA) 20 11 6 0 0% 0%   
   44Yngve & 
Chambers 
Vulpius 22 3 16 3  - - x x 
 
* avg df in stance 24.1      x = <5 years average follow up 
 
 
TABLE 4: Zone 1:  Proximal Calf Gastrocnemius Recession 
 
 
Author Procedure Feet Hemis Dis Quads Recurrent 
equinus % 
Calcaneus % F/up 
 <5 yrs 
Gait 
analysis 
16Craig & Van 
Vuren 
Strayer 100 - - - 9% 3%   
21Gough et al Strayer  22 0 12 0 - -  x 
22Gough et al Strayer   21 0 12 0  25% -   
25Kay et al Strayer 38 12 22 4 19% 22%  x 
26Lofterod & 
Terjesen 
Strayer 10 4 6 0 10% 10%  x 
27 Lofterod & 
Terjesen 
Strayer 42 - -       - -                      -    x 
36 Saraph et al Baumann 28 0 22 0  0% 0%  x 
37 Saraph et al Baumann 23  0 32 0 - -  x 
39 Sharrard & 
Bernstein 
Strayer 53 5 25 23 15% 2%   
40Steinwender et al Baumann  34 0 17 0 - -  x 
45 Zwick et al  Strayer 11 0 6 0 - -  x 
 
* avg df in stance 24.1      x = <5 years average follow up 
 
TABLE 5:   Equinus Surgery Outcomes in Spastic Diplegia   
 
Author Procedure Diplegic 
Feet 
Recurrent 
equinus % 
Calcaneus % F/up 
 >5 yrs 
Gait 
analysis 
11Abel et al  Vulpius 42 0% 0% x x 
12Adolfsen et al  Vulpius , TAL (NS) 20 - -  x 
13Baddar et al Vulpius 22 - 0% x x 
15Borton et al Baker  
Z TAL 
Hoke TAL(P) 
 
 
110 
 
 
16% 
 
 
40% 
  
 
x 
17Damron et al Baker, Vulpius 
Z TAL 
 
37 
 
- 
 
0% 
  
18Dietz et al Hoke TAL(O), Z 
TAL 
34pts - 41%   
19Engsberg et al HCA 
Vulpius 
White TAL 
 12 
10 
10 
 
 
- 
 
 
- 
 
 
x 
 
 
x 
20Fabry et al  TAL(O)(NS) 
Z TAL(P)(NS) 
11 
6 
- - x x 
21Gough et al  Strayer 22 - - x x 
22Gough et al Strayer 22 25% - x x 
24Javors & Klaaren Vulpius 46 0% 0%   
25Kay et al Strayer 
TAL (NS) 
22 
4 
- - x x 
26Lofterod et al Strayer  
Z TAL 
14 7% - x x 
27Lofterod et al Strayer 
 
34 - - x x 
28Lyon et al Hoke TAL, Z TAL 23 35% ?High*  
x 
 
x 
29Olney et al Baker 108 44%                   0%   
33Rattey et al  Z TAL  56 18% 2%   
34Rose et al Baker 19 - - x x 
35Sala et al Hoke TAL 17 24% -   
36Saraph et al Baumann 28 0% 0% x x 
37Saraph et al  Baumann 23 - -  x 
 
 
 
TABLE 5:   Equinus Surgery Outcomes in Spastic Diplegia  (continued) 
 
 
Author Procedure Diplegic 
Feet 
Recurrent 
equinus % 
Calcaneus % F/up 
 >5 yrs 
Gait 
analysis 
38Segal et al Vulpius 
Hoke TAL (P) 
Z TAL 
White TAL 
HCA 
2 
12 
12 
6 
6 
- 30%  x 
39Sharrard &      
Bernstein 
Z TAL 
Strayer 
12 
25 
33% 
4% 
0% 
4% 
  
40Steinwender et al Baumann 34   - -  x 
42Uyttendaele et al Z TAL  15 33%  -   
43Yoshimoto et al Vulpius + HCA 6 0% 0%   
  44Yngve & 
Chambers 
Vulpius 
Z TAL 
16 
16 
 
- 
 
- 
 
x 
 
x 
45Zwick et al  Strayer 11 - -  x 
 
* avg df in stance 24.1        
 
TABLE 6:   Equinus Surgery Outcomes in Spastic Hemiplegia  
 
 
Author Procedure Hemis Recurrent 
equinus % 
Calcaneus 
% 
F/up 
 >5 yrs 
Gait 
analysis 
12Adolfsen et al Strayer 
TAL(NS) 
10 - -  x 
15Borton et al Baker  
Z TAL 
Hoke TAL(P) 
45 
 
 
38% 4%  x 
17Damron et al Baker, Vulpius 
Z TAL 
4 
 
- 0% 
 
  
18Dietz et al Hoke TAL(O), Z 
TAL 
23 - 0%   
23Graham & Fixsen White TAL  35 43% 0%   
24Javors & Klaaren Vulpius 15 4% 0%   
25Kay et al Strayer 
TAL(NS) 
12 
11 
-   - x 
 
x 
 
27Lofterod  & Terjesen Strayer  
 
13 - - x x 
26Lofterod & Terjesen  Strayer  
Z TAL 
6 0% - x x 
29Olney et al Baker 90 62% 0%   
31Park et al Z TAL(NS) 
Vulpius 
13 
3 
- 
 
- 
 
        x                     x 
33Rattey et al  Z TAL  29 41% 7%   
34Rose et al Baker 5 - - x x 
35Sala et al Hoke TAL 4 50% -   
39Sharrard & Bernstein Z TAL 
Strayer 
37 
5 
27% 
40% 
0% 
0% 
  
42Uyttendaele et al Z TAL  10 20% -   
43Yoshimoto et al Vulpius + HCA 11 0% 0%   
44Yngve & Chambers Vulpius 
Z TAL 
3 
11 
 
- 
 
- 
 
x 
 
X 
 
 
TABLE 7: Single Event Multi-Level Surgery (SEMLS) Articles  
Author(s) 
 
Equinus 
Procedures 
Additional Procedures No of 
subjects 
(avg or) 
Age (years)  
Mean (range) 
Preop 
DF IC 
Postop 
DF IC 
Preop 
Max DF 
Postop 
Max DF 
Preop 
KF IC 
Postop 
KF IC 
Outcome 
Measures 
Follow-up 
(yrs/range) 
11Abel et al 
   
Vulpius ADD R, REC T, HAM L, 
STF 
27(7) 8.7 (4-20) 0 0 3 10 40 25 3DGA, GMFM 2 (1.6-3.1) 
12Adolfsen et 
al 
Strayer, 
TAL(NS) 
REC T, HAM L, POTB 31(6) 8.5 (5-15) -5 -2 7 12 31 21 3DGA, EMG, 
Clinical exam 
1.9 (0.7-6.4) 
18Dietz et al 
    
Hoke 
TAL(O), Z 
TAL( 
POTB, HAM L, REC T, 
ADD R 
79(6) 7.7 (2-47) - - - - - - OGA 
GRAFO 
7 ( - ) 
21Gough et al 
 
Strayer VDRO, HAM L, POTB, 
REC T, CO 
12(6.4) 9.8 - - -5 15 - - 3DGA, EMG 
Clinical exam 
1.5 (-) 
22Gough et al 
 
Strayer HAM L, POTB, CO, REC 
T 
12(5) 6.4 (5.9-6.9) - - - - - - 3DGA, GGI, EMG 
Clinical exam 
2 (2-5) 
25Kay et al 
    
Strayer, Z 
TAL(NS) 
POTB, HAM L, CO, VDO, 
SMO, REC T, FTT 
54(5) 9.8 (4-16) - - 0.6 16 - - 3DGA, PRS, 
Ashwoth 
1.5 (1-2) 
26Lofterod & 
Terjesen  
Strayer, Z 
TAL 
POTB, REC T, VDO, HAM 
L 
47(3.9) 11.5 (5-19) -21.9 -7 -6 10.9 23.9 18.4 3DGA exam 
GMFCS FMS 
* 1.2 (.8-1.5) 
28Lyon et al 
    
Z TAL, Hoke 
TAL 
HAM L, REC T, SMO, 
VDO, FTT, ADD R  
14(5.6) 9.1 (4-17) -6.8 10.8 10.1 24.1 40.5 32.9 3DGA * 1.5 (0.5-2.5) 
34Rose et al 
    
Baker VDO, SMO, POTB, ADD 
R, HAM L, REC T 
20(5.3) 6 (4-26) -5 -3 4 12 25 16 Clinical exam 
3DGA 
* 1 ( - ) 
36Saraph et al 
    
Baumann POTB, ADD R, HAM L, 
REC T, SMO, VDO  
22(8) 12.6 (7.4-
16.6) 
-16.8 2.2 11.8 7.1 27.2 18.9 Clinical exam 
3DGA 
* 2 (2.1-4) 
37Saraph et al 
 
Baumann POTB, ADD R, HAM L, 
REC T, SMO, VDO, FF  
32(8) 11.1 (8.7-
13.5) 
-3.9 4.6 6.4 16 - - Clincal exam, 
3DGA, EMG 
* 4.4(1.0-5.4) 
38Segal et al 
    
 
Hoke(P) TAL 
White/ZTAL, 
Vulpius, HCA 
POTB, ADD R, HAM L, 
VDO, SMO 
20(4) 5.2 (2.7-8.2) - 1.45 - 20.3 - 10.7 Clinical exam 
3DGA 
5.8 (1.1-11) 
40Steinwender 
et al 
Baumann POTB, ADD R, HAM L, 
REC T, SMO, VDO, FF 
17(13.5) 14.4 ( - ) -11 0 -6 7.5 28 21 Clinical exam 
3DGA 
* 3.9 ( - ) 
44Yngve & 
Chambers  
Z TAL, 
Vulpius 
POTB, VDRO, ADD R, 
HAM L, REC T 
33 9 ( - ) -13 0 -5 11 29 21 Clinical exam 
3DGA 
* 1 ( - ) 
45Zwick et al 
  
 Strayer POTB, ADD R, HAM L, 
REC T, SMO, VDO, FF 
17(8) 11.2 (5.7-
16.4) 
-3.6 1.4 -0.9 5.1 31.6 23.6 Clinical exam 
3DGA 
* 3.8 (2.6-5.7) 
 
VDO – Varus Derotational Osteotomy Femur     ADD R – Adductor Release         HAM L – Hamstring Lengthening          STF- Sub-Talar Fusion      FTT -  Foot Tendon Transfer 
REC T – Rectus Femoris Transfer     POTB – Intramuscular Psoas Lengthening      CO – Calcaneal Osteotomy     SMO – Supra Malleolar Osteotomy  FF -  Foot Fusion 
                                                         
ORTHOPAEDIC MANAGEMENT OF SPINAL DEFORMITY  
IN CEREBRAL PALSY 
 
Jeremy Fairbank MA MD FRCS  
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&  
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In principal, any growing child with a significant neurological deficit is vulnerable to 
developing combinations of scoliosis, lordosis and kyphosis. The more severe the 
deficit, the more likely is spinal deformity to occur, the earlier the age of onset, and 
curves are likely to be more severe. Curve progression is most obvious during spinal 
growth, but continues in adult life. These observations are based on personal 
experience. The quality of the available literature is poor. The closest we have to 
documented natural history of spinal deformity is Saito et al’s study,1 which we 
believe is consistent with these assertions. In general if a child with CP can walk, then 
serious scoliosis is much less likely compared with a wheelchair dependent 
individual. The aim of their study was to clarify the natural history of scoliosis from 
childhood through to adulthood and provide objective data on proper surgical 
indications for such patients. Authors retrospectively analyzed 37 institutionalized 
patients with severe spastic palsy and scoliosis. They reviewed the series of 
radiographs with an average follow up of 17.3 years. Assessed were five factors with 
the effect on the progression of scoliosis: sex, degree of spasticity, initial physical 
capability, pattern of spinal curve and location of curve. Their findings included the 
one that the scoliosis usually started before the age of ten years and progressed rapidly 
during the growth period. They also found that the progression of the scoliosis 
occurred in many cases even after the growth had ended. The mean Cobb angle of the 
curves at final examination was 55˚. In 85% of patients with the curve of >40˚ before 
the age of 15 years, the scoliosis progressed to >60˚ by the time of the spinal 
examination. In contrast to that, in only 13% of patients who had a curve <40˚ at the 
age of 15 years did the scoliosis progress to >60˚. Severe scoliosis (>60˚) developed 
predominantly in those patients with the total body involvement (67%), were 
bedridden (100%) or had thoracolumbar curves (57%). Authors concluded that the 
risk factors for progression of scoliosis in spastic cerebral palsy are: having total body 
involvement; being bedridden; and having a thoracolumbar curve. Their opinion was 
that the patients with these risk factors might benefit from early surgical intervention 
to prevent the progression to severe scoliosis – Oxford CEBM B. 
 
Cerebral palsy may be classified topographically (hemiplegia, diplegia and total body 
involvement etc) or neurologically (spastic, athetoid, ataxic, rigid or mixed). 
Deformities in cerebral palsy are mobile or fixed, and generally progress from mobile 
to become fixed. We may speculate on the cause of spinal deformity. It is generally 
assumed to be the lack of dynamic muscle control to counteract the deforming forces 
resulting from gravity. As the size of deformity increases so gravity takes an 
increasing role and hastens the progression of the deformity. There are strong 
biological drivers for the spine to grow “straight”. It is likely that there is some 
variability in this, and it may be that some children are more vulnerable to external 
deforming forces than others. The evidence for this statement is limited to personal 
observations. 
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INTERVENTIONS TO PREVENT AND TREAT SPINAL DEFORMITY 
Posturing 
Sleep systems are widely used but we have difficulty in finding evidence of efficacy. 
Daytime posturing has observational data mainly focussed on the hips.  
Seating 
This is an important element of managing a child with 4 limb involvement CP. 
Because it is universally applied it is difficult to establish efficacy. Seating can be 
moulded or modular. Reclining position or tilt-in-space can be used when gravity 
loading is a problem. However, tilting can interfere with quality of life if a child 
cannot see, or wants to use a keyboard, or during feeding.  
Bracing 
Custom moulded braces are useful especially in the younger child. We have used 
“soft” braces for “collapsing” spines. The problem is that as the child gets older and 
larger the surface loads on the brace can cause problems in progressive curves. It is 
also difficult to combine moulded seating and brace treatments, although it is easier to 
combine braces and modular seating. Evidence for efficacy is hard to come by. 
Surgery 
Surgical treatment is considered where there is a need to control progressive curves, 
to stabilise and correct pelvic obliquity, to control pain related to sitting and relieved 
by lying down, and where spinal deformity is contributing to respiratory problems. In 
some cases improvement of body image (for either patient or carers or both) is a 
benefit. Some carers report that lifting and handling of the patient is easier after the 
surgery. These potential benefits have to weighed against serious risks attached to 
such major surgery on a child or young adult with poor nutrition, respiratory function, 
poor bone quality and often major learning difficulties and limited communication 
capacity. Risks include mortality, infection, spinal cord and nerve damage, implant 
failure, infection, pseudoarthrosis, revision surgery, and perhaps worst of all, 
ventilator dependence. 
 
The decision to proceed to surgery often lies with the carers with limited or no 
contribution from the patient, which is particularly challenging for all concerned. The 
decision is based on estimate of quality of life now and in the future with or without 
the intervention. These can be some of the toughest decisions in spinal surgery. Help 
in decision making should be sought from all those involved in the care of the patient. 
 
Over the last 20 years there have been important advances in the implants available to 
surgeons. Where possible surgery is done posteriorly, but in some cases anterior 
release and instrumentation will contribute to a stable outcome. The more severe 
curves require preliminary anterior release and posterior stabilization. If there is fixed 
pelvic obliquity, the fusion should be extended to sacrum. Leaving the L5-S1 segment 
free leaves some spinal mobility, but risks instability and the need for further surgery 
later. 
 
Anaesthetic techniques have also improved enormously with better control of 
bleeding and respiratory function, post-operative care and pain control. 
 
 
 198          © International Society for Prosthetics & Orthotics 
EVIDENCE BASE FOR SPINAL SURGERY 
 
This remains based on observational studies and personal experience. Once a decision 
has been made to proceed to surgery there is a big incentive for both surgeons and 
carers to say that the intervention was worth it. Outcome measures, beyond the 
geometry of the curve before and afterwards and the presence of complications, are of 
poor quality. Scoliosis is common in children with cerebral palsy and occurs in 15-
25% of patients. Most curve patterns are long thoracolumbar or lumbar. 
 
Comstock et al. in 1998 analyzed the surgical treatment and patient and caregiver 
satisfaction in patients with the total-body-involvement cerebral palsy.2 In their 
nonrandomized descriptive case series authors analyzed the data from 79 of 100 
patients with total-body-involvement spastic cerebral palsy who underwent posterior 
Luque instrumentation, or anterior spinal fusion, or both. Functional status was 
evaluated by physical examination and a personal interview was conducted with the 
patient, parents and a primary caregiver. In a median follow-up of 4 years late 
progression of scoliosis (>10˚), pelvic obliquity (>5˚), and decompensation (>4cm) 
were noted in>30% of patients. More than 75% of patients with late progression were 
skeletally immature at the time of surgery and underwent a posterior procedure only. 
21% of the patients required a revision procedure because of the disease progression. 
Progression was not noted in any patients who underwent anterior fusion 
(instrumented or non-instrumented) with posterior instrumentation from the upper 
thoracic spine to the pelvis. 85% of caregivers were very satisfied with the results of 
surgery and noted a beneficial impact on the patient’s sitting ability, physical 
appearance, ease of care, and comfort. The authors concluded that to avoid late 
progression of trunk deformity in skeletally immature patients, anterior spinal release 
and fusion combined with posterior segmental spinal instrumentation and fusion from 
the upper thoracic spine to the pelvis are recommended. Skeletally mature patients 
with good curve flexibility can be treated with posterior instrumentation and fusion 
only. Skeletally mature patients with large fixed curves benefit from an anterior-
posterior procedure for better correction of the scoliosis and pelvis obliquity. Despite 
the surgical complexity and expected complications, the overall good surgical results 
and high patient and caregiver satisfaction confirm that corrective scoliosis surgery is 
indicated and beneficial for most patients with total-body-involvement cerebral palsy 
and scoliosis – Oxford CEBM C. 
 
Teli et al. in 2006 reported on the treatment of patients with cerebral palsy and 
neuropathic scoliosis with third-generation instrumented spinal fusion by Cotrel-
Dubousset instrumentation.3 In their retrospective study authors analyzed 60 patients 
with minimum follow-up of two years. Mean age of patients was 15 years at the time 
of surgery. There were 26 anteroposterior and 34 posterior-only procedures, with the 
correction of coronal deformity and pelvic obliquity of average 60% and 40% 
respectively. Major complications occurred in 13.5% of patients and included implant 
loosening, deep infection and pseudoarthrosis. Outcome questionnaires showed 
marked improvements in the areas of satisfaction, function and quality of life. Third- 
generation instrumented spinal fusion has enhanced correction and allows early 
ambulating and nursing. The limitations of this study included the retrospective 
design and the absence of an internal control group treated with second-generation 
implants. Authors observed that in their cohort group, percentage correction of 
scoliosis was very similar inpatients treated posteriorly and anteroposteriorly, 
although the latter group had by definition stiffer curves on preoperative imaging. 
Correction of pelvic obliquity was significantly higher in patients in patients treated 
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with the double approach, which might suggest a positive role of the anterior release 
of lumbar spine toward correction of pelvic deformity. The improvement of trunk 
balance and pelvic obliquity led to better sitting balance and the absence of pressure 
sores at follow-up. Patients with posterior-only procedures had the shortest hospital 
stay and operating time, but the highest incidence of complications, particularly 
superficial and deep infections. Authors concluded that segmental, third-generation 
instrumented spinal fusion provides lasting correction of spinal deformity and 
improved quality of life in patients with cerebral palsy and neuropathic scoliosis, with 
a lower pseudoarthrosis rate compared to reports on second-generation instrumented 
spinal fusion – Oxford CEBM C. 
 
Tsirikos et al. compared one-stage versus two-stage anteroposterior spinal fusion in 
paediatric patients with cerebral palsy and neuromuscular scoliosis.4 In this 
retrospective study the objective was to evaluate the outcomes and complications of 
two treatments in 45 paediatric patients and to document which procedure is more 
efficacious and provides better results. There was no statistically significant difference 
between one-stage and two-stage patients, considering age at surgery, preoperative 
scoliosis angle, pelvic obliquity, kyphosis angle, lordosis angle, levels of anterior 
release, percentage of scoliosis correction, radiographic follow-up, hospitalization 
time, and intensive care unit stay. Sequentially performed spinal procedures (one-
stage group) were associated with increased intraoperative blood loss, prolonged 
operative time, and a considerably higher incidence of medical and technical 
complications, including two perioperative deaths. Authors of this study concluded 
that the one-stage procedure were associated with a considerable mortality rate, 
increased operative morbidity and higher risk of technical complications. They 
recommended two-stage anteroposterior spinal fusion as safer and more advantageous 
over the single-stage procedure, especially in individuals with very large curves and 
concomitant medical illness – Oxford CEBM C. 
 
Tsirikos et al analyzed the life expectancy in patients with cerebral palsy and 
neuromuscular scoliosis following spinal fusion.4,5  In their retrospective cohort study 
they analyzed 288 severely affected paediatric patients with spasticity and 
neuromuscular scoliosis who underwent spinal fusion. Mean age of patients was 13 
years and 11 months at the time of surgery. Kaplan-Meier survival analysis was 
performed demonstrating a mean predicted survival time of 11 years and 2 months 
after spinal surgery for this group of globally involved children with cerebral palsy. 
The most significant determinants for reduced life expectancy in paediatric patients 
with cerebral palsy are the coexistence of other significant disorders such as 
respiratory malfunction, epilepsy, feeding disorders, the degree of neurological 
involvement, the presence of severe cognitive abnormality, and the level of 
ambulatory disability. Authors of this study observed that the preoperative degree of 
scoliotic deformity was not correlated statistically with survival rates. The days spent 
in the ICU appeared to be the most accurate predictive factor for the long-term 
survival of severely affected children and adolescents. They concluded that the 
number of days spent in the intensive care unit after surgery and the presence of 
severe preoperative thoracic hyperkyphosis were the only factors affecting the 
survival rates and that the parents of high-risk children should be counselled about the 
prognosis  – Oxford CEBM C. 
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OUTCOME MEASURES FOR NEUROMUSCULAR SCOLIOSIS.  
This section gives brief summaries of relevant papers. 
 
The Effect of Spinal Surgery on Function in Children with Neuromotor 
Disorders and Scoliosis: A prospective study using standardised measures. 
Nicky Courtier, John O’Dowd, Elspeth Will, Jonathan Lucas, Khai Lam, 
Elizabeth Wraige. Deformity Service, Guy’s and St.Thomas’s Spinal Unit, 
London (unpublished). 
Introduction: It is widely accepted that operating on children with neuromotor 
disorders and scoliosis who are full time wheelchair users is often to prevent/correct 
deformity with the primary goal of maintaining/ improving sitting ability. In those 
children who are ambulant, preventing further deformity is usually the objective with 
the effect on function being less clear. The purpose of this study was to assess the 
impact of spinal surgery on all aspects of function in children with neuromotor 
disorders using standardised functional measures. 
Methods: A consecutive series of 20 children (age range 2 –18) who underwent 
posterior only or anterior and posterior spinal fusion for neuromuscular scoliosis. 
Patients were assessed pre-op (A1), post-op (A2), at 3 months (A3) and 12 months 
(A4). The Seated Postural Control Measure (SPCM) examined posture and function 
(A1 – A4). The Paediatric Evaluation of Disability Inventory (PEDI) recorded. 
functional ability in the domains of self-care, mobility and social function (A1, A3, 
and A4). 
Results: The SPCM demonstrated an improvement in posture in 95% from A1 – A2 
with 25% demonstrating some regression at A3. Over 70% maintained or further 
improved posture by A4. The PEDI measured an increase or maintenance of self-care 
in at least 50% patients at A3. All patients demonstrated a reduction in mobility at A3. 
At least 60% when measured at 1 year post-op had regained their pre-op levels of 
mobility and self-care. 
Discussion: Although children within this group do improve their sitting ability post-
op, many other areas of their function are also affected following spinal surgery. 
These may have more of an impact on the child’s/families’ life. Both measures used 
in this study had some limitations but offered the opportunity to repeat assessments of 
care and independence over time exploring other considerations when deciding about 
spinal surgery. 
 
Longitudinal Parental Perceptions of Spinal Fusion for Neuromuscular Spine 
Deformity in Patients with Totally Involved Cerebral Palsy. Jones et al (JPO, 
2003) John Hopkins 6 
Prospective study over 3.5 yrs, consecutive pts 
N=17(of 25) 10-21yo (mean 14.2) 11M, 9F  
Cobb angle Complications   
PODCI questionnaire 
Scope – Comment on overall risks and carer perceived benefits of surgery for this 
small, homogenous patient group 
 
Process Measures and Patient/Parent Evaluation of Surgical Management of 
Spinal Deformities in Patients with Progressive Flaccid Neuromuscular Scoliosis 
(Duchenne’s Muscular Dystrophy and Spinal Muscle Atrophy). Bridwell et al 
(Spine, 1999) Missouri 7 
Prospective study assessing results and their own questionnaire 1985-95 
N=48(of 55) 7-18yo (mean 13.4) 29DMD, 16SMA  
 201          © International Society for Prosthetics & Orthotics 
Cobb angle 
Complications 
Questionnaire 
Scope  
Objective and subjective outcomes identified in a medium sized sample  
Tool for assessment tested in flaccid neuromuscular scoliosis patients 
 
Spinal Fusion and Instrumentation for Paediatric Neuromuscular Scoliosis: 
Retrospective Review. Thacker et al (J Orth Surg (Hong Kong), 2002) Singapore 
Retrospective study 1993-98   CP,DMD, SMA  
N=24   6-14yo (mean 10.6) 5.5 yr F/U  
Cobb angle  
Complications 
ITU stay   
FEV1 Sitting Ability 
 Scope   
Assessment of procedure safety 
 
Standards in Anterior Spine Surgery in Paediatric Patients with Neuromuscular 
Scoliosis. Sarwahi et al (JPO, 2001) Chicago 8 
Retrospective study  1988-95  CP, Spina Bifida, NF 
N=111  3-18yo (mean 12.3) 46M, 62F 
Cobb angle 
Complications 
Diagnosis 
Procedure 
Operative blood loss 
 Scope  
Identification of risk factors for complications in anterior spinal surgery 
 
Results and Morbidity in a Consecutive Series of Patients Undergoing Spinal 
Fusion for Neuromuscular Scoliosis. Benson et al (Spine, 1998) Connecticut 9 
Retrospective study  1990-95  CP, Spina Bifida, SMA 
N=50  4-29yo (mean 13.5) 22M, 28F  3.3yr F/U 
Cobb angle 
Degree of correction 
Complications 
 Scope  
Radiological results and complication rates recorded 
 
Goal setting in neuromuscular scoliosis surgery. Is it important? Nicky Courtier, 
John O’Dowd, Elspeth Will. Deformity Service, Guy’s and St. Thomas’ Spinal 
Unit, London (unpublished data). 
Introduction: In adolescent idiopathic scoliosis the decision to operate is based on the 
cosmetic appearance of the deformity. With neuromuscular scoliosis, the objective of 
surgery is to maintain/improve sitting ability. However, the effect of surgery on other 
aspects of function in this group is often overlooked. On this basis, the overall 
success/satisfaction of the surgical intervention is dependent on the realistic 
expectations from the family/carers of what the surgery can offer. 
Method: A group of 20 children who underwent spinal fusion for neuromuscular 
scoliosis were assessed using a postural and functional measure pre-op, post-op, at 3 
months and 12 months post-op. In addition, each patient was asked to record three 
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goals for undergoing the surgery. At one year post op, patients were asked to grade on 
a scale of 0 – 10, how satisfied they were that the goals had been achieved. 
 
Results: Nineteen patients had clear pre-op goals for the surgery relating to functional 
activities. The most frequent goals stated for the non-ambulant children were: Sitting 
for longer periods (7/46), making dressing easier (7/46) and sitting more upright 
(6/38). There were 15 other functional goals stated. The ambulant children stated: 
Appearing straighter (3/12), increasing in confidence (2/12), reducing pain (2/12) and 
maintaining respiratory function (2/12). There were 3 other functional goals stated. 
Seventeen patients completed the study, 2 were lost to follow up, 1 died. The average 
satisfaction rate from goals achieved 1 year post-op was 7.9/10. 
  
Discussion: Establishing goals that are realistic and contribute positively to the 
functional ability or practical management of the child with neuromuscular scoliosis 
undergoing spinal surgery, encourages the family to be central in the decision making 
process. It also allows unrealistic expectations to be discussed pre-op and may appear 
to be a key factor in the overall success and satisfaction of the surgical intervention.  
 
Conclusions: 
Bracing is first line treatment for CP related spinal deformity. The evidence basis is 
poor, and in each case treatment is experimental. This has to be linked with seating 
and sleep systems with an emphasis on standing where this is possible in a frame or 
with splints and walking aids.  
Surgery is used as part of the management of CP related spinal deformity only when 
non-operative treatment has failed. A careful discussion of risks and benefits is 
needed with all concerned parties, recognising that surgery is dangerous and takes 
many months to get over. The position of the Pelvis in coronal and sagittal planes is 
crucial. Patients with limited hip movement require particular consideration. The 
objective has to be a comfortable sitting posture. The reward is a patient whose pain 
has been relieved. Bonuses are when the rate of respiratory infections is reduced and 
when appetite is restored. Risks are of serious operative complications particularly of 
infections and repeat surgery. The surgeon must be constantly self critical and aware 
of their limitations. Surprising successes may encourage surgery against the odds and 
must be constantly guarded against. Non-surgeons should have the courage to 
question surgical decision making at all stages. 
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A SYSTEMATIC REVIEW OF THE USE OF ORTHOSES IN THE 
MANAGEMENT OF PATIENTS WITH CEREBRAL PALSY:  HIP, TRUNK, 
SPINE AND UPPER LIMB. 
 
Phil Stevens, MEd, CPO, FAAOP 
Specialized Prosthetic and Orthotic Technologies 
Salt Lake City, USA 
 
The purpose of this article is to provide a comprehensive review of the role of 
orthoses in the management of the hips, trunk, spine and upper extremities in persons 
with cerebral palsy.  The management of the lower extremities is treated in a separate 
literature review.  The majority of the referenced studies have been published since 
the first ISPO consensus conference on this topic in 1994, reflecting both newer 
treatment methods and enhanced experience in more traditional treatment approaches.  
Additionally, the larger acceptance of recent surgical, pharmaceutical and/or 
therapeutic modalities in the management of this complex population has created new 
adjunctive applications within the field of orthotics that are addressed.  Finally, where 
historical foundations were considered beneficial, older publications have also been 
referenced.  In reviewing this literature, the following questions were developed and 
answered according to the best available evidence: 
 
• Do spinal orthoses improve posture, balance and associated control of the head 
neck and upper extremities in children with cerebral palsy when compared to 
unbraced conditions? 
• Do spinal orthoses have a negative impact on pulmonary or circulatory function in 
children with cerebral palsy compared to unbraced conditions? 
• Do spinal orthoses prevent or delay curve progression compared to natural history 
in children with cerebral palsy? 
• Do hip orthoses prevent progressive hip subluxation compared to natural history 
in children with cerebral palsy? 
• Do daytime hip orthoses improve gross and/or fine motor function in children 
with cerebral palsy compared to unbraced controls? 
• Do daytime orthoses increase muscle activity in hip adductors in children with 
cerebral palsy compared to unbraced muscle activity? 
• Do the combined modalities of dynamic assist upper extremity orthoses and 
functional stimulation of antagonist muscle groups decrease upper limb spasticity 
and/or improve upper limb function in children with cerebral?  
• Do dynamic assist upper extremity orthoses maintain upper extremity range of 
motion more effectively than static splinting modalities in the treatment of patients 
with cerebral palsy? 
• Are there established benefits associated with the bracing of the wrist joint with 
static and/or dynamic splints in children with cerebral palsy? 
• Are there established benefits with respect to upper extremity function associated 
with the use of lycra garments in children with cerebral palsy? 
• Are there established benefits associated with the use of lycra garments with 
respect to lower limb function in children with Cerebral Palsy? 
• Are there established benefits associated with the use of Johnstone pressure splints 
in the management of children with cerebral palsy? 
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METHODS 
 
A search of the literature was conducted in April and May, 2007 using the Cochrane 
Central Register of Controlled Trials, Ovid Medline, CINHAL and RECAL Legacy.  
The following search terms were combined with the base term “cerebral palsy:”  
“orthoses,” “orthotic devices,” “brace,” “bracing,” “splints,” “splinting” “spinal 
curvatures,” “scoliosis,” “kyphosis,” “jacket,” “TLSO,” “hip,” and “upper extremity.”  
In addition, references in original articles were examined to verify that no relevant 
literature had been overlooked.  References were hand searched if they were 
published between 1994 and the present date.  Articles were selected for further 
review if they addressed the role of orthotic modalities with respect to the spine, 
trunk, hip and upper extremities of persons with cerebral palsy.  Publications focused 
solely on surgical techniques were not reviewed.  Likewise, articles focused on 
seating and positioning were not reviewed unless they made specific reference to 
spinal or hip orthoses.  When relevant, studies pertaining to adjuvant surgeries, 
therapies and other interventions were included. Relevant historic literature was also 
evaluated as appropriate to establish historical foundations where appropriate.   
 
In the “research design” section of the tables, the following phrases are utilized. 
 
Randomized controlled trial:  A prospective experimental study in which subjects 
are randomly assigned to either a control or intervention group.  Outcome measures 
are assessed after an appropriate follow-up time and results are compared between the 
control and intervention groups. 
 
Cohort study:  A prospective or retrospective observational study of subjects that 
may develop a specific condition.  Subjects may be sub-divided into groups based on 
exposure to factors that may influence occurrence of the condition.  Incidence of the 
condition is assessed after an appropriate follow-up time and subjects are compared to 
predict influential factors. 
 
Case Series:  A descriptive, observational study of the diagnosis, prognosis, treatment 
and/or outcomes of a subject group with the same  (or similar aspects of a) condition. 
 
Interrupted time series trial:  A prospective experimental study in which multiple 
subjects are assigned only to an intervention group.  No control group is formed; 
instead subjects serve as their own control.  Subjects are evaluated multiple times 
before and after one or more interventions.  Repeated outcome measures are assessed 
at known intervals and results are compared between the studied conditions. 
 
Controlled before-and-after trial:  A prospective experimental study in which 
multiple subjects are assigned only to an intervention group.  No control group is 
formed; instead subjects serve as their own control.  Subjects are evaluated once 
before and once after one or more interventions.  Outcome measures are assessed at 
known intervals and results are compared between the studied conditions. 
 
Qualitative Study:  A descriptive, observational study in which a subject group is 
evaluated through subjective, open-ended questions and interview techniques. 
 
Convenience Sample:  Subjects were chosen on the basis of availability. 
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Levels of Evidence were determined according to the Oxford Centre for Evidence-
based Medicine Levels of Evidence (May 2001) 
 
 
SPINE 
 
Do spinal orthoses improve posture, balance and associated control of the head 
neck and upper extremities in children with cerebral palsy when compared to 
unbraced conditions? 
 
The use thoracolumbar sacral orthoses (TLSOs) to treat spinal deformities in persons 
with cerebral palsy was first described in a preliminary report in 1977, in which the 
use of “removable orthoplast jackets” was found to temporarily halt the curve 
progressions with low instances of both complications and patient rejection1. 
 
Fifteen years later, citing high rates of pressure sores and skin irritation, as well poor 
general tolerance of rigid spinal orthoses among patients with neuromuscular scoliosis 
(NMS), authors detailed their preliminary use of the “Soft Boston Orthosis” among 
NMS patients, the majority of which were patients with quadriplegic cerebral palsy2.”  
The construct of this device was reported as two layers of Aliplast, with high density 
polyethylene panels compressed at intervals between the two layers.  Responding to 
questionnaires, staff members reported improved head and trunk control and enhanced 
postural position and sitting stability associated with the use of the device.  
Subsequent investigations have reported similar benefits with both custom molded 
polypropylene and polyethylene TLSOs as well as “TLSOs with non-rigid SIDO 
frames” (essentially a posterior TLSHO which allows flexion and limited rotation of 
the trunk), including improved sitting balance and resultant postures of the head, trunk 
and extremities3,4 (See Table 1).  Such improvements have also been suggested within 
several expert opinion publications5,6.   
 
Do spinal orthoses have a negative impact on pulmonary or circulatory function 
in children with cerebral palsy compared to unbraced conditions? 
 
Addressing concerns of respiratory compromise with the use of the Soft Boston 
Orthoses, the authors cited earlier reported no appreciable compromise in oxygen 
saturation levels associated with the use of the spinal orthosis2.  In reference to this 
last concept, careful distinction needs to be drawn between the reported negative 
impacts of spinal bracing on neuromuscular scoliosis due to myopathies and those 
observed with the bracing of neuromuscular scoliosis due to neuropathy.  Reports of 
reduced vital capacity historically observed in patients with muscular dystrophies and 
spinal muscle atrophies7 should not be generalized to the cerebral palsy population.  
The sole publication addressing this concept within the cerebral palsy population 
found no significant differences in any of the major indices of pulmonary mechanics 
when patients with spastic quadriplegia were assessed with and without their Soft 
Boston Orthosis in sitting and supine8 (See Table 2). 
 
Do spinal orthoses prevent or delay curve progression compared to natural 
history in children with cerebral palsy? 
 
The ability of spinal orthoses to retard curve progression and delay or prevent 
scoliosis is poorly understood.  In a study whose population was said to exclude all 
but the most severely spastic quadriplegic patients, the use of custom molded 
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Wilmington orthoses failed to impact group curve progression rates or magnitudes 
compared to those of an unmatched cohort of unbraced controls9.  Unfortunately, the 
magnitude and flexibility of the curves at the time when bracing was initiated were 
not reported.  In a later study, children with spastic quadriplegia were considered 
within a larger cohort of NMS in which prefabricated Boston type braces were used.  
Subjects were monitored for an average of 3 years following the discontinuation of 
bracing.  In nine of the 37 children with quadriplegic cerebral palsy, bracing was 
found to be successful, with curves failing to progress more than 10° during the 
observation period10.  When subjects with athetosis are excluded from these findings, 
seven of 25 cases met the authors’ criteria for success.  Among the broad diagnosis of 
NMS, successful bracing outcomes were related to shorter, smaller curves.  
Unfortunately, given the mixed diagnoses reported on in the publication, these 
characteristics can only be cautiously generalized to the cerebral palsy population. 
 
A final publication reported on retrospective analysis of 86 patients with spastic 
quadriplegic cerebral palsy who were managed with custom molded TLSOs3.  The 
mean Cobb angle at the initiation of bracing for this cohort was 68°.  As with the 
Wilmington orthoses, researchers found that as a group, the rate of curve progression 
within their braced subjects was similar to reported natural history values11.  
However, their report included a small cohort of patients, 16% of those under the age 
of 15 and 64% of those 15 or older, whose braced curves progressed less than 1° per 
year.  Their numbers are strikingly similar to those suggested by a commonly sited 
source for expert opinion which observed that no more than 15% of braced curves 
stop progressing12.  Regression analysis found that neither the Cobb angle at initiation 
of bracing, the type of scoliosis or the amount of observed pelvic obliquity was 
predictive of successful outcomes with bracing.  The only variable associated with 
slowed curve progression was initial in-brace correction.  Among their conclusions, 
the authors suggest that greater correction in the orthosis seems to be the only 
changeable factor associated with curve progression.  However, given that the 
orthoses in the study were all made by the same team of experienced clinicians, 
clinical experience suggests that the variable outcomes observed could also have 
resulted from differences in curve flexibility (See Table 3). 
 
Adjunctive Considerations 
 
Ginsburg and Lauder recently reported their observations of rapid progressions of 
scoliosis in patients with spastic quadriplegia following the insertion of an intrathecal 
baclofen pump13.  Reporting on 19 consecutively observed patients, the authors report 
a mean preoperative Cobb measurement of 10.2°.  The average postoperative Cobb 
measurements for the same group, taken at an average of 20.9 months after pump 
insertion was 25.0°.  Further analysis found that subjects were experiencing a 6-fold 
increase in the curve progression rate following the pump insertion.  As a result, the 
authors report that they are now recommending spinal bracing once pumps are 
inserted with in-brace radiographs taken at 4 month intervals.  As the use of 
intrathecal baclofen pumps becomes more common in the treatment of spasticity, the 
impact of these pumps on scoliotic curve progression rates and the implications with 
respect to spinal bracing will warrant further investigation. 
 
Similarly, multiple articles have been published addressing selective dorsal rhizotomy 
within the diplegic and quadriplegic cerebral palsy populations with increased 
incidences of scoliosis14-19, hyperlordosis14-16,18-19, spondylolysis16, 
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spondylotisthesis14,16-18, and abnormal kyphosis18-19.  The extent and nature with 
which this phenomenon will affect spinal bracing remains to be seen. 
 
Conclusions and Recommendations: Spine 
 
The primary benefits associated with the use of TLSO’s in the cerebral palsy 
population appear to be related to improved balance and stability with positive 
secondary affects in the form of improved control of the extremities, head, neck and 
trunk.  Concerns regarding possible respiratory compromise associated with the use of 
TLSO’s appear to be unfounded.  Though spinal curves appear to progress in most 
patients with cerebral palsy, there is a minority of patients for whom TLSO’s appear 
to be effecting in slowing or halting curve progression.  Curve flexibility may be a 
good predictor of the efficacy of TLSO’s in slowing the progression of spinal 
curvatures.  The adjunctive treatment modalities of intrathecal baclofen pumps and 
dorsal rhizotomies appear to influence the natural history of spinal deformities in this 
population.  The extent to which this will affect bracing recommendations and 
outcomes remains to be seen. 
 
 
HIP 
 
Hip instability is a universally acknowledged challenge in the management of patients 
with cerebral palsy.  In addition to the associated pain, compromised sitting stability 
and risk for pressure ulcers, hip subluxation has also been closely linked with the 
development of pelvic obliquity which is, in turn, closely associated with the presence 
of progressive scoliosis1-3.  A recent systematic review has identified those patients 
with quadriplegic cerebral palsy as being at the greatest risk for hip instability, while 
those ambulatory patients with hemiplegia and diplegia are at a far lesser risk4.  
Similarly, gross motor function levels appear to be strongly associated with hip 
displacement rates, with lowest levels of motor function predictive of the highest rates 
of hip displacement5.  Hip surveillance programs have been advocated, in which 
regular radiographs are taken for earlier detection of displacing hips and preventative 
surgeries are performed.  Such programs have resulted in decreases in late hip 
dislocations and their described sequelae6-7. 
 
Various nonoperative modalities, including assorted bracing approaches and 
alignment systems have been described, both to discourage initial hip displacement 
and maintain proper hip alignment postoperatively8-12.  However, patient compliance 
and the general efficacy of such treatments have been justifiably questioned6,9,13-14.  
Clinical trials with respect to hip orthoses and the management of hip displacement 
are currently limited to a single publication15 (See Table 4).  
 
Do hip orthoses prevent progressive hip subluxation compared to natural history 
in children with cerebral palsy? 
 
The publication in question was a randomized, controlled evaluation of the combined 
effects of regular botulinum toxin A (Botox A) injections to the adductors and 
hamstrings and sustained regular use of a variable abduction hip orthosis on reducing 
hip displacement rates compared to matched controls.  Both populations were 
followed for three years, with regular radiographs documenting hip displacement 
levels.  At the conclusion of the trial period, progressive hip displacement was 
observed in both groups with the rate of hip displacement in the treatment group being 
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only slightly reduced relative to that of the control group15.  The observed benefits 
largely failed to justify to temporal, procedural and financial costs of the treatment. 
 
Do daytime hip orthoses improve gross and/or fine motor function in children 
with cerebral palsy compared to unbraced controls? 
 
In addition to the questioned effects of variable abduction hip orthoses combined with 
Botox A injections on hip displacement rates, an earlier investigation was performed 
to evaluate the effects of the same treatment on gross motor function levels16 (See 
Table 5).  In this randomized, controlled trial, gross motor function was assessed in 
experimental and controlled populations at 12 month intervals.  Groups were 
comprised of children with bilateral spastic cerebral palsy between the ages of 1-4 
years old at enrollment, the majority of which were classified at Gross Motor 
Function Classification System (GMFCS) levels IV and V, consistent with lower 
motor function and greater disability17.  As with the previously described trial, 
controls received regular Botox A injections at the hip adductors and hamstrings.  In 
addition, they were provided with a variable abduction hip orthosis which they were 
instructed to use 6-8 hours daily.  Gross motor function was assessed using the Gross 
Motor Function Measure (GMFM) as described by Russell et al18.  Hip orthoses were 
not used during either the initial or concluding assessments.  Authors reported that 
GMFM scores improved comparably in both study groups, with the GMFM scores of 
experimental group failing to improve beyond the rates observed in the matched 
controls16. 
 
Relevant to the expert opinion claims that hip orthoses are poorly tolerated with 
questionable compliance, the parents of the experimental study subjects reported via 
questionnaires that the orthosis, the Standing Walking and Sitting Hip (SWASH) was 
comfortable, durable and easy to don and doff.  Furthermore, the majority reported 
improved sitting and standing balance with the SWASH.  Brace wear was reported at 
a mean value of 5.6 hours per day, suggestive of good compliance16. 
 
The findings of this study should be carefully considered against other publications 
which suggest that the outcome measure selected, the GMFM, may not have been 
appropriate to detect any existent changes in motor performance within the study’s 
population.  Five years has been suggested as the minimum age at which the GMFM 
should be used to assess motor function18-19.  Additionally, the sensitivity of the 
GMFM among patients at lower functioning, GMFCS levels IV and V, has been 
questioned19.  Therefore, the study cohort may have been both too young and too 
severely disabled for the GMFM to detect changes in gross motor function.  
Interestingly, a treatment affect was observed among experimental subjects at 
GMFCS level III.  These findings may either reflect improved treatment outcomes in 
patients with lesser levels of disability or simply an increased sensitivity of the 
selected outcome measure in this population. 
 
Do daytime orthoses increase muscle activity in hip adductors in children with 
cerebral palsy compared to unbraced muscle activity? 
 
It has been suggested that hip bracing is poorly tolerated by children with cerebral 
palsy because the passive abduction in the brace activates stretch reflexes in the 
spastic hip adductors6,14.  However, the sole quantitative evaluation of this hypothesis 
failed to support it20 (See Table 6).  Using surface electromyography (SEMG) in a 
cross-over design with children with spastic diplegia, SEMG amplitudes at the hip 
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adductors were found to be similar with and without the SWASH orthosis.  The study 
suggests that clinical concerns regarding increased adductor muscle activity with the 
use of the SWASH orthosis seem unwarranted20. 
 
Adjunctive Considerations 
 
There is a small body of literature which has investigated the components and 
relevance of a functional sitting position for children with cerebral palsy21-23.  A hip 
orthosis, consisting of two thigh cuffs separated by a spring, was described as one 
means of creating the symmetrical weight bearing distribution necessary for 
functional sitting21.  Authors later used SEMG to record values from various leg 
muscles in various seat inclinations, both with and without an abduction orthosis 
while study subjects engaged in an upper extremity task22.  Results indicated that a 
horizontal, forward-leaning seat with the use of an abduction orthosis decreased lower 
extremity muscle activity and might facilitate improved upper extremity function22.  A 
later investigation with similar methodology failed to support the findings of the 
preceding study, observing similar SEMG findings, both with and without the use of 
hip abduction orthoses23.  The later study suggests that when the other components of 
the functional sitting position are maintained, a hip abduction orthosis may be 
unnecessary. 
 
Conclusions and Recommendations: Hip 
 
While widely utilized, there is very little evidence to support or oppose the use of hip 
orthoses in the treatment of cerebral palsy.  Static hip orthoses and their impact on hip 
subluxation rates have not received objective scrutiny.  Functional hip orthoses such 
as the SWASH do not appear to impact hip displacement rates, but may be better 
tolerated than their static predecessors.  The assertion that functional hip orthoses may 
encourage increased use of the hip adductors appears to be unfounded.  The basic 
purposes of functional hip abduction orthoses in discouraging scissoring gait patterns 
and improving sitting stability have received limited scrutiny.  Hip abduction appears 
to be an important component of functional sitting postures.  The use of hip orthoses 
in facilitating this alignment has been observed. 
 
 
UPPER LIMB 
 
Do the combined modalities of dynamic assist upper extremity orthoses and 
functional stimulation of antagonist muscle groups decrease upper limb 
spasticity and/or improve upper limb function in children with cerebral?  
 
There is a small body of literature supporting the combined treatments of brief daily 
use of neuromuscular electrical stimulation (NMES) coupled with simultaneous 
dynamic bracing and concomitant static nocturnal bracing (See Table 7).  The 
treatment is based on the premise that spasticity has both a static and dynamic 
component.  It has been suggested that orthoses address the static component of 
shortened muscles while NMES addresses the dynamic component of abnormal tone 
and muscle imbalances1.  The first of these trials reported retrospectively on the 
observed affects of the treatment on 19 patients with hemiplegia, mild to moderate 
proximal spasticity (scapula, shoulder and elbow) and moderate to severe spasticity of 
the wrist and fingers.  NMES was applied for one hour a day over the elbow extensors 
and wrist and finger extensors while subjects were wearing dynamic upper extremity 
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bracing1.  The later study was a prospective design in which 24 subjects were 
randomly assigned to one of three treatment groups, NMES only, dynamic bracing 
only, and NMES combined with dynamic bracing2.  Similar orthoses were used in 
each endeavor, inclusive of elbow-wrist-hand-finger orthoses with dynamic elbow 
extension and metacarpophalangeal extension joints. 
 
In the first endeavor, authors reported universal decreases in spasticity and improved 
wrist and finger postures according to the Zancolli’s classification system3.  Similar 
improvements within the same classification system were reported in the later study, 
but only among those patient’s who received both NMES and dynamic bracing.  Grip 
strength and an upper extremity dexterity measure, the Melbourne Assessment of 
Unilateral Limb Function4 were also reported outcomes in the later trial.  Again, 
improvements in these measures were restricted to those patients receiving the 
combined treatments.  Importantly, in the later study, authors reported that all of the 
improvements observed in the combined treatment group lasted for only one to three 
months after the conclusion of the treatments2. 
 
Do dynamic assist upper extremity orthoses maintain upper extremity range of 
motion more effectively than static splinting modalities in the treatment of 
patients with cerebral palsy? 
 
In addition to these trials, there have two reports on small case series in which 
dynamic bracing of the elbow was used in children with CP following injections of 
botulinum toxin A into the biceps and brachioradialis and several weeks of corrective 
serial casting (See Table 8).  In the first of these, three children with quadriplegic 
cerebral palsy underwent the injections and four weeks of serial casts bilaterally.  For 
each child, each arm was fitted with one of two “maintenance orthoses” which were 
worn for an average of 4 hours per day.  One arm was randomly assigned to receive a 
bivalved long arm cast while the other was fit with an elbow-wrist-hand orthosis with 
dynamic elbow extension assist joints.  The authors reported significant improvements 
in passive range of motion at the elbow following the injections and serials casts.  
However, these improvements were found to be temporary, with range of motion 
limitations returning as the injections wore off.  The losses in range of motion during 
the maintenance period were not as great with the arms treated with the orthosis.  
However, given the small sample size, statistical power for this finding was lacking5. 
 
In the second case series, authors retrospectively reported their observations of six 
children fitted with a similar, dynamic elbow extension assist orthosis.  Treatment 
protocols were poorly defined and reported.  Similarly, the data from this series are 
poorly presented and suggest only that there may be a small clinical benefit in 
increasing range of motion at the elbow with such devices, but that it is highly 
dependent on the compliance of the patients and their families in using the prescribed 
devices6. 
 
Conclusions and Recommendations: Upper limb 
 
The combined treatments of dynamic assist bracing and electrical stimulation appear 
to be effective in reducing upper extremity tone and improving dexterity and grip.  
However, the treatment effect has not been shown to endure once the modalities have 
been discontinued.  The use of dynamic extension assist joints at the elbow as an 
adjunct to serial casting has been reported.  Compliance with these bulky devices 
appears to impact their effectiveness. 
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WRIST/HAND 
 
As with other body segments, function at the wrist and hand in children with 
quadriplegic and hemiplegic cerebral palsy is adversely affected by spasticity.  Within 
this population, ulnar deviation, wrist flexion and thumb adduction posturing and 
contractures are commonly observed.  The use of various hand splints have been 
suggested to prevent progressive contracture of these spastic muscles and to assist in 
motor control functions such as grip, pinch and dexterity. 
 
Are there established benefits associated with the bracing of the wrist joint with 
static and/or dynamic splints in children with cerebral palsy? 
 
Case studies and anecdotal reports of subjective changes associated with various wrist 
and hand orthoses have not been uncommon1-6.  However, within the time parameters 
established for this review, there has only been a single clinical trial investigating the 
impact of wrist orthoses within this population7 (See Table 9). 
 
In this endeavor, ten children with hemiplegic cerebral palsy served as the 
experimental group while five age matched, non-affected children acted as controls.  
Grip strength, pinch strength, dexterity and surface EMG recordings at the muscles of 
the shoulder, elbow and wrist were recorded in three different conditions.  These 
included a no-splint condition, a static splint condition, in which a custom static wrist-
hand orthosis made in 15°-20° wrist extension was worn, and a dynamic splint 
condition in which a wrist-hand orthosis of spiral design was worn, fabricated in 15°-
20° wrist extension, but allowing 30° of wrist movement. 
 
Among the authors’ key findings were the following:  Children with hemiplegia 
demonstrated reduced grip, pinch and dexterity measures relative to controls.  
Children with CP demonstrated the greatest grip strength when wearing their dynamic 
splints.  In contrast, static wrist splints compromised grip strength relative to the 
unbraced condition.  The greatest values for lateral pinch were observed in the 
unbraced condition.  Dexterity improved in both braced conditions, with the greatest 
improvements in the dynamic splint condition.  Muscle activation was decreased in 
the static splint condition, suggesting a possible risk of disuse atrophy.  Muscle 
activity at the shoulder was increased relative to controls in the static and no-splint 
conditions, suggesting compensatory proximal joint activity.  In contrast, with 
dynamic splints, the muscle activity at the shoulder in children with CP was similar to 
that of controls. 
 
Conclusions and Recommendations: wrist/hand 
 
There appear to be trade-offs with the use of the various designs of wrist hand 
orthosis.  It appears as though dynamic splints might facilitate better function in tasks 
that require grip and dexterity.  However, splints may compromise pinch strength.  
While the use of static wrist-hand orthoses failed to suggest improvements in the 
functional outcomes studied, the trial did not evaluate the ability of such orthoses to 
prevent or delay contracture at the at-risk joints of the wrist and hand over time.  
While further inquiry is needed in this area, it would appear that decisions regarding 
the bracing of the wrist and hand should be made on a case by case basis, addressing 
the individual needs of each patient. 
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LYCRA GARMENTS 
 
The theory behind the use of Lycra garments in children with cerebral palsy lies in the 
close relationship between proximal stability and distal control.  Proponents of this 
intervention have suggested that such garments reduce tone in spastic muscles, 
decrease involuntary movement and improve trunk tone in children with postural 
hypotonia1. 
 
Are there established benefits with respect to upper extremity function 
associated with the use of Lycra garments in children with cerebral palsy? 
 
Are there established benefits associated with the use of Lycra garments with 
respect to lower limb function in children with Cerebral Palsy? 
 
There currently exists a small body of literature that has attempted to identify the 
potential benefits of the therapy, common deterrents to the therapy, and which 
populations may respond more positively to the therapy (See Tables 10 and 11).  
However, consensus conclusions are challenging to draw for several reasons.  
 
The types of lycra garments used vary greatly from study to study, including 
“UPsuits1,” “Camp lycra body suits2,” “Camp full body suits3,” “full suits, sleeved 
vests and gloves4,” “total body,” “shorts,” “gloves,” and “long-sleeved vests5,” and 
“second skin upper limb garments6.” Additionally, the outcome measures varied 
greatly across the various reports.  Nicholson et al and Edmonson et al reported on 
vaguely defined “functional improvements” and “positive and negative effects,” 
Nicholson et al  and Rennie et al reported on everyday functional abilities as assessed 
with the Pediatric Evaluation of Disability Inventory or PEDI7, Knox et al reported on 
gross motor abilities as assessed with the Gross Motor Function Measure or GMFM8 
and on function and movement quality of the upper limbs as assessed by the Quality 
of Upper Extremity Skills Test or QUEST9, and Corn et al reported on the quality of 
upper limb movement as determined using the Melbourne Assessment10. Finally, 
sample sizes were both generally small, ranging from 2 to24 subjects, and extremely 
heterogeneous, including subjects with athetosis, dystonia, ataxia, hypotonia and 
spasticity, as well as subjects with quadriplegia, diplegia and hemiplegia. Functional 
improvements, when identified, were consistently very small and largely offset by 
challenges with the devices, including difficulties with donning and doffing, excessive 
heat and restrictiveness, difficulties with toileting and incontinence and respiratory 
compromise.  Two of the three publications that reported on the usage of Lycra 
garments after the trials reported that only a single subject from each trial continued to 
use the modality4-5. 
 
Conclusions and Recommendations: Lycra 
 
The use of Lycra garments in the management of cerebral palsy appears to be of some 
benefit in individual cases.  Current literature suggests that hypotonic patients and 
patients with athetosis may derive the greatest benefit.  However, these benefits were 
often found to be comparatively small and were often offset by other detrimental 
effects of the devices. 
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JOHNSTONE PRESSURE SPLINTS 
 
Several decades ago, it was postulated that impulses from cutaneous receptors had a 
direct influence on motor neuron excitability1.  It has been suggested that the 
application of neutral heat and pressure decrease the excitability of thermal and tactile 
neurons, thereby decreasing the excitability of motor neurons. 
 
The application of these principles was first reported on clinical trials of adults with 
hemiplegia1-3.  Decreased spasticity values were reported in these early trials.   
 
Johnstone Pressure splints (JPS) have described as “transparent inflatable plastic 
pressure splints to support extremities in postures antagonistic to the spastic posture4 
(Kerem 01).”  It has been suggested that they are used to 1)  “stimulate proprioceptive 
and cutaneous receptors by application of deep pressure,” 2) “provide required support 
for extremity stabilization during exercise,” 3) “control combined motor patterns,” and 
4) “inhibit pathological reflexes.” 2,4. 
 
Are there established benefits associated with the use of Johnstone pressure 
splints in the management of children with cerebral palsy? 
 
There is a small body of literature which has investigated the efficacy of these splints 
in children with Cerebral Palsy (See Table 12).  The first of these was a randomized 
controlled trial in which thirty-four children with cerebral palsy underwent 3 months 
of physical therapy based on neurodevelopmental therapy (NDT).  Seventeen of these 
children served as a control group.  The remaining seventeen children, matched to the 
controls according to age and motor development levels, underwent the same physical 
therapy regimen, but with the addition of a defined set of JPS’s, applied bilaterally for 
20 minutes. 
 
At the conclusion of the treatment period, authors reported significant improvements 
in lower extremity range of motion (ROM) in both groups with the ROM 
improvements of the treatment group being significantly higher than those of the 
controls.  Further, while group means for spasticity values decreased in several tested 
muscles in the control group, these values decreased in all tested muscles in the 
treatment group.  Finally, sensory function, as evidenced by latencies in 
somatosensory evoked potentials (SEP), appeared to improve in both groups, with the 
improvements of the treatment group reported to be significantly higher than those of 
the control group4. 
 
The second trial compared the clinical benefits derived from the use of JPS compared 
to those observed with the use of Botulinum Toxin A (BTX) in the medial hamstrings 
and hip adductors5.  Both treatment groups received NDT exercises 3 times per week 
for 12 weeks.  Outcomes measures were collected for both groups at the beginning 
and end of the treatment period.  These included Gross Motor Function Measures, 
passive range of motion into hip abduction, modified Ashworth scale assessment of 
the spasticity in the hip adductors and the measured distance between the medial 
femoral condyles in maximum abduction.  Relative to group means, statistically 
significant increases were reported in all outcome measures in both treatment groups.  
However, those in the BTX groups were consistently superior to those in the JPS 
group. 
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Conclusions and Recommendations: Johnstone Pressure splints 
 
The use of JPS appears to have value as an adjunct to NDT physical therapy with 
respect to improvements in ROM, reduced spasticity and improved sensory function.  
However, because those benefits associated with JPS are only experienced during the 
comparatively brief treatment sessions themselves, these benefits do not appear to be 
as significant as those gained through the use of BTX injections. 
 
 
LIMITATIONS AND CONCLUSIONS 
 
The preceding review has a number of limitations which warrant further consideration.  
First of all, while the current literature provides some evidence regarding the efficacy 
of individual orthotic modalities on individual body segments, it provides little or no 
insight on the cumulative effect of multiple orthoses on the overall well being of the 
patient.  The pervasive nature of this pathology, often affecting the head, trunk and 
multiple extremities, is such that the use of orthoses across every joint could be 
rationalized.  Little has been done to elucidate a hierarchy of available benefits to 
provide guidance that might determine when the inconvenience, discomfort and/or 
expense of a given orthosis outweighs its benefits, particularly when multiple devices 
have already been prescribed or recommended.  Further investigation along these lines 
would assist patients, families and rehabilitation professionals in deciding just how 
much to intervene. 
 
Additionally, the modalities used in the management of persons with cerebral palsy 
continue to change.  Interventions such as Botulinum toxin injections, 
neurodevelopmental therapies and dorsal rhizotomies are used with increasing 
frequency and acceptance.  To the extent that these interventions alter the natural 
history of the pathology, they will impact the appropriateness of the various orthotic 
modalities.  The potential benefits of spinal orthoses following dorsal rhizotomy or the 
use of orthoses to augment the effect ot Botox injections are two such examples.  It is 
incumbent on the field at large to continue to recognize the effects of these 
rehabilitative modalities and the resultant implications and opportunities upon the field 
of orthotics.   
 
Cerebral palsy is a broad diagnosis, with varying levels of associated disability.  As 
such, recent attempts to further define subpopulations with respect to their needs and 
abilities, such as the Gross Motor Function Classification System and report upon the 
outcomes observed with a targeted modality upon various subpopulations has been 
highly informative.  Future research should continue to report on outcomes with 
respect to clearly defined subpopulations, as these will provide better clinical 
guidance.  Along these lines, continued investigation is needed to define which 
outcome measures are more appropriate in evaluating the various subpopulations. 
 
With respect to the orthotic management of the cerebral palsied patient, the clinical 
treatment plan should be based on the collective goals of the medical professionals, 
the family and the patient.  Such goals might include the prevention of initial or 
aggravated contracture, the facilitation of improved balance, and improved function of 
targeted extremities.  Close communication with other health care providers is 
necessary to ensure that the provided treatments are complimentary and consistent 
with the established goals.  An awareness of the limited findings of clinical trials to 
date can assist practitioners in recommending more affective orthotic approaches. 
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Table 1:  Do spinal orthoses improve posture, balance and/or associated control of the head, neck or extremities in children 
with cerebral palsy when compared to unbraced conditions? 
 
Author # of 
subjects 
Type of 
Orthosis 
Research Design Evidence 
Level 
Key Findings 
Letts M et al, 
1992 
55 (41)* “Soft Boston” 
TLSO 
Case Series, Convenience 
sample, Qualitative study 
(caregiver questionnaire) 
4 - improved head and trunk control 
- improved sitting stability 
- improved general appearance 
- improved patient handling 
Terjeson T et al, 
2000  
86 (57)** Custom molded 
polypropylene 
or polyethylene 
TSLO 
Case Series, Convenience 
sample, Qualitative study 
(caregiver interview) 
4 - improvement of sitting balance 
- better head/neck control 
- improved sitting function 
Verkerdy Z et al, 
2007 
42 TLSO with 
non-rigid SIDO 
frame*** 
Case Series, Convenience 
sample, Controlled before-
and-after trial, Qualitative 
study (family 
questionnaire) 
4 - improved feeding 
- improved trunk posture 
- improved head posture 
-  improved posture of the extremities 
* 55 patients with neuromuscular scoliosis a varying etiology, 41 patients with quadriplegic cerebral palsy 
** 86 patients in the case series, 57 of which were used to generate parent/caregiver feedback 
***  essentially a posterior TLSHO which allows flexion and limited rotation of the trunk 
 
Table 2:  Do spinal orthoses have a negative impact on respiratory function in children with cerebral palsy compared to 
unbraced conditions? 
 
Author # of 
subjects 
Research Design Protocols Evidence 
Level 
Key Findings 
Letts M et 
al, 1992 
36 (55)* Case Series, 
Convenience 
sample, Controlled 
before-and-after 
trial (A-B) 
- Oxygen saturation 
levels measured before 
and after orthosis 
application 
4 -  no appreciable differences in oxygen 
saturation levels before and after the 
application of the orthosis. 
Leopando M 
et al,  1999 
12 Case Series, 
Convenience 
sample, 
Controlled before-
and-after trial (A-B-
C) 
- Pulmonary mechanics 
of subjects were 
obtained in 3 postions 
- Sitting with TLSO 
- Sitting without TLSO 
- Supine without TLSO 
4 - no appreciable differences in pulmonary 
resistance, compliance, tidal volume, 
minute ventilation, work of breathing, 
oxygen saturation or end-tidal CO2 tension 
were measured with the subjects seated 
both with and without the orthosis and in 
the supine position without the orthosis. 
- Subjects tended to have an increased work 
of breathing when seated without the 
orthoses compared to the other two 
conditions. 
*55 subjects were treated with the soft Boston orthosis, in-brace oxygen saturation levels were only measured in 36. 
 
Table 3:  Do spinal orthoses prevent or delay curve progression compared to natural history in children with cerebral palsy? 
 
Author # of 
subjects 
Type of 
orthosis 
Research 
Design 
Evidence 
Level 
Key Findings 
Miller A et 
al, 1996 
21(43)* Wilmington, 
custom-
molded 
Cohort Study,  
Convenience 
sample 
(unmatched 
controls) 
2b - the use of the orthoses (mean duration = 67 
months) was found to have no statistically 
significant effect on curve magnitude or on the 
rate of curve progression relative to unbraced, 
unmatched controls. 
Olafsson  
Y et al, 
1999  
38(90)** Prefabricated 
Boston-type 
TLSO 
Case Series, 
Convenience 
sample 
4 - bracing was found to be successful (spinal curves 
failed to progress more than 10° during the 
observation period) in 9/37 (24%) patients with 
cerebral palsy. 
- success rates improve to 7/27 (26%) when patients 
with athetosis are excluded 
Terjesen T 
et al, 2000 
86 Custom 
molded 
polypropylene 
or 
polyethylene 
TSLO 
Cohort Study 
(retrospective), 
Convenience 
sample 
2b - in-brace curve progression rates were similar to 
reported natural history values (4.5°/year). 
- 16% of those subjects under the age of 15 had 
curve progression rates < 1°/year. 
- 64% of those subjects 15 y/o or older had curve 
progression rates < 1°/year. 
- neither the Cobb angle at initiation of bracing, 
scoliotic curve type nor degree of pelvic obliquity 
were predictive of successful bracing outcomes. 
- initial correction in the orthosis was found to 
significantly influence in brace curve progression 
rates. 
* Twenty one subjects were received TLSOs, twenty-two subjects served as controls 
** Ninety subjects with neuromuscular scoliosis, thirty-eight of which had spastic quadriplegia
 
Table 4:  Do hip orthoses prevent progressive hip subluxation compared to natural history in children with cerebral palsy? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Graham H 
et al, 2008 
47(91)* Randomized 
Controlled 
Trial 
- Treatment:  BTX injections to 
the adductor and medial 
hamstring muscles every six 
months for three years, 
SWASH hip orthosis 
prescribed, to be worn for 6 
hrs/day. 
- Control:  No BTX or orthosis 
1b - Progressive hip displacement observed in 
both groups. 
- Very slight reduction in displacement rates (-
1.4 % per year) was observed in the 
treatment group. 
- Clinical significance was considered 
questionable given the associated costs of 
treatment. 
* forty-seven subjects were treated with hip orthoses, forty-four additional children served as matched controls 
 
Table 5:  Do daytime hip orthoses improve gross and/or fine motor function in children with cerebral palsy compared to 
unbraced controls? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Boyd R 
et al, 
2001 
19(39)* Randomized 
Controlled 
Trial 
- Treatment:  BTX injections to the 
adductors and medial hamstrings 
every 6 months for one year, 
prescription of SWASH hip 
orthosis to be used 6-8 hours per 
day, regular physical therapy. 
- Control:  Regular physical therapy 
only, without BTX or hip orthosis 
1b - Both groups demonstrated 
improvements in total GMFM 
scores. 
- No additional treatment effects 
were found for the treatment 
group. 
- The GMFM may not have been 
sensitive to changes in the studied 
populations.  
* nineteen subjects were treated with the hip orthosis, twenty additional subjects served as controls
 
Table 6:  Do daytime orthoses increase muscle activity in hip adductors in children with cerebral palsy compared to unbraced 
muscle activity? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Embrey D 
et al, 2006 
10 Case Series, 
Controlled 
before-and-
after trial (A-B) 
- surface electromyography 
data collected from the hip 
adductor and hip abductor 
muscles during standing, 
walking and sitting, both 
with a without the use of the 
SWASH orthosis 
4 - No statistically significant differences 
were observed with and without the use 
of the SWASH orthosis relative to 
surface electromyography data obtained 
from the hip adductor and hip abductor 
muscles in either sitting, standing or 
walking conditions. 
 
 
Table 7:  Do the combined modalities of dynamic assist upper extremity orthoses and functional stimulation of antagonist 
muscle groups decrease upper limb spasticity and/or improve upper limb function in children with cerebral palsy relative to 
controls? 
 
Author 
 
# of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Shecker F 
et al, 
1999 
19 Case Series, 
Convenience 
sample, 
Interrupted 
time series 
trial (A-B-B-
B . . .) 
- Electrical stimulation: applied over the wrist 
and finger extensors and triceps 
- Dynamic orthosis: wrist/hand: static support 
in wrist extension (10° short of end range) 
with an adjustable pan splint which locked 
the PIP and DIP joints in extension while 
allowing dynamic extension of the MCP 
joints 
- Dynamic orthosis: elbow: forearm positioned 
in maximum supination, dynamic elbow 
extension assist joint. 
- Electrical Stimulation and Dynamic orthosis 
were used simultaneously for 1 hour/day 
- Static wrist/hand orthosis used at night to 
maintain ROM
4 - Universal improvements observed 
according to Zancolli’s  
classification of deformity, 
suggestive of improved wrist and 
finger function. 
Ozer K et 
al, 2006 
8(24)* Randomized 
controlled 
trial 
- Electrical stimulation:  as per Shecker et al. 
- Dynamic orthosis:  as per Shecker et al. 
- Group 1: Two 30-minute sessions of 
electrical stimulation to antagonist extensors 
per day.  Nocturnal static brace. 
- Group 2:  Two 30-minute sessions of 
dynamic bracing per day.  Nocturnal static 
brace. 
- Group 3:  Two 30-minutes sessions of 
electrical stimulation to antagonist extensors 
during concurrent use of dynamic bracing.  
Nocturnal static brace. 
1b - Group 3 demonstrated significant 
improvements in dexterity. 
- These improvements lasted only 1 
month post treatment 
- Group 3 demonstrated a steady 
increase in grip strength during 
treatment which subsequently 
declined post treatment 
- Group 3 demonstrated the greatest  
improvements in Zancolli’s 
classification system, but regressed to 
pretreatment values 3 months after 
treatment.
* Eight subjects were treated with the combined treatments, eight subjects were treated with electrical stimulation alone, eight additional 
subjects were treated with the dynamic orthosis alone.
 
Table 8:  Do dynamic assist upper extremity orthoses maintain upper extremity range of motion more effectively than static 
splinting modalities in the treatment of patients with cerebral palsy? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Yasukawa 
A et al, 
2003 
3 Cohort study - Pre-trial: BTX injections to 
biceps and brachioradialis 
bilaterally followed by 4 
sequential serial casts until gains 
in range of motion had 
plateaued.  Subjects fit with two 
types of “maintenance orthosis,” 
one on each arm, to be worn 4+ 
hours daily. 
- Bivalve long arm cast 
- Ultraflex dynamic elbow 
extension assist elbow wrist 
hand orthosis.  
2b - Increases gained in elbow range of 
motion were found to be temporary 
- As the BTX wore off, each subject 
had difficulty wearing either 
maintenance orthosis, requiring 
replacement bivalve casts and 
adjustments to the orthoses. 
- Ultraflex orthoses were found to 
maintain elbow ROM longer than the 
bivalve cast. 
- Subjects’ parents indicated a 
preference for the ultraflex orthosis 
over the bivalved cast. 
Yasukawa 
A et al, 
2008 
6 Case series, 
Convenience 
sample 
- Loosely defined:   
- subjects used a combination of 
oral baclofen, BTX injections 
or no medications 
- All subjects underwent serial 
casting at the wrist to improve 
ROM prior to the use of the 
orthosis 
- Orthoses were elbow-wrist-
hand orthoses with static wrist 
joints and dynamic elbow 
extension assist joints 
4 - Increases in passive range of motion 
in the upper extremity were 
correlated with compliance to the 
wearing scheduled of the orthosis. 
- Subjects and caregivers consistently 
reported that the brace was not used 
at night because the discomfort 
interfered with sleeping. 
 
 
Table 9:  Are there established benefits associated with the bracing of the wrist joint with static and/or dynamic splints in 
children with cerebral palsy? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Burtner 
et al, 
2008 
10(15)* Case Series, 
Convenience 
Sample, 
Controlled 
before-and-
after trial 
(A-B-C) 
- Data collected 
during grip, pinch 
and peg-board tests 
in each of 3 
conditions: 
- “static splint” 
immobilizing the 
wrist in 15°-20° 
wrist extension. 
- “dynamic splint” of 
spiral design, 
fabricated in 15°-
20° wrist extension, 
but allowing 30° of 
wrist movement 
- “no-splint” 
4 - children with hemiplegia demonstrated reduced grip, 
pinch and dexterity measures relative to controls. 
- children with CP demonstrate greater grip strength 
with dynamic splints. 
- static wrist splints compromised grip strength in 
children with CP compared to the unbraced 
condition. 
- the greatest values for lateral pinch were observed in 
the unbraced condition. 
- dexterity improved in both braced conditions, with 
the greatest improvements in the dynamic splint 
condition. 
- muscle activation is decreased in the static splint 
condition suggesting a possible risk of disuse 
atrophy 
- muscle activity at the shoulder was increased 
relative to controls in the static and no-splint 
conditions, suggesting compensatory proximal joint 
activity.   
- with dynamic splints, muscle activity at the shoulder 
in children with CP was similar to that of controls 
* Ten subjects with CP, five age matched control subjects 
 
Table 10.  Are there established benefits with respect to upper extremity function associated with the use of lycra garments in 
children with cerebral palsy? 
 
Author # of 
subjects 
Research Design Protocols Evidence 
Level 
Key Findings 
Blair et al, 
1995 
24 Case series, 
Convenience 
Sample, Interrupted 
time series trial (A-
B-A-B), Qualitative 
Study. 
- Subjects used the garments 
(UPsuits) according to the 
following schedule: 
- Weeks 1-3: without 
- Week 4: lycra introduced 
- Weeks 5-7: with lycra 
- Weeks 8-10: without 
- Weeks 11-16: with 
- Videos taken at the 
conclusion of weeks 3,7,10 
and 13 in the 
corresponding condition 
4 - Observers (parents, teachers therapists) tended to view the 
garments as having a positive effect on such dynamic 
functions as crawling, walking and both fine and gross 
motor function of the upper extremities. 
- Similar trends were reported with respect to static functions 
such as sitting, standing, the reduction of involuntary 
movement and maintaining an erect head posture. 
- Blinded video raters rated improvements in postural 
stability and the quality of upper-limb movement when 
subjects were wearing the lycra garments. 
- Researchers identified respiratory compromise and 
intractable peripheral cyanosis as medical contraindications 
for the lycra suits. 
Edmonson et 
al, 1999 
15 Case Series, 
Convenience 
Sample, Controlled 
before-and-after 
trial (A-B) as well 
as Qualitative 
Study 
- Lycra garments (body 
suits) worn for at least 
6hrs/day for 12 months. 
4 - All children showed some functional improvements 
according to the authors’ unspecified assessments of gross 
and fine motor function. 
- Parent responses were variable, citing both benefits and 
problems. 
- 7/15 subjects continued to use the suit after the trial. 
Nicholson et 
al, 2001 
12 Case Series, 
Convenience 
Sample, Controlled 
before-and-after 
trial (A-B) as well 
as Qualitative 
Study 
- Lycra garments worn for at 
least 6 hours/day for 6 
weeks. 
- Garments used included 
“full suit,” “sleeved vest” 
and/or gloves 
- PEDI assessments made at 
the beginning and the 
conclusion of the trial. 
- Five subjects were selected 
for motion analysis of the 
trunk and upper extremities 
8 weeks after receiving the 
garments. 
4 - All subjects made mild improvements according to the 
PEDI following the 6 week wear period. 
- Improved proximal stability was observed in 4/5 children 
receiving motion analysis. 
- Garments increased smoothness of movement in children 
with athetosis and ataxia, but made movements more jerky 
in subjects with spasticity. 
- All children had problems wearing the garments, including 
toileting difficulties and urinary incontinence. 
- The parents of only 1/12 subjects wanted to continue use of 
the garment. 
 
Table 10.  Are there established benefits with respect to upper extremity function associated with the use of lycra garments in 
children with cerebral palsy? (continued) 
 
Author # of 
subjects 
Research Design Protocols Evidence 
Level 
Key Findings 
Knox et al, 
2003 
8 Case series, 
Convenience 
sample,  Controlled 
before-and-after 
trial (A-B) as well 
as Qualitative 
Study. 
- Lycra garments (total body, 
shorts, gloves, and/or long-
sleeved vest) worn 4 
hrs/day for 4 weeks. 
- GMFM and QUEST 
outcomes assessed before 
and after the intervention. 
- Questionnaires completed 
by parents and subjects at 
the conclusion of the trial. 
4 - 3/8 subjects withdrew from the trial citing discomfort of the 
suit, restrictiveness and donning difficulties. 
- Of the 4 subjects who remained in the trial, all showed 
improvements in either GMFM (3/4) or QUEST (2/4). 
- Observed benefits included improved sitting balance, 
grasping of objects and self-feeding. 
- Perceived disadvantages included the time required to don 
and doff, the heat and restrictiveness of the garment and the 
reduction of certain functions. 
- 1/8 subjects wore a second garment once the originals were 
outgrown. 
Corn et al, 
2003 
2(4)* Case series, 
Convenience 
sample. Interrupted 
time series trial (B-
A) 
- Subjects with CP had worn 
“second skin” upper limb 
garments for at least 12 
months prior to the trial 
- Quality of upper limb 
movement established 
using the Melbourne 
Assessment. 
4 - No changes of statistical significance were seen between the 
two conditions. 
- Trends were towards reduced performance with the “second 
skin.” 
- Data collection for the 2 subjects was described as 
“problematic” due to compromisingly low assessment 
scores and required splint modifications. 
* Four subjects were included in the trial.  Only two of these were diagnosed with cerebral palsy. 
 
Table 11.  Are there established benefits associated with the use of lycra garments with respect to lower limb function in 
children with Cerebral Palsy? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Rennie DJ 7(8)* Case Series, 
Convenience 
Sample, 
Controlled 
before-and-
after trial (A-
B) as well as 
Qualitative 
Study 
- Lycra garments worn 
for at least 6 hours/day 
for 6 weeks. 
- Garments were full 
body suits, extending 
from the ankles to the 
neck and from the 
neck to the wrist 
joints. 
- PEDI assessments 
made at the beginning 
and the conclusion of 
the trial. 
- Subjects underwent 
motion analysis 8 
weeks apart with root 
mean square error 
(RMSE) values 
between trials used as 
a measure of proximal 
and distal joint 
stability. 
- Parents completed a 
questionnaire on 
practicality and 
compliance of using 
the garment. 
4 - 4/7 subjects showed reduced RMSE values at the 
pelvis with the lycra garments, suggestive of 
improved proximal stability. 
- 3/7 subjects showed reduced RMSE values at the 
hip, knee and ankle joints with the lycra garments, 
suggestive of improved distal stability. 
- With respect to proximal and distal stability, a 
subject with athetosis demonstrated the greatest 
improvements with the garments. 
- Other subjects demonstrated increased RMSE 
values with the garments, suggestive of 
compromised proximal and distal stability. 
- There were no statistically significant changes in 
RMSE before and after use of the garment. 
- 5/7 subjects improved in one aspect of the PEDI.  
- There were no significant changes in self-care, 
mobility, social function or the level of caregiver 
assistance required when the group was looked at as 
a whole. 
- Parents generally found the suits easy to don and no 
respiratory problems were reported. 
- 5/7 subjects experienced toileting difficulties. 
- The parents of 6/7 subjects indicated that they 
would not consider using lycra garments in the 
future, citing problems with toileting, excessive heat 
and discomfort.  The parents of the remaining 
subject were undecided. 
* Seven of the eight subjects in the study had cerebral palsy, a remaining subject had Duchenne muscular dystrophy.
 
Table 12.  Are there established benefits associated with the use of Johnstone pressure splints in the management of children 
with cerebral palsy? 
 
Author # of 
subjects 
Research 
Design 
Protocols Evidence 
Level 
Key Findings 
Kerem et 
al, 2001 
17(34)* Randomized 
Controlled 
Trial 
- Control: 
Neurodevelopmental 
Therapy, five days a 
week for three months. 
- Treatment:  As with 
controls with the 
additional use of 
various Johnstone 
pressure splints, 
applied bilaterally for 
20 minutes each 
session. 
1b - Significant improvements in lower extremity range 
of motion (ROM) were seen in both groups 
- ROM improvements of the treatment group were 
significantly higher than those of the controls 
- Group means for spasticity values decreased in 
several tested muscles in the control group and in 
all tested muscles in the treatment group. 
- Sensory function, as evidenced by latencies in 
somatosensory evoked potentials (SEP), appeared to 
improve in both groups. 
-  Improvements in SEP were significantly higher in 
the treatment group relative to those of the control 
group. 
Hazneci 
et al, 
2006 
21(43)** Randomized 
Controlled 
Trial 
- BTX treatment group: 
300 IU of Botox 
injected into adductors 
and medial 
hamstrings.  NDT 
exercises 3 days/week 
for 12 weeks  
- JPS treatment group:  
long leg JPS applied 3 
days/week during the 
same NDT exercises 
for 12 weeks. 
1b - At the conclusion of the treatment period, 
statistically significant improvements were seen in 
the group means of both treatment groups with 
respect to:  
- gross motor functions measurements (GMFM),  
- passive hip abductions ROM,  
- spasticity (as measured by the modified Ashworth 
scale) and  
- the measured distance between the medial femoral 
condyles in maximum abduction. 
- Improvements in the BTX groups were superior to 
those in the JPS group across all measured 
variables. 
* Seventeen subjects were treated with Johnstone pressure splints, seventeen other children served as controls 
** Twenty-one children were treated with Johnstone pressure splints, twenty-two others served as controls
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To produce this review, a systematic literature search was conducted for relevant 
articles published in the period between the date of the previous ISPO consensus 
conference report on cerebral palsy (1994) and April 2008. The search terms were 
“cerebral and pals* (palsy, palsies), “hemiplegia”, “diplegia”, “orthos*” (orthoses, 
orthosis) orthot* (orthotic, orthotics), brace or AFO. Papers were selected for review 
if they addressed the use of lower limb orthoses in cerebral palsy.  Papers relating to 
adult onset pathology were rejected. Papers relating to the direct application of hip 
orthoses were excluded as this area is addressed in a separate review on the effects of 
orthoses on the hips, spine and upper limbs. Abstracts were rejected if their content 
was subsequently located in full research papers. Only English language papers were 
included. Databases searched were EMBASE (ovid), Science Direct, social services 
abstracts, psychINFO, Medline (ovid), APAIS Heath (informit), AMI, Cinahl, 
PubMed, Recal, the NHS Scotland e-library and Google Scholar. The literature 
review on orthotic management of cerebral palsy by Morris  [1] was also consulted.  
 
The authors wish to acknowledge the assistance of Emily Ridgewell at the National 
Centre for Prosthetics and Orthotics, La Trobe University, Melbourne, Australia for 
conducting the literature search.  
 
As a result of reading and reviewing the literature, a number of questions were 
developed and answered according to the best available evidence. 
 
• Do lower limb orthoses influence the temporal and spatial parameters of gait? 
• What are the effects of orthoses on the ankle and foot? 
• What are the indirect effects of orthoses on the knee? 
• What are the effects of orthoses on the hip? 
• What are the effects of orthoses on the pelvis? 
• What effect do orthoses have on the metabolic and cardiopulmonary cost of 
walking? 
• What effect do orthoses have on muscle activity? 
• What effect do orthoses have on muscle length? 
• How do orthoses affect function and ability? 
• What are the benefits of tuning ankle-foot orthoses? 
• Can lower limb orthoses influence the upper limb? 
• What are the perceptions of users and parents regarding orthotic treatment? 
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A number of abbreviations are used in this review 
 
ADL  Activities of daily living 
AFO  Ankle-foot Orthosis 
BTA  Botulinum Toxin A 
CP  Cerebral Palsy 
DAFO  Dynamic AFO (AFO with tone reducing features) 
DST  Double Support Time 
EEI  Energy Efficiency Index 
EMG  Electromyography 
FRAFO Floor Reaction AFO (synonymous with GRAFO) 
GRAFO Ground Reaction AFO (synonymous with FRAFO) 
GRF  Ground Reaction Force 
GMAE Gross Motor Ability Estimator 
GMFCS Gross Motor Function Classification System 
GMFM Gross Motor Function Measure 
GMPM Gross Motor Performance Measure 
HAFO  Hinged AFO (also known as Articulated AFO) 
MAS  Modified Ashworth Scale 
PBS  Pediatric Balance Scale 
PCI  Physiological Cost Index 
PEDI  Pediatric Evaluation of Disability Inventory  
PLS  Posterior Leaf Spring AFO 
PODCI Pediatric Outcomes Data Collection Instrument  
ROM   Range of Motion 
SAFO  Solid AFO (or rigid AFO) 
SD  Standard Deviation 
SMO  Supramalleolar AFO 
SST  Single Support Time 
STS  Sit to Stand 
SWOC  Standardised Walking Obstacle Course 
VVG  Video Vector Generator 
 
 
Where appropriate, evidence from the reviewed scientific papers has been presented 
under separate headings reflecting the nature of the participants in the study in 
question. Studies that included a mixed cohort of subjects, irrespective of whether 
separate analysis was conducted, are included in the “mixed” section. 
 
 
DO LOWER LIMB ORTHOSES INFLUENCE THE TEMPORAL AND 
SPATIAL PARAMETERS OF GAIT? 
 
1. VELOCITY 
 
Mixed  
The majority of studies [2-7] conducted on mixed groups of subjects (i.e. hemiplegia 
and diplegia) reported an increase in velocity using a variety of AFOs, including 
SAFO, HAFO, PLS, DAFO, “standard polypropylene” and “wrap-around 
polyethylene”. In one study where velocity reportedly increased [4] the type of AFO 
was not described. The increase in velocity was statistically significant in most studies 
[2-4, 6]   but not in all [7]. While in one study [5] velocity increased in both 
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hemiplegic and diplegic subjects using SAFOs and DAFOs, the increase only reached 
statistical significance in the diplegic group.  This study was one of only two [3, 5] 
which classified subjects by their GMFCS level. The other study [3]  reported a 
statistically significant increase in all subjects with GMFCS I, II and III. Interestingly, 
this improvement was attributed to increased step length rather than cadence, which 
decreased slightly. One study [2] investigated the effect of Botulinum Toxin A (BTA) 
on the gait of predominantly spastic children whose velocity had increased when 
using PLS. No further increase was reported after BTA.  A single study [8] 
investigating the effects of DAFOs and SAFOs found no change in velocity. 
 
Hemiplegia 
The majority of studies investigating the effects of AFOs on velocity in hemiplegic 
subjects reported statistically significant increases using a variety of designs [9-14].  
Two studies [10, 11] reported a significant increase using HAFOs, while others found 
similar results using SAFOs [9, 12]. It is interesting to note that in the study by 
Brunner [12] velocity increased more when using a flexible AFO than using a SAFO. 
However, the authors report that with the SAFO the heel lost contact with the floor 
too early, suggesting inadequate tibial inclination in the orthosis, and a need for tuning 
(see Tuning AFOs for optimum function). It is also interesting to note that the 
“SAFOs” in the study by Thompson [9] were clearly not rigid. Increases in velocity 
have also been reported using PLS, Dual Carbon Fibre Spring AFO, and Orteam® 
AFO [13]. In one study [14] velocity increased significantly when using PLS and a 
Dual Carbon Fibre Spring AFO compared to the barefoot condition, but not compared 
to gait with shoes. A further study investigating the effects of HAFO, SAFO, PLS 
[15] found no significant change in velocity using orthoses when compared to 
barefoot gait. 
 
Diplegia  
Only one study [16] reported a significant increase in velocity in diplegic subjects 
using AFOs. This study investigated the effects of SAFOs, although as in the study by 
Thompson [9] the SAFOs were clearly not rigid. The majority of studies on diplegic 
children [17-24] reported no significant increases in velocity with a variety of AFO 
designs including SAFOs, SMOs, DAFOs, HAFOs and PLS. One of these studies 
[17] reported that gait with HAFOs was significantly slower in comparison to PLS. 
One study [25]  reported a decrease in velocity with AFOs although this was not 
statistically significant. A further study [21], found a decrease in velocity when 
comparing SAFOs with shoes only, although again this was not statistically 
significant. One abstract [24] reported increase in velocity in two children, who also 
used assistive devices for ambulation, being faster in SMOs than HAFOs.  
 
Conclusions 
The majority of investigations into the effect of orthoses on velocity in hemiplegic 
gait report significant increases using orthoses. By contrast, the evidence for orthoses 
increasing velocity in diplegic subjects is equivocal, with some studies showing little 
or no effect on velocity. There is some evidence that the use of shoes alone can 
increase velocity. It is therefore important that future research isolates the effect of 
orthoses from that of footwear.  
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2. CADENCE 
 
Mixed  
Most studies on mixed subjects [3, 5, 6, 8, 26] report a decrease in cadence using a 
variety of AFO designs, including SAFO, DAFO, HAFO, PLS, standard 
polypropylene and wrap around polyethylene. However only three of these studies [6, 
8, 26] found this decrease to be statistically significant in both the hemiplegic and 
diplegic subjects. While in the study by White [3] the decrease  in cadence for the 
complete group was statistically insignificant, subgroup analysis revealed statistically 
significant decrease for the subjects with GMFCS levels I and II. Subjects with 
GMFCS Level III actually showed a small but statistically insignificant increase. 
There was no difference in the decrease in cadence between patients using SAFO and 
HAFO. One study [5] found a statistically significant reduction in cadence only in the 
hemiplegic group (GMFCS level 1), with no reported decrease in the diplegic 
subjects, while another [4] reported no change in cadence at all.  A further study [27] 
investigated the effect of shoes alone on the gait of mixed subjects, reporting no 
significant change in cadence. A further statistically significant decrease in cadence 
was reported following BTA in patients described only as “predominantly spastic”, 
using PLS [2]. 
 
Hemiplegia 
A number of studies [9, 11-13, 15]  report a significant decrease in cadence in 
hemiplegic subjects when using varying designs of AFOs, including HAFO, SAFO, 
PLS, flexible AFO, Dual Carbon Fibre Spring AFO, and an Orteam® AFO. As 
previously noted, the SAFOs in the study by Thompson [9] were clearly not rigid. In 
the study by Brunner [12] cadence decreased more with a SAFO than a with a flexible 
AFO, however the early heel rise observed with the SAFO may be indicative of 
inadequate tibial inclination. One study [14] reported a significant reduction in 
cadence when walking with shoes only in comparison to barefoot. Further non-
significant reduction was observed using PLS and Dual Carbon Fibre Spring AFO 
compared to shoes only. It is also interesting to note that in this study. One study [10] 
reported no significant change in cadence with HAFO use. 
 
Diplegia  
Most studies into the effects of HAFO, SAFO, PLS, DAFO and SMO on cadence in 
diplegic subjects report no significant effect [16, 18-23]. Although Abel [16] found no 
change in cadence using SAFOs, it should be noted that the SAFOs in question could 
not truly be regarded as solid ankle design, as some dorsiflexion was allowed by 
buckling. However, statistically significant reduction in cadence was reported by 
Buckon [17] using HAFO, SAFO and PLS.  Investigating the effect of SAFOs and 
SMOs vs. Shoes, Carlson [18] found the only significant difference was between 
shoes and SMOs. 
 
Conclusions 
The majority of studies that investigated the effect of orthoses on cadence in subjects 
with hemiplegia reported significant reductions when using a variety of AFOs. 
However, as with the findings relating to velocity, the effects of orthotic intervention 
on cadence in diplegia are more equivocal. While two studies on diplegic subjects 
reported reduction in cadence using orthoses, the majority found no effect. There is 
some suggestion that the use of shoes alone has a beneficial effect on cadence. It is 
therefore important that future research isolates the effect of the orthosis from that of 
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the footwear. There a suggestion that the use of BTA may further improve the effects 
of AFOs on cadence.  
 
3. STEP LENGTH 
 
Mixed 
The majority of papers [2, 3, 5, 6, 28] investigating the effects of AFOs on step length 
in mixed groups of hemiplegic and diplegic subjects report statistically significant 
increases using a variety of orthoses (HAFO, SAFO, PLS, SMO, standard 
polypropylene and wrap-around polyethylene). It should be noted that in the studies 
by White [3] and Hayek [5] there was a statistically significant increase on both sides 
in the hemiplegic group, although the gait remained asymmetrical. De Groot [27] 
investigated the effect of shoes alone on gait. While no details of the footwear 
characteristics are reported, step length increased with the shoes only intervention. 
Huenaerts [2] investigated the effect of PLS before and after BTA in participants 
described only as “predominantly spastic”. While the PLS alone increased step length, 
further increase was observed after the BTA. 
 
Hemiplegia 
All studies into the effect of orthoses on step length in hemiplegic subjects reported 
statistically significant increases [9, 11-15, 29]. These improvements were noted using 
HAFO, SAFO, DAFO, PLS, flexible AFO, Dual Carbon Fibre Spring AFO, and 
Orteam® AFO. It should be noted that the SAFOs used in the study by Thompson [9] 
were not rigid. In the study by Brunner [12] step length increased more when using a 
flexible AFO than using a SAFO. As previously observed, the early heel rise seen 
with the SAFO may suggest inadequate tibial inclination in the orthosis, and a need 
for tuning.  
 
Diplegia 
Buckon [17] described a trial investigating the effects of HAFOs, SAFOs and PLS on 
diplegic gait, reporting that step length increased with all orthoses (p<0.005). 
 
Conclusions 
The use of AFOs has been demonstrated to increase step length in both hemiplegic 
and diplegic subjects. Some of this effect may be due to the wearing of shoes, which 
have also been demonstrated to increase step length when used without orthoses. 
 
4. STRIDE LENGTH  
 
Mixed  
All studies into the effect of AFOs on stride length conducted on mixed groups of 
hemiplegic and diplegic subjects report statistically significant increases [3-5, 26, 30]. 
Improvements were noted using SAFO, HAFO, DAFO, PLS, standard polypropylene, 
wrap around polyethylene and Klenzak AFOs. In the study by White [3] each of the 
subgroups investigated (SAFO, HAFO, hemiplegia, diplegia, GMFCS levels I, II, and 
III) showed statistically significant improvement. De Groot [27] investigated the 
effect of shoes alone on mixed subjects, reporting statistically significant increase in 
stride length simply by wearing shoes. 
 
Hemiplegia  
Statistically significant increases in stride length were reported in all studies 
investigating the effects of AFOs on subjects with hemiplegia [10-12, 15, 29]. 
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Orthoses used included SAFO, HAFO, DAFO, PLS, and flexible AFO. In the study 
by Brunner [12] the same test orthosis was used in both trials, the SAFO having had 
its flexibility increased by removal of an anterior wedge of material. While both 
orthoses increased stride length, the increase was more pronounced in the flexible 
orthosis. This might suggest that the SAFO was inadequately inclined, and needed 
tuning (while the authors stated that equinus was accepted in cases where dorsiflexion 
was limited, they did not make it clear whether any wedging was added to the SAFOs 
to compensate for this). Additionally, the use of flexible AFOs (or free-dorsiflexion 
HAFOs) in the presence of a plantarflexion contracture is contraindicated, making the 
results questionable. 
 
Diplegia  
 Statistically significant improvement in stride length was reported in a number of 
studies [16-19, 23, 31] using SAFO, HAFO, PLS, SMO and DAFO. In the study by 
Buckon [17] the SAFOs investigated were clearly not rigid and allowed some 
dorsiflexion as they deflected. The study by Rethlefsen [20] investigating the effects 
of SAFO and HAHO reported no change in stride length. Smiley [21] investigated the 
effects of SAFOs, HAFOs and PLS on the gait of children with spastic diplegia. 
While stride was slightly increased in the HAFOs and the PLS, it was slightly reduced 
in the SAFOs, possibly because of inadequate tibial inclination in the orthosis. None 
of the differences in stride length were significant. Kornhaber [24] investigated the 
effects of SMOs and HAFOs on spastic diplegic gait finding  increase in stride length  
only in those who wore SMOs and used assistive devices for ambulation. Crenshaw 
[32] investigated the effects of tone reducing features on the gait of diplegic children. 
Subjects were tested wearing shoes only, a HAFO, a HAFO with tone-reducing 
features, and a SMO with tone-reducing features. Increase in stride length was only 
significant in the tone reducing HAFO.  
 
Conclusions 
The majority of papers that investigated the effect of orthoses on stride length 
reported improvement as a result of various types of AFO intervention. In a few cases 
the results using SAFOs were not as good as using AFOs that allowed dorsiflexion. 
This may indicate that the SAFO is resisting tibial advancement at too early a stage in 
stance, adversely affecting stride length. When using a stiff AFO, the issue of tuning 
the orthosis is very important, if unacceptable resistance to tibial progression is to be 
avoided. It is of interest that the SAFOs that were somewhat flexible produced results 
comparable to HAFOs or PLS, although such buckling should be considered 
undesirable as it will compromise triplanar control of the foot. 
 
5. SINGLE SUPPORT 
 
Mixed 
White [3] reported statistically significant increase in single support time (SST) in a 
mixed group of patients using four AFO variations (SAFO, HAFO, standard 
polypropylene and wrap around polyethylene). All of the subgroups (SAFO, HAFO, 
hemiplegia, diplegia, GMFCS I or II, and GMFCS III) showed statistically significant 
increase in SST. The more involved subgroups (i.e. those with diplegia and those with 
GMFCS level III) demonstrated greater improvement. Interestingly, in the hemiplegic 
group, the affected and unaffected leg demonstrated the same increase in SST. 
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Hemiplegia 
Balaban [10] reported improvement in SST using a HAFO when treating hemiplegic 
subjects. Brunner [12] investigated the effect of SAFO and a flexible AFO (this was 
the SAFO with an anterior wedge removed) reporting that the SAFO significantly 
increased SST, but there was no change with the flexible AFO. Romkes [11] found no 
significant change in SST using a HAFO.  
 
Diplegia  
Abel [16] improved SST using SAFOs (although the AFOs buckled under load).  
 
Conclusions 
The duration of single support appears to be increased in both hemiplegic and diplegic 
subjects by the use of a variety of AFO designs. 
 
 
6. DOUBLE SUPPORT 
 
Mixed  
Hayek [5] compared SAFOs and HAFOs to barefoot in a mixed group of subjects 
who were examined in the orthosis they habitually used, rather than being fitted with 
both types of AFO. Double support time (DST) decreased in the diplegic group, while 
in the hemiplegic group, the number of patients achieving symmetry in the initial 
double support period of the gait cycle increased with AFO use.  
 
Hemiplegia 
While Romkes [11] found no significant change in DST in hemiplegic subjects using 
a HAFO, Balaban [10] reported significant decrease in DST with a HAFO on a 
similar patient group. Surprisingly, Brunner [12] reported an increase in double 
support time with a SAFO and a flexible AFO (SAFO > flexible FAFO). An 
explanation for this unexpected increase may lie in the fact that while an equinus 
position in the AFOs was accepted where dorsiflexion was limited, it is unclear 
whether any wedging was added to the SAFOs to compensate for this. Additionally, 
the presence of a plantarflexion contracture should be regarded as a contraindication 
to the use of flexible AFO allowing dorsiflexion.  
 
Diplegia 
Abel [16] reported that DST was decreased in diplegic subjects using a SAFO, 
although the orthosis in question allowed dorsiflexion by buckling. Rethlefsen [20] 
reported that DST was significantly longer using HAFOs than in SAFOs or shoes 
alone. 
 
Conclusions  
What little evidence there is appears to support the hypothesis that orthoses, 
particularly SAFOs can reduce DST, but suggests that to do so they must be well 
aligned.  
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CONCLUSIONS RELATING TO ALL TEMPORAL AND SPATIAL 
PARAMETERS 
 
In general, the available evidence suggests that orthoses can have positive effects on 
all temporal and spatial parameters of gait, i.e. velocity, cadence, step length, stride 
length, single and double support.  
 
 
WHAT ARE THE EFFECTS OF ORTHOSES ON THE ANKLE AND FOOT? 
 
1. ANKLE KINETICS 
 
Mixed 
Ounpuu [33] found that the peak power-generating capabilities of the ankle were 
reduced when wearing a PLS, finding that more mechanical energy was absorbed 
during midstance and less produced during terminal stance. The authors concluded 
that while the PLS improved ankle function, it did not store mechanical energy, or 
return this in the propulsive phase of gait. Molenaers [6] also reported that ankle 
power at push-off was decreased with PLS use. Kirkeide [8] reported a significant 
decrease in forefoot force with DAFOs compared to barefoot, but a significant 
increase with a SAFO compared to shoes. Molenaers [34] investigated the effect of 
BTA combined with orthotic management and short leg casting, reporting an increase 
in power generation at ankle at push-off with all regimes. 
 
Hemiplegia 
Balaban [10] reported a significant decrease in ankle power in stance with a HAFO. 
Buckon [15] investigated the effects of a HAFO, a SAFO and a PLS, reporting 
significant decrease in power with all orthoses. Desloovere [14] investigated push-off 
using “identically tuned” PLS and dual carbon fibre spring AFO. The dual carbon 
fibre spring AFO allowed significantly better power generation in pre-swing while the 
PLS significantly improved power absorption in loading response.  Romkes [29] 
reported significant reduction in power absorption with a HAFO and a DAFO, but no 
change in power generation.      
 
Diplegia 
Hassani [35] compared HAFOs and DAFOs to barefoot, finding that both orthoses 
produced significant differences in peak ankle plantarflexion moment, but no 
significant difference in power. Crenshaw [32] investigated the effects of HAFOs, 
HAFOs with tone reducing features and SMOs.  Both HAFO variants increased 
plantar flexion moments when compared to SMO and shoes only. Ankle power 
absorption was increased significantly only with HAFOs, while greatest power was 
generated with shoes only. Radtka [19] found significant differences in pre-swing 
peak ankle power between no orthosis and SAFOs and between HAFOs and SAFOs. 
Peak ankle power was reduced by SAFOs, while using HAFOs it remained similar to 
that with no orthosis. Rethlefsen [20] also reported lower power generation with 
SAFOs compared to HAFOs. Chambers [36] reported that “standard AFOs” resulted 
in significant reduction in power generation at push-off due to reduced plantar flexion, 
and that using DAFOs with contoured footplates allowed ankle power generation that 
was similar to shoes only. Carlson [18] found that neither SAFOs or SMOs increased 
ankle power at push-off, although only the SAFOs improved propulsive moments. 
Abel [16] found that SAFOs significantly reduced ankle power, an effect which would 
have presumably been greater had the SAFOs not buckled. Lam [23] found that both 
 242          © International Society for Prosthetics & Orthotics 
SAFOs and DAFOs improved maximum plantar flexion moment in comparison to 
barefoot, with SAFOs enabling generation of a significantly higher 2nd peak of the 
GRF. Investigating the effects of  HAFOs, SAFOs and PLS, Buckon [17] reported 
that power generation in stance decreased significantly, with the greatest decrease 
seen in the SAFO, and least in the PLS. The timing of peak power generation also 
changed significantly, being later and closer to normal in all three AFO configurations 
compared with barefoot. Power absorption, showed slight change towards normal, 
particularly with the SAFO but this was not significant. Bennett [37] investigated the 
effect of “AFOs” on mechanical energy recovery, reporting a significant increase in 
peak push-off moments. 
 
Conclusions 
Orthoses that restrict ankle joint motion have been demonstrated to reduce power 
generation and absorption at the ankle. This reduction in power is inevitable, and the 
value of this finding is of questionable clinical value. There is a suggestion that 
carbon fibre construction may improve power generation without sacrificing control 
of unacceptable ankle kinematics. Further research is required to properly investigate 
this. Loss of power generation with some orthoses may be an acceptable compromise 
in order to optimise other parameters of gait. SAFOs may improve ankle joint 
moments in the propulsive phase of gait and help increase the 2nd peak of the ground 
reaction force in late stance.  
 
2. ANKLE KINEMATICS 
 
Mixed 
Investigating the effect of PLS Ounpuu [33] reported a statistically significant 
improvement in ankle dorsiflexion in both swing and end stance. Molenaers [6] also 
reported improvements in ankle position throughout stance with PLS. Radtka [26] 
significantly reduced plantarflexion using SAFOs and DAFOs with plantarflexion 
stop. Kirkeide [8] found that SAFOs and DAFOs significantly reduced ankle 
excursion and timing. Heel contact time was significantly increased by both orthoses 
when compared to barefoot, with the greater effect seen in DAFOs, which also 
produced plantar dynamics closest to normal. Hayek [5] reported significant 
improvements in dorsiflexion in swing and at initial contact using SAFOs and 
HAFOs,  with the type of AFO having borderline significance. There were no 
significant changes to loading response with either orthosis. Hainsworth [38] also 
found that SAFOs and HAFOs with 900plantarflexion stop improved ankle 
kinematics. Hobbs [28] compared the effects of SAFOs, HAFOs and SMOs, reporting 
that HAFOs and SMOs demonstrated “improved” dorsiflexion at terminal stance. 
Desloovere [30]  found that Klenzack AFOs, SAFOs, HAFOs and PLS led to more 
dorsiflexion at initial contact and less plantarflexion at push-off.   
 
Hemiplegia 
Balaban [10] and Romkes [11] reported significant correction of equinus using a 
HAFO, as did Thompson [9] using a SAFO. Buckon [15] investigated the effects of a 
HAFO, a SAFO and a PLS finding that ankle dorsiflexion at initial contact was 
significantly increased in all AFOs compared to barefoot, with greatest improvement 
noted in the HAFO, and least in the PLS, whereas one might have expected this from 
the SAFO. The authors acknowledged that the SAFOs deformed into dorsiflexion in 
almost all cases, which may infer that plantarflexion could also have been occurring. 
Peak stance dorsiflexion was significantly increased in all AFO configurations 
compared to barefoot, particularly the HAFO. Ankle dynamic range was significantly 
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decreased in all orthoses, and was understandably significantly less in the SAFO. 
Improvements in ankle dorsiflexion with the knee extended of the order of 20 were 
noted only in the HAFO and the PLS, leading the authors to conclude that “this 
refutes claims that stretch of plantarflexors increases spasticity”. It is questionable 
whether a change of 20 is clinically significant. Brunner [12] reinstated heel-toe 
pattern with both a SAFO and a flexible AFO. The reported early heel rise suggests 
that the SAFO may have benefitted from tuning.  It is also interesting to note that the 
flexible AFO and the SAFO allowed almost the full range of functional dorsiflexion. 
Van Gestel [13] improved dorsiflexion angle at initial contact with a PLS, a Dual 
Carbon Fibre Spring AFO, and an Orteam® AFO, although only the improvement 
with the Carbon Fibre orthosis was significant. The carbon fibre spring orthosis 
reportedly produced the most physiological 3rd rocker. Excessive stance phase 
dorsiflexion of the ankle was noted in both the PLS and Orteam® AFO, suggesting 
inadequate resistance to dorsiflexion, despite the reported tuning. Dorsiflexion was 
also considered excessive in swing in these two devices, possibly suggesting poor 
alignment. Desloovere [14] significantly improved 1st and 2nd ankle rocker and foot 
clearance in swing using a PLS and a dual carbon fibre spring orthosis. The dual 
carbon fibre spring orthosis allowed better ankle motion during push off, and 
significantly increased ankle angular velocity in prewsing, while the PLS significantly 
improved power absorption at loading response and produced a slightly more normal 
ankle moment. Significant improvement in ankle range of motion and ankle angular 
velocity was also reported with shoes only. Romkes [29] found that both a HAFO and 
a DAFO significantly increased dorsiflexion at initial contact and peak dorsiflexion, 
with the HAFO (which unlike the DAFO had a plantarflexion stop) producing a more 
normal ankle angle.   
 
Diplegia 
Abel [16] significantly improved ankle excursion with a SAFO, while acknowledging 
that the “SAFOs” were actually designed to allow dorsiflexion by buckling. Lucareli 
[39] reviewed the effect of hinged FRAFOs, reporting significant reductions in ankle 
dorsiflexion in those with maximum stance knee extension greater than 150. 
Rethlefsen [20] reported increased dorsiflexion at initial contact and terminal stance 
using both SAFOs and HAFOs, with terminal stance dorsiflexion greatest in HAFOs. 
Interestingly this was reported to be greater than the amount of passive dorsiflexion 
available, leading the authors to conclude that this additional dorsiflexion may be 
allowing a stretch to the triceps surae. An alternative interpretation is that the 
additional dorsiflexion used up gastrocnemius length at the expense of knee 
extension, which was reportedly slightly less in the HAFOs. Some of the subjects in 
SAFOs exhibited considerable hyperextension of the knee at terminal stance, 
suggesting inadequate tibial progression and a need for tuning. Radtka [19] also 
compared SAFOs and HAFOs, finding that both reduced excessive plantarflexion 
throughout stance. Again, dorsiflexion at terminal stance was greater in the HAFOs 
compared to SAFOs. 
 
Buckon [17] significantly improved dorsiflexion at initial contact and swing using  
SAFOs, HAFOs and PLS,  while dynamic ankle range significantly decreased. The 
increase in peak stance dorsiflexion was greater in HAFOs than SAFOs. Using the 
same orthoses, Smiley [21] found that all designs appeared to produce an abnormal 
amount of dorsiflexion across the gait cycle. Hassani [35] found that compared to 
barefoot, both HAFOs and DAFOs produced significant differences in peak stance 
dorsiflexion, and peak swing plantarflexion, with no statistical significant differences 
between the two designs. Carlson [18] found that compared to shoes only, equinus 
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was improved by SAFOs but not by SMOs. Lam [23] found that SAFOs and DAFOs 
both significantly improved ankle position and peak mean stance dorsiflexion, while 
reducing plantar flexion at push off and overall ankle ROM. Crenshaw [32] reported 
that both HAFOs and tone reducing HAFOs significantly reduced plantarflexion at 
heel strike and toe-off compared to shoes only and SMOs.  
 
Chambers [36] found that DAFOs with contoured footplates and “standard” restricted 
ankle motion during walking, reporting a tendency towards “toe-in” with both 
designs. All subjects in this study had equino-valgus foot deformity, correction of 
which would be expected to internally rotate (adduct) the mid tarsal joint, potentially 
highlighting more proximal transverse plane abnormalities. By contrast,  Dole [40] 
reported a significant reduction in the angle of toe-in using HAFOs. 
 
Conclusions 
It is fairly clear that AFOs of different designs can impact positively on ankle 
kinematics. Solid ankle designs or those with plantarflexion stops are best at 
preventing equinus. Excessive dorsiflexion, as seen in crouch gait, is best addressed 
with SAFOs or AFOs with dorsiflexion stops. The increases in late stance 
dorsiflexion that have been reported using HAFOs should be considered in the context 
of gastrocnemius length and the possible adverse effect on knee and hip kinematics in 
late stance, if dorsiflexion is allowed to occur when this muscle is short.  
 
3. EFFECT OF ORTHOSES ON FOOT ALIGNMENT 
 
Only one study [41] was identified that addressed the important issue of the ability of 
AFOs to influence foot and ankle alignment.  X-rays and quantitative segmental 
analysis were used to investigate the effect of AFOs on mixed triplanar foot 
deformities in a mixed group of ambulant children. AFO designs investigated in this 
study included SAFO, PLS, HAFO and GRAFO. While the study showed statistically 
significant changes in all measurements of segmental alignment, the authors 
concluded that as the actual changes were small (<100) they were clinically 
insignificant, and that AFOs had failed to improve static foot alignment in the 
majority of feet. Correction was most successful in the pronated (valgus) foot, 
possibly due to the greater flexibility commonly associated with this type of 
deformity. It is possible that the age of subjects may have adversely affected the 
results, as some subjects were skeletally quite mature (up to 18 years old). 
 
Conclusions 
It is difficult to draw conclusions from the little evidence that exists for orthotic effect 
on foot alignment.  While statistically significant improvements in foot alignment 
have been reported, the suggestion that corrections of the order of up to 100 are 
clinically insignificant is perhaps open to question. Control of alignment in the 
growing child is critical if progression to skeletal deformity of the foot is to be 
resisted. More research is required in this area, particularly on the feet of those who 
have yet to develop fixed deformities.  
 
WHAT ARE THE INDIRECT EFFECTS OF ORTHOSES ON THE KNEE? 
 
Mixed  
Hayek [5] investigated the effect of SAFOs and HAFOs reporting significant 
reduction in knee flexion at initial contact in the hemiplegic group, but no change in 
the diplegic group. Surprisingly, neither orthosis had any significant effect on knee 
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kinematics in loading response, single support or swing phase, raising questions about 
the alignment and design characteristics of the orthoses. Desloovere [30] analysed the 
effects of Klenzack AFOs, SAFOs, HAFOs and PLS on gait. Compared to barefoot, 
AFO use significantly increased knee flexion during loading response, with SAFOs 
producing a more pronounced knee extension moment during stance. Lampe [42] 
studied the influence of orthopaedic shoes, insoles, DAFOs, ring orthoses and AFOs 
on the kinetics and kinematics of gait in a mixed group of 18 children including some 
with CP. Barefoot, one child with diplegia had a 150 knee extension deficit throughout 
stance, which increased to 250 using orthopaedic shoes. Duration of knee joint 
extension was also increased markedly by these shoes, while extension moment in 
initial stance decreased slightly. The use of a shoe with an orthotic insole, compared 
to barefoot, resulted in improved knee extension in early stance phase in one 
hemiplegic child. Use of an AFO in a diplegic child improved knee extension and 
knee stability in stance and increased swing knee flexion.  
 
Molenaers [34] investigated the effect of BTA combined with short leg casting and 
orthotic management. All children, except those who already had casting prior to 
BTA, demonstrated improved stance knee kinematics post BTA. Huenaerts [2] 
investigated the effects of a PLS before and after BTA. Although the appropriateness 
of using PLS in the presence of spasticity may be questionable, the PLS after BTA 
improved knee kinematics compared to barefoot walking. However, knee kinetics 
with the PLS after BTA showed that the alignment of the ground reaction force to the 
knee was not always appropriate, suggesting that retuning of AFOs is of major 
importance after BTA. 
 
Hemiplegia 
Balaban [10] reported significant reduction in knee flexion at initial contact using a 
HAFO, but no significant change in maximum stance knee extension or peak swing 
knee flexion. Romkes [29] also reported no improvement in knee hyperextension 
using a HAFO, although timing of peak knee extension was significantly delayed by 
both a HAFO and a DAFO. Peak knee flexion was also significantly improved with 
both orthoses. Romkes [11] reported that a HAFO improved loading response knee 
kinematics and led to more dynamic knee movement, and creation of a flexion-
extension pattern, suggesting that these findings might be the result of the increased 
walking speed. Brunner [12] found that a SAFO reduced maximum knee extension 
(compared to barefoot) and reduced the knee range of motion throughout gait, 
whereas a flexible AFO had only a slight influence on the knee. Buckon [15] reported 
greater improvement in knee hyperextension with a HAFO than with a SAFO, which  
is surprising as the orthoses were made from the same plaster model. However, it was 
acknowledged that most SAFOs deformed into dorsiflexion, so it is possible that they 
also deformed into plantarflexion, compromising knee hyperextension control. 
Jagadamma [43] investigated the effect on knee joint kinetics and kinematics of 
incrementally wedging a SAFO. Neither the SAFO nor was the footwear was 
adequately described, both of which influence outcomes. For the child in this study, a 
130 angle of tibial inclination (achieved using an 80 wedge) produced optimal knee 
alignment. Desloovere [14] reported that compared to barefoot, both a PLS and a dual 
carbon fibre spring AFO significantly improved knee shock absorption and maximum 
stance knee flexion, and changed the amount and timing of maximum swing knee 
flexion. Compared to shoes however, maximum knee flexion and timing of peak 
swing knee flexion were unchanged, although maximum knee flexion in stance 
remained significantly higher. The PLS was also significantly associated with 
minimal knee hyperextension. Although both orthoses significantly increased knee 
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flexion velocity at toe-off, this effect was considerably greater with the PLS, perhaps 
indicating inadequate resistance to tibial progression. Van Gestel [13] reported 
decrease in maximum stance knee extension in using a PLS and an Orteam®AFO, 
whereas a Dual Carbon Fibre Spring AFO actually encouraged hyperextension, 
suggesting that the carbon fibre orthosis was not optimally tuned.  Knee velocity in 
swing was also increased in all orthoses, as was peak knee flexion, and knee shock 
absorption. Maximal knee flexion was decreased, but remained higher than normal. 
Desloovere [14] found that using shoes only (compared to barefoot) led to significant 
changes in knee motion, increasing knee shock absorption, flexion in swing and 
maximal knee extension in stance. 
 
Diplegia 
Abel [16] (1998) reported significant improvement in knee excursion using a SAFO, 
but found that the effect on the knee in stance was not significant, perhaps due to the 
fact that the SAFO was clearly not rigid. Farmer [44] used SAFOs as part of a 
programme of targeted training for crouch posture. Using SAFOs to support the lower 
legs in an inclined alignment on a sprung “wobble board” the interaction between the 
hip and knee flexors and extensors was enhanced by throwing and catching a ball. 
After three months the angle of tibial inclination was reduced, and a 100 reduction in 
knee flexion reported at six months. It is interesting that improved control of standing 
was demonstrated prior to measurable increase in hamstring length, challenging the 
view that muscle length must be gained as a precursor to improving control. Further 
research is required to investigate this effect. Wesdock [45] investigated the effect of 
900 SAFOs on patients with crouch gait. The orthoses were used with shoes alone and 
also following the addition of heel wedges. No significant improvements were made 
in knee extension using these interventions. Possible reasons for this include poor foot 
progression angle in approximately half of the subjects, and gastrocnemius shortening 
which was not accommodated in the SAFOs. Proximal muscle weakness and/or 
spasticity were also suggested as possible factors, with the authors noting that the 
amount of knee flexion demonstrated by all subjects exceeded the amount of 
contracture measured at the knee. The wedge was the only footwear modification, 
with no attempt made to interrupt anatomical 3rd rocker by stiffening the sole of the 
shoes. There was no mention of SAFO stiffness, another critical factor. The fact that 
the addition of wedges made no difference to knee extension is perhaps not surprising, 
as the effect of adding wedges when the heel is off the ground is to realign the GRF 
posteriorly, actually reducing the knee extension moment. Lucareli [39] reported  
significant reduction of knee flexion hinged FRAFOs (with dorsiflexion stop) 
particularly in the more involved subjects. Rethlefsen [20] reported no significant 
differences in knee kinematics between SAFOs and HAFOs. It is, however, 
interesting to consider whether the greater angle of terminal stance knee flexion seen 
in the HAFO was linked to the observation that dorsiflexion in the HAFO at this stage 
of gait exceeded the passive range recorded in the gastrocnemius. Ankle dorsiflexion 
in the absence of adequate gastrocnemius length will limit knee extension. Also of 
interest is the observation that some subjects in the SAFO exhibited considerable 
hyperextension of the knee at this stage, suggesting inadequate tibial progression and 
a need for the SAFOs to be tuned. Radtka [19] also found that excessive knee flexion 
in barefoot stance was unchanged with either HAFOs or SAFOs, nor were knee 
moments in stance. The authors concluded that the concerns expressed by some 
clinicians regarding the possibility of increased knee flexion in crouched gait resulting 
from using HAFOs, rather than SAFOs were unsubstantiated. However, had the 
SAFOs blocked ankle dorsiflexion as intended, the external knee extension moments 
generated would have been greater, and differences between the two AFO designs 
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may have been evident. Buckon [17] reported no change in knee kinematics, with 
SAFOs, HAFOs and PLS, although the early stance knee extensor moment was 
significantly increased with HAFOs. Buckling of the SAFOs was reported, which 
must have negatively affected their function. Smiley [21] reported statistically 
significant differences in maximum knee flexion in swing using HAFOs, and in knee 
flexion in mid swing using HAFOs and SAFOs, but not PLS. Chambers [36] 
compared the effects of DAFOs and “standard” AFOs reporting that the “tall 
standard” AFO made from thicker plastic was best at restricting dorsiflexion, with 
significant improvement in mean stance knee extension. Lam [23] found that DAFOs 
significantly increased knee flexion at initial contact compared to barefoot, while 
SAFOs reduced this. Hassani [35] reported that compared to barefoot there were 
significant differences in peak knee flexion in stance and swing using HAFOs and 
DAFOs, but no significant difference in peak knee extension in stance or swing with 
either orthosis.  
 
Conclusions 
The indirect effects of AFOs on the kinetics and kinematics of the knee joint have 
been reported by a number of authors using a number of different orthosis designs. 
Knee hyperextension can be influenced by SAFOs or by HAFOs with plantarflexion 
stops, while excessive flexion is best addressed using SAFOs or AFOs with 
dorsiflexion stops. The alignment of the AFOs is critical if optimum effect is to be 
achieved at the knee, with tuning of the AFOs likely to be beneficial. 
 
WHAT ARE THE INDIRECT EFFECTS OF ORTHOSES ON THE HIP? 
 
Mixed  
The indirect effects of AFOs on hip joint kinematics in mixed groups of subjects have 
been investigated by a number of authors [2, 5, 6, 27, 28, 30, 34]. Molenaers [6] 
reported improvement in hip extension throughout stance using PLS. Desloovere [30] 
analysed the effects of Klenzack AFOs, SAFOs, HAFOs and PLS compared to 
barefoot, finding that use of PLS and HAFOs increased hip extension at terminal 
stance and decreased hip abduction during swing, but had no effect on hip rotation. 
Hayek [5] found that SAFOs and HAFOs had minimal effect on hip kinematics when 
compared to barefoot. Hobbs [28] reported that SAFOs significantly increased both 
hip extension during stance and hip flexion in swing, whereas use of HAFOs and 
SMOs led to excessive hip flexion, relative to normal. Huenaerts [2] investigated the 
effects of PLS before and after BTA on the gait of children described only as 
“predominantly spastic”, reporting that PLS significantly decreased internal rotation 
of the hip at initial contact. At midstance and terminal stance there was further 
significant improvement after BTA. Hip extension also significantly increased after 
BTA. Molenaers [34] investigated the effect of multilevel BTA combined with 
daytime AFOs, night time KAFOs and serial casting if required, finding that those 
children without casting showed greater hip extension at terminal stance following 
BTA injections. The incidence of internal hip rotation in stance and swing 
significantly decreased for all patients after treatment.  
 
De Groot [27] investigated the effect of shoes only on gait, reporting a significant 
decrease in minimum hip flexion in stance and a significant increase in hip range of 
motion.  
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Hemiplegia  
Romkes [11] reported  an increase in hip flexion at initial contact using a HAFO, 
compared to walking with no orthosis. The authors suggest that this increase may 
have been related to increases in velocity and step length, which have been 
demonstrated to increase peak hip flexion and extension in healthy children. Brunner 
[12] investigating the effects of a SAFO and a flexible AFO found that the SAFO 
increased hip flexion, extension and abduction, but decreased adduction. Changes to 
abduction and adduction were more pronounced in the flexible AFO. Perhaps 
surprisingly, the reported arcs of hip flexion and extension were similar in both 
orthoses. This similarity should however be considered in the context of the amount 
of ankle dorsiflexion reported in the two different orthosis designs. The SAFO clearly 
buckled, showing an average of 8.40 dorsiflexion compared to 11.90 in the flexible 
AFO. With similar ankle kinematic graphs, it is reasonable to expect similar orthotic 
effect at the hip in the two test conditions. Investigating a PLS, a Dual Carbon Fibre 
Spring AFO, and an Orteam® AFO, Van Gestel [13]  reported significant  
improvements in hip moments and power, except for maximal abduction moment in 
stance and maximal power generation at pre-swing. Although there were only small 
differences between the different orthoses, the Dual Carbon Fibre Spring AFO created 
a significantly higher maximal hip flexion moment in stance. It was reported that 
maximal hip extension in stance increased with the PLS and the Dual Carbon Fibre 
Spring orthosis, the Orteam® orthosis decreased it, although neither change was 
significant. Desloovere [14]  reported that compared to barefoot gait, using shoes only 
increased coronal hip angle and pelvic obliquity in swing. While these changes were 
stated to be statistically significant, they were of the magnitude of only a few degrees, 
and therefore perhaps not clinically significant. 
 
Diplegia 
Using SAFOs, Abel [16] demonstrated significant improvement in hip excursion, 
even though the SAFOs allowed some dorsiflexion by buckling, while Van Rooijen 
[31] reported significant decrease in minimum hip flexion in stance. Lucareli [39] 
reviewed the effect of hinged FRAFOs, finding no significant changes to maximum 
hip extension. Buckon [17] reported no changes at the hip using HAFOs, SAFOs and 
PLS. Lam [23]  evaluated the effects of SAFOs and DAFOs reporting that  DAFOs 
significantly increased hip flexion at initial contact compared to barefoot. Hassani 
[35]  reported significant differences in peak hip flexion in stance with both HAFOs 
and DAFOs, compared to barefoot. There was however, no significant difference to 
peak hip extension in stance or peak hip flexion in swing. Crenshaw [32]  investigated 
the effects of tone reducing features in lower limb and reported that the AFOs without 
these features showed significant increase in maximum extension moment and total 
power generation at the hip. 
 
Conclusions 
There is some evidence that hip joint kinetics and kinematics can be influenced by 
AFOs. In order to achieve indirect orthotic effect at the hip, the AFOs must be 
successful in controlling ankle kinematics. Control of the permitted arc of ankle 
motion in flexible AFOs and HAFOs, and the stiffness of SAFOs are critical factors if 
the ground reaction force is to be successfully manipulated. Tuning of the orthoses is 
important if the hip is to be positively influenced. There is some evidence that the use 
of shoes only can influence hip kinematics. 
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WHAT ARE THE INDIRECT EFFECTS OF ORTHOSES ON THE PELVIS? 
 
Mixed  
A number of authors [2, 6, 30, 34] investigated the indirect effect of AFO use on the 
pelvis in mixed subjects. Two studies [6, 30] investigated the effects of a range of 
AFOs including, SAFOs, HAFOs and PLS, reporting decreased pelvic motion in the 
transverse place, compared to barefoot, in all but the Klenzack AFOs. The other two 
studies [2, 34] investigated the effect of BTA when used in conjunction with orthoses. 
Molenaers [34] used 3D gait analysis and EMG to investigate the effects of BTA 
combined with daytime AFO use and KAFOs at night (using short leg casting when 
indicated). Increased pelvic stability was reported, with greatest improvement seen in 
those who had short leg casting before BTA. Huenaerts [2] investigated the effects of 
a PLS before and after BTA reporting no changes in pelvic kinematics as a result of 
either.  
 
Hemiplegia  
Brunner [12] investigated the effect of a SAFO and a flexible AFO on hemiplegic 
gait. The SAFO improved pelvic obliquity, had no effect on pelvic tilt, but adversely 
affected (i.e. increased) pelvic rotation. The flexible AFO improved pelvic obliquity, 
slightly increased pelvic tilt, and had an adverse effect on pelvic rotation less than the 
SAFO. Romkes [11] found no significant change at the pelvis using a HAFO.  
 
 
Diplegia 
Abel [16] reported significant improvement in pelvic excursion using a SAFO 
(although the AFO did buckle under load). Buckon [17] reported no changes at the 
pelvis in diplegic subjects using HAFOs, SAFOs and PLS.  
 
Conclusions 
Little evidence exists to support the hypothesis that AFOs can positively impact on 
pelvic motion, although there is a suggestion that this may be possible. If using 
SAFOs, the rigidity and the alignment of these is important if the effect at the pelvis is 
to be positive, rather than negative.  
 
What effect do orthoses have on the metabolic and cardiopulmonary cost of walking? 
 
Hemiplegia 
Two studies investigated the effect on oxygen consumption of different AFOs 
including HAFO, SAFO and PLS. Buckon [15] compared the effects of all three 
designs on hemiplegic subjects. At self selected speed, there were no significant 
changes in oxygen consumption or energy cost (energy consumption/velocity), 
however in all three AFO configurations self selected speed significantly increased. In 
fast walking oxygen consumption was unchanged, but energy cost was significantly 
decreased when wearing the HAFO. Balaban [10] reported a significant reduction in 
oxygen consumption with HAFO use, testing subjects at the same speed, rather than at 
self-selected speed. 
 
Diplegia 
A number of studies [17, 21, 25, 46] investigated the effects of a number of AFO 
designs including HAFO, SAFO, PLS and “conventional plastic AFOs” on the gait of 
children with diplegia. Mossberg [25] investigated the effects of bilateral 
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“conventional plastic AFOs” on energy expenditure at self-selected speed. Most 
subjects demonstrated a statistically significant decrease in Physiological Cost Index 
(PCI) when using AFOs. Maltais [46] investigated the effects of HAFOs on the 
metabolic and cardiopulmonary cost of walking. Net oxygen uptake was significantly 
reduced at both slow and fast speed, but not at self-selected walking speed. Significant 
reduction in net pulmonary ventilation was reported at slow speed.  There was no 
effect on heart rate or respiratory exchange ratio at any of the three speeds, or on any 
physiological variable at self-selected walking speed. Smiley [21] compared the effect 
of HAFOs, SAFOs, and PLS to shoes alone on energy cost at self selected walking 
speed. The measure used was the Energy Efficiency Index (EEI), which is defined as 
heart rate minus resting heart rate divided by speed. No significant differences were 
found in the EEI between the three AFOs, but it is unclear whether the EEI was 
different between the AFOs and the shoes alone condition.  Buckon [17] also 
investigated the effects of HAFO, SAFO, and PLS, reporting significant reduction in 
energy cost at self selected and fast walking speeds with all designs when compared 
to shoes only. Oxygen consumption was significantly reduced using the HAFO and 
SAFO at self selected and fast walking speeds. Reduction in oxygen consumption 
with the PLS was not statistically significant due to the resulting increase in velocity.  
 
A further study by Van de Walle  [7]  failed to describe the type of subjects fitted with 
PLS. In this study the slight increase in velocity was associated with increase in 
energy consumption, leading the authors to conclude that there was no benefit in 
terms of gait efficiency when using AFOs.  
 
Conclusions 
There is some evidence that the metabolic and cardiopulmonary cost of walking may 
be improved by the use of AFOs. In some studies where walking speed has been 
standardised, reduction in oxygen consumption has been reported with AFO use. In 
other studies at self-selected walking speed, oxygen consumption has been unchanged 
by AFO use, but self-selected walking speed has increased.  
 
WHAT EFFECT DO ORTHOSES HAVE ON MUSCLE ACTIVITY? 
 
Mixed 
Dumas [47] investigated the effects of an AFO on the reflex and non reflex 
components of hypertonia, in one hemiplegic and one diplegic subject. Unfortunately, 
no details were given regarding either child, or of the AFO design employed. After six 
months of AFO use, the resistive forces for the non-reflex component were reduced 
by 19.7% in the diplegic child, and by 44.5% in the hemiplegic child. These forces 
had returned to pre-AFO values two months after discontinuing AFO use, suggesting 
a temporary effect. The reduction in the reflex component, seen only in the 
hemiplegic child at six months was also lost two months after discontinuing AFO use. 
These effects were consistent with the Modified Ashworth Scale (MAS) scores which 
were initially 4 in both children, decreasing to 2 in the diplegic and 1 in the 
hemiplegic at six months. Two months after discontinuing AFO use, only the 
hemiplegic MAS increased (to 2). In both children passive dorsiflexion was increased 
after six months AFO use, but this gain was also lost within two months of 
discontinuation. Lampe [42] studied the effects of orthopaedic shoes, insoles, DAFOs, 
ring orthoses and AFOs in a mixed group which included few CP children. One 
diplegic child used both a “long and short orthosis” (not described), with minimal 
influence on quadriceps muscle tone. Neither orthosis had any effect on EMG signal 
intensity of biceps femoris or gluteals. In the hemiplegic subject, use of a shoe plus 
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orthotic insole resulted in improved knee extension in early stance phase, which 
correlated with increased activity of rectus femoris, which reduced through mid and 
late stance. Due to the small number of patients, the findings have limited 
applicability. Following BTA combined with short leg casting and orthotic 
management, Molenaers [34] reported persistence of premature gastrocnemius 
activity in stance, with most subjects showing lower levels of gastrocnemius activity 
at initial contact with all regimes. The frequency of tibialis anterior activity during 
terminal swing and loading response increased after BTA. Radtka [26] found that 
neither SAFOs nor DAFOs changed abnormal muscle timing. 
 
Hemiplegia 
Romkes [11] used EMG to investigate the effect of a HAFO on muscle activity, 
compared to barefoot. Tibialis anterior showed the greatest EMG reduction, with 
average peak activity reducing by 36.1% during initial contact/loading response, and 
by 57.3% just after toe off. While slight changes were detected in rectus femoris, 
semitendinosis, biceps femoris, vastus medialis and lateralis during swing, these 
changes resulted in no notable functional effects. Surprisingly, no data was collected 
relating gastrocnemius or soleus. Matthews [48] investigated the effect of a HAFO 
with neurophysiological features in a single subject, reporting reduction in upper limb 
spasticity and night cramps in the calf. Unfortunately, the comparison was with a 
SAFO without any neurophysiological features, so any specific effect of 
neurophysiological modifications was not isolated.  
 
 
Diplegia 
Van Rooijen [31] reported that compared to non-disabled controls, barefoot diplegic 
gait showed significantly higher coactivation (hamstrings and rectus femoris; tibialis 
anterior and gastrocnemius medialis). Wearing SAFOs, significantly decreased the 
amplitude of rectus femoris and tibialis anterior, significantly increased the amplitude 
of medial hamstrings and had no effect on the amplitude of gastrocnemius medialis. 
While there were no significant effects on coactivation over gait cycle as a whole, 
there was significant increase of coactivation in the shank during loading response. 
While this study implies that SAFOs have only small effects on EMG amplitudes and 
little influence on coactivations, the authors suggest that further modifications to the 
SAFO and/or footwear (i.e. tuning) may have resulted in greater improvements in gait 
and lower levels of co-activation. Lam [23]  reported that when compared to non-
disabled controls, median frequency of EMG signal indicated extremely high firing in 
the lower limbs of diplegic subjects, resulting in tiredness. While neither SAFOs nor 
DAFOs changed total muscle contracting duration compared to barefoot, SAFOs 
significantly reduced median frequency of EMG signal while the DAFOs did not. 
This suggests potential for improvement of walking endurance when wearing SAFOs. 
Radtka [19] found no change in the timing of muscle activity (pretibial, triceps surae, 
quadriceps femoris, and hamstrings) using SAFOs and HAFOs. Rethlefsen [20] 
(1999) found no differences in peak EMG amplitude of calf muscles using HAFOs 
and SAFOs. 
 
Conclusions 
There is limited evidence that muscle activity may be positively affected by the use of 
AFOs, indicating a clear need for further research. When such effect has been 
reported, it has been noted to be restricted to the period of orthosis use, or slightly 
longer.  The issue of whether orthoses can influence the physiological properties of 
muscle has interested researchers for some time. Williams [49] reported changes in 
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muscle following periods of immobilisation, including modification of the number of 
sarcomeres and the degree of overlap of myosin and actin filaments. Resultant 
improvement in muscle tension was reported, especially in younger children. Tardieu 
has demonstrated that at least six hours of immobilisation per day is required to 
change resistance to passive stretch and decrease tone in the soleus. Given the 
prolonged daily periods of orthotic use for many patients, it is possible that SAFOs 
may indeed confer this effect, albeit to the muscles actually immobilised by the 
orthosis. Pharmacological interventions may be required to influence tone in the 
proximal muscles so that the orthosis can optimise proximal joint kinetics and 
kinematics [34, 50]. 
 
Ronan [50] cautions against the use of ankle joints that assist dorsiflexion in case 
these elicit a spastic response in the plantarflexors. However, significant stretch of the 
plantarflexors can also occur in stance phase using free-dorsiflexion ankle joints. 
Some orthoses incorporate the features of so-called “inhibitory casts” which are 
thought to encourage reflexive relaxation by stimulation of one of the tonic reflexes of 
the foot [51]. Mills [52] has demonstrated changes in EMG activity of spastic muscles 
using such inhibitory casts. 
 
WHAT EFFECT DO ORTHOSES HAVE ON MUSCLE LENGTH? 
 
Mixed  
One study [47] investigated the effects of an AFO on the reflex and non reflex 
components of hypertonia. Only two participants were studied, one hemiplegic and 
one diplegic. No details were given regarding either child, or of the AFO design(s) 
employed. In both children passive dorsiflexion was increased after six months AFO 
use, but this gain was lost within two months of discontinuation. 
 
Hemiplegia 
One study [9] investigated whether proximal muscle length in subjects with 
hemiplegia is modifiable by the use of AFOs.  Joint angles calculated from Vicon gait 
analysis were used to model muscle length throughout the gait cycle, using Software 
for Interactive Musculoskeletal Modelling (Musculographics, Evanston, IL, USA). 
While maximum length of semimembranosus, semitendinosus, biceps femoris, rectus 
femoris, iliacus, and psoas were calculated throughout gait, the only significant 
increase reported was in the length of the hamstrings and rectus femoris. This effect 
was less marked in the more involved children in the study (GMFCS level II and III) 
than in the group as a whole. No modelling of gastrocnemius or soleus was 
undertaken in this study. The study results may have been affected by the use of 
comparative data from adults, which the authors acknowledged as less than ideal.  
 
Diplegia  
Two studies [17, 44] investigated the effect of AFOs on muscle length in subjects 
with diplegia. Buckon [17] reported no changes in passive dorsiflexion range using 
HAFOs, SAFOs and PLS. In a single case study Farmer [44] investigated the use of 
SAFOs as part of a programme of targeted training for a child with crouch posture. 
With the child standing on a sprung “wobble board,” inclined SAFOs were used while 
interaction between the hip and knee flexors and extensors was enhanced by throwing 
and catching a ball in such a way that perturbation was ensured. The angle of tibial 
inclination was reduced after 3 months. At 6 months the popliteal angles had reduced 
by 100, indicating hamstring lengthening. Knee flexion in standing and walking was 
also reduced by approx 100. 
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Conclusions 
There is limited evidence of beneficial effect of AFO use on muscle length, although 
there is a suggestion that this may be positively influenced by orthosis use. Further 
research is required.  
 
HOW DO ORTHOSES AFFECT FUNCTION AND ABILITY? 
 
Russell [53] investigated whether the Gross Motor Function Measure (GMFM-88) is 
sensitive to within-child changes in function arising from the use of ambulatory aids, 
including orthoses. Paired t-tests comparing barefoot and aided assessments revealed 
that the GMFM-88 total scores were significantly higher for assessments using AFOs, 
ambulatory aids, and AFO plus ambulatory aid, demonstrating that the GMFM-88 is 
sensitive to functional changes of the magnitude conferred by aids and/or orthoses. 
With regard to the changes seen in the orthoses group, the significance varied by 
GMFCS level, with the GMFM-88 sensitive enough to detect changes in levels I, III, 
and IV but not level II. This may have been because of the small sample size at level 
II and insufficient power to detect a difference, even if one existed. The authors 
concluded that the GMFM-88 might provide a clinically useful tool to help in 
understanding the impact of ambulatory aids and orthoses on gross motor skills of 
children with CP. Evans [54] used the GMFM and the Gross Motor Performance 
Measure (GMPM) to evaluate the effects of lower extremity orthoses on pre-
ambulatory children with spastic CP. Although significant improvement was observed 
in the group using orthoses in addition to physiotherapy,  no significant difference in 
gross motor function as measured by the GMFM-88 dimensions D (Standing) and E 
(Walking, Running, and Jumping) or in GMPM was found. In the study by Bjornson 
[55] significant improvements were detectable in crawling/kneeling, standing, and 
walking/running and jumping skills in  children with spastic CP wearing DAFOs, 
using the GMFM 88 and the Gross Motor Ability Estimator 66. Kott [56] investigated 
orthotic effect on performance using the Standardized Walking Obstacle Course 
(SWOC), the Pediatric Balance Scale (PBS), performance on individualized goals 
related upright function, and self-reports of comfort and stability. The SWOC and 
PBS detected no significant differences in performance with and without orthoses. 
However, some children performed better on an individualized goal with their 
orthoses, while approximately half reported feelings of improved comfort and stability 
while wearing their orthoses.  The results of this study do not reveal improved 
ambulation and balance wearing orthoses, when measured in a functional context.  
 
Hemiplegia  
Buckon [15] investigated the effects of HAFOs, SAFOs and PLS on functional tasks 
in children with hemiplegia, using the GMFM and GMPM. Functional mobility was 
assessed using Functional Skills-Mobility Dimension of the Pediatric Evaluation of 
Disability Inventory (PEDI). While the GMFM showed no changes between 
conditions, the GMPM showed improved performance in coordination and weight 
shift, but not alignment and stability. Functional skills, assessed using the PEDI, 
improved significantly with all three orthoses. The PEDI results reinforced the 
GMFM/GMPM findings indicating that AFO use enhanced performance of already 
mastered skills rather than attainment of new skills.  
 
Diplegia 
Maltais [46] also found no change in these GMFM dimensions in a study of children 
with spastic diplegia using HAFOs.  Hassani [57]  evaluated the effect of HAFOs and 
DAFOs in children with spastic diplegia, reporting that while gait and temporal stride 
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measures were sensitive to changes between braced and unbraced conditions, no 
significant differences were detectable with either the GMFM or the Pediatric 
Outcomes Data Collection Instrument (PODCI), which correlated strongly with each 
other. Buckon [17]  investigated the effects of HAFOs, SAFOs and PLS on functional 
tasks in diplegic subjects using the GMFM, reporting no improvement within the 
standing dimension but significant improvements to  the walking/running/jumping 
dimensions. No significant improvements were detected using either the GMPM or 
PEDI with any AFO. Ferdjallah [58] investigated the relationship between postural 
stability, gait, and GMFM goal scores in a study of the effectiveness of HAFOs and 
DAFOs on children with spastic diplegia. GMFM goal total scores increased when 
children were assessed with orthoses compared to barefoot, but did no information 
was provided on which dimensions of the GMFM were used. The authors 
recommended that a combination of measures should be used to evaluate the effects 
of AFOs, including measures of postural stability, gait, and GMFM assessment. 
Kornhaber [24] investigated the effects of SMOs and HAFOs on gross motor function 
in children with spastic diplegia. All scored higher on the GMFM in SMOs than in 
HAFOs for tasks that required ankle mobility. Performance in mat mobility and STS 
improved in younger children. Older children improved in more difficult tasks such as 
stair climbing and jumping. Most children scored lower for standing on one foot, but 
not on other tasks that required ankle stability. 
 
SITTING BALANCE 
 
Only one study [59] investigated the effects of SAFOs on seating position in non 
ambulatory children. Seating position was standardised, with 15 degrees of hip 
abduction achieved using a wedge. The only significant change observed was a 
decrease in kyphosis in all four children. The small sample size, coupled with the fact 
that this study relied on comparison of tracings of projected images, must bring the 
value of the results into question. 
  
Conclusions 
It is not possible to draw any conclusions from the very limited research on the effect 
of orthoses on sitting balance. 
 
STANDING BALANCE 
 
Diplegia 
Wesdock [45]  investigated the effect of 900 SAFOs on standing balance, and the 
influence of adding heel wedges. Balance time increased when SAFOs with wedged 
shoes were used compared to no orthosis, but without statistical significance. There 
was also an increase in balance time using SAFOs with wedged shoes compared to 
SAFOs without, but again the difference was not statistically significant. However, it 
is interesting to note that balance time in subjects who were already able to stand 
without orthoses for at least 15 seconds, significantly improved when using a SAFO 
with wedged shoes compared to no orthosis, and when using a SAFO with wedged 
shoes compared to a SAFO without. Standing balance was best in the SAFO plus 
wedge combination. Subjects with GMFCS level of II or III demonstrated greater 
improvements using SAFOs with wedged shoes compared to SAFOs alone, 
contrasting with the results of those at GMFCS IV, who demonstrated very small 
differences, supporting the hypothesis that children who exhibited better balance to 
begin with derive greater benefit from the addition of wedged shoes to their AFOs. 
Farmer [44] investigated the effects of targeted training and SAFOs on crouch posture 
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in a single child with diplegia. Interaction between the hip and knee flexors and 
extensors was enhanced by throwing and catching a ball while standing with SAFOs 
on a sprung “wobble board”. After three months standing posture had improved, with 
the child able to maintain an erect posture.  
 
Burtner [60] investigated the effect of SAFOs and carbon fibre AFOs of a spiral 
design on perturbed stance in  children with diplegia. It was found that their preferred 
pattern of muscle-recruitment was well established and not altered by either AFO 
design. The SAFOs however, led to decreased activation of distal musculature 
(gastrocnemius) as well as decreased recruitment of ankle strategies (which are seen 
in normally developing children) for balance. These trends were not found with 
carbon fibre AFOs. The authors concluded that spiral design carbon fibre AFOs may 
be advantageous for children with spastic CP when balance control is required during 
unexpected perturbations in stance. However, the small sample size (four) in this 
study makes generalizing results difficult. Näslund [61] (2005) investigated whether 
DAFOs improved standing stability in children with diplegia GMFCS levels III and 
IV, reporting that that DAFOs did not improve standing posture, or distribution of 
body weight, compared to shoes only, although some showed improvement in weight 
distribution between the feet and improved sagittal plane alignment of the knee.  
Carmines [62] investigated the effect of DAFOs on static balance in spastic diplegia, 
using non-disabled barefoot children and barefoot CP children as controls. Mean 
centre of pressure was analysed, and it was reported that use of the DAFOs created an 
irregular M/L shift in the base of support, and a significant posterior shift. Jesinkey 
[63] investigated the effects of DAFOs compared to shoes only, on coordination of 
standing posture and reaching movement in spastic diplegia. With DAFOs a greater 
number of subjects showed anticipatory divergence of centre of pressure. DAFOs also 
led to improvement in weight distribution between the feet and sagittal plane 
alignment of the shank, but not lateral stability. Compensatory postural adjustments 
with proximal to distal muscle activation (which is considered to be an immature 
response) were reduced with DAFOs. The study was limited by the small sample 
(four) and the potential training effect from wearing DAFOs for three years prior to 
testing. Crenshaw [32] investigated standing balance using HAFOs, HAFOs with 
tone-reducing features, and SMOs with tone reducing features in diplegic subjects, 
compared to shoes alone, reporting no significant difference between test conditions. 
Jones [64] investigated whether AFOs would improve standing balance in children 
with GMFCS < II, using non-CP children as a control. Standing balance was assessed 
using an instrumented Romberg test, and postural sway parameter was measured 
during 20-second trials. While AFOs did not significantly reduce postural sway in the 
CP group when eyes were open, there was a significant reduction in sway when used 
with eyes closed.  
 
Conclusions 
There is some evidence to support the hypothesis that orthoses can improve standing 
balance. Further research is needed in this area.  
 
SIT TO STAND 
 
The effect of HAFOs and SAFOs on performance of the sit to stand (STS) manoeuvre 
in subjects with diplegia has been investigated in a number of studies [65-67].  In a 
study on perambulatory children, Wilson [65] compared the effect of a 900 SAFO and 
a HAFO with 900 plantarflexion stop reporting that those whose performance was 
already comparable to normal performed better without AFOs, which actually 
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hindered STS. Patients more than one standard deviation (SD) slower than normal 
showed significant improvements using HAFOs. Those patients with equinus in 
barefoot standing derived most benefit from HAFO use. SAFO use produced no 
significant improvement. Although the authors stated that “control of equinus using 
HAFOs” significantly improved the speed of STS, the SAFO provided the same 
equinus control as the HAFO, so the difference is clearly not to do with equinus 
control per se. Haideri [66] also investigated the effect of SAFOs and HAFOs in 
subjects with dynamic equinus, again reporting that subjects whose performance was 
already close to normal were better without AFOs, and performed worst using 
SAFOs.  As in the study by Wilson [65] improvements were reported in the subset 
who were more than one SD slower than normal.  
 
Park [67] used a motion analysis system to investigate the effect of HAFOs in 
subjects who were able to perform STS without using their upper limbs, unlike the 
study of Wilson [65] where this was allowed. The control condition was barefoot. 
Total duration of STS was significantly shortened by use of a HAFO. Significant 
increases were noted in initial knee flexion angle, and initial and final angle of ankle 
dorsiflexion with the HAFO. Maximal moment and power at the hip and knee were 
significantly increased, whereas maximal moment and power at the ankle were not 
significantly changed. The authors suggested that the increase in the speed of 
performing the task may have contributed to the changes in power at the knee and hip.  
 
Conclusions 
It is perhaps understandable that no papers were identified that related to STS 
manoeuvre in hemiplegic subjects. In diplegic subjects, there is some evidence that 
HAFOs can improve performance of the STS manoeuvre, but that this benefit may be 
limited in those whose performance is already close to normal. A number of authors 
have suggested that the ability to dorsiflex the ankle is important, with Wilson [65] 
identifying dorsiflexion as the only consistent strategy for STS. However, it should be 
remembered that in the presence of gastrocnemius shortening, the use of free 
dorsiflexion ankle joints is contraindicated. The use of HAFOs to bring about 
improvements in STS may be detrimental to walking performance. An alternative way 
to consider this issue is that it may actually be the angle of tibial inclination that is 
important, and that SAFOs that prevent tibial inclination, i.e. SAFOs that maintain the 
tibia in a position too close to vertical, may impede STS. It is possible that SAFOs 
that have been tuned to a position of some tibial inclination may be more effective. 
Further research is needed to clarify these issues.  
 
Stair Climbing 
Only one paper [68] was identified that investigated the impact of different AFO 
designs on stair locomotion in subjects with spastic hemiplegia. All subjects, who 
were able to ascend and descend stairs in a reciprocal fashion without assistance, were 
evaluated using a HAFO, a SAFO, a PLS, and barefoot. The stair-specific items from 
the Pediatric Evaluation of Disability Inventory (PEDI) were used to evaluate 
function, and a motion analysis system evaluated kinematics. Velocity ascending and 
descending stairs, as compared to non-disabled peers, improved using all AFOs, with 
the greatest improvement noted when using HAFO, and least with PLS. Differences 
were not statistically significant for velocity during stair ascent and descent, or in 
single limb stance. The results of this study suggest that stair ambulation in children 
with spastic hemiplegia is not impaired by the use of an AFO. 
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Conclusions 
There is no evidence that AFO use impairs stair climbing in children with cerebral 
palsy. What little evidence there is appears to support the view that AFOs actually 
improve stair performance.  
 
WHAT ARE THE BENEFITS OF TUNING ANKLE-FOOT ORTHOSES? 
 
In the study by Owen [69] on independently ambulant children using SAFOs, all 
orthoses were tuned using the Orthotics Research and Locomotor Assessment Unit  
transportable Video Vector Generator (VVG). Tuning involved making fine 
adjustments to the angle of tibial inclination of each AFO using wedges under the 
heel, in order to manipulate and optimise the relationship of the ground reaction force 
(GRF) to the knee and hip.  Regardless of whether the AFO had been cast in a 
dorsiflexed, neutral or plantarflexed alignment, optimal knee and hip kinetics were 
always achieved with some angle of tibial inclination. It is interesting to note that the 
mean angle of tibial inclination was 11.860 which approximates to the angle observed 
at midstance in normal gait. Stallard [70] also used the portable VVG to investigate 
the effect of tuning SAFOs, reporting that tuning improved the biomechanical 
alignment in the majority of subjects. Based on this experience the authors suggest 
that tuning with kinematic/kinetic monitoring should become routine clinical practice, 
but stress that if the alignment of the GRF is to be successfully influenced, the AFOs 
must have appropriate mechanical properties, i.e. they must be appropriately stiff. 
Butler [71] also concluded that tuning SAFOs can improve knee kinetics and 
kinematics, advocating that pre-bracing knee kinematics is a good predictor of those 
most likely to benefit from tuning. Greatest improvements were strongly associated 
with knee flexion no greater than 200 in the first third of stance, combined with 
movement towards knee extension in the second third of stance to 100 flexion or less. 
Attempts at tuning those with knee flexion of greater than 350 in the first third of 
stance and greater than 150 degrees in mid stance were reported to be unsuccessful. A 
popliteal angle in excess of 450 was a poor prognostic sign, as was hip flexion 
contracture greater than 150. The authors conclude that it may be necessary to address 
proximal problems of tightness and control at hip and knee before attempting tuning. 
They also suggest that the presence of ataxia was a barrier to successful tuning. In a 
single case study, Jagadamma[43] used gait analysis to investigate the effects of an 
incrementally wedged SAFO on hemiplegic knee joint kinetics and kinematics. 
Unfortunately, no details were provided on the characteristics of either the SAFO or 
footwear, which are critical issues when tuning. In this study, optimal knee alignment 
was found with tibial inclination of 130. Van Gestel [13] reported that each of the 
three AFOs fitted to hemiplegic subjects was “optimally tuned”, defined as having the 
shank in an alignment ranging from neutral to maximum 10 degrees inclined. How the 
orthoses were judged to have been successfully tuned in this context is not described. 
As dorsiflexion was permitted by all the orthoses investigated, the tuning process can 
only have been of benefit in early stance phase.  
 
In some cases, footwear modifications may assist in optimising terminal stance 
kinetics [72]. Optimal GRF alignment at this stage of gait is anterior to the knee and 
posterior to the hip, as seen in normal gait.  With excessive tibial inclination, as seen 
in crouch gait, this GRF alignment may become impossible, thereby compromising 
stability. While a rigid SAFO can help retard tibial progression, it may still prove 
inadequate if the normal anatomical 3rd rocker allows the knee centre to pass in front 
of the GRF too early in terminal stance. Modification of the footwear, to block the 
normal 3rd rocker, replacing it with a more anteriorly placed “point-loading rocker”, 
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has been shown to further improve resistance to tibial progression, and enable optimal 
knee and hip kinetics. These point loading rockers were most successful with their 
apex located in front of the metatarsal-phalangeal joints. Nuzzo [73] successfully used 
an extended posterior heel flare shoe adaptation, with a SAFO set at an angle of 7 – 
10 degrees of tibial inclination, to treat knee hyperextension at initial contact, 
although  the approach was unsuccessful in the presence of athetosis. 
 
Conclusions 
The issue of tuning AFOs to optimise their function has been addressed by a number 
of investigators. There is emerging evidence that tuning AFOs can significantly 
improve their effectiveness, with beneficial effects reported at the proximal joints. 
However, in order to achieve benefit, the orthoses must be cast in a position that 
accommodates any gastrocnemius shortening, and they must be appropriately stiff, or 
must block ankle motion at appropriate angles, so that the ground reaction vector can 
be successfully manipulated. Some angle of tibial inclination appears to be most 
appropriate, regardless of whether the AFOs have been cast in a plantarflexed or 
dorsiflexed angle. Proximal contractures and/or spasticity may need to be addressed 
prior to tuning. Footwear modifications can also be beneficial in this process, in order 
to optimise entrance to and exit from stance. 
 
 
CAN LOWER LIMB ORTHOSES INFLUENCE THE UPPER LIMB? 
 
Very few studies [12, 17, 48] have reported changes in upper limb function when 
subjects wear AFOs. Brunner [12] investigated the effect of a SAFO and a flexible 
AFO on hemiplegic gait, reporting improvement in upper limb movement during gait 
only with the SAFO. Matthews [48] investigated the effect of a HAFO incorporating 
neurophysiological features and a SAFO on a single hemiplegic subject. While upper 
limb spasticity was reportedly reduced, it is unclear whether this effect was 
attributable to the hinged rather than solid design, or to the neurophysiological 
features in the HAFO. Only Buckon [17] actually measured the effect on performance 
of upper limb functional tasks in subjects with diplegia using HAFOs, SAFOs and 
PLS. Upper limb coordination, speed and dexterity all significantly improved with all 
AFO designs. 
 
Conclusions 
It is inappropriate to draw conclusions from the very small amount of evidence that 
exists in this area. 
 
WHAT ARE THE PERCEPTIONS OF USERS AND PARENTS REGARDING 
ORTHOTIC TREATMENT? 
 
Only one study [74] was identified that investigated the perceptions of parents of 
children receiving lower limb orthotic treatment. The parents of children with spastic 
diplegia using DAFOs were invited to open-ended interviews in order to elicit their 
responses. The parents’ perceptions were that the DAFOs had contributed to 
mechanical changes in posture, making the foot and ankle more stable, and enabling 
better postural control and alignment. They also felt that they had contributed to 
improvements in ADL. Additionally, some felt that the DAFOs had a beneficial effect 
on the leg muscles, which required less stretching. These generally favourable results 
may have been biased by the fact that the interviews were conducted by 
physiotherapists involved in the treatment.  
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Conclusions 
It is important to ascertain the opinions of orthosis users and their carers. Little 
evidence exists at present, and further research is required in this area. 
 
 
OBSERVATIONS ON THE REVIEW 
 
The authors of this review feel compelled to make a number of disappointing 
observations on the available literature. There is evidence that lower limb orthoses can 
confer a number of beneficial effects when treating cerebral palsy. However, before 
clinicians can attempt to make use of this (or indeed any) evidence in the treatment of 
patients, there are a couple of very important questions that must be addressed:  
 
• Are the patients to be treated the same as (or similar to) the study patients? 
• Can the orthotic intervention in the study be accurately reproduced? 
 
Unfortunately, many of the reviewed papers failed to provide important clinical 
details about the subjects in the study. In the worst cases, subjects are described as 
“children with CP” as if this was a homogeneous population or as having hemiplegia, 
or diplegia. Differentiating between types (e.g. hemiplegia and diplegia) is only a start 
in visualising the subjects, but more information is clearly needed.  Clinicians 
appreciate the critical importance of many interrelated factors when prescribing and 
fitting lower limb orthoses, including joint range of motion, contracture, muscle tone 
and spasticity. Too many papers failed to provide adequate information on these 
factors. In studies where range of motion was discussed, the focus was primarily on 
ankle dorsiflexion, and often it was not made clear whether this was achieved with the 
knee flexed or extended. This information is of critical importance. If dorsiflexion (to 
900 for example) can only be achieved with the knee flexed due to shortening or 
hypertonus in the gastrocnemius, then an AFO that positions the ankle at this angle 
will actually limit knee extension. It was disappointing to note that a number of 
studies reported that subjects with plantarflexion contractures were provided with 
AFOs that held the ankle at 900. Furthermore, when HAFOs are used in cases like 
this, any dorsiflexion that occurs can only do so at the expense of knee extension. 
Ignoring gastrocnemius shortening in this way is inevitably detrimental to the kinetics 
and kinematics at the knee and at the hip. High tone and/or spasticity in gastrocnemius 
can have similar effects, if not addressed. Proximal contractures, whether true or 
dynamic, also have a profound influence on outcomes, particularly contractures in the 
biarticular muscles. All too frequently these issues are not discussed. Confusion is 
compounded in those studies on non-homogenous groups in which results are not 
presented separately.  
 
Remarkably, many studies provided inadequate information on the orthosis being 
investigated, making reproduction of the intervention a challenge. In the worst 
examples, the intervention was only described as “an AFO”. Some papers used 
confusing terms to describe the type of orthosis being investigated, such as 
“conventional AFO” and “standard AFO”. Such terms are ambiguous, meaning 
different things to different people, and should be avoided.  To some the term 
“dynamic AFO” clearly means a supramalleolar orthosis with tone reducing features 
such as a contoured footplate, while to others it means a “spring-like” orthosis, 
perhaps of a spiral design, rendering the term potentially misleading.  The term 
“independent ambulation” is also ambiguous. In most studies this term was used to 
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describe ambulation without any walking aids, but in some studies the “independent 
ambulators” used crutches or walking sticks.   
 
A large percentage of the reviewed papers failed to explicitly state the angle of 
plantarflexion or dorsiflexion at which the orthosis positioned the foot and ankle, and 
very few specifically mentioned how the orthosis controlled the subtalar joint or the 
midtarsal joint. In general, there appeared to be little or no attempt to quantify “fit” 
which underpins optimal orthotic treatment. Information on fitting complications and 
rejection rates was rarely provided. Information on the materials used in the 
construction of the orthosis was seldom provided. The quality of a number of papers 
studying SAFOs was compromised by the fact that these “solid” AFOs were able to 
deflect into dorsiflexion (and perhaps even plantarflexion). Rarely were attempts 
made at measuring this deflection, making the results questionable. Worryingly, some 
authors actually described this deflection as intentional, ignoring the fact that as the 
AFOs buckle, the intimacy of their fit is inevitably compromised, with detrimental 
effects on the alignment of unstable subtalar and midtarsal joints. In the papers 
investigating the use of HAFOs, there was often inadequate detail on the actual arc of 
motion permitted by the ankle joints. In many cases there was no specific statement 
that the HAFO blocked plantarflexion, merely a suggestion that this might be the case.  
 
A number of papers correctly highlighted the fact that footwear has an impact on 
biomechanics, but only rarely did papers provide adequate information on the 
footwear being used with the orthoses. Some authors made no mention of the 
footwear at all, while others simply stated that “tennis shoes” or “training shoes” were 
used. The effective heel height of the footwear, i.e. the difference between the 
thickness of the heel and the sole, is an important factor but this information was 
rarely provided. Knowledge of the effective heel height, combined with the AFO 
angle, is essential if we are to appreciate the resulting tibial inclination angle, which is 
the critical issue when considering whether the orthoses are appropriately “tuned”.  
The angle of tibial inclination is only rarely mentioned in the literature. Little detail 
was provided on footwear modifications, which can also have a significant impact on 
biomechanics.  Some papers did not explicitly state whether controls wore shoes or 
were barefoot and there appeared to be no consensus regarding this. 
 
 
RECOMMENDATIONS  
 
To ensure that future research has optimal influence on clinical practice, it is 
important that detailed information is routinely provided on the subjects being 
studied. This should include information on: 
• diagnosis 
• age 
• passive range of motion at all lower limb joints 
• “dynamic” range of motion i.e. range observed when tested at speed to elicit the 
effects of tone and spasticity  
• detailed information on the multi-joint muscles (gastrocnemius, hamstrings and 
rectus femoris) with the gastrocnemius being perhaps the most critical when 
designing AFOs  
• torsional abnormalities affecting the foot progression angle  
• prior surgery 
• use of BTA within previous six months 
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Details of the orthotic intervention should be comprehensive and explicit, and 
should include: 
• the type of the orthosis 
• the angle at which the orthosis positions the ankle joint, and how this relates to 
the length of the gastrocnemius 
• the alignment of the subtalar and midtarsal joints  
• the range of ankle joint motion (plantarflexion and/or dorsiflexion) being 
permitted in HAFOs, but also in other flexible AFO designs  
• information on the rigidity of SAFOs, and details of any motion that is occurring   
• the type and thickness of the materials used to construct the orthosis  
• details on footwear specification and modification (if any), specifically, the 
effective heel height (i.e. the difference between heel and sole thickness). 
 
Details on the research methodology should also be provided, including 
• whether the fit of different orthoses has been standardised by fabricating from 
the same plaster casts  
• order of testing 
• whether tests have been conducted on the same or different days 
• period of acclimatisation 
• subgroup analysis, if appropriate  
• whether the subjects have been investigated with or without walking aids 
• whether the control group has been investigated with or without shoes 
 
If this level of detail on the subjects and interventions under investigation is routinely 
provided, and ambiguous terminology can be avoided, then research can be more 
effectively converted into clinical practice, to the benefit of all orthosis users. 
 
It is particularly disappointing to realise that many of these same recommendations 
were made in the ISPO “Report of a consensus conference on the orthotic 
management of stroke patients” published in 2004. 
 
Table 1. Do lower limb orthoses influence the temporal and spatial parameters of gait? 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Balaban, 2007 N=11 
mean age 
7.18±1.16  
Hemiplegia HAFO Prospective 
Within subject 
comparison 
study 
4 velocity improved  
cadence unchanged 
stride length improved 
single support improved 
Brunner,1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 velocity improved (both) 
cadence decreased (both) 
step length increased(both) 
stride length improved (both); greater improvement in flexible AFO 
single support increased SAFO; no change flexible AFO 
Buckon, 2001  N=30 
mean age 9y4m 
(range 4-18) 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 velocity no significant change  
cadence slight decrease 
step length improved 
stride length improved 
Desloovere, 2006 N=15 
mean age  
5.86 years ±1.76 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Prospective 
Crossover study 
4 velocity improved both designs vs. barefoot; not significant vs. shoes 
cadence reduced both vs. barefoot; not significant vs. shoes; shoes 
alone cadence decreased  
step length improved both vs. barefoot; not significant vs. shoes 
stride length increased 
Romkes, 2002 N=12 
mean age 11.9±4.9 
Hemiplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 step length improved in both; no difference between orthoses 
stride length improved in both; no difference between orthoses 
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison 
study 
4 velocity improved  
cadence decreased  
step length improved, stride length improved 
single support unaffected 
Thompson, 2002 N=18 
mean age 8y5m 
range 5y8m-11y 
Hemiplegia SAFO Prospective 
Within-subject 
comparison  
4 
 
velocity improved  
cadence decreased  
step length increased 
Van Gestel, 2008 N=36 
mean age 
8y5m±2y8m 
range 4-14 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Orteam® AFO 
Retrospective 
Cohort study 
 
2b 
 
velocity improved all 
cadence decreased all 
step length increased all 
 
 
Table 1. Do lower limb orthoses influence the temporal and spatial parameters of gait? (continued) 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Diplegia       
Abel, 1998 N=35 
mean age 8.7 
range 2.5-19 
Diplegia SAFO Retrospective 
Within subject 
comparison 
study 
4 
 
velocity improved  
cadence unchanged  
stride length improved 
single support improved 
double support decreased 
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 velocity no significant change in; slower in HAFOs than PLS 
cadence decreased all 
step length increased all 
stride length improved all 
Carlson, 1995 
(abstract) 
N=11 
age range 4-11 
Diplegia SAFO 
SMO 
Prospective 
Crossover study 
4 velocity no significant effect  
cadence no significant effect  
Carlson, 1997 N=11 
age not stated 
Diplegia SAFO 
SMO 
Prospective 
Crossover study 
4 velocity no significant change 
cadence decreased SMO 
stride length improved both 
Crenshaw, 2000 N=8 
age 8.9±2.4 
(range 4-11) 
Diplegia HAFO 
HAFO + tone 
reducing features 
SMO + tone 
reducing features 
Prospective 
Crossover study 
4 stride length increased in HAFO + tone reducing features  
 
Kornhaber, 2006 
(abstract) 
N=4 
age range 4-15 
Diplegia SMO 
HAFO 
Prospective 
Crossover study 
4 children using assistive devices faster in SMOs than HAFOs 
stride length improved in children using assistive devices 
Lam, 2005 N=13 
average age 
5.9±1.81 
range 3.3-9.7 
Diplegia SAFO 
DAFO 
Prospective 
Crossover study 
4 velocity no significant effect 
cadence no effect 
stride length improved both 
Mossberg, 1990 N=18 
mean age 8.3±2.8 
range 3-14  
Diplegia AFOs Retrrospective 
Within subject 
comparison 
study 
4 faster without AFOs, not significant 
 
 
 
 
Table 1. Do lower limb orthoses influence the temporal and spatial parameters of gait? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Radtka, 2005 N=12 
average age 
7.5±3.83 
range 4-16  
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 velocity no significant effect 
cadence no significant effect 
stride length improved both 
Rethlefsen, 1999 N=21 
average age 
9.1±2.2 
range 5.3-13.5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 velocity no significant effect 
cadence no significant effect 
stride length no significant effect 
double support increased HAFOs 
Smiley, 2002 N=14 
average age 10.7 
range 6.9-16 
Diplegia SAFO 
HAFO 
PLS 
Prospective 
Crossover study 
4 velocity slight increase HAFOs and PLS, slight reduction SAFO; not 
significant 
cadence slightly reduced HAFO and SAFO, slightly increased PLS; 
not significant 
stride length improved HAFO and PLS; SAFO slightly reduced  
Van Rooijen, 2006 
(abstract) 
N=12 
mean age 11.1 
Diplegia SAFO Retrrospective 
Within subject 
comparison 
study 
4 stride length improved 
Mixed       
De Groot, 2006 
(abstract) 
N=13 
mean age 11.6 
range 7-16 
 
Mixed Shoes only Prospective 
Within subject 
comparison 
study 
4 cadence unaffected 
stride increased 
step length increased 
stride length increased 
Dursun, 2002 N=24 
mean age 6.6±0.73 
Mixed AFO not described Prospective 
Within subject 
comparison 
study 
4 velocity increased 
cadence no effect  
stride length increased 
Hayek, 2007 N=56 
mean age 8.8 ± 3.5 
range 4-17 
Mixed SAFO 
HAFO 
Retrrospective 
Within subject 
comparison 
study 
4 velocity increased both; marginally in hemiplegics 
cadence decreased in hemiplegic, not diplegic 
step length increased both  
stride length increased both  
double support decreased in diplegic group 
 
 
 
 
Table 1. Do lower limb orthoses influence the temporal and spatial parameters of gait? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hobbs, 2003 
(abstract) 
N=24 
age not stated 
Mixed SAFO 
HAFO 
SMO 
Retrrospective 
Within subject 
comparison 
study 
4 step length increased  
Huenaerts, 2004 
(abstract) 
N=23 
age not stated 
Mixed PLS 
(effect of BTA) 
Retrospective 
Within subject 
comparison 
study 
4 velocity improved PLS 
velocity no change after BTA 
step length increased after BTA 
cadence decreased after BTA 
step length increased PLS, further improvement post BTA 
Kirkeide, 1999 
(abstract) 
N=5 
mean age 5.2 
Mixed DAFO 
SAFO 
Study design 
unclear 
 velocity no change  
cadence reduced both (vs barefoot) 
Molenaers, 2006 
(abstract) 
N=30 
mean age 9.0±4.9 
range 4-14 
Mixed PLS Retrospective 
Within subject 
comparison 
study 
4 velocity increased  
cadence decreased  
step length increased  
Radtka, 1997 N=10 
average age 
6.5±1.86 
range 3.5-8.5 
Mixed SAFO 
DAFO 
Prospective 
Crossover study 
4 Significant decrease in cadence with both. 
Both increased stride length 
Van de Walle, 2005 
(abstract) 
N=9 
age range 6-10 
Mixed PLS Within subject 
comparison 
study 
4 velocity increased slightly, not significant 
White, 2002 N=115 
mean age 9 
range 5-15 
Mixed HAFO 
SAFO 
Standard 
Polypropylene 
Wrap-around 
polyethylene 
Retrospective 
Within subject 
comparison 
study 
4 velocity improved all 
cadence slight decrease in (not significant); greatest in GMFCS I and II 
step length improved all 
stride length improved all 
single support improved all 
 
 
 
Table 2. What are the effects of orthoses on the ankle and foot? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Balaban, 2007 N=11 
mean age 
7.18+1.16 
Hemiplegia HAFO Prospective 
Within subject 
comparison 
study 
4 ankle power decreased  
equinus corrected 
Brunner, 1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 heel toe pattern reinstated both 
Buckon, 2001  N=30 
mean age 9y4m 
(range 4-18) 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 ankle power decreased all 
equinus improved all (HAFO & SAFO best) 
peak stance dorsiflexion improved all 
ankle dynamic range improved all 
dorsiflexion greater in all 
peak dorsiflexion greatest HAFO 
Desloovere, 2006 N=15 
mean age  
5.86 years ±1.76 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Prospective 
Crossover study 
4 power generation better in pre-swing dual carbon spring AFO; better 
power absorption in loading response PLS  
equinus and 1st and 2nd rocker improved both 
angular velocity in pre-swing better dual carbon orthosis 
ankle moment and power absorption in loading response more normal 
PLS 
ankle motion and angular velocity also improved shoes 
Romkes, 2002 N=12 
mean age 11.9±4.9 
Hemiplegia HAFO 
DAFO  
Prospective 
Crossover study 
4 power absorption significantly reduced both 
power generation unchanged by either 
dorsiflexion at initial contact and peak dorsiflexion increased in both 
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison 
study 
4 equinus corrected 
 
Table 2. What are the effects of orthoses on the ankle and foot? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Thompson, 2002 N=18 
mean age 8y5m 
range 5y8m-11y 
Hemiplegia SAFO Prospective 
Within subject 
comparison 
study 
4 
 
equinus corrected 
Van Gestel, 2008 N=36 
mean age 
8y5m±2y8m 
range 4-14 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Orteam® AFO 
Retrospective 
Cohort study 
 
 
2b 
 
equinus corrected in all; only significant dual carbon spring 
3rd rocker most normal dual carbon spring 
Diplegia       
Abel, 1998 N=35 
mean age 8.7 
range 2.5-19 
Diplegia SAFO Retrospective 
Within subject 
comparison 
study 
4 
 
ankle power decreased  
ankle excursion improved 
Bennett, 2005 
(abstract) 
N=15 
Mean age 
(experiment 1) 
9y8m 
(experiment 2) 
7y11m 
Diplegia AFO not described Prospective 
Within subject 
comparison 
study 
4 peak push off moment increased 
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 power generation greatest reduction SAFO; least in PLS 
timing of peak power generation improved in all 
 
Carlson, 1997 N=11 
age not stated 
Diplegia SAFO 
SMO 
Prospective 
Crossover study 
4 propulsive moments improved SAFO 
ankle power at push off increased neither 
power generated and absorbed decreased SAFO 
equinus improved SAFO, not SMO 
Chambers, 1999 
(abstract) 
N=9 
mean age 8.2 
range 6-11 
Diplegia DAFO 
“Standard AFO” 
Prospective 
Crossover study 
4 power generated at push off decreased “Standard AFO” 
power generation in DAFO similar to shoes only 
ankle motion restricted both, standard AFO better (difference between 
orthoses not statistically significant)  
 
Table 2. What are the effects of orthoses on the ankle and foot? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Crenshaw, 2000 N=8 
age 8.9±2.4 
(range 4-11) 
Diplegia HAFO 
HAFO + tone 
reducing features 
SMO + tone 
reducing features 
Prospective 
Crossover study 
4 plantarflexion moments increased HAFO and tone reducing HAFO 
power absorption increased HAFO 
power generation greatest in shoes only 
plantarflexion significantly reduced both HAFO designs vs. SMO or 
shoes 
Dole, 1997 
(abstract) 
N=1 
age 5 
Diplegia HAFO Single case study 5 foot progression angle improved 
Hassani, 2004 N=16 
mean age 7.5±2.9 
Diplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 significant effect on plantarflexion moment with both  
significant increase in peak stance dorsiflexion and peak swing 
plantarflexion in both 
no significant difference between orthoses 
Lam, 2005 N=13 
average age 
5.9±1.81 
range 3.3-9.7 
Diplegia SAFO 
DAFO 
Prospective 
Crossover study 
4 maximum plantarflexion moment improved both 
higher 2nd peak of GRF enabled in SAFO 
quines improved both (SAFO better) and peak mean dorsiflexion 
Lucareli, 2007 N=71 
average age 
12.2±3.9 
Diplegia Hinged FRAFO Retrospective 
within subject 
comparison 
study 
4 dorsiflexion decreased 
Radtka, 2005 N=12 
average age 
7.5±3.83 
range 4-16  
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 increased power generation HAFOs vs. SAFOs 
peak ankle power with HAFOs similar to no AFO 
dorsiflexion improved both 
dorsiflexion at terminal stance greater HAFO 
Rethlefsen, 1999 N=21 
average age 
9.1±2.2 
range 5.3-13.5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 power generation higher HAFOs 
dorsiflexion improved at initial contact both 
dorsiflexion at terminal stance greater in HAFO 
Smiley, 2002 N=14 
average age 10.7 
range 6.9-16 
Diplegia SAFO 
HAFO 
PLS 
Prospective 
Crossover study 
4 all designs appeared to produce an abnormal amount of dorsiflexion 
across gait cycle 
 
 
 
Table 2. What are the effects of orthoses on the ankle and foot? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Mixed       
Desloovere, 1999 
(abstract) 
N=47 
age range 5-12 
Mixed Klenzak AFO 
SAFO 
HAFO 
PLS 
Retrospective 
Within subject 
comparison 
study 
4 dorsiflexion increased at initial contact 
plantarflexion reduced at push off 
Hainsworth, 1997 N=12 
mean age 4y8m 
range 3y11m-
7y5m 
Mixed 
 
SAFO 
HAFO 
Prospective 
Within subject 
comparison  
4 ankle kinematics improved 
Hayek, 2007 N=56 
mean age 8.8 ± 3.5 
range 4-17 
Mixed SAFO 
HAFO 
Retrrospective 
Within subject 
comparison  
4 dorsiflexion improved in both; type of AFO had borderline significance 
Hobbs, 2003 
(abstract) 
N=24 
age not stated 
Mixed SAFO 
HAFO 
SMO 
Retrrospective 
Within subject 
comparison  
4 dorsiflexion in terminal stance increased HAFO and SMO 
Kirkeide, 1999 
(abstract) 
N=5 
mean age 5.2 
Mixed DAFO 
SAFO 
Study design 
unclear 
 forefoot force decreased DAFO; increased with SAFO; ankle excursion  
and timing reduced both heel contact time increased both (DAFO better) 
Molenaers, 1999 
(abstract) 
N=33 
age range 4-9 
Mixed AFO not described 
BTA 
Retrospective 
Cohort study 
2b power generation increased post BTA 
Molenaers, 2006 
(abstract) 
N=30 
mean age 9.0±4.9 
range 4-14 
Mixed PLS Retrospective 
Within subject 
comparison  
4 ankle power decreased  
ankle position improved 
Ounpuu, 1996 N=31 
mean age 10.6±3.8 
Mixed PLS Retrospective 
Within subject 
comparison  
4 mechanical energy not stored or returned in propulsive phase 
terminal swing and end stance dorsiflexion improved 
peak stance dorsiflexion no effect  
Radtka, 1997 N=10,  
age 6.5±1.86 
range 3.5-8.5 
Mixed SAFO 
DAFO 
Prospective 
Crossover study 
4 plantarflexion decreased with both 
Westberry, 2007 N=102 
mean age 10 
range 5.1-18.7 
Mixed SAFO 
PLS 
HAFO 
GRAFO 
Retrospective 
Within subject 
comparison 
study 
4 all measurements of segmental alignment changed (statistically 
significant)  
improvements considered clinically insignificant by authors 
correction most successful in pronated feet 
 
 
 
Table 3. What are the indirect effects of orthoses on the knee? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Balaban, 2007 N=11 
mean age 
7.18+1.16 
Hemiplegia HAFO Prospective 
Within subject 
comparison 
study 
4 knee flexion reduced at initial contact 
maximum knee flexion in stance, or in swing no change 
Brunner,1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 maximum knee extension reduced SAFO (vs barefoot)  
knee range of motion reduced throughout gait SAFO 
flexible AFO had only a slight influence  
Buckon, 2001  N=30 
mean age 9y4m 
(range 4-18) 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 knee hyperextension improvement greater with HAFO vs. SAFO 
Desloovere, 2006 N=15 
mean age  
5.86 years ±1.76 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Prospective 
Crossover study 
4 knee shock absorption and maximum knee flexion in stance vs. barefoot 
improved both 
amount and timing of maximum knee flexion in swing  changed both vs. 
barefoot  
maximum knee flexion and timing of peak knee flexion in swing 
unchanged vs shoes  
minimal hyperextension  allowed in PLS 
knee flexion velocity at toe-off increased both, particularly PLS 
knee shock absorption, flexion in swing and maximal knee extension in 
stance increased in shoes only vs  barefoot 
Jagadamma, 2007 
(abstract) 
N=1 
age 12 
Hemiplegia SAFO Within subject 
comparison 
study 
5 knee alignment improved by addition of wedging under SAFO  
optimum result  with 130 of tibial inclination 
Romkes, 2002 N=12 
mean age 11.9±4.9 
Hemiplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 timing of peak knee extension significantly delayed by both  
peak knee flexion improved in both  
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison 
study 
4 knee kinematics improved in loading response 
flexion-extension pattern created 
 
Table 3. What are the indirect effects of orthoses on the knee? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Van Gestel, 2008 N=36 
mean age 
8y5m±2y8m 
range 4-14 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Orteam® AFO 
Retrospective 
Cohort study 
 
4 
 
maximum stance knee extension decreased PLS and an Orteam®AFO 
hyperextension encouraged in Dual Carbon Fibre Spring AFO 
knee velocity in swing and peak knee flexion increased in all orthoses 
maximal knee flexion decreased, but remained higher than normal.  
knee shock absorption improved. 
Diplegia       
Abel, 1998 N=35 
mean age 8.7 
range 2.5-19 
Diplegia SAFO Retrospective 
Within subject 
comparison 
study 
 
4 
knee excursion improved 
effect on knee in stance not significant 
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 knee kinematics no change 
knee extensor moment in early stance increased with HAFOs  
Carlson, 1997 N=11 
age not stated 
Diplegia SAFO 
SMO 
Prospective 
Crossover study 
4  mean stance knee extension improved in SAFO 
Farmer, 1999 N=1 
age 7y10m 
Diplegia SAFO Single case study 5 improvements in knee flexion angle (standing and walking) by 
progressively reducing angle of tibial inclination combined with 
throwing and catching exercises 
Hassani, 2004 N=16 
mean age 7.5±2.9 
Diplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 peak knee flexion in stance and swing significant differences vs. 
barefoot 
peak knee extension in stance or swing no significant difference with 
either  orthosis 
Lam, 2005 N=13 
average age 
5.9±1.81 
range 3.3-9.7 
Diplegia SAFO 
DAFO 
Prospective 
Crossover study 
4 knee flexion significantly increased at initial contact DAFOs vs. 
barefoot 
knee flexion at initial contact reduced with SAFO 
Lucareli, 2007 N=71 
average age 
12.2±3.9 
Diplegia Hinged FRAFO Retrospective 
within subject 
comparison  
4 knee flexion reduced significantly in more involved subjects 
 
Table 3. What are the indirect effects of orthoses on the knee? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Radtka, 2005 N=12 
average age 
7.5±3.83 
range 4-16  
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 excessive knee flexion in barefoot stance unchanged with either  
knee moments during stance also unaffected by either 
Rethlefsen, 1999 N=21 
average age 
9.1±2.2 
range 5.3-13.5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 knee kinematics no significant differences between test conditions 
terminal stance knee flexion greater HAFO  
Smiley, 2002 N=14 
average age 10.7 
range 6.9-16 
Diplegia SAFO 
HAFO 
PLS 
Prospective 
Crossover study 
4 maximum knee flexion in swing statistically significant differences in 
HAFO and SAFO, but not PLS 
Wesdock, 2003 N=11 
average age 7±2.6  
range 4-13.5 
Diplegia SAFO 
Plus wedges 
Prospective 
within subject 
comparison 
study 
4 effects on knee extension not significant 
Mixed       
Desloovere, 1999 
(abstract) 
N=47 
age range 5-12 
Mixed Klenzak AFO 
SAFO 
HAFO 
PLS 
Retrospective 
Within subject 
comparison 
study 
4 knee flexion during loading response significantly increased AFOs vs 
barefoot 
more pronounced knee extension moment during stance in SAFO  
Hayek, 2007 N=56 
mean age 8.8 ± 3.5 
range 4-17 
Mixed SAFO 
HAFO 
Retrrospective 
Within subject 
comparison 
study 
4 knee flexion at initial contact reduced in hemiplegic group; no change in 
diplegic group 
knee kinematics in loading response, single support or swing phase no 
significant effect in either orthosis  
Huenaerts, 2004 
(abstract) 
N=23 
age not stated 
Mixed PLS 
(effect of BTA) 
Retrospective 
Within subject 
comparison 
study 
4 knee kinematics improved in PLS after BTA, but GRF alignment to the 
knee not always appropriate 
 
Table 3. What are the indirect effects of orthoses on the knee? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Lampe, 2004 N=18 
(not all CP) 
age range 15-18 
Mixed Orthopaedic shoes 
Insoles 
DAFO 
Ring orthosis 
AFO 
Retrospective 
within subject 
comparison 
study 
4 150 knee extension deficit in stance increased to 250 using orthopaedic 
shoes in child with diplegia 
duration of knee joint extension increased markedly by shoes; extension 
moment in initial stance decreased slightly.  
early stance knee extension improved in shoe plus orthotic insole in 
child with hemiplegia vs. barefoot  
knee extension and knee stability in stance improved; increased swing 
knee flexion with AFO in diplegic child 
Molenaers, 1999 
(abstract) 
N=33 
age range 4-9 
Mixed AFO not described 
BTA 
Retrospective 
Cohort study 
4 stance knee kinematics improved post BTA in all children, except those 
who already had casting prior to BTA 
 
 
Table 4. What are the indirect effects of orthoses on the hip? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Brunner,1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 hip flexion, extension and abduction increased SAFO, but adduction 
decreased  
changes to abduction and adduction were more pronounced in the 
FAFO; arcs of hip flexion and extension similar to SAFO 
Desloovere, 2006 N=15 
mean age  
5.86 years ±1.76 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Prospective 
Crossover study 
4 coronal hip angle and pelvic obliquity in swing increased shoes only (vs. 
barefoot) 
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison 
study 
4 hip flexion at initial contact increased  
Van Gestel, 2008 N=36 
mean age 
8y5m±2y8m 
range 4-14 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Orteam® AFO 
Retrospective 
Cohort study 
 
4 
 
hip range of motion, hip moments and power improved 
hip moment and power graphs all significantly increased, except 
maximal abduction moment in stance and maximal power generation at 
pre-swing 
significantly higher maximal hip flexion moment in stance in CFO; 
improvement also reported in about half of hip kinematics.  
maximal hip extension in stance increased in PLS and carbon fibre 
orthosis; Orteam® orthosis decreased it  
Diplegia       
Abel, 1998 N=35 
mean age 8.7 
range 2.5-19 
Diplegia SAFO Retrospective 
Within subject 
comparison 
study 
4 
 
hip excursion improved  
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4  no changes at the hip 
 
Table 4. What are the indirect effects of orthoses on the hip? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Crenshaw, 2000 N=8 
age 8.9±2.4 
(range 4-11) 
Diplegia HAFO 
HAFO + tone 
reducing features 
SMO + tone 
reducing features 
Prospective 
Crossover study 
4 increase in maximum extension moment and total power generation at 
hip in AFOs without tone reducing features  
Hassani, 2004 N=16 
mean age 7.5±2.9 
Diplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 significant differences noted in peak hip flexion in stance with both vs. 
barefoot, 
peak hip extension in stance and peak hip flexion in swing no significant 
difference 
Lam, 2005 N=13 
average age 
5.9±1.81 
range 3.3-9.7 
Diplegia SAFO 
DAFO 
Prospective 
Crossover study 
4 hip flexion at initial contact significantly increased DAFOs vs barefoot 
Lucareli, 2007 N=71 
average age 
12.2±3.9 
Diplegia Hinged FRAFO Retrospective 
within subject 
comparison 
study 
4 maximum hip extension no significant changes 
Mixed       
Desloovere, 1999 
(abstract) 
N=47 
age range 5-12 
Mixed Klenzak AFO 
SAFO 
HAFO 
PLS 
Retrospective 
Within subject 
comparison 
study 
4 hip extension increased at terminal stance and hip abduction decreased 
during swing PLS and HAFOs vs. barefoot 
hip rotation no observed AFOs effect 
De Groot, 2006 
(abstract) 
N=13 
mean age 11.6 
range 7-16 
 
Mixed Shoes only Prospective 
Within subject 
comparison 
study 
4 minimum hip flexion in stance decreased 
hip range of motion increased  
Hayek, 2007 N=56 
mean age 8.8 ± 3.5 
range 4-17 
Mixed SAFO 
HAFO 
Retrrospective 
Within subject 
comparison 
study 
4 hip kinematics minimal effect 
 
 
 
 
 
Table 4. What are the indirect effects of orthoses on the hip? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hobbs, 2003 
(abstract) 
N=24 
age not stated 
Mixed SAFO 
HAFO 
SMO 
Retrrospective 
Within subject 
comparison 
study 
4 hip extension during stance and hip flexion in swing improved SAFOs 
hip flexion detrimentally increased relative to normal HAFOs and 
SMOs  
Huenaerts, 2004 
(abstract) 
N=23 
age not stated 
Mixed PLS 
(effect of BTA) 
Retrospective 
Within subject 
comparison 
study 
4 internal rotation of hip at initial contact significantly decreased PLS 
further improvement at midstance and terminal stance after BTA   
hip extension increased after BTA 
Molenaers, 1999 
(abstract) 
N=33 
age range 4-9 
Mixed AFO not described 
BTA 
Retrospective 
Cohort study 
4 greater hip extension at terminal stance after BTA 
internal hip rotation in stance and swing significantly decreased for all 
patients after BTA 
Molenaers, 2006 
(abstract) 
N=30 
mean age 9.0±4.9 
range 4-14 
Mixed PLS Retrospective 
Within subject 
comparison 
study 
4 hip extension throughout stance improved 
Van Rooijen, 2006 
(abstract) 
N=12 
mean age 11.1 
Diplegia SAFO Retrrospective 
Within subject 
comparison 
study 
4 minimum hip flexion in stance decreased 
 
 
Table 5. What are the indirect effects of orthoses on the pelvis? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Brunner, 1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 pelvic obliquity improved SAFO; no effect on pelvic tilt; adversely 
affected (i.e. increased) pelvic rotation; obliquity improved in flexible 
AFO; slightly increased pelvic tilt; adverse effect on pelvic rotation less 
than the SAFO 
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison  
4 no significant change at the pelvis  
 
Diplegia       
Abel, 1998 N=35 
mean age 8.7 
range 2.5-19 
Diplegia SAFO Retrospective 
Within subject 
comparison 
4 pelvic excursion improved 
Buckon, 2004 N=16 
age 8 y4m ± 2y4m 
 range 4y4m-
11y6m 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 no changes at the pelvis 
Mixed       
Desloovere, 1999 
(abstract) 
N=47 
age range 5-12 
Mixed Klenzak AFO 
SAFO 
HAFO & PLS 
Retrospective 
Within subject 
comparison 
study 
4 decreased excursion of pelvis in the transverse plane in all children 
except those wearing Klenzak AFO 
Huenaerts, 2004 
(abstract) 
N=23 
age not stated 
Mixed PLS 
(effect of BTA) 
Retrospective 
Within subject 
comparison  
4 Pelvic kinematics no changes as a result of either PLS or BTA  
 
Molenaers, 1999 
(abstract) 
N=33 
age range 4-9 
Mixed AFO not described 
BTA 
Retrospective 
Cohort study 
 pelvic stability increased with BTA plus orthotic management (AFOs 
during the day and KAFOs at night); greatest improvements in those 
who had short casting before BTA 
Molenaers, 2006 
(abstract) 
N=30 
mean age 9.0±4.9 
range 4-14 
Mixed PLS Retrospective 
Within subject 
comparison  
 transverse pelvic ROM significantly decreased in AFOs vs. barefoot in 
both groups 
 
 
Table 6. What effect do orthoses have on the metabolic and cardiopulmonary cost of walking? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Balaban, 2007 N=11 
mean age 
7.18+1.16 
Hemiplegia HAFO Prospective 
Within subject 
comparison 
study 
4 significant reduction in oxygen consumption  
(all subjects were tested at the same speed, not at their self selected 
speed) 
Buckon, 2001  N=30 
mean age 9y4m 
(range 4-18) 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 no significant changes in O2 consumption or energy cost (energy 
consumption / velocity) at self selected speed; all three AFO 
configurations increased self selected speed 
O2 consumption unchanged in fast walking; energy cost significantly 
decreased in HAFO  
O2 consumption increased with increased velocity; no significant 
increase in energy cost with any AFO or shoes at faster speed.  
energy efficiency improved in 21/30 children, with 13 demonstrating 
greatest improvement in HAFO and PLS 
Diplegia       
Maltais, 2001 N=10 
mean age 9±2.1 
Diplegia HAFO Retrospective 
within subject 
comparison 
study 
4 net oxygen uptake reduced significantly at slow and at fast speed; no 
effect at comfortable speed. Net pulmonary ventilation significantly 
lower with HAFOs at slow speed. Heart rate or respiratory exchange 
ratio unaffected by HAFOs at any of the 3 speeds, no effect on any 
physiologic variable at comfortable walking speed 
Mossberg, 1990 N=18 
mean age 8.3±2.8 
range 3-14 
Diplegia AFOs Retrrospective 
Within subject 
comparison  
4 average PCI of children with diplegia stated to be approximately 3- 4 
times higher than normal; significant decrease in 13/18 using AFOs  
Smiley, 2002 N=14 
average age 10.7 
range 6.9-16 
Diplegia SAFO 
HAFO 
PLS 
Prospective 
Crossover study 
4 EEI not significantly different between orthoses; unclear whether EEI 
was different between the braced and unbraced condition.   
energy cost of gait for children in this study almost twice the average for 
the normal paediatric population 
Mixed       
Van de Walle, 2005 N=9 
age range 6-10 
Mixed PLS Within subject 
comparison  
4 velocity slight increase was associated with increase in energy 
consumption; concluded that there was no benefit in terms of gait 
efficiency when using AFOs 
 
Table 7. What effect do orthoses have on muscle activity? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Matthews, 2000 N=1 
age 11 
Hemiplegia HAFO with 
neurophysiological 
features 
SAFO 
Retrrospective 
Within subject 
comparison 
study 
5 upper limb spasticity and night cramps in the calf reportedly reduced vs. 
SAFO without any neurophysiological features  
effect of neurophysiological modifications not isolated  
 
Romkes, 2006 N=10 
mean age 9.7±1.6 
Hemiplegia HAFO Retrospective 
Within subject 
comparison 
study 
4 greatest EMG change with HAFO noted in tibialis anterior; average 
peak activity decreased by 36.1% during initial contact/loading 
response, and 57.3% just after toe off vs. barefoot 
slight changes detected in rectus femoris, semitendinosis, biceps 
femoris, vastus medialis and lateralis in swing, but no notable functional 
effects 
no data relating gastrocnemius or soleus  
Diplegia       
Lam, 2005 N=13 
average age 
5.9±1.81 
range 3.3-9.7 
Diplegia SAFO 
DAFO 
Prospective 
Crossover study 
4 duration of total muscle contracting unaffected by either orthosis vs. 
barefoot 
median frequency (MF) of EMG signal indicated that compared to 
controls, extremely high firing was found in the lower limbs of the 
subjects, resulting in tiredness 
MF significantly reduced only in SAFOs suggesting potential 
improvement of walking endurance when wearing SAFOs. 
Radtka, 2005 N=12 
average age 
7.5±3.83 
range 4-16  
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 timing of muscle activity (pretibial, triceps surae, quadriceps femoris, 
and hamstrings) unchanged 
no change in the abnormal timing of triceps surae activity during stance, 
although the abnormal ankle plantar flexion motion reduced by both 
orthoses 
Rethlefsen, 1999 N=21 
average age 
9.1±2.2 
range 5.3-13.5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 no differences in peak EMG amplitude of calf muscles vs. shoes 
 
Table 7. What effect do orthoses have on muscle activity? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Van Rooijen, 2006 
(abstract) 
N=12 
mean age 11.1 
Diplegia SAFO Retrrospective 
Within subject 
comparison 
study 
4 the amplitude of rectus femoris and tibialis anterior decreased in 
SAFOs; amplitude of medial hamstrings increased; no change in the 
amplitude of gastrocnemius medialis 
no significant effects on coactivation over gait cycle; when analysed 
separately there was significant increase of coactivation in the shank 
(11%) during loading 
suggests that SAFOs only have small effects on EMG amplitudes and 
little influence on coactivations 
Mixed       
Dumas, 1994 
(abstract) 
 
 
 
 
N=2 
diplegic age 5.5 
hemiplegic age 2.2 
Mixed AFO 
(not described) 
Prospective 
Within subject 
comparison 
study 
4 resistive forces for the non-reflex component of hypertonia reduced by 
19.7% in diplegic child after 6 months AFO use; reduced by 44.5% in 
hemiplegic 
resistive forces returned to baseline values after 2 months not wearing 
AFOs (suggesting temporary AFO effect) 
reflex component of hypertonia reduced (force reduction 73.9% and 
absence of reflex response in soleus) only in hemiplegic child; this 
effect also lost two month follow-up 
Modified Ashworth Scale (MAS) scores (initially 4 in both children) 
decreased to 2 in the diplegic and 1 in the hemiplegic at six months; two 
months after discontinuation, only the hemiplegic MAS increased (to 2) 
Lampe, 2004 N=18 
(not all CP) 
age range 15-18 
Mixed Orthopaedic shoes 
Insoles 
DAFO 
Ring orthosis 
AFO 
Retrospective 
within subject 
comparison 
study 
4 minimal influence on quadriceps muscle tone in 1 diplegic child using 
both a “long” and “short” orthosis (not described), with; neither orthosis 
had any effect on EMG signal intensity of biceps femoris or gluteals 
knee extension in early stance phase improved by shoe plus orthotic 
insole; this correlated with increased activity of rectus femoris; lower 
level noted through mid and late stance 
Molenaers, 1999 
(abstract) 
N=33 
age range 4-9 
Mixed AFO not described 
BTA 
Retrospective 
Cohort study 
4 premature gastrocnemius activity in stance remained common after BTA 
lower levels of gastrocnemius activity at initial contact with all regimes 
in most subjects 
frequency of tibialis anterior activity during terminal swing and loading 
increased after BTA  
 
Table 7. What effect do orthoses have on muscle activity? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Radtka, 1997 N=10 
average age 
6.5±1.86 
range 3.5-8.5 
Mixed SAFO 
DAFO 
Prospective 
Crossover study 
4 abnormal muscle timing unchanged 
 
 
Table 8. What effect do orthoses have on muscle length? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia       
Thompson, 2002 N=18 
mean age 8y5m 
range 5y8m-11y 
Hemiplegia SAFO Prospective 
Within subject 
comparison 
study 
4 
 
modelled muscle length throughout gait cycle 
length of the hamstrings and rectus femoris increased significantly 
following AFO use; effect less marked in the more involved children 
(type II and III)  
no modelling of gastrocnemius or soleus undertaken  
used comparative data from adults 
Diplegia       
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 no changes in passive dorsiflexion range after orthosis use  
Farmer, 1999 N=1 
age 7y10m 
Diplegia SAFO 
Plus targeted 
training 
Single case study 5 popliteal angles reduced by 100 after 6 months (reducing slightly further 
in one leg after 9 months) indicating hamstring lengthening 
knee flexion in standing and walking reduced by approx 100. 
Mixed       
Dumas, 1994 
(abstract) 
N=2 
diplegic age 5.5 
hemiplegic age 2.2 
Mixed AFO 
(not described) 
Prospective 
Within subject 
comparison 
study 
4 resistive forces for the non-reflex component of hypertonia reduced by 
19.7% in diplegic child after 6 months AFO use; reduced by 44.5% in 
hemiplegic 
resistive forces returned to baseline values after 2 months not wearing 
AFOs (suggesting temporary AFO effect).  
reflex component of hypertonia reduced (force reduction 73.9% and 
absence of reflex response in soleus) only in hemiplegic child; this 
effect also lost at two month follow-up 
Modified Ashworth Scale (MAS) scores (initially 4 in both children) 
decreased to 2 in the diplegic and 1 in the hemiplegic at six months; two 
months after discontinuation, only the hemiplegic MAS increased (to 2).  
passive dorsiflexion range increased after six months AFO use in both 
children; benefit also lost within two months of discontinuation. 
 
 
Table 9. How do orthoses affect function and ability? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Hemiplegia        
Buckon, 2001  N=30 
mean age 9y4m 
(range 4-18) 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 GMFM showed no changes between conditions GMPM showed 
improved performance, but alignment and stability were not improved. 
functional skills, assessed using the PEDI, improved with all three 
orthoses   
AFO use enhanced stability during static and dynamic functional motor 
skills, but did not enable children to master GMFM skills that they were 
unable to do barefoot 
PEDI results reinforced the GMFM/GMPM findings indicating that 
AFO use enhanced performance of already mastered skills rather than 
the attainment of new skills 
Sienko Thomas, 
2002 
N=19 
mean age 9±3 
range 6-15 
Hemiplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 percentage able to keep up with peers ascending stairs rose from 32% 
barefoot to 42% using a PLS, 47% with SAFO and 67% with a HAFO  
descending stairs, 26% could keep up with peers barefoot, 32% with a 
PLS, 37% with a SAFO and 53% with a HAFO 
differences in velocity during ascent and descent not statistically 
significant for stance  
suggests stair ambulation not impaired by the use of AFO 
Diplegia        
Buckon, 2004 N =16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4 standing dimension of GMFM not improved although  orthoses 
improved walking/running/jumping dimensions 
quality of movement (GMPM) did not improve significantly with any 
AFO  
PEDI showed no significant improvement 
Burtner, 1999 N=4 
(+ 4 control) 
(age range 3.6-15) 
Diplegia SAFO 
Carbon Fibre spiral 
AFO 
Prospective 
Crossover study 
4 preferred balance patterns in CP are well established and not altered by 
AFOs 
decreased activation of distal musculature (gastrocnemius) and 
decreased recruitment of ankle strategies (which are seen in normally 
developing children) for balance in SAFO; not in DAFO 
 
Table 9. How do orthoses affect function and ability? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Carmines, 2000 
(abstract) 
N=15 
age not stated 
Diplegia DAFO Prospective 
Within subject 
comparison 
study 
 
4 irregular M/L shift in the base of support, and a significant posterior 
shift in centre of pressure with DAFOs 
Crenshaw, 2000 N=8 
age 8.9±2.4 
(range 4-11) 
Diplegia HAFO 
HAFO + tone 
reducing features 
SMO + tone 
reducing features 
Prospective 
Crossover study 
4 difference in standing balance not significant  
Farmer, 1999 N=1 
age 7y10m 
Diplegia SAFO 
Plus targeted 
training 
Single case study 5 after 3 months standing posture had improved, with the child able to 
maintain an erect posture  
Ferdjallah, 2000 N=5 
average age 
7.1±2.8 
Diplegia HAFO 
DAFO 
Prospective  
Within subject 
comparison 
4 GMFM goal total scores increased with orthoses vs. barefoot 
no information on which dimensions of the GMFM used to calculate the 
goal total scores 
recommended combination of measures should be used to evaluate the 
effects of AFOs, including measures of postural stability, gait, and 
GMFM assessment 
Haideri, 1995 
(abstract) 
N=9 
age range 2-5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 subjects whose sit to stand performance already close to normal better 
without AFOs 
performance worst using SAFOs  
improvements in the subset more than 1 SD slower than normal 
Hassani, 2002 N=16 
mean age 7.5±2.9 
Diplegia HAFO 
DAFO 
Prospective 
Crossover study 
4 no significant differences detectable with either GMFM or PODCI 
(which correlated strongly with each other) although gait improved 
Jesinkey, 2005 N=4 
age range 5-12 
Diplegia DAFO Retrospective  
Within subject 
comparison 
study 
 
4 greater number of trials performed showed anticipatory divergence of 
centre of pressure in DAFOs (vs. shoes only) 
weight distribution between the feet and sagittal plane alignment of the 
shank improved in DAFOs, but not lateral stability 
compensatory postural adjustments with proximal to distal muscle 
activation (considered to be an immature response) reduced in DAFOs 
 
Table 9. How do orthoses affect function and ability? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Kornhaber 2006 
(abstract) 
N=4 
age range 4-15 
Diplegia SMO 
HAFO 
Prospective 
Crossover study 
4 all scored higher on GMFM in SMO vs. HAFO for tasks that required 
ankle mobility  
performance in mat mobility and stand-to-sit improved in younger 
children 
older children improved in more difficult tasks such as stair climbing 
and jumping  
3 scored lower for standing on one foot, but not on other tasks that 
required ankle stability 
Maltais, 2001 N=10 
mean age 9±2.1 
Diplegia  Retrospective 
within subject 
comparison 
study 
4 no change in GMFM goal total scores (Standing and Walking, Running, 
and Jumping dimensions) 
Näslund, 2005 N=6 
mean age 7.8 
range 5-12 
Diplegia DAFO Retrospective 
within subject 
comparison 
study 
4 improvement in equality of weight distribution between the feet and 
improved sagittal plane alignment of the knee (vs. shoes only) in some  
standing posture or distribution of body weight not improved 
Park, 2004 N=19 
mean age 
45.2±13.3 months 
range 2-6 years 
Diplegia HAFO Prospective 
within subject 
comparison 
study 
4 total duration of sit to stand significantly shortened by use of a HAFO  
proximal compensatory patterns (increased pelvic tilt and hip flexion) 
not modified by the HAFO. 
 
 
 
 
 
 
 
 
 
 
 
Table 9. How do orthoses affect function and ability? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Wesdock, 2003 
 
 
 
 
 
 
N=11 
average age 7±2.6  
range 4-13.5 
Diplegia SAFO Prospective 
within subject 
comparison 
study 
4 balance time increased when wedged AFOs were used vs. no orthosis 
(not statistically significant)  
balance time increased using AFOs with wedging vs. AFOs without 
(not statistically significant) 
statistically significant improvement in balance in 4 subjects already 
able to stand unsupported for at least 15 seconds (no orthosis vs. AFO 
with wedge, AFO vs. AFO with wedge)  
standing balance best in the AFO plus wedge combination 
8 subjects with GMFCS level of II or III demonstrated greater 
improvements in duration of standing balance using AFOs with wedges 
vs. AFOs alone; 3 subjects classified as level IV, demonstrated very 
small differences 
children who exhibited better balance to begin with appeared to derive 
a greater benefit from the addition of wedged shoes to their AFOs 
Wilson, 1997 N=15 
age range 2-5 
Diplegia SAFO 
HAFO 
Prospective 
Crossover study 
4 subjects whose performance already comparable to normal performed 
better without AFOs, which hindered sit to stand 
those with stance phase equinus while barefoot showed most benefit 
performance of thosae more than 1 standard deviation slower than 
normal (8/15) significantly improved by HAFOs  
SAFO produced no significant improvement  
Mixed       
Kott, 2002 N=28 
mean age 10.6±4.5 
range 5.4-19.1 
Mixed Orthosis not 
described 
Retrospective 
Within subject 
comparison 
study 
4 no significant differences in performance on SWOC and PBS with and 
without orthoses 
only 18% of children performed better on an individualized goal with 
orthoses; 48% reported feelings of improved comfort and stability 
wearing orthoses 
results do not reveal improved ambulation and balance wearing 
orthoses, when measured in a functional context 
subjects performed similarly with and without orthoses on SWOC and 
PBS, with half performing similarly on individualized upright functional 
goals 
 
 
 
Table 9. How do orthoses affect function and ability? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Russell, 2005 N=257 
mean age 
7y4m±2y11m 
range 2-15 
Mixed AFO Retrospective 
Within subject 
comparison 
study 
4 GMFM-88 total scores significantly higher for assessments using AFO, 
ambulatory aid, and AFO plus ambulatory aid 
GMFM-88 is sensitive to functional changes of the magnitude conferred 
by using aids and/or orthoses 
Significance varied by GMFCS level, with the GMFM-88 sensitive 
enough to detect changes in levels I, III, and IV but not level II  
(NB small numbers in level II) 
Diagnosis unclear       
Beals, 2001 N=4 
age not stated 
Non-
ambulatory 
SAFO Prospective 
Within subject 
comparison 
study 
4 tested SAFO effect on sitting balance 
posterior pelvic tilt decreased in 2 children (not significant)  
2 children showed increased posterior pelvic tilt  
all four had a statistically significant decrease in kyphosis 
Bjornson, 2006 N=23 
4.3 ± 1.5 
(1.9 – 7.3) 
 
Spastic CP DAFO Prospective 
Within subject 
comparison 
study 
4 significant improvements in crawling/kneeling, standing, and 
walking/running and jumping skills using Gross Motor Function 
Measure (GMFM) 88 and the gross motor ability estimator 66 
Evans, 1994 
(abstract) 
N=34 
(17 used AFOs) 
age range 1-4 
Perambulatory Orthosis not 
described 
RCT 1b no significant difference in gross motor function as measured by the 
GMFM-88 dimensions D (Standing) and E (Walking, Running, and 
Jumping) or in GMPM, although significant improvement observed in 
the orthoses plus physiotherapy group vs. physiotherapy only over 4 
months 
Jones, 2007 
(abstract) 
N=9 
age not stated 
Subjects not 
described 
Orthosis not 
described 
Within subject 
comparison 
study 
4 AFOs did not significantly reduce postural sway when eyes were open 
significant reduction in sway when used with eyes were closed 
 
 
Table 10. What are the benefits of tuning ankle-foot orthoses? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Butler, 2007 N=21 
mean age 7y1m 
(range 4y0m-
12y11m) 
Mixed SAFO Retrospective 
Within subject 
comparison 
study 
4 tuning can improve knee kinetics and kinematics 
analysis of knee kinematics prior to bracing advocated as a good 
predictor of success 
greatest improvements strongly associated with knee flexion no greater 
than 200 in the first third of stance, and movement towards knee 
extension in the second third of stance to 100 flexion or less  
attempts at tuning those with knee flexion greater than 350 in the first 
third of stance and greater than 150 degrees in mid stance unsuccessful  
popliteal angle in excess of 450 and hip flexion contracture greater than 
150 poor prognostic sign 
may be necessary to address proximal problems of tightness and control 
at hip and knee before attempting tuning 
suggest that ataxia (1 child) seemed to resist tuning, and that diplegia or 
hemiplegia most responsive 
Jagadamma, 2007 
(abstract) 
N=1 
age 12 
Hemiplegia SAFO Within subject 
comparison 
study 
5 optimal knee alignment found with tibial inclination of 130 
Nuzzo, 1986 N=10 
age range 7-12 
 SAFO 
Footwear 
modification 
(posterior heel 
flare) 
Prospective 
Within subject 
comparison 
study 
4 posterior heel flare used with SAFO set at 7 – 100 tibial inclination, 
successful in the treatment of knee hyperextension when this occurred at 
initial contact 
procedure unsuccessful for 3 athetoid cases in the series, considered 
success for the remaining subjects 
Owen, 2002 N=74 
(50 CP) 
age not stated 
Mixed SAFO 
(plus wedges) 
Retrospective 
Within subject 
comparison 
study 
4 optimal knee and hip kinetics was with tibia inclined regardless of 
whether AFO cast dorsiflexed, neutral or plantarflexed 
for the children with CP (69 AFOs) mean angle of tibial inclination was 
11.860 
Owen, 2004 N=12 
age not stated 
 SAFO 
Footwear 
modification (point 
loading rockers) 
Retrospective 
Within subject 
comparison 
study 
4 resisted early exit from stance in crouch 
point loading rockers most successful with apex in front of metatarsal-
phalangeal joints, at a mean of 78% of the length of footwear 
 
Table 10. What are the benefits of tuning ankle-foot orthoses? (continued) 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Stallard, 2003 N=62 
Age range 1y10m-
15y2m 
 SAFO Retrospective 
Within subject 
comparison 
study 
 tuning improved biomechanical (GRF) alignment in more than 68% of 
subjects 
useful outcome achieved in all but 2/61  
suggest that tuning with kinematic/kinetic monitoring should become 
routine clinical practice 
stress that if the alignment of the GRF is to be successfully influenced, 
the AFOs must have appropriate mechanical properties, i.e. stiff 
Van Gestel et al, 
2008 
N=36 
mean age 
8y5m±2y8m 
range 4-14 
Hemiplegia PLS 
Dual carbon spring 
AFO 
Orteam® AFO 
Retrospective 
Cohort study 
 
4 
 
 AFOs “optimally tuned” defined as having tibia alignment ranging 
from neutral to maximum 100 inclined 
 
 
Table 11. Can lower limb orthoses influence the upper limb? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Brunner,1998 N=14 
median age 11.42 
(range 6.46-20.08) 
Hemiplegia SAFO 
Flexible AFO 
Prospective 
Crossover study 
4 improvement in upper limb movement during gait noted with SAFO 
Matthews, 2000  N=1 
age 11 
Hemiplegia HAFO with 
neurophysiological 
features 
SAFO 
Within subject 
comparison 
study 
5 upper limb spasticity observed to be reduced in HAFO with 
neurophysiological features 
unclear whether effect due to hinged rather than solid design, or to 
neurophysiological features 
Buckon, 2004 N=16 
mean age 8 y4m 
± 2y4m 
 (range 4y4m-
11y6m) 
Diplegia HAFO 
SAFO 
PLS 
Prospective 
Crossover study 
4  upper limb coordination, speed and dexterity improved with all 
interventions 
 
 
 
Table 12. What are the perceptions of users and parents regarding orthotic treatment? 
 
First Author, year Number and age 
range of subjects 
Type of 
subjects 
Type of Orthosis Research 
Design 
Evidence 
Level 
Key Findings 
Näslund, 2003 N=15 
age range 4-18 
Diplegia DAFO Cross sectional 
survey 
4 parents believed DAFO had contributed to mechanical changes in 
posture, making the foot and ankle more stable, enabling better postural 
control and alignment, and improvement in activities of daily living  
parents believed children were less dependent, e.g. when going to the 
bathroom or transferring  
most important thing identified was that DAFO appeared to improve 
stability, security, agility and speed, improving participation in play and 
other activities with the child’s peers was improved 
some felt that DAFO had beneficial effect on the leg muscles, which 
required less stretching 
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APPENDIX I: QUESTIONS USED IN DISCUSSION SESSIONS 
 
 
Discussion session 1 
 
1. Is social inclusion/participation the ultimate goal of health care for people with 
cerebral palsy?  
 
2. Recommendation and type of care must reflect resources of the country? 
 
3. Should the recently revised definition of cerebral palsy be adopted by this conference 
and recommended in the report?  
 
4. Is the treatment goal of enabling activities more important than improving patterns of 
movement? If these goals conflict, how can they be reconciled? 
 
5. When is Gait classification helpful? 
 
6. When can fully instrumented gait analysis be recommended and utilized? 
 
 
Discussion session 2 
 
7. Is it necessary, feasible and ethical to conduct a high quality RCTs in physiotherapy? 
In terms of evidence-based medicine, what are credible alternatives to RCTs? 
 
8. You are designing a new research study evaluating a area of PT practice. What are the 
principles which should guide you choice of outcome measure? 
 
9. Given your interpretation of the evidence resented yesterday, and your own 
clinical/research experience, which PT interventions should be a) discontinued, b) 
retained, or c) delivered only in a research context? 
 
10. How do you decide the dose of a PT treatment? 
 
11. How do we explain the discrepancy between the popularity of PT with families and 
the current limited evidence of their efficacy? 
 
12. How can physiotherapy inform orthotic clinical practice? 
 
 
Discussion session 3 
 
13. Recommend ways to improve the methodological rigor and transparent reporting of 
research in lower limb orthoses in ambulant children with CP?  
 
14. Produce a PICO structured research question to evaluate the effectiveness of thumb 
abduction orthoses? 
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15. Given that spinal orthoses do not appear to prevent progressive deformity are there 
other reasons to provide them, if so what are the treatment goals and outcome 
measures? 
 
16. Given that the SWASH orthosis does not prevent progressive hip subluxation are 
there other reasons to use hip positioning devices (orthoses, seating, postural 
management devices), if so what are the treatment goals and outcome measures? 
 
 
Discussion session 4 
 
17. Should weight bearing programmes be advocated for children in GMFCS Levels IV 
and V?  If yes, propose indications, methods and relevant outcomes. 
 
18. What are the effects on child and family wellbeing that should be considered in the 
medical management of children in GMFCS levels IV and V? 
 
19. Do we have sufficient evidence to identify those children in different GMFCS levels 
who should receive botulinum toxin and what are the goals of treatment?  
 
20. Given the complexity and lifespan issues associated with CP, how can the broad 
range of health care services required by children and families be coordinated 
efficiently? 
 
 
Discussion session 5 
 
21. What are the modalities which may be used in the management of equinus in the 
ambulant child, and can you propose a logical sequence in which these interventions 
should be utilised during childhood? 
 
22. What are the goals of orthopaedic surgery for scoliosis & kyphosis and what are the 
appropriate outcome measures? 
 
23. Recommend improvements that can be proposed to improve the methodological rigor 
and transparent reporting of research in orthopaedic surgery? 
 
24. Given the high incidence of hip subluxation in GMFCS level III-V, what are the signs 
of a hip at risk and how should health services respond appropriately? 
 
 
Discussion session 6 
25. Recommend ways to improve the methodological rigour and transparent reporting of 
research in lower limb orthotics in ambulant children with CP. 
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26. Produce a PICO structured research question to evaluate the effectiveness of thumb 
abduction orthoses. 
 
27. Given that spinal orthoses do not prevent progressive deformity are there other 
reasons to provide them. If so what are the treatment goals and outcome measures. 
 
28. Given that the SWASH orthosis doees not prevent progressive hip subluxation are 
there other reasons to use hip positioning devices (orthoses, seating, postural 
management devices) and if so what are the treatment goals and outcome measures. 
 
 
APPENDIX II: Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001) 
 
Level Therapy/Prevention, 
Aetiology/Harm 
Prognosis Diagnosis Differential diagnosis/symptom 
prevalence study 
Economic and decision analyses 
1a SR (with homogeneity*) of RCTs  SR (with homogeneity*) of inception 
cohort studies; CDR† validated in 
different populations 
SR (with homogeneity*) of Level 1 
diagnostic studies; CDR† with 1b 
studies from different clinical centres 
SR (with homogeneity*) of 
prospective cohort studies  
SR (with homogeneity*) of Level 1 
economic studies 
1b Individual RCT (with narrow 
Confidence Interval‡) 
Individual inception cohort study with 
> 80% follow-up; CDR† validated in 
a single population 
Validating** cohort study with 
good††† reference standards; or 
CDR† tested within one clinical 
centre 
Prospective cohort study with good 
follow-up**** 
Analysis based on clinically sensible 
costs or alternatives; systematic 
review(s) of the evidence; and 
including multi-way sensitivity 
analyses 
1c All or none§  All or none case-series Absolute SpPins and SnNouts†† All or none case-series Absolute better-value or worse-value 
analyses †††† 
2a SR (with homogeneity*) of cohort 
studies 
SR (with homogeneity*) of either 
retrospective cohort studies or 
untreated control groups in RCTs 
SR (with homogeneity*) of Level >2 
diagnostic studies 
SR (with homogeneity*) of 2b and 
better studies 
SR (with homogeneity*) of Level >2 
economic studies 
2b Individual cohort study (including low 
quality RCT; e.g., <80% follow-up) 
Retrospective cohort study or follow-
up of untreated control patients in an 
RCT; Derivation of CDR† or 
validated on split-sample§§§ only 
Exploratory** cohort study with 
good†††reference standards; CDR† 
after derivation, or validated only on 
split-sample§§§ or databases 
Retrospective cohort study, or poor 
follow-up 
Analysis based on clinically sensible 
costs or alternatives; limited 
review(s) of the evidence, or single 
studies; and including multi-way 
sensitivity analyses 
2c "Outcomes" Research; Ecological 
studies 
"Outcomes" Research   Ecological studies Audit or outcomes research 
3a SR (with homogeneity*) of case-
control studies 
 SR (with homogeneity*) of 3b and 
better studies 
SR (with homogeneity*) of 3b and 
better studies 
SR (with homogeneity*) of 3b and 
better studies 
3b Individual Case-Control Study  Non-consecutive study; or without 
consistently applied reference 
standards 
Non-consecutive cohort study, or 
very limited population 
Analysis based on limited 
alternatives or costs, poor quality 
estimates of data, but including 
sensitivity analyses incorporating 
clinically sensible variations. 
4 Case-series (and poor quality cohort 
and case-control studies§§) 
Case-series (and poor quality 
prognostic cohort studies***) 
Case-control study, poor or non-
independent reference standard  
Case-series or superseded 
reference standards 
Analysis with no sensitivity analysis 
5 Expert opinion without explicit critical 
appraisal, or based on physiology, 
bench research or "first principles" 
Expert opinion without explicit critical 
appraisal, or based on physiology, 
bench research or "first principles" 
Expert opinion without explicit critical 
appraisal, or based on physiology, 
bench research or "first principles" 
Expert opinion without explicit critical 
appraisal, or based on physiology, 
bench research or "first principles" 
Expert opinion without explicit critical 
appraisal, or based on economic 
theory or "first principles" 
 
 
Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. 
 
 
 
 
Notes 
Users can add a minus-sign "-" to denote the level of that fails to provide a conclusive answer because of:  
• EITHER a single result with a wide Confidence Interval (such that, for example, an ARR in an RCT is not statistically significant but whose confidence intervals fail to 
exclude clinically important benefit or harm)  
• OR a Systematic Review with troublesome (and statistically significant) heterogeneity.  
• Such evidence is inconclusive, and therefore can only generate Grade D recommendations.  
 
* By homogeneity we mean a systematic review that is free of worrisome variations (heterogeneity) in the directions and degrees of results between individual studies. Not all systematic 
reviews with statistically significant heterogeneity need be worrisome, and not all worrisome heterogeneity need be statistically significant. As noted above, studies displaying worrisome 
heterogeneity should be tagged with a "-" at the end of their designated level. 
† Clinical Decision Rule. (These are algorithms or scoring systems which lead to a prognostic estimation or a diagnostic category. ) 
‡ See note #2 for advice on how to understand, rate and use trials or other studies with wide confidence intervals. 
§ Met when all patients died before the Rx became available, but some now survive on it; or when some patients died before the Rx became available, but none now die on it. 
§§ By poor quality cohort study we mean one that failed to clearly define comparison groups and/or failed to measure exposures and outcomes in the same (preferably blinded), objective way 
in both exposed and non-exposed individuals and/or failed to identify or appropriately control known confounders and/or failed to carry out a sufficiently long and complete follow-up of 
patients. By poor quality case-control study we mean one that failed to clearly define comparison groups and/or failed to measure exposures and outcomes in the same (preferably 
blinded), objective way in both cases and controls and/or failed to identify or appropriately control known confounders. 
§§§ Split-sample validation is achieved by collecting all the information in a single tranche, then artificially dividing this into "derivation" and "validation" samples. 
†† An "Absolute SpPin" is a diagnostic finding whose Specificity is so high that a Positive result rules-in the diagnosis. An "Absolute SnNout" is a diagnostic finding whose Sensitivity is so high 
that a Negative result rules-out the diagnosis. 
‡‡ Good, better, bad and worse refer to the comparisons between treatments in terms of their clinical risks and benefits. 
††† Good reference standards are independent of the test, and applied blindly or objectively to applied to all patients. Poor reference standards are haphazardly applied, but still independent of 
the test. Use of a non-independent reference standard (where the 'test' is included in the 'reference', or where the 'testing' affects the 'reference') implies a level 4 study. 
†††† Better-value treatments are clearly as good but cheaper, or better at the same or reduced cost. Worse-value treatments are as good and more expensive, or worse and the equally or more 
expensive. 
** Validating studies test the quality of a specific diagnostic test, based on prior evidence. An exploratory study collects information and trawls the data (e.g. using a regression analysis) to 
find which factors are 'significant'. 
*** By poor quality prognostic cohort study we mean one in which sampling was biased in favour of patients who already had the target outcome, or the measurement of outcomes was 
accomplished in <80% of study patients, or outcomes were determined in an unblinded, non-objective way, or there was no correction for confounding factors. 
**** Good follow-up in a differential diagnosis study is >80%, with adequate time for alternative diagnoses to emerge (eg 1-6 months acute, 1 - 5 years chronic) 
 
Grades of Recommendation 
 
A consistent level 1 studies  
B consistent level 2 or 3 studies or extrapolations from level 1 studies 
C level 4 studies or extrapolations from level 2 or 3 studies  
D level 5 evidence or troublingly inconsistent or inconclusive studies of any level 
 
"Extrapolations" are where data is used in a situation which has potentially clinically important differences than the original study situation. 
 
